{"meta":{"query_hash":"13e8c2465994","filters":{"venue":"Cancer Immunology Research"},"cohort_total":359,"direct_labels_cover":0,"predictions_cover":359,"exported":359,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/13e8c2465994","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cancer+Immunology+Research"},"results":[{"id":"W2084785039","doi":"10.1158/2326-6066.cir-14-0177","title":"Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Huazhong University of Science and Technology","keywords":"Antigen; Immunotherapy; Dendritic cell; Immune system; Cancer research; Immunology; DNA vaccination; T cell; Innate immune system; Antigen presentation; Biology; Immunization","score_opus":0.0358350077736466,"score_gpt":0.328043116793005,"score_spread":0.2922081090193584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084785039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721905,0.023302421,0.00037612492,0.000691812,0.0016830327,0.00039126998,0.000019634173,0.00015494217,0.0011902645],"genre_scores_gemma":[0.99082804,0.00023825192,0.00012936426,0.000261864,0.0001276103,0.00014310512,0.000015524723,0.00006965552,0.008186606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99487025,0.0020179774,0.00060730305,0.00068786985,0.00011928038,0.0016973291],"domain_scores_gemma":[0.9967679,0.001442055,0.00013893432,0.001052969,0.0005371364,0.000061017377],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0017386159,0.00034215278,0.00055539084,0.00045392668,0.0008634346,0.00007218183,0.0012913352,0.000340635,0.0028055038],"category_scores_gemma":[0.00061021,0.00031855103,0.00015664769,0.00046534743,0.00081840315,0.00015960334,0.000779238,0.0014741744,0.0030123354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010360208,0.00015406997,0.0009255812,0.00005882523,0.00018425634,0.000020584988,0.00043963615,0.00006840022,0.98700386,0.00014694963,0.0060655233,0.003896306],"study_design_scores_gemma":[0.002899008,0.0006709922,0.0013689413,0.000115105744,0.000037663416,0.00011043866,0.00045692606,0.00017318172,0.96971905,0.00031838866,0.023790052,0.00034025332],"about_ca_topic_score_codex":0.0006864504,"about_ca_topic_score_gemma":0.00003948659,"teacher_disagreement_score":0.023064168,"about_ca_system_score_codex":0.00019525005,"about_ca_system_score_gemma":0.00022576531,"threshold_uncertainty_score":0.9999266},"labels":[],"label_agreement":null},{"id":"W2101338052","doi":"10.1158/2326-6066.cir-14-0113","title":"B7-H4 Expression by Nonhematopoietic Cells in the Tumor Microenvironment Promotes Antitumor Immunity","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University Health Network; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Canada Research Chairs","keywords":"Immune system; Cancer research; Downregulation and upregulation; Biology; Tumor microenvironment; Carcinogenesis; Cancer immunotherapy; Cancer; Immunity; Immunology; Acquired immune system; MHC class I; Immunotherapy; Major histocompatibility complex; Gene; Genetics","score_opus":0.03392099231862885,"score_gpt":0.3403574733914932,"score_spread":0.30643648107286436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101338052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763126,0.016904997,0.00002266631,0.004499184,0.00021927069,0.0010513911,0.000018757602,0.000027299642,0.000943865],"genre_scores_gemma":[0.9938695,0.003425356,0.00007772624,0.00078653375,0.00009052999,0.0004972227,0.000025608073,0.000034953424,0.0011926016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968769,0.001004459,0.00038740237,0.00043549534,0.0005112096,0.0007845546],"domain_scores_gemma":[0.99846154,0.00036001435,0.00008888382,0.0009444323,0.00008074658,0.00006439478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023625966,0.00021623464,0.00038105252,0.00021777992,0.0003260649,0.000043845597,0.00062980026,0.0001478185,0.0006857525],"category_scores_gemma":[0.00009039784,0.00014521705,0.000108176944,0.0004953143,0.0010583445,0.00007669289,0.00018508607,0.0011709989,0.000105183084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001314426,0.0004344509,0.005927424,0.00010492343,0.00006360042,0.0000263078,0.000995434,4.831676e-7,0.972973,0.0000149113,0.013524176,0.004620853],"study_design_scores_gemma":[0.003730506,0.0009608176,0.038853396,0.00047967213,0.000021075628,0.000114211965,0.0016047221,0.000029373428,0.84464866,0.00011028025,0.10922502,0.00022228414],"about_ca_topic_score_codex":0.0009565684,"about_ca_topic_score_gemma":0.00004605632,"teacher_disagreement_score":0.12832437,"about_ca_system_score_codex":0.00031579417,"about_ca_system_score_gemma":0.00016198563,"threshold_uncertainty_score":0.7508509},"labels":[],"label_agreement":null},{"id":"W2102986151","doi":"10.1158/2326-6066.cir-13-0155","title":"CD4 T Cells Require ICOS-Mediated PI3K Signaling to Increase T-Bet Expression in the Setting of Anti-CTLA-4 Therapy","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Cancer Institute; U.S. Department of Defense","keywords":"CTLA-4; Immunotherapy; Medicine; Cancer research; Immunology; Cell biology; T cell; Immune system; Biology","score_opus":0.0604348810993394,"score_gpt":0.37876869473358404,"score_spread":0.3183338136342446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102986151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98122376,0.010289404,0.000012252667,0.0060535017,0.00018703805,0.0016175443,0.000020813757,0.000029573424,0.0005660952],"genre_scores_gemma":[0.99381715,0.00369225,0.00012645104,0.0011666857,0.0001362971,0.0006469138,0.000026247166,0.000036878766,0.00035112628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99678355,0.0008816801,0.00053432956,0.00042459668,0.000590581,0.0007852478],"domain_scores_gemma":[0.99781364,0.00080869754,0.000121473895,0.00070298585,0.00045610833,0.00009711788],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023483166,0.00020459632,0.00045736885,0.00051778875,0.000195306,0.00004013221,0.00057681085,0.00024359416,0.0014194367],"category_scores_gemma":[0.00023304674,0.00013594708,0.00010744873,0.0013978335,0.00044464163,0.00017467751,0.00014456506,0.0008407299,0.0000802074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020866438,0.0001927863,0.012467293,0.000061724975,0.00010887375,0.000019743526,0.0030679004,0.0000070562814,0.95557636,0.0000049397945,0.0047227517,0.021683937],"study_design_scores_gemma":[0.0046629063,0.0010099855,0.11240892,0.0007425884,0.000010228629,0.000020693753,0.0037722092,0.000057664955,0.86493623,0.00007183247,0.012086454,0.00022031034],"about_ca_topic_score_codex":0.0052596754,"about_ca_topic_score_gemma":0.000060509785,"teacher_disagreement_score":0.099941626,"about_ca_system_score_codex":0.0002224261,"about_ca_system_score_gemma":0.0004604357,"threshold_uncertainty_score":0.9994934},"labels":[],"label_agreement":null},{"id":"W2108895019","doi":"10.1158/2326-6066.cir-15-0017","title":"Neutrophils Increase Oral Squamous Cell Carcinoma Invasion through an Invadopodia-Dependent Pathway","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Invadopodia; Paracrine signalling; Gentamicin protection assay; Cancer research; Cell culture; In vitro; Cancer cell; Cancer; Immunology; Medicine; Biology; Metastasis; Internal medicine; Receptor","score_opus":0.12205516892000047,"score_gpt":0.3560395586847223,"score_spread":0.23398438976472186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108895019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91123015,0.072008416,0.000024338127,0.00074909016,0.0037386713,0.00091160176,0.000106219704,0.00018711758,0.0110444175],"genre_scores_gemma":[0.98783433,0.0011538722,0.00009791425,0.00045707013,0.00022712677,0.0005868364,0.00027992437,0.00012107793,0.009241829],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.992227,0.0033838113,0.0007210155,0.001255975,0.0003306467,0.0020815106],"domain_scores_gemma":[0.99612135,0.00047362107,0.00021521717,0.0018950077,0.0011223997,0.00017241409],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0024552022,0.00053654885,0.00077076297,0.00047194475,0.0007369861,0.00008168533,0.001869099,0.0011113726,0.002339598],"category_scores_gemma":[0.00040144523,0.0005042729,0.00015207233,0.000727354,0.0021640025,0.00073953276,0.0012804347,0.002902999,0.0033305404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030361605,0.0008914899,0.009900548,0.00005929587,0.00013656683,0.00025320638,0.003954115,0.00005026073,0.95158553,0.0016019476,0.02324095,0.0052899416],"study_design_scores_gemma":[0.008822159,0.0025234835,0.004445445,0.0000349212,0.00005125057,0.00024731268,0.003422307,0.0000059409335,0.80443305,0.0015424781,0.17372067,0.0007509541],"about_ca_topic_score_codex":0.014186083,"about_ca_topic_score_gemma":0.0006853828,"teacher_disagreement_score":0.15047973,"about_ca_system_score_codex":0.0012290397,"about_ca_system_score_gemma":0.0025470024,"threshold_uncertainty_score":0.9997409},"labels":[],"label_agreement":null},{"id":"W2110660168","doi":"10.1158/2326-6066.cir-14-0239","title":"PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"CD8; Biology; Tumor microenvironment; Cancer research; Ovarian cancer; Cytotoxic T cell; Flow cytometry; Antigen; Tumor-infiltrating lymphocytes; Immunology; Immune system; Cancer; In vitro","score_opus":0.11156452962012832,"score_gpt":0.40350539865578133,"score_spread":0.29194086903565303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110660168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756294,0.011887719,0.0000069368148,0.008243327,0.0005283109,0.0012451783,0.000072218754,0.00006233151,0.002324608],"genre_scores_gemma":[0.99169767,0.0034708083,0.000086593835,0.0008056964,0.0003055092,0.0007074593,0.000017530032,0.000057246456,0.0028514739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99695086,0.0004138377,0.00044136884,0.00065822393,0.00057725544,0.0009584215],"domain_scores_gemma":[0.9983756,0.00022614196,0.000099338504,0.0005287124,0.00052295846,0.00024725517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014133984,0.00026450207,0.00055556855,0.00047607344,0.0002112721,0.00007874326,0.00031128406,0.00036383918,0.00051118014],"category_scores_gemma":[0.00024001807,0.00022790532,0.000064981854,0.00067671953,0.0011184764,0.00011059241,0.00015713427,0.0012635355,0.000038404105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0190316,0.0006500254,0.050446797,0.00019762921,0.00051196857,0.00033090115,0.0018423215,0.000027542586,0.89074576,0.00067320786,0.018239094,0.017303148],"study_design_scores_gemma":[0.047199283,0.008428607,0.36552367,0.003909137,0.00016213836,0.000118841956,0.004024394,0.0003374606,0.3876644,0.0021920975,0.1790741,0.0013658936],"about_ca_topic_score_codex":0.0078890845,"about_ca_topic_score_gemma":0.0010684595,"teacher_disagreement_score":0.5030814,"about_ca_system_score_codex":0.0008192094,"about_ca_system_score_gemma":0.0012674684,"threshold_uncertainty_score":0.9987175},"labels":[],"label_agreement":null},{"id":"W2115490568","doi":"10.1158/2326-6066.cir-14-0236-t","title":"Mass Cytometry Analysis Shows That a Novel Memory Phenotype B Cell Is Expanded in Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Howard Hughes Medical Institute","keywords":"Immunoglobulin D; Population; Immunology; Biology; Multiple myeloma; Peripheral blood mononuclear cell; Antibody; Memory B cell; Mass cytometry; Flow cytometry; B cell; Cancer; CD19; Cancer research; Phenotype; Medicine; Genetics; Gene; In vitro","score_opus":0.11130535440587887,"score_gpt":0.3444086314343332,"score_spread":0.23310327702845435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115490568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9372388,0.051366955,0.00044066724,0.00095733756,0.0015723476,0.00069337303,0.00014670566,0.00014614254,0.0074376366],"genre_scores_gemma":[0.9655977,0.0009190332,0.00015253494,0.00028808397,0.000072181065,0.00040387674,0.00017166715,0.000063529435,0.03233141],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945534,0.0012142417,0.00070391106,0.0012295238,0.00025138946,0.0020475478],"domain_scores_gemma":[0.9969041,0.0007867094,0.0002154045,0.0013776878,0.00060431904,0.00011178033],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0019688308,0.0005011189,0.001157605,0.0032638656,0.0004184683,0.000052496966,0.0014974932,0.0013209058,0.0034431475],"category_scores_gemma":[0.00027666503,0.00046638193,0.00031139835,0.0040978845,0.0018475285,0.00023712932,0.0007424983,0.0025112126,0.0020341454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015422655,0.0005494708,0.0619009,0.000026062316,0.0016914498,0.000044587956,0.0022762306,0.00003615042,0.9238792,0.00006880451,0.005034188,0.0029506765],"study_design_scores_gemma":[0.010997031,0.00061137,0.013576775,0.00003852162,0.00026203552,0.000043684766,0.006794729,0.00010806403,0.93161154,0.00031789238,0.034890898,0.00074743707],"about_ca_topic_score_codex":0.003236306,"about_ca_topic_score_gemma":0.0013917418,"teacher_disagreement_score":0.050447922,"about_ca_system_score_codex":0.00066961226,"about_ca_system_score_gemma":0.00079734053,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W2123176392","doi":"10.1158/2326-6066.cir-14-0191","title":"Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Phoenix Technologies (Canada); Arbutus Biopharma (Canada); University of British Columbia","funders":"AstraZeneca","keywords":"Monoclonal antibody; Cancer research; CD80; Cancer immunotherapy; Antibody; T cell; Immunotherapy; In vivo; Cytotoxicity; PD-L1; Immune system; Chemistry; In vitro; Cytotoxic T cell; Pharmacology; Immunology; Biology; CD40; Biochemistry","score_opus":0.09984791139134354,"score_gpt":0.4369662327177876,"score_spread":0.3371183213264441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123176392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930021,0.0040403404,0.00010354842,0.0017987293,0.00039638742,0.0004176078,0.000048562142,0.0000291693,0.00016354906],"genre_scores_gemma":[0.9939095,0.004768263,0.00003165737,0.000082852086,0.00015658882,0.000061106424,0.00028588754,0.000021967306,0.0006822207],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983486,0.00023333207,0.0003633694,0.00033018267,0.00039910205,0.000325408],"domain_scores_gemma":[0.9985959,0.00005234905,0.000121344216,0.0003909705,0.00071869494,0.000120718694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012388449,0.00011578432,0.00029597865,0.00032627108,0.00012221484,0.00003011038,0.00016491009,0.00016805499,0.00012257184],"category_scores_gemma":[0.000109099834,0.00010467052,0.000035941794,0.0004778263,0.0008764258,0.00020259374,0.00006906702,0.00030222503,0.0000116491965],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025932654,0.00013139771,0.03324335,0.0000724006,0.00014980095,0.000009617264,0.00067386683,2.8894098e-7,0.9467163,0.00012818097,0.000111271496,0.016170278],"study_design_scores_gemma":[0.002754759,0.0009078312,0.76369,0.0001247417,0.000043653297,0.00009179986,0.00048336518,0.00032387025,0.22526273,0.0001318842,0.006050597,0.00013475104],"about_ca_topic_score_codex":0.00045025768,"about_ca_topic_score_gemma":0.000013260823,"teacher_disagreement_score":0.73044664,"about_ca_system_score_codex":0.0001608338,"about_ca_system_score_gemma":0.0006029046,"threshold_uncertainty_score":0.426834},"labels":[],"label_agreement":null},{"id":"W2124668663","doi":"10.1158/2326-6066.cir-14-0222","title":"Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Hospital for Sick Children","keywords":"T-cell receptor; Chemistry; Major histocompatibility complex; Antigen; T cell; Biology; Epitope; Molecular biology; Cell biology; Immunology; Immune system","score_opus":0.09014275203993506,"score_gpt":0.39063135939160626,"score_spread":0.3004886073516712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124668663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9664224,0.026023516,0.0018606196,0.0011463672,0.00012746731,0.0035472868,0.000073399715,0.000017081991,0.00078189076],"genre_scores_gemma":[0.979821,0.01728469,0.0003505971,0.000041618965,0.00011614285,0.0007400248,0.000028522216,0.000043683704,0.001573692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781275,0.000444907,0.00029592897,0.00036294706,0.0005378801,0.0005455602],"domain_scores_gemma":[0.9962127,0.001740442,0.00015007347,0.000483709,0.0013055095,0.00010753506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033215487,0.00015031354,0.00047417753,0.00025793863,0.00016227501,0.00001521266,0.00025599808,0.00016300101,0.00017471319],"category_scores_gemma":[0.0008051074,0.00011015847,0.000081765895,0.0006089345,0.00096870563,0.000094053066,0.000166036,0.00058462465,0.0000013815464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067223697,0.00032072476,0.0040463884,0.000117273026,0.00024132285,0.000003910422,0.0008488532,0.00010263369,0.89841616,0.000026061027,0.00081311306,0.088341214],"study_design_scores_gemma":[0.006595019,0.0019607327,0.0034501164,0.00006463564,0.000026473383,0.0000158259,0.0009422225,0.0021639431,0.9795614,0.00006289005,0.0050548045,0.000101923455],"about_ca_topic_score_codex":0.0010170238,"about_ca_topic_score_gemma":0.000012157037,"teacher_disagreement_score":0.08823929,"about_ca_system_score_codex":0.0003011691,"about_ca_system_score_gemma":0.000517497,"threshold_uncertainty_score":0.4492132},"labels":[],"label_agreement":null},{"id":"W2132290857","doi":"10.1158/2326-6066.cir-14-0215","title":"Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":468,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; York University; National Cancer Institute; National Heart, Lung, and Blood Institute; University of Pennsylvania","keywords":"Medicine; Pancreatic cancer; Immunotherapy; Immune checkpoint; Tumor microenvironment; Cancer research; Immunology; T cell; CTLA-4; Immunity; Immune system; Cancer; Internal medicine","score_opus":0.10303665455813443,"score_gpt":0.365672754383077,"score_spread":0.26263609982494257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132290857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96454954,0.031661812,0.0000027271624,0.0019138551,0.0001836173,0.00058113463,0.000022545393,0.000013475489,0.0010712832],"genre_scores_gemma":[0.99535286,0.0029110694,0.00014336032,0.00006540458,0.000055191358,0.000102590806,0.000008126269,0.000020624644,0.0013407427],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981532,0.0003980308,0.00034307275,0.00034390917,0.00031394942,0.0004478121],"domain_scores_gemma":[0.99881697,0.000236155,0.000071509945,0.00041625986,0.00032575818,0.00013333315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013685243,0.00015458875,0.0004823725,0.00043822444,0.00009896764,0.000018177536,0.00015489671,0.00016234726,0.00002736232],"category_scores_gemma":[0.00019793084,0.00014046027,0.00003384228,0.00066642236,0.00080841035,0.0000860572,0.00018457035,0.000553226,0.0000025999939],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007901107,0.00009724981,0.14869793,0.00021414553,0.000101930906,0.00001288635,0.0020363582,3.4036103e-7,0.83644867,0.00004140766,0.0003040859,0.004143869],"study_design_scores_gemma":[0.005720284,0.0010274978,0.9146021,0.0002275864,0.000027582457,0.000025260522,0.0033911322,0.00001343606,0.070688285,0.00020154791,0.003913026,0.0001622826],"about_ca_topic_score_codex":0.0074035237,"about_ca_topic_score_gemma":0.0012006985,"teacher_disagreement_score":0.7659041,"about_ca_system_score_codex":0.00033937042,"about_ca_system_score_gemma":0.00047964326,"threshold_uncertainty_score":0.99920624},"labels":[],"label_agreement":null},{"id":"W2139188064","doi":"10.1158/2326-6066.cir-13-0173","title":"Transient Complement Inhibition Promotes a Tumor-Specific Immune Response through the Implication of Natural Killer Cells","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique; Université du Québec à Montréal","funders":"","keywords":"Immune system; Cytotoxic T cell; Immunology; Complement system; CD8; Biology; Natural killer cell; Complement receptor; Cancer research; In vitro","score_opus":0.04914346902087771,"score_gpt":0.33632520840867086,"score_spread":0.2871817393877931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139188064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96196294,0.02349901,0.00012495507,0.0067573735,0.0052322093,0.0016556979,0.000008158908,0.00006022279,0.0006994434],"genre_scores_gemma":[0.9881422,0.0010213121,0.000027132126,0.00014706404,0.00003892165,0.00093345984,0.000108078835,0.000025615107,0.009556195],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99652165,0.001644533,0.00064263237,0.00040890748,0.00013233644,0.0006499638],"domain_scores_gemma":[0.9976319,0.0005869498,0.00021413343,0.00068070577,0.0008718656,0.000014413282],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010685228,0.00020726403,0.00031558663,0.00022870516,0.00060023327,0.000037861708,0.0003962993,0.00018730895,0.0073405188],"category_scores_gemma":[0.00007979393,0.00014806236,0.00014865986,0.00047745902,0.0011417402,0.00027639576,0.0001647106,0.0011647887,0.0014936007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018043983,0.0001759634,0.000028871133,0.000016048698,0.00018161655,7.6717674e-7,0.0021599876,0.0000042085576,0.93481797,0.0006275109,0.057005443,0.003177208],"study_design_scores_gemma":[0.0012116194,0.00045012138,0.021216735,0.00006282511,0.000010976495,0.00004220759,0.0026866372,0.000007507569,0.71687603,0.00016506024,0.25713748,0.00013277069],"about_ca_topic_score_codex":0.0013814552,"about_ca_topic_score_gemma":0.000013274413,"teacher_disagreement_score":0.21794192,"about_ca_system_score_codex":0.0002806578,"about_ca_system_score_gemma":0.00014769747,"threshold_uncertainty_score":0.99928385},"labels":[],"label_agreement":null},{"id":"W2139640503","doi":"10.1158/2326-6066.cir-13-0059-t","title":"Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy","year":2013,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"McMaster University; Cancer Research Society; Breast Cancer Alliance","keywords":"Oncolytic virus; Immunogenic cell death; Immune system; Antigen; Immunogenicity; Herpes simplex virus; Cancer research; CD8; Medicine; Immunotherapy; Cytotoxic T cell; Cancer; Immunology; Virus; Biology; In vitro; Internal medicine","score_opus":0.02820720336490473,"score_gpt":0.3353655360830851,"score_spread":0.3071583327181804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139640503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8662225,0.13080344,0.000025775767,0.0011033427,0.00019151687,0.0012151536,0.0000149249145,0.000034418375,0.0003889455],"genre_scores_gemma":[0.98013693,0.014054512,0.00010645275,0.00020903502,0.0002718825,0.0014759536,0.000032976735,0.0001295644,0.0035826997],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957354,0.00067628745,0.00044618789,0.0010527925,0.0005065014,0.0015828182],"domain_scores_gemma":[0.9976349,0.00020192594,0.00014909395,0.0011547983,0.00066431105,0.00019500409],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009269502,0.0004404932,0.0005313964,0.00025435563,0.00066784857,0.00017223315,0.000931908,0.00033626606,0.00027379466],"category_scores_gemma":[0.000045183744,0.00037905018,0.000112477006,0.0004912174,0.0010625381,0.000035006728,0.00052941876,0.0012254098,0.000069826354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029758466,0.00017430379,0.0031367757,0.000057802732,0.00051104295,0.000007775174,0.00042757933,0.00005815464,0.9437583,0.00001259299,0.00016725188,0.04871257],"study_design_scores_gemma":[0.0054299473,0.003608633,0.032309134,0.00015796823,0.000046343834,0.000039049046,0.0006362464,0.0002325801,0.95447725,0.000074928466,0.002394051,0.0005938463],"about_ca_topic_score_codex":0.003734246,"about_ca_topic_score_gemma":0.0006089953,"teacher_disagreement_score":0.11674893,"about_ca_system_score_codex":0.00023840228,"about_ca_system_score_gemma":0.0010899522,"threshold_uncertainty_score":0.9998661},"labels":[],"label_agreement":null},{"id":"W2143000924","doi":"10.1158/2326-6066.cir-14-0146","title":"CD25 Identifies a Subset of CD4+FoxP3− TIL That Are Exhausted Yet Prognostically Favorable in Human Ovarian Cancer","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Victoria; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"IL-2 receptor; FOXP3; Tumor-infiltrating lymphocytes; CD8; Immunology; Immune system; Biology; Cancer research; Interleukin 10; T cell","score_opus":0.07835711587237613,"score_gpt":0.36815878259923146,"score_spread":0.2898016667268553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143000924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782138,0.010981612,0.00004293424,0.0012489845,0.003607213,0.000645916,0.000029028666,0.00007975445,0.005150769],"genre_scores_gemma":[0.97515124,0.00095178804,0.0000071261015,0.00011121645,0.00004964298,0.00050843996,0.00013452495,0.00003702622,0.023049023],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965543,0.001241834,0.0005846809,0.000576523,0.0001437425,0.0008989309],"domain_scores_gemma":[0.9979925,0.00047962513,0.00024671748,0.0006235501,0.00062539487,0.000032205287],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013900953,0.00025263705,0.0005876305,0.0007123064,0.00038687643,0.0000420259,0.000583373,0.0005889673,0.005243669],"category_scores_gemma":[0.00051569217,0.00023827385,0.00011080329,0.0006345108,0.001111005,0.00023237916,0.0002656837,0.0015366301,0.00039842346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096132304,0.00030719346,0.05619499,0.000098687786,0.00031076837,0.0000068315326,0.0006408117,0.000013152878,0.91689605,0.0019245339,0.01936703,0.0032786345],"study_design_scores_gemma":[0.0041860538,0.00063091924,0.23527487,0.00068975025,0.000051225663,0.00003590431,0.0025841142,0.000031555268,0.6668737,0.0007371012,0.08848199,0.0004228234],"about_ca_topic_score_codex":0.0052110897,"about_ca_topic_score_gemma":0.001917626,"teacher_disagreement_score":0.25002235,"about_ca_system_score_codex":0.00028601018,"about_ca_system_score_gemma":0.00025636563,"threshold_uncertainty_score":0.99566567},"labels":[],"label_agreement":null},{"id":"W2147475006","doi":"10.1158/2326-6066.cir-13-0136","title":"Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; National Institute of General Medical Sciences; Cancer Research UK","keywords":"Ovarian cancer; Cancer; Gene; Biology; Scale (ratio); Variation (astronomy); Oncology; Medicine; Computational biology; Cancer research; Internal medicine; Genetics","score_opus":0.05060239366827162,"score_gpt":0.35329576349481945,"score_spread":0.3026933698265478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147475006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427809,0.0534107,0.000023275932,0.0007048742,0.0010702254,0.00057980465,0.00003212806,0.000038330574,0.0013597317],"genre_scores_gemma":[0.99518305,0.0021264558,0.000020779235,0.000047524114,0.00003425908,0.0003386751,0.00006380516,0.000031251417,0.0021541736],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99456877,0.0030770644,0.0007493799,0.0005918395,0.00018062683,0.00083231146],"domain_scores_gemma":[0.99811816,0.00040571336,0.0002521271,0.00063181954,0.0005646687,0.000027518898],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0051141437,0.00023466958,0.00061011524,0.00061114714,0.0003125053,0.000013277884,0.00043007798,0.00086483243,0.0015945254],"category_scores_gemma":[0.00014215139,0.00022362692,0.00007042619,0.00055410585,0.00095245853,0.00012875338,0.00031673248,0.0011112621,0.000104840336],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002496572,0.00027178144,0.07568204,0.000049254715,0.00017994626,9.684604e-7,0.0019283858,0.0000873742,0.90585124,0.0011019321,0.00017976225,0.014417625],"study_design_scores_gemma":[0.01192484,0.0004829224,0.5533617,0.00012031135,0.00017335663,0.00002671824,0.001226981,0.0009869135,0.4164296,0.0032534932,0.011558359,0.00045474916],"about_ca_topic_score_codex":0.0028379618,"about_ca_topic_score_gemma":0.0016698763,"teacher_disagreement_score":0.48942167,"about_ca_system_score_codex":0.00029975467,"about_ca_system_score_gemma":0.0003413614,"threshold_uncertainty_score":0.9993181},"labels":[],"label_agreement":null},{"id":"W2160141570","doi":"10.1158/2326-6066.cir-14-0211","title":"Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Peter MacCallum Cancer Centre","keywords":"Adenosine A2A receptor; Immunotherapy; Granzyme B; Medicine; Blockade; CD8; Immune system; Adenosine receptor; Cancer research; T cell; Pharmacology; Immunology; Receptor expression; Tumor microenvironment; Cancer immunotherapy; Cytotoxic T cell; Receptor; Biology; Internal medicine; In vitro","score_opus":0.07078595446986687,"score_gpt":0.37898367900522667,"score_spread":0.3081977245353598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160141570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92459226,0.07277537,0.00008653452,0.0009890234,0.0002201896,0.00030125031,0.000038601105,0.000014718039,0.0009820365],"genre_scores_gemma":[0.9904926,0.005029657,0.00015839648,0.000111043686,0.00054157875,0.00008850887,0.000058013906,0.00003342236,0.0034868086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976489,0.00071826717,0.00032204058,0.00043432732,0.00032921718,0.0005472605],"domain_scores_gemma":[0.99816567,0.00029540114,0.00012439035,0.00070737244,0.00062882755,0.00007834331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008908645,0.00018533535,0.00028027323,0.00009543976,0.00020441556,0.000022936605,0.00071601727,0.00022311132,0.00014711553],"category_scores_gemma":[0.00081202935,0.00013751855,0.00009236031,0.0004213229,0.00093186094,0.000009776417,0.00043583123,0.00040670575,0.00004309052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017719102,0.00019807948,0.0018089393,0.00002168993,0.00015377774,0.0000063368198,0.00028695143,0.00006250846,0.9564108,0.000053516174,0.038982574,0.00024286678],"study_design_scores_gemma":[0.0016095953,0.0006600717,0.002037791,0.00004608481,0.0000238457,0.000016166581,0.00062520744,0.0000031330537,0.93824273,0.00005044651,0.05652625,0.00015866547],"about_ca_topic_score_codex":0.0007468748,"about_ca_topic_score_gemma":0.000010373772,"teacher_disagreement_score":0.067745715,"about_ca_system_score_codex":0.0000412012,"about_ca_system_score_gemma":0.00079320546,"threshold_uncertainty_score":0.5607844},"labels":[],"label_agreement":null},{"id":"W2168530155","doi":"10.1158/2326-6066.cir-14-0202","title":"Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"York University; National Cancer Institute; Ludwig Institute for Cancer Research; Cancer Research Institute","keywords":"Adjuvant; Medicine; Immunogenicity; Internal medicine; Gastroenterology; CD8; Immunology; Vaccination; Immune system; Regimen","score_opus":0.04056324419270861,"score_gpt":0.33778034112680255,"score_spread":0.2972170969340939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168530155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705199,0.024987109,0.00003844852,0.0005224512,0.0006079635,0.0028707057,0.000109756016,0.0001165896,0.0002271064],"genre_scores_gemma":[0.9916871,0.00059980754,0.00014764028,0.00006159098,0.000041256968,0.002356308,0.00035374862,0.00008309445,0.0046694363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9939016,0.0029606072,0.000625542,0.000866299,0.00020439117,0.0014415784],"domain_scores_gemma":[0.99686253,0.0004575258,0.00027586863,0.0010370166,0.0013120873,0.000054985067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025930782,0.0004171187,0.0006968664,0.0009004307,0.00058863085,0.00005894355,0.001028315,0.00081168115,0.00054124015],"category_scores_gemma":[0.0008884935,0.00033659057,0.00008813082,0.00077798165,0.00072530535,0.0005204636,0.00023895121,0.0015561876,0.00032942957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23062238,0.0048804074,0.16458756,0.00011990969,0.002689645,0.000041108062,0.0072320206,0.000079588404,0.34311876,0.0063375733,0.0029534255,0.23733762],"study_design_scores_gemma":[0.037252817,0.025732312,0.71017456,0.00020662342,0.000056977,0.000024744577,0.0025642845,0.000008432665,0.19605313,0.0042243334,0.022810891,0.0008909067],"about_ca_topic_score_codex":0.003991372,"about_ca_topic_score_gemma":0.00048780628,"teacher_disagreement_score":0.545587,"about_ca_system_score_codex":0.0007327862,"about_ca_system_score_gemma":0.0010796505,"threshold_uncertainty_score":0.9999086},"labels":[],"label_agreement":null},{"id":"W2177919716","doi":"10.1158/2326-6066.cir-15-0051","title":"Validation of Intratumoral T-bet+ Lymphoid Cells as Predictors of Disease-Free Survival in Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Proportional hazards model; Univariate analysis; Survival analysis; Pathology; Cancer; Multivariate analysis; Gastroenterology","score_opus":0.055572904644834754,"score_gpt":0.3663105896333311,"score_spread":0.3107376849884963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2177919716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831502,0.011122397,0.0000018580694,0.0030201578,0.0009997183,0.0005538918,0.00029480425,0.000020858035,0.0008361479],"genre_scores_gemma":[0.99418783,0.0044593336,0.000013761164,0.000054615735,0.00019728809,0.00018487276,0.000036647838,0.000031867017,0.0008338105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738634,0.0004001343,0.0005397737,0.0003547872,0.00078193634,0.0005370615],"domain_scores_gemma":[0.9979799,0.00013651037,0.00015770594,0.0006889541,0.00085339556,0.00018352851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013727222,0.00017267538,0.0005093421,0.0005007539,0.00004232313,0.000009984653,0.00044401918,0.00018025834,0.00058649335],"category_scores_gemma":[0.00015496925,0.00015358129,0.0001087219,0.001037103,0.0010763372,0.00012774237,0.0001818372,0.00041142997,0.000009076744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030743344,0.00043754003,0.60743284,0.00025581763,0.00047158627,0.000032813496,0.0010022732,0.000042366733,0.34887183,0.000108680695,0.0053055496,0.005295377],"study_design_scores_gemma":[0.013778508,0.0010827564,0.6094215,0.0008058834,0.000098176926,0.000035627316,0.0016227411,0.000050130137,0.36979392,0.00044881273,0.0025979201,0.0002640514],"about_ca_topic_score_codex":0.011290128,"about_ca_topic_score_gemma":0.00023738557,"teacher_disagreement_score":0.0209221,"about_ca_system_score_codex":0.0008244256,"about_ca_system_score_gemma":0.0034754984,"threshold_uncertainty_score":0.9952938},"labels":[],"label_agreement":null},{"id":"W2194675780","doi":"10.1158/2326-6066.cir-15-0141","title":"Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Melanoma; Immunotherapy; Pathology; Immunology; Oncology; Immune system; Cancer research","score_opus":0.11306137541957614,"score_gpt":0.4120534297064699,"score_spread":0.2989920542868938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2194675780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635419,0.025927322,0.00019131004,0.007101906,0.00029184815,0.0014612237,0.000048732752,0.000056357967,0.001379378],"genre_scores_gemma":[0.98077154,0.002104359,0.0004520302,0.00021498419,0.00028279438,0.0029893755,0.000059523067,0.000044860306,0.0130805345],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998486,0.000113706665,0.00019482327,0.00035336337,0.00030323907,0.0005489101],"domain_scores_gemma":[0.9986441,0.00010264939,0.000044771914,0.00038018046,0.0007132516,0.000115014554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005273543,0.0001571371,0.00028634773,0.00024513717,0.00012743103,0.000024829233,0.00010977045,0.00016645507,0.00021593289],"category_scores_gemma":[0.000034694207,0.00011083076,0.000086228545,0.00035922238,0.00043596476,0.00008464833,0.00003167595,0.0002041235,0.000040054543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2176852,0.000985485,0.099527374,0.0001657889,0.0042815767,0.00023285155,0.004746503,0.0000048442243,0.05892446,0.0002730338,0.017979298,0.59519356],"study_design_scores_gemma":[0.044303793,0.030658562,0.09670339,0.00029742016,0.0003005619,0.0003282166,0.0021894702,0.00024147013,0.055916727,0.00038760187,0.76816386,0.00050893746],"about_ca_topic_score_codex":0.0008605258,"about_ca_topic_score_gemma":0.00058587414,"teacher_disagreement_score":0.75018454,"about_ca_system_score_codex":0.001353709,"about_ca_system_score_gemma":0.0012553041,"threshold_uncertainty_score":0.45195472},"labels":[],"label_agreement":null},{"id":"W2258216786","doi":"10.1158/2326-6066.cir-15-0118","title":"Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Biotechnology Research Institute","funders":"","keywords":"NKG2D; Medicine; Immune system; Immunotherapy; CD8; Immunology; Lymphoma; Cancer research; In vivo; Cancer; Ex vivo; Cytotoxic T cell; Natural killer cell; Cancer immunotherapy; Cell therapy; Cell; In vitro; Internal medicine; Biology","score_opus":0.02961590419996368,"score_gpt":0.34438242997220786,"score_spread":0.3147665257722442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258216786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989289,0.006174323,0.000009689478,0.00025313825,0.0025648081,0.0015957737,0.000007699841,0.0000345322,0.00007105335],"genre_scores_gemma":[0.9902962,0.0024917105,0.0000047567223,0.00009752834,0.000017599916,0.0005037565,0.000039642062,0.00003823655,0.006510575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965219,0.0012864722,0.0006431155,0.00057323225,0.00013342075,0.00084189087],"domain_scores_gemma":[0.99822915,0.00041934222,0.0002560008,0.0005480056,0.0005174381,0.000030075682],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000538473,0.00027627323,0.00064126775,0.00054999767,0.00025646584,0.000009992496,0.00042066205,0.00022669016,0.0016827979],"category_scores_gemma":[0.00007464014,0.00015414867,0.000069512775,0.00046130843,0.0005569302,0.0002077391,0.0001053902,0.00047747148,0.00011257168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17159231,0.00650391,0.02423769,0.000016862548,0.000443678,0.000011779755,0.0015003812,0.0000037476786,0.7201042,0.000004383932,0.0006811119,0.07489992],"study_design_scores_gemma":[0.2982221,0.043307498,0.16208461,0.00025805843,0.000023826235,0.00001857693,0.003465148,0.0000024443925,0.47921628,0.000009471882,0.012888375,0.00050361996],"about_ca_topic_score_codex":0.0005173195,"about_ca_topic_score_gemma":0.00022883178,"teacher_disagreement_score":0.24088795,"about_ca_system_score_codex":0.0003309382,"about_ca_system_score_gemma":0.0003842753,"threshold_uncertainty_score":0.9992298},"labels":[],"label_agreement":null},{"id":"W2264702568","doi":"10.1158/2326-6066.cir-15-0200-t","title":"Using Quantitative Seroproteomics to Identify Antibody Biomarkers in Pancreatic Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Pancreatic cancer; Stable isotope labeling by amino acids in cell culture; Antibody; Cancer; Immunology; Medicine; Cancer vaccine; Antigen; Cancer research; Immunotherapy; Cancer immunotherapy; Internal medicine; Biology; Proteomics","score_opus":0.2264068331726535,"score_gpt":0.5496808490037097,"score_spread":0.3232740158310562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2264702568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98167765,0.0062280134,0.00077726785,0.008276932,0.00027249256,0.001706598,0.000045082572,0.00003710554,0.0009788808],"genre_scores_gemma":[0.9857533,0.007491233,0.0028828122,0.00022003357,0.00014784328,0.0010114218,0.000007557978,0.00006310507,0.0024227093],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959765,0.00080011925,0.000517685,0.0007045587,0.00061515265,0.0013859625],"domain_scores_gemma":[0.99730897,0.0009201296,0.00007961089,0.00063147675,0.0007838739,0.0002759572],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022412394,0.00023413048,0.00083207345,0.0012321173,0.00022973443,0.000026472935,0.00040671273,0.0003351091,0.0013285642],"category_scores_gemma":[0.0013913128,0.00016523626,0.0000875147,0.0016072792,0.0011837585,0.00016003719,0.0003369042,0.00071496196,0.00031984926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019320248,0.00009519254,0.46769136,0.00006632258,0.00052737055,0.00012561335,0.00039239103,0.0000023035943,0.5251444,0.00025944965,0.0003597869,0.0034037717],"study_design_scores_gemma":[0.0051292833,0.0011120436,0.96161306,0.0020914348,0.000120848155,0.000073844116,0.0013071623,0.0004454345,0.025667233,0.00072554575,0.0013915411,0.0003225931],"about_ca_topic_score_codex":0.008317873,"about_ca_topic_score_gemma":0.0008188148,"teacher_disagreement_score":0.49947718,"about_ca_system_score_codex":0.0018915893,"about_ca_system_score_gemma":0.0022099253,"threshold_uncertainty_score":0.9995844},"labels":[],"label_agreement":null},{"id":"W2270309512","doi":"10.1158/2326-6066.cir-15-0186","title":"Eosinophilic Fasciitis and Acute Encephalopathy Toxicity from Pembrolizumab Treatment of a Patient with Metastatic Melanoma","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pembrolizumab; Eosinophilic fasciitis; Vasculitis; Adverse effect; Dermatology; Toxicity; Rash; Cancer; Internal medicine; Surgery; Gastroenterology; Fasciitis; Disease; Immunotherapy","score_opus":0.03993165404668665,"score_gpt":0.3415279533362609,"score_spread":0.30159629928957427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2270309512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97708815,0.018897466,0.000016840564,0.002674048,0.00006028142,0.0005893418,0.00016554048,0.000019845824,0.00048850727],"genre_scores_gemma":[0.98760915,0.011135602,0.00016889331,0.00003989755,0.000023582863,0.00028813593,0.000012838236,0.000022561437,0.00069935026],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982631,0.00019526134,0.00026570656,0.00043742015,0.00036379238,0.00047470472],"domain_scores_gemma":[0.9988128,0.0002750683,0.000076006,0.00046721447,0.0002472689,0.00012164383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112055764,0.00018526136,0.0005737588,0.00022609788,0.000109736735,0.000011031042,0.00011583288,0.00008694596,0.00049372937],"category_scores_gemma":[0.000041964657,0.00010087952,0.00006148896,0.00025299596,0.0010736414,0.00007959177,0.00007573901,0.0001255844,0.000015871658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006430653,0.0014625482,0.12355597,0.00008717742,0.0037306782,0.001191236,0.0062341276,3.6815905e-7,0.2737957,0.0006350713,0.0002225191,0.58265394],"study_design_scores_gemma":[0.03703406,0.06067839,0.6528385,0.0013924792,0.0010001601,0.0018184016,0.0035094204,0.000027121949,0.22747622,0.0046644122,0.008803815,0.00075700425],"about_ca_topic_score_codex":0.0013979498,"about_ca_topic_score_gemma":0.00018444342,"teacher_disagreement_score":0.58189696,"about_ca_system_score_codex":0.00023330041,"about_ca_system_score_gemma":0.00037754275,"threshold_uncertainty_score":0.54059905},"labels":[],"label_agreement":null},{"id":"W2313482121","doi":"10.1158/2326-6066.cir-13-0208","title":"Murine Splenic CD4+ T Cells, Induced by Innate Immune Cell Interactions and Secreted Factors, Develop Antileukemia Cytotoxicity","year":2014,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Cytotoxic T cell; Interleukin 12; Immunology; Cancer immunotherapy; Immune system; Immunotherapy; Biology; CD8; Acquired immune system; CTL*; Interleukin 21; Natural killer T cell; Antigen-presenting cell; T cell; Cell biology; Cancer research; In vitro","score_opus":0.03560949819122649,"score_gpt":0.314459115087851,"score_spread":0.2788496168966245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313482121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98397064,0.007450247,0.00013344176,0.00036871983,0.0046875454,0.00044800743,0.000034440538,0.00015958662,0.0027473853],"genre_scores_gemma":[0.97384316,0.0021708026,0.000017375965,0.00012965985,0.00006333155,0.00014597783,0.0004401357,0.000056741635,0.023132814],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99621457,0.0012521938,0.00063589856,0.00074743445,0.0001144923,0.0010354117],"domain_scores_gemma":[0.99780244,0.0006309739,0.00023109032,0.00063984323,0.0006310222,0.00006463361],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00088311196,0.00039324522,0.000554532,0.00057264976,0.00090611674,0.00007146248,0.0005056157,0.0006189419,0.0042887866],"category_scores_gemma":[0.00029443583,0.0003667792,0.0001044199,0.000701999,0.0006619432,0.00034117833,0.00048725624,0.0027062418,0.00087217276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005029733,0.00014253728,0.0006521013,0.00003433597,0.00025188515,0.0000012628179,0.00051683374,0.0000012738,0.9775793,0.00009708209,0.018051045,0.0021693457],"study_design_scores_gemma":[0.0017206852,0.0003661388,0.008758237,0.000049317223,0.000022849037,0.0000226592,0.00055830815,0.000035413785,0.76618505,0.000024754063,0.2219562,0.00030039376],"about_ca_topic_score_codex":0.0026231594,"about_ca_topic_score_gemma":0.0001099825,"teacher_disagreement_score":0.21139427,"about_ca_system_score_codex":0.0005184127,"about_ca_system_score_gemma":0.00028692433,"threshold_uncertainty_score":0.99990577},"labels":[],"label_agreement":null},{"id":"W2336577938","doi":"10.1158/2326-6074.tumimm14-b88","title":"Abstract B88: Combination therapy of reovirus and checkpoint inhibition","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada); Institute of Cancer Research","funders":"","keywords":"Oncolytic virus; Immune system; Immune checkpoint; Cancer research; Immunotherapy; Antigen; Immunology; Innate immune system; Medicine; Acquired immune system; Biology; Virology","score_opus":0.09997797559208603,"score_gpt":0.4035108601861042,"score_spread":0.30353288459401817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336577938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768418,0.020710204,0.000009852892,0.0007241663,0.00008515982,0.00033194464,0.000014110018,0.000008942709,0.0012738111],"genre_scores_gemma":[0.98755044,0.011720124,0.000023693525,0.0000533996,0.00009255504,0.00012942817,0.000051614872,0.000023878178,0.00035486527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984467,0.00030099135,0.0002172893,0.00032707737,0.00033320513,0.00037472174],"domain_scores_gemma":[0.99870884,0.000036182926,0.000065964974,0.00038836704,0.0007091173,0.0000914991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016494568,0.00011216558,0.00015824924,0.00018400684,0.00009313796,0.00001903231,0.00019872109,0.000218545,0.00007038433],"category_scores_gemma":[0.00016235292,0.00010623943,0.00003966405,0.00023383598,0.00067866856,0.000008844028,0.00016392353,0.00033187013,0.000016973752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004023108,0.00011334923,0.001370585,0.000012919462,0.0000859376,0.0000029308069,0.00019454259,0.000006773024,0.9594488,0.000088871624,0.00080526166,0.033846926],"study_design_scores_gemma":[0.0023014965,0.0034510812,0.00796834,0.00001883234,0.0000014516938,0.000006613227,0.00024313509,0.000010625832,0.978813,0.0009108525,0.0061659035,0.000108685286],"about_ca_topic_score_codex":0.00028028918,"about_ca_topic_score_gemma":0.00014227009,"teacher_disagreement_score":0.03373824,"about_ca_system_score_codex":0.000072826246,"about_ca_system_score_gemma":0.0005060722,"threshold_uncertainty_score":0.4332318},"labels":[],"label_agreement":null},{"id":"W2338380682","doi":"10.1158/2326-6074.tumimm14-a12","title":"Abstract A12: PDL-1 blockade and Sunitinib enhance the efficiency of oncolytic viral therapy","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Oncolytic virus; Sunitinib; Cancer research; Immune system; Myeloid-derived Suppressor Cell; Cytotoxic T cell; Medicine; Immunotherapy; In vivo; Immunology; Renal cell carcinoma; Cancer; Biology; In vitro; Oncology; Internal medicine; Suppressor","score_opus":0.08431225315404275,"score_gpt":0.41986677362980523,"score_spread":0.3355545204757625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338380682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94995195,0.046548266,0.000008073515,0.001246776,0.00011808919,0.00045388244,0.000018867002,0.000008944616,0.0016451719],"genre_scores_gemma":[0.9890804,0.009323447,0.0000143581965,0.000106544634,0.00020096,0.00017981624,0.000013394801,0.000030299048,0.0010507222],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977031,0.0005031026,0.00026053854,0.0004205476,0.0004483184,0.0006643926],"domain_scores_gemma":[0.9983434,0.00014981112,0.000077012606,0.0007240152,0.00059272355,0.00011302403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021378205,0.00016346046,0.00021387496,0.00013140592,0.00020938677,0.000031253177,0.0007749891,0.00021869008,0.00008455173],"category_scores_gemma":[0.00027193403,0.0001198228,0.000060164726,0.00032110748,0.0017159232,0.0000067390515,0.00030333817,0.00059245323,0.0000145825425],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035287798,0.00011290646,0.0005671835,0.000012492315,0.00012844651,0.0000044072854,0.000352064,0.000018194172,0.95900536,0.000029203182,0.0009306627,0.035310324],"study_design_scores_gemma":[0.0013445967,0.003780378,0.0018690852,0.000019910807,0.0000036785636,0.000011224216,0.00048334972,0.000018908759,0.97656715,0.00017341631,0.015586641,0.00014163287],"about_ca_topic_score_codex":0.00031644112,"about_ca_topic_score_gemma":0.00021857914,"teacher_disagreement_score":0.039128527,"about_ca_system_score_codex":0.00006234534,"about_ca_system_score_gemma":0.0008954394,"threshold_uncertainty_score":0.63223904},"labels":[],"label_agreement":null},{"id":"W2338745842","doi":"10.1158/2326-6074.cricimteatiaacr15-a084","title":"Abstract A084: Identification of mutation-reactive T cells in patients with gastrointestinal cancers","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"clone (Java method); Cancer research; Cancer; CD8; Biology; Somatic cell; Mutation; Germline mutation; Cancer cell; Cell culture; Metastasis; Human leukocyte antigen; Exome sequencing; T cell; Molecular biology; Antigen; Immunology; Gene; Genetics; Immune system","score_opus":0.041750560219818406,"score_gpt":0.37331365738303157,"score_spread":0.3315630971632132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338745842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973551,0.00019013773,0.000043267468,0.0006009891,0.00007271342,0.00084091374,0.000049483246,0.000014815695,0.0008325837],"genre_scores_gemma":[0.9971339,0.00013966885,0.00005418339,0.000010653034,0.000041561536,0.00022418241,0.00001663964,0.000030246434,0.0023489695],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99778324,0.00016820495,0.00037724592,0.00038700993,0.0007073265,0.00057698326],"domain_scores_gemma":[0.9975998,0.00045354897,0.00013440927,0.00044886424,0.0012782329,0.000085174484],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008243655,0.00012610614,0.0002799024,0.00058696885,0.00006072006,0.000010855788,0.00022555146,0.00008263727,0.0020720526],"category_scores_gemma":[0.00024344418,0.0000869017,0.000042921452,0.00063808705,0.0009077557,0.0001457809,0.00005893997,0.00054000225,0.0000691179],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044995626,0.00018026218,0.2631061,0.000038715305,0.00008460956,0.000023038114,0.00020749934,0.0000073674496,0.6992096,0.000016922504,0.000120352415,0.032506015],"study_design_scores_gemma":[0.0036643343,0.0007894297,0.74341536,0.00036460604,0.000006996453,0.0000077043505,0.00020219854,0.0000052025703,0.25128445,0.000039469527,0.00015199475,0.00006827391],"about_ca_topic_score_codex":0.0020518864,"about_ca_topic_score_gemma":0.00029743326,"teacher_disagreement_score":0.48030925,"about_ca_system_score_codex":0.001471268,"about_ca_system_score_gemma":0.0011631518,"threshold_uncertainty_score":0.9988402},"labels":[],"label_agreement":null},{"id":"W2339872372","doi":"10.1158/2326-6074.tumimm14-a69","title":"Abstract A69: The immunological environment in triple negative breast cancer; impact on clinical outcomes towards a prognostic clinical test","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Tumor microenvironment; Stromal cell; CD8; Laser capture microdissection; Stroma; Cytotoxic T cell; Triple-negative breast cancer; Tumor-infiltrating lymphocytes; Breast cancer; Gene signature; Cancer research; Immunotherapy; Biology; Cancer; Medicine; Immunology; Immune system; Internal medicine; Gene expression; Immunohistochemistry; Gene; Genetics","score_opus":0.2470849145066478,"score_gpt":0.5129981754542506,"score_spread":0.2659132609476028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339872372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587508,0.010258634,0.0000015169373,0.026743712,0.0010083109,0.002078991,0.00019711508,0.00006011096,0.0009008198],"genre_scores_gemma":[0.9753611,0.02117017,0.000027487666,0.00092149957,0.00045181296,0.0010502756,0.000020913805,0.00005199269,0.0009447557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940059,0.0014215062,0.0014307736,0.0009264048,0.00093934033,0.0012760401],"domain_scores_gemma":[0.99379355,0.004173886,0.00027672743,0.0010853404,0.00034932134,0.00032118327],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0071095494,0.0004428587,0.0011723299,0.00031351656,0.00025794777,0.00006174242,0.0008084161,0.00068899314,0.0016717287],"category_scores_gemma":[0.002922302,0.00024383163,0.00061407115,0.00074112194,0.0033826146,0.00011610878,0.00033818133,0.0037161328,0.00026659574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01961525,0.0019252432,0.78651416,0.00001398355,0.0011190148,0.0001422447,0.00036171006,0.000011093936,0.00050353474,0.000012619176,0.003984071,0.18579707],"study_design_scores_gemma":[0.011336165,0.004782664,0.97790015,0.00022347127,0.00006170231,0.000077636294,0.0008530865,0.000037285703,0.00014915984,0.00016881315,0.004150914,0.0002589471],"about_ca_topic_score_codex":0.007855298,"about_ca_topic_score_gemma":0.00034336862,"teacher_disagreement_score":0.19138598,"about_ca_system_score_codex":0.0018855928,"about_ca_system_score_gemma":0.0030026855,"threshold_uncertainty_score":0.9993296},"labels":[],"label_agreement":null},{"id":"W2346926528","doi":"10.1158/2326-6074.cricimteatiaacr15-b024","title":"Abstract B024: Single-chain traps targeting transforming growth factor-beta (TGF-beta) home to tumors and reduce tumor growth and metastasis by counteracting TGF-beta-mediated immunosuppression","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada","funders":"","keywords":"Transforming growth factor beta; Cancer research; TGF beta signaling pathway; Antibody; CD8; Monoclonal antibody; Immunotherapy; Metastasis; Biology; TGF beta 1; Immune system; Cancer immunotherapy; Angiogenesis; Transforming growth factor; Immunology; Medicine; Cancer; Cell biology; Internal medicine","score_opus":0.05835201712480142,"score_gpt":0.35704266751243385,"score_spread":0.29869065038763243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346926528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589195,0.020737533,0.000029488543,0.017596474,0.0002563123,0.0010917553,0.00054655544,0.00009243963,0.0007299071],"genre_scores_gemma":[0.99079835,0.007109279,0.00017213656,0.00023796859,0.00025535308,0.0002408762,0.000095607196,0.00011323991,0.0009771563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940791,0.00056181883,0.0009284343,0.0012041881,0.001226365,0.0020001018],"domain_scores_gemma":[0.99547845,0.0024939426,0.00019432318,0.00043124316,0.0007304819,0.00067153247],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017973157,0.0005838767,0.001103958,0.00082781,0.0008475149,0.0001553136,0.0005222168,0.00029426304,0.00073643745],"category_scores_gemma":[0.00076482823,0.0004045564,0.00017835302,0.0007614623,0.0012149713,0.00058378524,0.00042652083,0.0016984046,0.000061440966],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002902087,0.00018552803,0.013953073,0.000484866,0.0005155368,0.00021842151,0.0013020667,1.3450162e-7,0.94765514,0.00009072177,0.0016601428,0.031032268],"study_design_scores_gemma":[0.0042884876,0.0016245934,0.08665687,0.001908234,0.00009288598,0.00036933355,0.0019981603,0.000019503233,0.88896376,0.00010452808,0.013168393,0.0008052369],"about_ca_topic_score_codex":0.0020746314,"about_ca_topic_score_gemma":0.00003944435,"teacher_disagreement_score":0.07270379,"about_ca_system_score_codex":0.00036138072,"about_ca_system_score_gemma":0.0004198075,"threshold_uncertainty_score":0.9998406},"labels":[],"label_agreement":null},{"id":"W2356803257","doi":"10.1158/2326-6066.cir-15-0302","title":"Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Queen's University Belfast; Queen's University; Cancer Research UK","keywords":"Colorectal cancer; Immune system; Adjuvant; Medicine; Stage (stratigraphy); Chemotherapy; Oncology; Immunotherapy; Cancer; Immunology; Internal medicine; Biology","score_opus":0.03448511688458177,"score_gpt":0.3306681204005528,"score_spread":0.29618300351597104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2356803257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787703,0.015115467,0.00002813862,0.0025709218,0.000380934,0.0023504673,0.00046049926,0.00007729344,0.00024597684],"genre_scores_gemma":[0.98254675,0.009407149,0.00032290132,0.0001457785,0.0000843565,0.0027669475,0.000068569534,0.00013096257,0.004526572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956387,0.00033878323,0.0006581751,0.0009354235,0.0011223657,0.0013065146],"domain_scores_gemma":[0.9969075,0.00031874632,0.00032550681,0.00070159644,0.0015281899,0.0002185129],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00054971856,0.00046006474,0.0010340399,0.0003526351,0.00036074294,0.000021802782,0.00059237884,0.00042689947,0.0034457988],"category_scores_gemma":[0.00018630137,0.0002941871,0.00014274864,0.0007625096,0.0017585189,0.00019191622,0.00041079242,0.0006731888,0.000008870164],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010868194,0.00049883785,0.25419834,0.00010157576,0.0004248372,0.0000057048132,0.0007625114,0.0000016089077,0.7220093,0.0000033945496,0.0041965465,0.006929157],"study_design_scores_gemma":[0.009549606,0.0032387231,0.22477117,0.00068811263,0.00004669648,0.000003390754,0.00016151166,0.000004973434,0.75674087,0.0000070292285,0.0045065805,0.0002813431],"about_ca_topic_score_codex":0.002115842,"about_ca_topic_score_gemma":0.00022333037,"teacher_disagreement_score":0.03473157,"about_ca_system_score_codex":0.0009873539,"about_ca_system_score_gemma":0.0012992807,"threshold_uncertainty_score":0.999951},"labels":[],"label_agreement":null},{"id":"W2396416961","doi":"10.1158/2326-6074.cricimteatiaacr15-a137","title":"Abstract A137: Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and PD-1 blockade provides effective tumor control through a mechanism of epitope spreading","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Immunovaccine (Canada)","funders":"","keywords":"ELISPOT; Medicine; Immune system; Immunogenicity; Tumor microenvironment; Cancer vaccine; Immunotherapy; Cancer research; Immunology; CD8; Cytotoxic T cell; Epitope; Cancer; Peptide vaccine; Cancer immunotherapy; Cyclophosphamide; Antigen; Biology; Chemotherapy; Internal medicine; In vitro","score_opus":0.0236350580915843,"score_gpt":0.3161261455084398,"score_spread":0.29249108741685553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396416961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92753005,0.06876927,0.0005058705,0.0007475699,0.00033049023,0.0018071888,0.00012692326,0.00006823975,0.000114402865],"genre_scores_gemma":[0.9884141,0.007878915,0.00017076834,0.000045586752,0.000039097187,0.0012880355,0.000008787318,0.00006873684,0.0020859363],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99639124,0.0010245156,0.00056375837,0.0007651588,0.00009781228,0.0011575466],"domain_scores_gemma":[0.99626136,0.0024276646,0.00029266288,0.00066352653,0.00031575066,0.000039033774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085627125,0.00047181657,0.00097490905,0.0003726731,0.0004696446,0.000027645556,0.00046326694,0.00035075072,0.0004884009],"category_scores_gemma":[0.00022153616,0.00029102198,0.00015575842,0.00026549096,0.0012852586,0.00033028453,0.00014538683,0.0006266039,0.00011689532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014872058,0.00035421332,0.007124796,0.000044329056,0.0027084933,0.000026427677,0.0009547985,0.000002646095,0.9346436,0.0006100179,0.0000519613,0.038606633],"study_design_scores_gemma":[0.018686477,0.004200176,0.07563047,0.0003908565,0.00011260062,0.00014684799,0.0007010914,0.0000036072213,0.89325964,0.0002823545,0.006206294,0.0003795559],"about_ca_topic_score_codex":0.004114149,"about_ca_topic_score_gemma":0.00026875918,"teacher_disagreement_score":0.068505675,"about_ca_system_score_codex":0.0005859671,"about_ca_system_score_gemma":0.0005739884,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W2397071140","doi":"10.1158/2326-6074.cricimteatiaacr15-a176","title":"Abstract A176: Efficacy and safety of allogeneic double negative T cell as anti-AML therapy and its underlying mechanism","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Institute of Cancer Research; University of Toronto","funders":"","keywords":"Medicine; Myeloid leukemia; Chemotherapy; Leukemia; CD8; Minimal residual disease; Stem cell; Immunotherapy; Oncology; Immunology; Transplantation; Cytotoxic T cell; Cancer research; Internal medicine; Immune system; In vitro; Biology","score_opus":0.16024945242818145,"score_gpt":0.42543022106325934,"score_spread":0.2651807686350779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397071140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721044,0.020603847,0.000007680372,0.0026534284,0.000099823184,0.0013292925,0.000018232342,0.000031296615,0.0031520461],"genre_scores_gemma":[0.9179397,0.0762483,0.000029153349,0.000051895116,0.00006460758,0.00010915805,0.0000033267615,0.000050623195,0.005503179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973913,0.00027725866,0.00035025997,0.00059535,0.0005637075,0.0008221482],"domain_scores_gemma":[0.99751216,0.0011212188,0.0000926068,0.00048955355,0.0005897707,0.00019466561],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013755779,0.00022236301,0.0005347157,0.000407421,0.00024503647,0.00002571636,0.000273974,0.00029876846,0.004648509],"category_scores_gemma":[0.0001421737,0.00015436232,0.000065639506,0.00037094095,0.00094251335,0.00012640005,0.00026186238,0.0007235779,0.000071116054],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006290541,0.00014190223,0.0017723246,0.0000916935,0.0003626324,0.000038048252,0.0006456516,5.06863e-7,0.9329979,0.0010450472,0.000047378468,0.056566373],"study_design_scores_gemma":[0.015797412,0.0014528062,0.09530194,0.00026379141,0.00001713721,0.000056317356,0.00041257378,0.000006446073,0.8828792,0.0011077912,0.0025251408,0.0001794538],"about_ca_topic_score_codex":0.0005612191,"about_ca_topic_score_gemma":0.000024830102,"teacher_disagreement_score":0.09352961,"about_ca_system_score_codex":0.00022740869,"about_ca_system_score_gemma":0.00064951414,"threshold_uncertainty_score":0.99626136},"labels":[],"label_agreement":null},{"id":"W2397649686","doi":"10.1158/2326-6074.cricimteatiaacr15-b077","title":"Abstract B077: Evaluating oncolytic vaccines targeting mutated epitopes in a murine fibrosarcoma model CMS-5","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McMaster University","funders":"","keywords":"Oncolytic virus; Immune system; Epitope; Antigen; Immunotherapy; Vaccination; Tumor antigen; Immunology; Biology; Cancer research; Virology; Medicine","score_opus":0.08255336065278163,"score_gpt":0.43335719420822527,"score_spread":0.35080383355544364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397649686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862069,0.010815407,0.000043851713,0.001569502,0.00011383626,0.0005996843,0.000034997593,0.000029113706,0.0005866891],"genre_scores_gemma":[0.9934027,0.003343842,0.00022240098,0.00006878999,0.0002646341,0.0005132029,0.00003954164,0.00007498677,0.0020698945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99619347,0.00063649286,0.00050395593,0.00082747167,0.00051119155,0.0013273933],"domain_scores_gemma":[0.99817586,0.00025267646,0.00009779004,0.0007330097,0.00061509677,0.00012556776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028764082,0.0002667622,0.00033264307,0.0003900324,0.00024407844,0.000040674247,0.00082670007,0.00033318455,0.00043809877],"category_scores_gemma":[0.0009998255,0.00020783588,0.000098412216,0.0005062715,0.0004155362,0.000019966677,0.00054799224,0.0006084603,0.00009790862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041607977,0.00010234072,0.0037449738,0.000034892913,0.00011222049,0.000021601374,0.000105002044,0.00094474835,0.93750876,0.000008140953,0.00088316196,0.052373372],"study_design_scores_gemma":[0.003996679,0.0026413475,0.007155158,0.0001934424,0.0000063103566,0.000011526512,0.00017941021,0.0025707113,0.98098344,0.00065341394,0.0012206524,0.00038793977],"about_ca_topic_score_codex":0.00031483584,"about_ca_topic_score_gemma":0.00075103494,"teacher_disagreement_score":0.05198543,"about_ca_system_score_codex":0.00030465896,"about_ca_system_score_gemma":0.0011469267,"threshold_uncertainty_score":0.8475301},"labels":[],"label_agreement":null},{"id":"W2397997709","doi":"10.1158/2326-6074.cricimteatiaacr15-a135","title":"Abstract A135: Phosphodiesterase-5 inhibition augments postoperative natural killer cell antitumor immunity by reducing myeloid-derived suppressor cell function","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Myeloid-derived Suppressor Cell; Medicine; Immune system; In vivo; Cancer research; Immunotherapy; Immunology; Cancer; Natural killer cell; Perioperative; Cytotoxic T cell; Cell; Adoptive cell transfer; T cell; Pharmacology; Internal medicine; In vitro; Suppressor; Biology; Surgery","score_opus":0.02674075746872229,"score_gpt":0.3068978497950183,"score_spread":0.280157092326296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397997709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9245753,0.05991646,0.000051940904,0.001984552,0.009293925,0.00096613873,0.00023399667,0.00015495096,0.002822699],"genre_scores_gemma":[0.9547117,0.005969635,0.000027012278,0.00030133498,0.0001082317,0.00053001294,0.00043035482,0.00009668561,0.037825033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948454,0.0012867103,0.0007629207,0.0011041673,0.00024077254,0.0017600413],"domain_scores_gemma":[0.9969657,0.0007644022,0.00032153394,0.0010774751,0.00080599723,0.00006490626],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001144902,0.0005636648,0.00066547666,0.00042130708,0.0013320773,0.0000813094,0.00077574997,0.001004929,0.008153806],"category_scores_gemma":[0.00017950586,0.00044171885,0.00018822135,0.0004689566,0.0020778952,0.0006853226,0.0006673198,0.0029087663,0.0028751553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022058918,0.00033884498,0.00038369102,0.00005899872,0.00029935373,0.000016042284,0.0009183493,0.000003065369,0.9037485,0.000024865134,0.086771496,0.0052308748],"study_design_scores_gemma":[0.0050968016,0.00043775805,0.009871941,0.00026017797,0.000037902428,0.000024606126,0.0008270101,8.695604e-7,0.9049094,0.000046334764,0.07797418,0.00051307277],"about_ca_topic_score_codex":0.0018553142,"about_ca_topic_score_gemma":0.000047235273,"teacher_disagreement_score":0.053946823,"about_ca_system_score_codex":0.0011560522,"about_ca_system_score_gemma":0.0005599511,"threshold_uncertainty_score":0.99996805},"labels":[],"label_agreement":null},{"id":"W2398791138","doi":"10.1158/2326-6074.cricimteatiaacr15-b032","title":"Abstract B032: Targeting the PD-1/PD-L1 immune evasion axis with DNA aptamers","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Aptamer; Immunogenicity; Immune system; Antibody; Epitope; Ipilimumab; Monoclonal antibody; Cancer research; Cancer immunotherapy; In vivo; Immunotherapy; PD-L1; Biology; Immunology; Chemistry; Molecular biology; Medicine","score_opus":0.04202662263459932,"score_gpt":0.3342557354737899,"score_spread":0.29222911283919056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398791138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87553054,0.10997827,0.00005320775,0.010188609,0.0013789905,0.00086715166,0.000050247534,0.00016708858,0.0017859146],"genre_scores_gemma":[0.9660233,0.014769695,0.000021911655,0.0002240891,0.00011200518,0.00051422534,0.000035010395,0.000095563315,0.018204171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.994477,0.0018019929,0.000714564,0.000821698,0.0002476919,0.0019370506],"domain_scores_gemma":[0.9952564,0.0023909102,0.00027509488,0.0014106893,0.0006247462,0.000042144537],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["sts","insufficient_payload"],"category_scores_codex":[0.003102292,0.0004829428,0.0006330162,0.00044507164,0.0018174954,0.00006740369,0.0016098438,0.00064596435,0.0066620484],"category_scores_gemma":[0.00059809996,0.00024857948,0.00023131342,0.00075232063,0.0043443562,0.00035644957,0.00044356968,0.0017970277,0.0023263325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007262418,0.00013520253,0.0009813788,0.000019856896,0.0009904836,0.000019256806,0.0008438492,0.0000013377899,0.9028826,0.0003440834,0.0063001565,0.08021943],"study_design_scores_gemma":[0.00368805,0.0008230135,0.049381513,0.00034596815,0.000033722532,0.00012266464,0.0018280142,4.7499807e-7,0.6086024,0.00014533095,0.33459687,0.00043196123],"about_ca_topic_score_codex":0.0012388736,"about_ca_topic_score_gemma":0.000067100525,"teacher_disagreement_score":0.32829672,"about_ca_system_score_codex":0.00039784895,"about_ca_system_score_gemma":0.0007543527,"threshold_uncertainty_score":0.99999666},"labels":[],"label_agreement":null},{"id":"W2401152531","doi":"10.1158/2326-6074.cricimteatiaacr15-b096","title":"Abstract B096: Oncolytic vaccination for HPV induced cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; McMaster University","funders":"","keywords":"Oncolytic virus; Vaccination; Medicine; Cervical cancer; Cancer; Head and neck cancer; Immunotherapy; Immunology; Antigen; Disease; Oncology; Head and neck squamous-cell carcinoma; Cancer research; Virology; Internal medicine","score_opus":0.09600100539049997,"score_gpt":0.44479630692068883,"score_spread":0.3487953015301889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401152531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98241687,0.008517203,0.00008291244,0.006691084,0.00038016163,0.0009786336,0.00009986385,0.000023549148,0.0008097369],"genre_scores_gemma":[0.9870098,0.006101411,0.000023563816,0.00021462805,0.0006334831,0.002364288,0.000032034783,0.00006400877,0.0035567833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975576,0.0002388716,0.0002638444,0.0006393129,0.00034564335,0.00095474446],"domain_scores_gemma":[0.99805593,0.00018757461,0.000075227705,0.00066358584,0.0009042681,0.000113413524],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012635116,0.0001883831,0.00021434098,0.00024054736,0.00028337617,0.00003327027,0.000664723,0.00038822734,0.0011014364],"category_scores_gemma":[0.00038203102,0.00014485519,0.00010763654,0.00028452525,0.00022469033,0.000013038507,0.00021189392,0.0003295668,0.00007460801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030952767,0.000053264524,0.00052009855,0.000022098542,0.00016678794,0.0000015740493,0.00002751218,0.0000034410104,0.7168488,0.000028057046,0.0051502986,0.2740828],"study_design_scores_gemma":[0.0025947667,0.0024418773,0.014178345,0.000037764225,0.00000778828,0.0000027265671,0.000049758335,0.000009220116,0.93118876,0.00032737813,0.048936978,0.00022463665],"about_ca_topic_score_codex":0.00021032534,"about_ca_topic_score_gemma":0.00123936,"teacher_disagreement_score":0.2738582,"about_ca_system_score_codex":0.00038298144,"about_ca_system_score_gemma":0.0009800678,"threshold_uncertainty_score":0.9998117},"labels":[],"label_agreement":null},{"id":"W2401647293","doi":"10.1158/2326-6074.cricimteatiaacr15-a029","title":"Abstract A029: Cell-based cancer immunotherapy using tumor presenting cells: A phase II trial with local advance prostate cancer patients","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Axela (Canada)","funders":"","keywords":"Immunotherapy; Medicine; Prostate cancer; MHC class I; Cancer research; Cytotoxic T cell; Cancer; Population; Antigen presentation; Cancer immunotherapy; Immunology; T cell; Antigen; Internal medicine; Major histocompatibility complex; Oncology; Immune system; Biology; In vitro","score_opus":0.036754641157797426,"score_gpt":0.36560618642976217,"score_spread":0.32885154527196475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401647293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9262244,0.06757962,0.00021839458,0.00059339416,0.002234655,0.002456892,0.0003974513,0.00021199227,0.00008319311],"genre_scores_gemma":[0.9832171,0.0077692056,0.00006746677,0.00022660216,0.0001586338,0.0025903492,0.00004019168,0.00025084606,0.005679602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99343383,0.0014241291,0.0010265684,0.00125753,0.00037180286,0.0024861416],"domain_scores_gemma":[0.9961742,0.00088898913,0.00063091196,0.0011003921,0.0011243167,0.00008114953],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["sts"],"category_scores_codex":[0.0012174745,0.0007473979,0.0009863395,0.00066965533,0.0015232031,0.000076261684,0.001189085,0.00054529385,0.003468302],"category_scores_gemma":[0.00009963163,0.0005150428,0.00026574524,0.0008635964,0.0031219625,0.0005705659,0.00031195887,0.001533186,0.00011323726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15921491,0.0021086964,0.0015463562,0.00007275633,0.0007926928,0.000024623501,0.00079679705,0.0001434414,0.7719288,0.0000064756136,0.0007615009,0.06260298],"study_design_scores_gemma":[0.13568336,0.0046594837,0.0014436573,0.00073637906,0.000060878167,0.0000091685,0.00030294986,0.000022498416,0.7850991,0.000023767241,0.07119401,0.000764776],"about_ca_topic_score_codex":0.0041189883,"about_ca_topic_score_gemma":0.00018445861,"teacher_disagreement_score":0.070432514,"about_ca_system_score_codex":0.0010675678,"about_ca_system_score_gemma":0.0026902447,"threshold_uncertainty_score":0.99977666},"labels":[],"label_agreement":null},{"id":"W2407340489","doi":"10.1158/2326-6074.cricimteatiaacr15-b082","title":"Abstract B082: Reovirus treated NK cells exhibit enhanced cetuximab mediated antibody- dependent cellular cytotoxicity against colorectal cancer cell lines","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Antibody-dependent cell-mediated cytotoxicity; Cetuximab; Cytotoxicity; Cytotoxic T cell; Cancer research; Antibody; Interleukin 12; Immune system; Cancer cell; Chemistry; Immunology; Biology; Cancer; Monoclonal antibody; In vitro; Biochemistry","score_opus":0.028833994554002384,"score_gpt":0.3471352347735426,"score_spread":0.3183012402195402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407340489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971866,0.024027292,0.00005550179,0.00040404286,0.00040918653,0.0011141928,0.0005819538,0.000079901096,0.0014619218],"genre_scores_gemma":[0.9305161,0.064915046,0.000018913799,0.00012821131,0.0005386813,0.0007682353,0.00026163983,0.0001425754,0.0027105645],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99405056,0.0008819795,0.0006712067,0.0014967887,0.0008789562,0.0020205167],"domain_scores_gemma":[0.9968453,0.00028203003,0.00022304499,0.0011694969,0.0011359771,0.0003441751],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001395701,0.00057090214,0.0006197233,0.00031078537,0.00048467342,0.000075675736,0.0013609151,0.0009147327,0.0018186817],"category_scores_gemma":[0.0002214035,0.0004514718,0.00024181501,0.0005818606,0.0011894825,0.00003383147,0.0006160672,0.0008642608,0.000396276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007910951,0.000391238,0.001260564,0.00006254749,0.00041045735,0.00006516588,0.00008231495,0.000029429613,0.9772671,0.0000015978975,0.00095130346,0.011567333],"study_design_scores_gemma":[0.0040357523,0.0021117514,0.0014973637,0.00010647663,0.000018036631,0.000002878158,0.00009270502,0.00001643546,0.9890586,0.000014023746,0.0024834783,0.00056246406],"about_ca_topic_score_codex":0.0013763484,"about_ca_topic_score_gemma":0.003913756,"teacher_disagreement_score":0.041349873,"about_ca_system_score_codex":0.00068515836,"about_ca_system_score_gemma":0.0014412423,"threshold_uncertainty_score":0.9997937},"labels":[],"label_agreement":null},{"id":"W2407448809","doi":"10.1158/2326-6074.cricimteatiaacr15-a134","title":"Abstract A134: The immunoregulatory enzyme IDO induces resistance to common chemotherapy drugs via base excision repair pathway","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Lawson Health Research Institute","funders":"","keywords":"Cancer research; Immune system; Indoleamine 2,3-dioxygenase; Medicine; Immunotherapy; CD8; Immunology; Biology","score_opus":0.05595747684208299,"score_gpt":0.3480774577969711,"score_spread":0.2921199809548881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407448809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737039,0.0059043076,0.000021336524,0.016133782,0.0005347496,0.00073250214,0.000034665652,0.00020179676,0.0027329496],"genre_scores_gemma":[0.9903181,0.0018118444,0.000024452636,0.0018162563,0.0001614829,0.00035748942,0.0000011507902,0.000058454694,0.005450773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959915,0.0008484006,0.00041382256,0.00090338173,0.00077548285,0.001067359],"domain_scores_gemma":[0.9962031,0.0018507785,0.0001160752,0.001509039,0.00018682824,0.0001341568],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016561514,0.00027119648,0.00030977782,0.00030506658,0.0008138766,0.00007412082,0.0015965969,0.00024073581,0.0011494207],"category_scores_gemma":[0.0006365545,0.00016225479,0.00015220199,0.00094019854,0.0016306316,0.00026626146,0.00038325824,0.0007727644,0.00062442996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008809224,0.00009254471,0.00010523476,0.000013881598,0.000022719629,0.000019021709,0.00093762396,0.0000010068668,0.8949465,0.000930847,0.011495845,0.09055384],"study_design_scores_gemma":[0.0010827443,0.00013572909,0.03443553,0.00014744961,0.0000014505765,0.0000050685685,0.00032086964,0.0000023298858,0.84576535,0.0022575858,0.115601934,0.00024397243],"about_ca_topic_score_codex":0.00016695862,"about_ca_topic_score_gemma":0.00016655201,"teacher_disagreement_score":0.10410609,"about_ca_system_score_codex":0.00035342795,"about_ca_system_score_gemma":0.00035830506,"threshold_uncertainty_score":0.99976367},"labels":[],"label_agreement":null},{"id":"W2408318972","doi":"10.1158/2326-6074.cricimteatiaacr15-b074","title":"Abstract B074: Tumor-reactive CD4+ T cells in metastatic gastrointestinal cancer refractory to chemotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"CIITA; Cancer research; CD8; Cancer; Major histocompatibility complex; Immunotherapy; T cell; Tumor-infiltrating lymphocytes; MHC class I; Medicine; Biology; Immune system; Immunology; MHC class II; Internal medicine","score_opus":0.0541671101081283,"score_gpt":0.3716468242514702,"score_spread":0.3174797141433419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408318972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97044384,0.022402646,0.000065321045,0.004255245,0.0009794428,0.0009358057,0.00016089035,0.00009181976,0.0006649629],"genre_scores_gemma":[0.9824621,0.0037976338,0.000101198675,0.0005748883,0.00007726113,0.001128527,0.000011601377,0.00009625243,0.011750525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99512386,0.001227838,0.0007008609,0.0008904613,0.00018117875,0.0018757931],"domain_scores_gemma":[0.99667454,0.0017278846,0.00019705882,0.00085696817,0.00047265837,0.000070899514],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016739804,0.00045651715,0.0007397205,0.0010088764,0.00034588,0.000035963258,0.0010320012,0.00022780999,0.008717961],"category_scores_gemma":[0.0004137578,0.00033710164,0.00016465115,0.0008173549,0.001326421,0.00030902616,0.00023527349,0.0014803085,0.0022431735],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007136427,0.00036990378,0.0031504473,0.000021810925,0.00035673723,0.000070760725,0.00075498124,0.0000043849554,0.9184499,0.000079045174,0.004156299,0.06544934],"study_design_scores_gemma":[0.0047633396,0.0010048519,0.113023184,0.0007719827,0.00001417999,0.00013896565,0.00070508773,4.0381164e-7,0.7505241,0.00015849329,0.12843738,0.00045799708],"about_ca_topic_score_codex":0.0037614044,"about_ca_topic_score_gemma":0.00043518606,"teacher_disagreement_score":0.16792573,"about_ca_system_score_codex":0.0010516599,"about_ca_system_score_gemma":0.0011414703,"threshold_uncertainty_score":0.9999081},"labels":[],"label_agreement":null},{"id":"W2421079281","doi":"10.1158/2326-6074.tumimm14-a49","title":"Abstract A49: Systemic oncolytic reovirus for the treatment of primary and secondary brain tumors","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Medicine; Virotherapy; Glioma; Immunotherapy; Radiation therapy; Cancer research; Systemic administration; Immune system; Immunology; In vivo; Internal medicine; Biology","score_opus":0.08491880032555363,"score_gpt":0.3954175406100843,"score_spread":0.3104987402845306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2421079281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88477916,0.11227296,0.000014825167,0.00103858,0.000120514684,0.0010519893,0.00008527719,0.000007242296,0.0006294566],"genre_scores_gemma":[0.98596764,0.010492436,0.000025143903,0.00010862367,0.0002393995,0.00092293986,0.00005054554,0.000038663486,0.0021546106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982791,0.0002820027,0.00026069186,0.00039290712,0.00025426847,0.00053105474],"domain_scores_gemma":[0.9983716,0.00039249114,0.000074667936,0.00063541497,0.0004210368,0.00010480529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014589689,0.00015540925,0.0002778795,0.00012037332,0.0001752028,0.000023069482,0.00040116947,0.00018563383,0.000033555963],"category_scores_gemma":[0.00016930944,0.0001114864,0.00008274169,0.00016274428,0.00081405207,0.000005431116,0.0001237436,0.00022689899,0.000008943231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0079610115,0.00013690673,0.0005650275,0.00009860994,0.00042057104,0.0000069043517,0.00039137003,0.00003090558,0.8717325,0.00002584713,0.0037762392,0.11485416],"study_design_scores_gemma":[0.0075474544,0.023664929,0.0068162484,0.00009313214,0.000031518768,0.000086352185,0.0015873973,0.00006581079,0.8367049,0.00022083096,0.122862004,0.00031941722],"about_ca_topic_score_codex":0.00031821805,"about_ca_topic_score_gemma":0.00030969415,"teacher_disagreement_score":0.11908577,"about_ca_system_score_codex":0.00029647534,"about_ca_system_score_gemma":0.0018472722,"threshold_uncertainty_score":0.45462835},"labels":[],"label_agreement":null},{"id":"W2510555501","doi":"10.1158/2326-6066.cir-15-0189","title":"Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Université du Québec; Sunnybrook Hospital; Centre hospitalier de l'Université Laval; Université de Montréal; Université Laval; Mediprobe Research (Canada); Hamilton Health Sciences; McMaster University","funders":"National Cancer Institute","keywords":"MUC1; Glycopeptide; Immunotherapy; Medicine; Antigen; CD8; Immunology; Immune system; Prostate cancer; Vaccination; Cancer; Internal medicine; Biology; Microbiology","score_opus":0.03450507726481634,"score_gpt":0.3604231592846476,"score_spread":0.32591808201983125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510555501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97285974,0.024395524,0.0000071874774,0.00067279086,0.0003371652,0.0014072648,0.00023663916,0.000023155988,0.00006053564],"genre_scores_gemma":[0.9914235,0.005205925,0.000016845332,0.000019806737,0.000014349714,0.0006903008,0.000033753444,0.000035176363,0.0025603299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967644,0.0011953997,0.0006008782,0.00048626188,0.00013978043,0.0008132839],"domain_scores_gemma":[0.998307,0.00053178007,0.0002386157,0.0004049334,0.00049280084,0.000024868938],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00092146767,0.00026314388,0.0005787618,0.0006090047,0.00030440008,0.00001730569,0.0003199905,0.0002702546,0.001099984],"category_scores_gemma":[0.00016871707,0.0001709892,0.000053471842,0.0004831951,0.0009654454,0.00026147775,0.0001588603,0.0005213669,0.00001938724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29074076,0.0010539822,0.0074769733,0.000051514147,0.0005685842,0.0000068164936,0.0013220016,6.945044e-7,0.5681209,0.00014649419,0.0001580609,0.13035321],"study_design_scores_gemma":[0.31909272,0.02574786,0.24163318,0.00077274215,0.00007849149,0.000011880948,0.00072447554,0.000001451476,0.4033602,0.00030246147,0.0077108834,0.0005636947],"about_ca_topic_score_codex":0.0012102817,"about_ca_topic_score_gemma":0.00034144477,"teacher_disagreement_score":0.2341562,"about_ca_system_score_codex":0.00026456203,"about_ca_system_score_gemma":0.0005940453,"threshold_uncertainty_score":0.99981314},"labels":[],"label_agreement":null},{"id":"W2513504681","doi":"10.1158/2326-6066.cir-16-0179","title":"Zeroing in on Tumor-Reactive TILs","year":2016,"lang":"en","type":"letter","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Adoptive cell transfer; Cancer immunotherapy; Cancer; Immunotherapy; Cancer research; Adoptive immunotherapy; Tumor cells; Medicine; Immunology; T cell; Immune system; Internal medicine","score_opus":0.11938313846503769,"score_gpt":0.4404190876862732,"score_spread":0.3210359492212355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2513504681","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06681279,0.0057134703,0.0000017219321,0.8585442,0.0009120904,0.0023903633,0.00009575296,0.00009805314,0.06543161],"genre_scores_gemma":[0.018870467,0.008032167,0.000028824812,0.4017226,0.017541712,0.004207599,0.0002788427,0.0006910044,0.5486268],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925965,0.0013521087,0.00052616856,0.0012899003,0.0016852199,0.0025500671],"domain_scores_gemma":[0.99514556,0.002187454,0.000118875985,0.0016578634,0.0007559775,0.00013426835],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0020906292,0.00048544956,0.0011231216,0.0025479593,0.00017395701,0.000052777974,0.0009046586,0.0014518446,0.015100274],"category_scores_gemma":[0.0006311296,0.00037926654,0.00023865409,0.0009995439,0.0014814112,0.00008973372,0.00043746672,0.014619197,0.0021475295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028282036,0.000087543725,0.001284342,0.00022197825,0.00052868866,0.0061522895,0.00025445397,2.1650021e-7,0.17417865,0.000034770987,0.76223874,0.052190136],"study_design_scores_gemma":[0.0030196982,0.001096122,0.0024270394,0.0018465022,0.00001839335,0.00017994618,0.000083619445,0.0000025940499,0.02393514,0.0003546028,0.96669954,0.00033678729],"about_ca_topic_score_codex":0.001392184,"about_ca_topic_score_gemma":0.00008459295,"teacher_disagreement_score":0.4831952,"about_ca_system_score_codex":0.0040946687,"about_ca_system_score_gemma":0.0023918783,"threshold_uncertainty_score":0.99986595},"labels":[],"label_agreement":null},{"id":"W2546886006","doi":"10.1158/2326-6066.imm2016-a144","title":"Abstract A144: Urease-mediated alkalization of tumor microenvironment and its effects on T cell proliferation, cytokine release, and PD-1/PD-L1 interactions","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Helix Biopharma (Canada)","funders":"","keywords":"Tumor microenvironment; Jurkat cells; Cancer cell; Cytotoxic T cell; Cytokine; Chemistry; Immunoconjugate; Cancer immunotherapy; Cancer research; Immunotherapy; Cell culture; T cell; Immune system; Biology; Molecular biology; Biochemistry; Cancer; In vitro; Immunology; Antibody; Monoclonal antibody","score_opus":0.017164598413812765,"score_gpt":0.31769814106090993,"score_spread":0.3005335426470972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546886006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99000275,0.008377905,0.000017709954,0.0007104329,0.000057505917,0.0005335798,0.00014574939,0.000006085364,0.00014829],"genre_scores_gemma":[0.988489,0.010087122,0.000010478407,0.000057608933,0.00008040733,0.0003104234,0.00010306171,0.000020370644,0.000841548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987495,0.00016245921,0.0001725865,0.0003871178,0.00019107228,0.00033726843],"domain_scores_gemma":[0.99928874,0.00012570166,0.00006823315,0.00024348576,0.00016633476,0.0001074848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018713032,0.00013229765,0.00014791747,0.00014713651,0.00013344962,0.00001597043,0.00010527329,0.000090815185,0.00009189254],"category_scores_gemma":[0.00020221216,0.000099555305,0.000028141741,0.00010858382,0.00023697861,0.000013318813,0.00012898252,0.00015762442,0.000022736864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011692451,0.00015592306,0.008830273,0.00008017804,0.00012997673,0.000012072872,0.000031262975,0.0000017567631,0.98325336,0.000019558383,0.0010000813,0.0053163343],"study_design_scores_gemma":[0.0020382795,0.0008858671,0.06401688,0.000104398525,0.000011486286,0.000012733431,0.000017794086,0.00000843555,0.9244004,0.000031224336,0.008376406,0.00009612581],"about_ca_topic_score_codex":0.00014999812,"about_ca_topic_score_gemma":0.00015256043,"teacher_disagreement_score":0.05885297,"about_ca_system_score_codex":0.00010019463,"about_ca_system_score_gemma":0.0001505235,"threshold_uncertainty_score":0.40597475},"labels":[],"label_agreement":null},{"id":"W2547013708","doi":"10.1158/2326-6066.imm2016-a019","title":"Abstract A019: Chimeric antigen receptors (CARs) as a low-impact treatment of pediatric ependymomas","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Chimeric antigen receptor; Medicine; Oncology; Cancer research; Internal medicine; Antigen; Targeted therapy; Immunotherapy; Pathology; Immunology; Cancer","score_opus":0.07416632144904588,"score_gpt":0.42540981846735254,"score_spread":0.35124349701830665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547013708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673249,0.028334357,6.039672e-7,0.0012633126,0.00030708621,0.0007797816,0.000055049808,0.000037722584,0.001897182],"genre_scores_gemma":[0.9544801,0.043579422,0.00002467745,0.000013330721,0.00026957475,0.00037893656,0.000018365921,0.000041550797,0.0011940419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977214,0.00015275934,0.00037291838,0.00048541737,0.0004542416,0.0008132618],"domain_scores_gemma":[0.9981837,0.0004364272,0.0001274494,0.00068186194,0.00035534496,0.00021520883],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000275973,0.00025864897,0.0005959366,0.00063319365,0.00012623277,0.00001207626,0.00019269534,0.00021187715,0.004850588],"category_scores_gemma":[0.0001617639,0.00014550333,0.00027938228,0.00071055326,0.00039389695,0.000082345985,0.00006908794,0.0001825456,0.0007841805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014517015,0.002635485,0.6632177,0.00005120781,0.0019275215,0.0006059146,0.0003934586,0.0000018071752,0.15198249,0.000081044105,0.0022897574,0.1753619],"study_design_scores_gemma":[0.0056272494,0.0040677236,0.837487,0.00012471626,0.00011802823,0.00010326269,0.00008914016,8.767466e-7,0.14731067,0.00007403748,0.0048528304,0.0001444976],"about_ca_topic_score_codex":0.0029866332,"about_ca_topic_score_gemma":0.000047052137,"teacher_disagreement_score":0.1752174,"about_ca_system_score_codex":0.0009819967,"about_ca_system_score_gemma":0.00093282445,"threshold_uncertainty_score":0.9999938},"labels":[],"label_agreement":null},{"id":"W2547018141","doi":"10.1158/2326-6066.imm2016-b092","title":"Abstract B092: Therapeutic targeting of tumorigenic EphA2+/EphA3+ brain tumor initiating cells with bi-specific antibody in glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Cancer research; Erythropoietin-producing hepatocellular (Eph) receptor; EPH receptor A2; SOX2; Population; Biology; Brain tumor; Glioma; Medicine; Immunology; Receptor; Pathology; Internal medicine; Embryonic stem cell; Receptor tyrosine kinase","score_opus":0.08607020072303567,"score_gpt":0.3796350187056222,"score_spread":0.29356481798258655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547018141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486697,0.0031397769,0.00007574225,0.0007428303,0.0002399674,0.00042175566,0.000024351042,0.00004979733,0.00043883268],"genre_scores_gemma":[0.99815315,0.0011699807,0.000027106804,0.00023540002,0.00012478288,0.00010013181,6.4782057e-7,0.000058529287,0.00013025232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960365,0.0007215045,0.0006073453,0.0007949178,0.0006579257,0.0011817806],"domain_scores_gemma":[0.9961247,0.002891786,0.00025703834,0.0004356026,0.0002090208,0.000081839724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014067915,0.0002504372,0.00041237695,0.00055954634,0.00027663397,0.00003686347,0.0008040833,0.000106536514,0.00057711045],"category_scores_gemma":[0.0004206716,0.00017470603,0.00007398042,0.0012948279,0.0010896338,0.00033895025,0.0002036795,0.0008344554,0.00012099761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008757855,0.00009958433,0.0064667156,0.000038449354,0.000014503145,0.0002521872,0.00027736073,0.000027963206,0.986126,0.0003069061,0.00009321242,0.005421346],"study_design_scores_gemma":[0.0012529828,0.0005651551,0.013214958,0.00040107153,0.00000243663,0.000028828279,0.00023332346,0.000022305061,0.9826571,0.00023689131,0.0011644321,0.00022055456],"about_ca_topic_score_codex":0.00009162972,"about_ca_topic_score_gemma":0.000033800887,"teacher_disagreement_score":0.0067482423,"about_ca_system_score_codex":0.00021481038,"about_ca_system_score_gemma":0.000431205,"threshold_uncertainty_score":0.71243054},"labels":[],"label_agreement":null},{"id":"W2547041422","doi":"10.1158/2326-6066.imm2016-b028","title":"Abstract B028: Blockade of the CD47 “Do not eat” signal by TTI-621 (SIRPαFc) leads to enhanced antitumor CD8+ T cell responses in vitro","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Jurkat cells; Phagocytosis; CD47; Macrophage; T cell; Antigen; Biology; Antigen presentation; CD8; Cell biology; Molecular biology; Immunology; Immune system; In vitro; Biochemistry","score_opus":0.040441897818639314,"score_gpt":0.3396606586410613,"score_spread":0.299218760822422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547041422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98135835,0.013470753,0.000025284155,0.0029991101,0.0005717499,0.0006477395,0.00020018406,0.000028182885,0.0006986576],"genre_scores_gemma":[0.98800987,0.0010606513,0.000012845598,0.00009080025,0.00004274257,0.00023016158,0.000016754566,0.00003679869,0.0104993675],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962817,0.0011388592,0.000666717,0.0006303144,0.00018712554,0.0010952771],"domain_scores_gemma":[0.9975677,0.00095559884,0.00020937459,0.00088419934,0.00034354173,0.000039552717],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013924796,0.00027906394,0.00056481775,0.00046080234,0.00032238165,0.000021504231,0.0010996324,0.0004889836,0.0012660911],"category_scores_gemma":[0.00035960492,0.00018215715,0.00016127834,0.00067728275,0.0013305818,0.00016412839,0.0004753459,0.00087446964,0.00036769453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043510534,0.00021793485,0.002172234,0.000025014453,0.00009798807,0.0000028674865,0.00036256475,0.0000038782496,0.9728248,0.000048571943,0.0030203022,0.016872767],"study_design_scores_gemma":[0.002105673,0.0002731638,0.07706897,0.00018358923,0.00001122958,0.000008057168,0.00014125824,3.847719e-7,0.90783024,0.000044747223,0.012128534,0.00020415158],"about_ca_topic_score_codex":0.000410719,"about_ca_topic_score_gemma":0.00005152986,"teacher_disagreement_score":0.07489673,"about_ca_system_score_codex":0.000357735,"about_ca_system_score_gemma":0.0005447162,"threshold_uncertainty_score":0.9996469},"labels":[],"label_agreement":null},{"id":"W2547074011","doi":"10.1158/2326-6066.imm2016-a029","title":"Abstract A029: A vaccine-induced, antigen-specific TH9 immune response blocks tumor cell engraftment","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immune system; Medicine; TLR3; Immunology; Carcinoembryonic antigen; Antigen; Cancer immunotherapy; Immunotherapy; Cancer research; Cancer vaccine; Cancer; Adjuvant; Toll-like receptor; Innate immune system; Internal medicine","score_opus":0.10201419043821038,"score_gpt":0.42256135599510314,"score_spread":0.3205471655568928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547074011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96387684,0.016446639,0.000014858988,0.015375809,0.00014560494,0.0007094224,0.000034369357,0.000092160815,0.0033042738],"genre_scores_gemma":[0.9853396,0.007873962,0.000059778675,0.00013141964,0.00029998965,0.00067677203,0.000008426482,0.000042350002,0.005567714],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973501,0.00021620542,0.00044664674,0.000623298,0.0004244098,0.00093934167],"domain_scores_gemma":[0.99734724,0.0007937779,0.000081188264,0.0010144166,0.0004959397,0.00026746094],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013489135,0.00023111209,0.00038521682,0.00019670885,0.00033824105,0.000025803927,0.00045440005,0.00021548857,0.004075812],"category_scores_gemma":[0.00021870686,0.00016245281,0.00012496517,0.0006234172,0.0003601482,0.000070024595,0.00016860856,0.0010363291,0.000729047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004815619,0.00036400507,0.0007322571,0.000034676876,0.00011808645,0.0001674406,0.00008381897,2.8005903e-7,0.97849697,0.0000687826,0.0043773563,0.01074072],"study_design_scores_gemma":[0.002775002,0.00021117064,0.060225338,0.000125206,0.000010981223,0.00008259734,0.00012294862,0.0000020328227,0.7499766,0.00006483689,0.18625493,0.00014836833],"about_ca_topic_score_codex":0.000043171472,"about_ca_topic_score_gemma":0.0000011684106,"teacher_disagreement_score":0.22852036,"about_ca_system_score_codex":0.00052732805,"about_ca_system_score_gemma":0.0006390344,"threshold_uncertainty_score":0.9968346},"labels":[],"label_agreement":null},{"id":"W2547344275","doi":"10.1158/2326-6066.imm2016-b058","title":"Abstract B058: Development of AVID200, a novel and highly potent TGF-beta neutralizing immunotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; National Research Council Canada","funders":"","keywords":"Cancer research; Immunotherapy; Tumor microenvironment; T cell; Ex vivo; Cancer immunotherapy; CD8; In vivo; Immune system; Medicine; Chemistry; Immunology; Biology","score_opus":0.12319739948423505,"score_gpt":0.4122587525665377,"score_spread":0.28906135308230263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547344275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713014,0.01678527,0.00005726588,0.009439343,0.0001363876,0.0004313266,0.000031936157,0.000025182493,0.001791932],"genre_scores_gemma":[0.9831681,0.009473284,0.00086343766,0.00012033952,0.000115304676,0.0001302821,0.000008369743,0.000035236906,0.0060856426],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99751043,0.00009188811,0.00048068658,0.00042982807,0.0006286892,0.0008585014],"domain_scores_gemma":[0.99843913,0.00039518622,0.00008180508,0.00038516062,0.00053053274,0.00016818257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010128244,0.00019626916,0.0004513408,0.0003953487,0.00026195342,0.000017977456,0.00030469443,0.00018938472,0.00061070727],"category_scores_gemma":[0.000064013366,0.00012314464,0.00008728442,0.00030796602,0.0010760784,0.000095834264,0.0002635671,0.0005585897,0.00007351605],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001579593,0.00017781167,0.012743142,0.00013731,0.0003914831,0.000024830062,0.00055235106,1.4880129e-7,0.7872367,0.0008402587,0.00033473145,0.19598167],"study_design_scores_gemma":[0.0031120793,0.00041681156,0.577926,0.000613839,0.000010653643,0.00007211955,0.00020045727,0.000003369128,0.3306279,0.00012708009,0.08670303,0.00018669904],"about_ca_topic_score_codex":0.00063776434,"about_ca_topic_score_gemma":0.000056571487,"teacher_disagreement_score":0.5651828,"about_ca_system_score_codex":0.00022633973,"about_ca_system_score_gemma":0.0008455209,"threshold_uncertainty_score":0.6686816},"labels":[],"label_agreement":null},{"id":"W2547397748","doi":"10.1158/2326-6066.imm2016-b047","title":"Abstract B047: Combining natural killer T cell immunotherapy with chemotherapy induced immunogenic cell death to target post-surgical breast cancer metastasis","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Beatrice Hunter Cancer Research Institute","funders":"","keywords":"Immunotherapy; Medicine; Cancer research; Metastasis; Natural killer T cell; Cancer; Cyclophosphamide; Gemcitabine; Breast cancer; Metastatic breast cancer; Immunology; Dendritic cell; Immune system; T cell; Chemotherapy; Internal medicine","score_opus":0.029922730648486405,"score_gpt":0.32446925554331646,"score_spread":0.2945465248948301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547397748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95359224,0.029562842,0.000035880206,0.007322938,0.0058545424,0.00097530644,0.0000829263,0.00018643755,0.00238687],"genre_scores_gemma":[0.954526,0.0052686473,0.00007164617,0.000737317,0.00014089671,0.0006845013,0.000083200786,0.0001434902,0.03834431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953239,0.00079629244,0.0007207949,0.001086365,0.00027659393,0.0017960836],"domain_scores_gemma":[0.99699336,0.0005468665,0.00027699754,0.0010157928,0.0010643281,0.00010265467],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009491562,0.00063720124,0.00081489555,0.00073601154,0.00084254774,0.00008825851,0.0010197245,0.0006553655,0.025187334],"category_scores_gemma":[0.00003193056,0.0004244303,0.00029319426,0.0007519202,0.0005836175,0.00046439492,0.0002546395,0.002024556,0.002340623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012121444,0.0004518976,0.0019630997,0.000023451657,0.0011094627,0.00003680265,0.00069811515,0.0000051065776,0.9467161,0.00007001827,0.0052888035,0.031515677],"study_design_scores_gemma":[0.011128306,0.0013147655,0.043543786,0.00022701417,0.00004355227,0.00045859386,0.0007850678,0.0000015830763,0.7180305,0.000019730287,0.22366552,0.0007815592],"about_ca_topic_score_codex":0.0026665467,"about_ca_topic_score_gemma":0.000066058274,"teacher_disagreement_score":0.2286856,"about_ca_system_score_codex":0.0008628864,"about_ca_system_score_gemma":0.00075310346,"threshold_uncertainty_score":0.99982077},"labels":[],"label_agreement":null},{"id":"W2547825706","doi":"10.1158/2326-6066.cir-16-0197","title":"Immunological Mechanisms Underneath the Efficacy of Cancer Therapy","year":2016,"lang":"en","type":"review","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Ligue Contre le Cancer; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Cancer; Medicine; Immunotherapy; Immune system; Cancer therapy; Radiation therapy; Cancer immunotherapy; Immunology; Cancer cell; Cancer research; Internal medicine","score_opus":0.17314985950208764,"score_gpt":0.44932260760969994,"score_spread":0.2761727481076123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547825706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010120795,0.98771393,0.00004210522,0.0005292315,0.00839591,0.0015790408,0.00006746922,0.00009420702,0.0014769086],"genre_scores_gemma":[0.0002492852,0.95096445,0.0000032796459,0.000065075,0.0001602956,0.0016466714,0.00010879589,0.00009381703,0.04670835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99305165,0.0035417227,0.0011233448,0.0008793184,0.00018568813,0.0012182596],"domain_scores_gemma":[0.9943652,0.0028960865,0.00067258364,0.0014238652,0.00061488274,0.000027342947],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0015298153,0.00064490305,0.0019723617,0.00062471075,0.0007240112,0.000037775495,0.0019546074,0.0017616933,0.017623067],"category_scores_gemma":[0.0003270634,0.00032850393,0.00087546045,0.0007971948,0.0025838655,0.00010756869,0.00061378547,0.003398993,0.0025550656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005659842,0.000206644,0.0000032116413,0.00034831022,0.0033006028,0.0000031932261,0.00011818602,1.5585533e-7,0.014116501,0.0035099243,0.0084589375,0.96936834],"study_design_scores_gemma":[0.0014505275,0.0004996821,0.000059006565,0.0040968647,0.00017581512,0.00006560694,0.00013021221,8.8218584e-8,0.00495838,0.00023012738,0.9879848,0.00034888842],"about_ca_topic_score_codex":0.0007813546,"about_ca_topic_score_gemma":0.000022333123,"teacher_disagreement_score":0.97952586,"about_ca_system_score_codex":0.0007196853,"about_ca_system_score_gemma":0.0014015203,"threshold_uncertainty_score":0.9999167},"labels":[],"label_agreement":null},{"id":"W2548114147","doi":"10.1158/2326-6066.imm2016-b113","title":"Abstract B113: Translational studies demonstrate that treatment with anti-PD-1 in unresponsive tumors can be improved by enhancing T cell activation in the tumor microenvironment with vaccine based immune therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre; Ottawa Hospital; Immunovaccine (Canada)","funders":"","keywords":"Tumor microenvironment; Cancer research; Immunotherapy; ELISPOT; Immune system; Tumor antigen; Medicine; T cell; Antigen; Immunology; Tumor-infiltrating lymphocytes","score_opus":0.04414680086246734,"score_gpt":0.3164271387736874,"score_spread":0.27228033791122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548114147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398002,0.050427996,0.000027779535,0.008095578,0.000073218114,0.0014465185,0.00007755668,0.000024479672,0.000026700696],"genre_scores_gemma":[0.987425,0.010417643,0.00002501566,0.0002652839,0.000012566401,0.0011678902,0.00007052992,0.000051173818,0.0005648642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995831,0.0017238926,0.0005506581,0.0006568422,0.00016845866,0.0010691531],"domain_scores_gemma":[0.9967125,0.0022751344,0.00024303305,0.00060297723,0.00014599838,0.000020370231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013291608,0.000470689,0.0006576972,0.00051882927,0.00045086397,0.00003063068,0.000512146,0.00022083177,0.00033110703],"category_scores_gemma":[0.000041455292,0.00024221762,0.000087761786,0.0005207328,0.001076634,0.00021392858,0.000036481208,0.00076142116,0.00001550747],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019965762,0.0006224403,0.010705784,0.000017768676,0.0005053798,0.000031186228,0.0028724342,0.000014264438,0.9516024,0.000005951753,0.000050862865,0.013605779],"study_design_scores_gemma":[0.012605771,0.002378301,0.15268095,0.00033098157,0.000014086002,0.000029839915,0.0043555386,9.35087e-7,0.82486224,0.0000128389465,0.0024458894,0.0002825968],"about_ca_topic_score_codex":0.0018647235,"about_ca_topic_score_gemma":0.001371792,"teacher_disagreement_score":0.14197516,"about_ca_system_score_codex":0.0007022579,"about_ca_system_score_gemma":0.0008931218,"threshold_uncertainty_score":0.98773474},"labels":[],"label_agreement":null},{"id":"W2548161278","doi":"10.1158/2326-6066.imm2016-a068","title":"Abstract A068: Determinants of efficacy in cancer immunovirotherapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Medicine; Immune system; Immunotherapy; Antigen; Immunology; Melanoma; Cancer immunotherapy; Cancer research; Cancer; Internal medicine","score_opus":0.0705228761182105,"score_gpt":0.4335871343961777,"score_spread":0.3630642582779672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548161278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750456,0.023329617,0.0000034956865,0.00061679014,0.00014622284,0.00046450234,0.000055190936,0.000008827218,0.00032971596],"genre_scores_gemma":[0.9685303,0.02940793,0.00001118853,0.000050438815,0.00014186793,0.00042602487,0.000005490375,0.000052671116,0.00137409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973567,0.00038677422,0.0004146767,0.0005591611,0.00036931926,0.00091332925],"domain_scores_gemma":[0.99848413,0.00015489783,0.000096083764,0.0008417638,0.0003484384,0.00007466224],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012414866,0.00019625215,0.00032353902,0.00035396754,0.000096139294,0.000012251974,0.000858409,0.00032460128,0.0009229388],"category_scores_gemma":[0.00017577645,0.00014782003,0.00010072977,0.00041805755,0.0009937207,0.000010155049,0.00024108303,0.00037568941,0.000051370647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004500952,0.00018470074,0.028940365,0.000018407969,0.000097038675,0.000008069572,0.000058988862,0.0000059969398,0.7694335,0.0000061508467,0.00023492935,0.19651088],"study_design_scores_gemma":[0.0027895682,0.0015396056,0.11967532,0.00014212314,0.0000021966064,0.0000032730507,0.0000365478,0.000001861457,0.8694058,0.000049763334,0.0061802934,0.00017362369],"about_ca_topic_score_codex":0.0008910566,"about_ca_topic_score_gemma":0.0025701327,"teacher_disagreement_score":0.19633725,"about_ca_system_score_codex":0.00017254836,"about_ca_system_score_gemma":0.0008411548,"threshold_uncertainty_score":0.99999034},"labels":[],"label_agreement":null},{"id":"W2548323002","doi":"10.1158/2326-6066.imm2016-b053","title":"Abstract B053: Characterizing the effects of the DNA methylation inhibitor 5-AZA-CdR during CD8 T cell expansion","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunotherapy; Cancer immunotherapy; Cytotoxic T cell; Cancer research; Immune system; Immune checkpoint; DNA methylation; Immunology; CD8; Cancer; Biology; T cell; Medicine; Genetics","score_opus":0.021777528994655,"score_gpt":0.3148692084796589,"score_spread":0.29309167948500386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548323002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988053,0.0100253355,0.000033581684,0.00080779026,0.0005417084,0.00037748733,0.000010133664,0.00000590117,0.00014501926],"genre_scores_gemma":[0.99413145,0.0048939586,0.00000981221,0.000020280992,0.00027113044,0.000101680525,0.0000073835636,0.000021964435,0.00054232264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985005,0.0003736412,0.0002347927,0.00029662452,0.00024404994,0.00035038847],"domain_scores_gemma":[0.99879146,0.00021341581,0.00013503116,0.00058909255,0.00023957416,0.000031454925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006593566,0.000118323725,0.00012575997,0.00005309891,0.0002848409,0.000015772051,0.00037886365,0.00021124643,0.000026637486],"category_scores_gemma":[0.00036192226,0.00006259316,0.00008844404,0.00017004783,0.00034325055,0.000008677118,0.00030186083,0.00023719062,0.000008927839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010235448,0.00002762933,0.004099209,0.00005509677,0.000039774608,6.3421425e-7,0.00011052902,0.0000019699728,0.9844084,0.000009451234,0.000044064265,0.011100921],"study_design_scores_gemma":[0.0004326519,0.00009717072,0.22543408,0.00007123814,0.0000064466344,5.154891e-7,0.000028334603,8.1156963e-7,0.7721283,0.00006131264,0.0016733715,0.000065756794],"about_ca_topic_score_codex":0.00004967761,"about_ca_topic_score_gemma":0.00002162928,"teacher_disagreement_score":0.22133487,"about_ca_system_score_codex":0.000054173535,"about_ca_system_score_gemma":0.00014178082,"threshold_uncertainty_score":0.25524747},"labels":[],"label_agreement":null},{"id":"W2548441506","doi":"10.1158/2326-6066.imm2016-b034","title":"Abstract B034: Smac mimetics synergistically improve the efficacy of cancer immunotherapies including immune checkpoint blockade in preclinical models","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Oncolytic virus; Cancer research; Immune system; Cancer immunotherapy; Immune checkpoint; Cancer; Immunotherapy; Necroptosis; Immunogenic cell death; Cancer cell; Programmed cell death; T cell; Tumor necrosis factor alpha; Immunology; Biology; Medicine; Apoptosis; Internal medicine","score_opus":0.1215056807900822,"score_gpt":0.4196001246765551,"score_spread":0.2980944438864729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548441506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7657863,0.22255704,0.00020842359,0.0058689597,0.0029566118,0.0012222878,0.00014274416,0.00008016974,0.0011774661],"genre_scores_gemma":[0.96135706,0.033831008,0.00009719811,0.00006819774,0.00014770747,0.00088067836,0.000011653775,0.000101283855,0.0035052365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9938011,0.0012525289,0.0018363427,0.0009814388,0.00029322147,0.0018353717],"domain_scores_gemma":[0.9912285,0.0057731727,0.0005126736,0.0016658037,0.0007745382,0.00004527074],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039365767,0.0005054962,0.0010874047,0.00050790794,0.00047904163,0.000033093325,0.0022629958,0.0010214198,0.0028126503],"category_scores_gemma":[0.0014249776,0.00031805717,0.00035463952,0.00077836623,0.0058329706,0.0002086512,0.0012285458,0.0026078161,0.00021793897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026575157,0.00038422144,0.0013470037,0.00006877382,0.0011146021,0.00000891323,0.0011227141,0.000090242924,0.89489967,0.0015038543,0.00019637741,0.09660613],"study_design_scores_gemma":[0.0076453807,0.00044583497,0.04566169,0.0009712867,0.00008433584,0.000014917109,0.00054191705,0.000025055559,0.9230161,0.002903405,0.018143468,0.0005466263],"about_ca_topic_score_codex":0.0049054273,"about_ca_topic_score_gemma":0.0004208783,"teacher_disagreement_score":0.19557074,"about_ca_system_score_codex":0.0008255028,"about_ca_system_score_gemma":0.0012361106,"threshold_uncertainty_score":0.99992716},"labels":[],"label_agreement":null},{"id":"W2548887552","doi":"10.1158/2326-6066.imm2016-b079","title":"Abstract B079: The efficacy of CD133 BiTEs and CAR-T cells in preclinical model of recurrent glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Antigen; Flow cytometry; Antibody; Population; Peripheral blood mononuclear cell; Immunophenotyping; Monoclonal antibody; Cancer research; Immunology; Medicine; Chimeric antigen receptor; Immunotherapy; Biology; In vitro; Immune system","score_opus":0.13215498967667308,"score_gpt":0.44975309362495114,"score_spread":0.31759810394827803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548887552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891287,0.006153531,0.0000046988134,0.0032245582,0.00010289659,0.0008001957,0.000041753072,0.000010524619,0.00053311535],"genre_scores_gemma":[0.9873916,0.009911913,0.00003055258,0.000017131835,0.00007117219,0.00011703746,0.0000012629287,0.000027164613,0.0024321584],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974328,0.0003794099,0.00057939655,0.00040169698,0.00059488916,0.00061178603],"domain_scores_gemma":[0.99541104,0.00314714,0.00010584415,0.00073752634,0.0004998687,0.00009860821],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023806603,0.00014083933,0.0005167309,0.00043739632,0.000055570654,0.0000073002398,0.0004097726,0.00023236235,0.0009780697],"category_scores_gemma":[0.0008779431,0.000072738076,0.00010893023,0.0005051202,0.002277499,0.000052822386,0.00032044694,0.00093416683,0.00001688068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074285828,0.00029928028,0.009309967,0.00011701834,0.00014218673,0.0000075384137,0.00050595764,0.000011047401,0.8744703,0.00006995669,0.00041360085,0.10722456],"study_design_scores_gemma":[0.007009929,0.0026076136,0.13079275,0.00087323535,0.00002540383,0.000012897452,0.00027234288,0.00044789416,0.85529894,0.00042946354,0.0020866846,0.00014283122],"about_ca_topic_score_codex":0.00025266342,"about_ca_topic_score_gemma":0.00018695115,"teacher_disagreement_score":0.12148278,"about_ca_system_score_codex":0.00018959967,"about_ca_system_score_gemma":0.00073788984,"threshold_uncertainty_score":0.99993515},"labels":[],"label_agreement":null},{"id":"W2548964503","doi":"10.1158/2326-6066.imm2016-b052","title":"Abstract B052: Peroxisome proliferator-activated receptor delta agonist GW501516 enhances the efficacy of adoptive cell therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD8; Biology; Carnitine; T cell; Cancer research; Agonist; Receptor; Peroxisome proliferator-activated receptor delta; Cell biology; Transcription factor; Nuclear receptor; Immunology; Immune system; Endocrinology; Biochemistry","score_opus":0.054252749332955014,"score_gpt":0.3480888424261176,"score_spread":0.2938360930931626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548964503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9295974,0.06262795,0.000011415078,0.0023997356,0.0021387087,0.0011487069,0.00016676846,0.00008974244,0.0018195633],"genre_scores_gemma":[0.9734016,0.018625155,0.000021630805,0.00011090702,0.00016274361,0.00063554524,0.00004708287,0.00007743624,0.0069178883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99550635,0.0012966588,0.00072987,0.00081551867,0.0002294383,0.0014221389],"domain_scores_gemma":[0.9950329,0.0022099952,0.000381114,0.0013038653,0.0010293387,0.00004277366],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015392313,0.000430332,0.00066545943,0.000307399,0.0007931979,0.00003627782,0.001783028,0.0007178394,0.008027697],"category_scores_gemma":[0.0003298897,0.00024501773,0.00021934771,0.00071072474,0.0050088055,0.0002303646,0.00041273824,0.0015564838,0.0012154626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034524165,0.0003777052,0.0010372989,0.00002583163,0.0006804083,0.000003053936,0.001184039,0.0000011679697,0.9458666,0.00015877215,0.009979224,0.037233517],"study_design_scores_gemma":[0.003619482,0.0005869468,0.011994655,0.00013687667,0.000013970887,0.0000083602445,0.0006302782,8.116871e-8,0.8640204,0.00007984252,0.118631504,0.0002775697],"about_ca_topic_score_codex":0.00057864893,"about_ca_topic_score_gemma":0.000033730932,"teacher_disagreement_score":0.10865228,"about_ca_system_score_codex":0.0004627769,"about_ca_system_score_gemma":0.0011381558,"threshold_uncertainty_score":0.9995622},"labels":[],"label_agreement":null},{"id":"W2548970834","doi":"10.1158/2326-6066.imm2016-b103","title":"Abstract B103: Intralesional administration of CTLA-4 blocking monoclonal antibodies as a means to optimize bladder cancer therapy","year":2016,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunotherapy; Bladder cancer; Cancer; Cytokine release syndrome; Immunology; Oncology; Internal medicine; Chimeric antigen receptor","score_opus":0.11231420276211847,"score_gpt":0.4422574268791818,"score_spread":0.32994322411706334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548970834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97219354,0.00967675,0.000040415453,0.013858249,0.00029399933,0.00082223216,0.0001473208,0.000038534952,0.00292897],"genre_scores_gemma":[0.9787581,0.015612496,0.00029046615,0.00034546107,0.00033106876,0.0005690037,0.00001081831,0.000042048567,0.0040405183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997725,0.00011999442,0.00038650198,0.00049416133,0.0006152844,0.0006590464],"domain_scores_gemma":[0.9983419,0.0002642149,0.00008851299,0.0004102129,0.000719965,0.00017517895],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038013692,0.00022683638,0.00045962125,0.00031411325,0.00017235639,0.000018733688,0.00025643787,0.00020357934,0.004556945],"category_scores_gemma":[0.0001230768,0.00015057962,0.000121845216,0.0002937024,0.0005571901,0.00011965818,0.00008815509,0.000353633,0.00008441776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013910326,0.00052987295,0.041451123,0.00007072477,0.0017981401,0.00011152331,0.0012609628,0.000019691535,0.7561789,0.00030206435,0.005631897,0.17873475],"study_design_scores_gemma":[0.0060834703,0.0024972772,0.32228425,0.00091325317,0.000069449045,0.00006990293,0.00024331476,0.000009664566,0.65348005,0.0004488954,0.013612597,0.00028786453],"about_ca_topic_score_codex":0.0015143765,"about_ca_topic_score_gemma":0.00020101218,"teacher_disagreement_score":0.28083313,"about_ca_system_score_codex":0.00036612002,"about_ca_system_score_gemma":0.001969294,"threshold_uncertainty_score":0.99635303},"labels":[],"label_agreement":null},{"id":"W2566878474","doi":"10.1158/2326-6074.tumimm14-ia22","title":"Abstract IA22: Regulation of metabolic plasticity in effector T cells","year":2015,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Effector; Cell biology; Biology; AMPK; T cell; Acquired immune system; Bioenergetics; Immune system; Kinase; Protein kinase A; Immunology; Mitochondrion","score_opus":0.09428215381281056,"score_gpt":0.40043620735981783,"score_spread":0.30615405354700725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566878474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98234373,0.014565718,0.000008185643,0.0005041791,0.00035006684,0.00048652585,0.000016767157,0.000016803404,0.0017079968],"genre_scores_gemma":[0.9977251,0.0013086167,0.0000531634,0.0000374153,0.00010319,0.00009996446,0.000010069257,0.000016798796,0.0006456609],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983864,0.00020294999,0.00033852924,0.00025081896,0.0004041538,0.00041719183],"domain_scores_gemma":[0.99894226,0.00026327366,0.00007828322,0.00028375178,0.00035114278,0.00008129071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010922296,0.00011270771,0.0003802597,0.0004508518,0.00003739206,0.000008008288,0.00016370173,0.00019304328,0.0005943869],"category_scores_gemma":[0.00021317299,0.00009670245,0.00007221602,0.0007157534,0.0005201195,0.000076484845,0.00005880993,0.000504996,0.000068024856],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075504985,0.000176314,0.02188892,0.00009174903,0.00019128031,0.000012943219,0.0005783348,0.000025246867,0.94690347,0.00010120538,0.0016613432,0.02081868],"study_design_scores_gemma":[0.0039695557,0.00033261036,0.61350006,0.00015478568,0.000015571706,0.00000763393,0.00019574253,0.000045558536,0.37060508,0.00008253833,0.01101183,0.00007906087],"about_ca_topic_score_codex":0.0025083341,"about_ca_topic_score_gemma":0.0002201414,"teacher_disagreement_score":0.59161115,"about_ca_system_score_codex":0.00025400333,"about_ca_system_score_gemma":0.00073219504,"threshold_uncertainty_score":0.650812},"labels":[],"label_agreement":null},{"id":"W2585311655","doi":"10.1158/2326-6066.cir-16-0162","title":"NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agricultural Research Institute of Ontario; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Interleukin 12; Oncolytic virus; Medicine; Cancer research; Dendritic cell; Cytotoxic T cell; Immunotherapy; Immunology; Debulking; Ovarian cancer; Ex vivo; Immunogenic cell death; Cancer; Immune system; In vivo; Biology; Internal medicine; In vitro","score_opus":0.10533089748509131,"score_gpt":0.40601420218892603,"score_spread":0.30068330470383475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585311655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98299724,0.014045421,0.0001719516,0.000960562,0.00009625471,0.001241357,0.00012632331,0.0000098692935,0.00035104295],"genre_scores_gemma":[0.99321944,0.0035706998,0.0005096208,0.000064962805,0.00024003605,0.0012412166,0.0001607537,0.00006680465,0.0009264726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99760395,0.00034659228,0.00028572782,0.0006931677,0.00036623236,0.0007043011],"domain_scores_gemma":[0.99720025,0.00004398916,0.00020446116,0.001751855,0.00067317154,0.00012629069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009728708,0.0002131532,0.000308545,0.00017332919,0.0008301446,0.00008890707,0.0011541572,0.00027663165,0.00012906479],"category_scores_gemma":[0.000053802265,0.00019322278,0.000086908905,0.00010976522,0.00061679416,0.000026507483,0.00031999132,0.00034797445,0.000006037266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009379226,0.00021812203,0.0057468284,0.000105789004,0.00020096399,0.000004261683,0.00024049504,0.000014197998,0.97018886,0.000007702537,0.00086412777,0.0130294245],"study_design_scores_gemma":[0.0023730432,0.0062770755,0.0033818365,0.00004800563,0.000021934866,0.0000046230925,0.00025391614,0.00018407869,0.9810717,0.00004847163,0.0061294017,0.00020588255],"about_ca_topic_score_codex":0.00069268234,"about_ca_topic_score_gemma":0.000398826,"teacher_disagreement_score":0.012823542,"about_ca_system_score_codex":0.000099538345,"about_ca_system_score_gemma":0.00063244934,"threshold_uncertainty_score":0.7879396},"labels":[],"label_agreement":null},{"id":"W2592537573","doi":"10.1158/2326-6074.tumimm16-a64","title":"Abstract A64: Mast cell expressed FcεR beta subunit (MS4A2) is prognostic in lung adenocarcinoma","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Adenocarcinoma; Gene signature; Lung cancer; Immune system; Biology; Cancer research; Carcinogenesis; Microarray analysis techniques; Gene expression profiling; Cancer; Immunology; Medicine; Oncology; Gene; Gene expression; Genetics","score_opus":0.05939431534377648,"score_gpt":0.34024845308764096,"score_spread":0.2808541377438645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592537573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9140704,0.062374387,0.000004209788,0.0020314974,0.00087493326,0.00069324346,0.00013738159,0.000047091395,0.019766811],"genre_scores_gemma":[0.96602094,0.0028905934,0.000013571548,0.00006519825,0.00009239176,0.00035269052,0.00008676876,0.000053059182,0.030424757],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964986,0.0004465354,0.0005121272,0.00083505135,0.0001390993,0.0015686146],"domain_scores_gemma":[0.99734,0.0003895622,0.00023863724,0.0016274964,0.0003377881,0.000066475244],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011724603,0.00033170267,0.0005650812,0.0004850011,0.0012119584,0.0001336174,0.0018294522,0.00070720573,0.009461553],"category_scores_gemma":[0.00019179887,0.00032104494,0.00011830328,0.00020787955,0.0019732267,0.00023193378,0.00075231603,0.0020930755,0.0015652301],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006231208,0.00041160302,0.27222213,0.0002584853,0.00023624707,0.00017448881,0.0015452503,0.0000021470964,0.6999353,0.0003996944,0.015644753,0.008546743],"study_design_scores_gemma":[0.0036169458,0.00022964823,0.75135267,0.00017871779,0.000030631254,0.000021504327,0.0005422832,0.000010430373,0.16791302,0.00012955634,0.07558404,0.00039053735],"about_ca_topic_score_codex":0.005173623,"about_ca_topic_score_gemma":0.0008176411,"teacher_disagreement_score":0.5320223,"about_ca_system_score_codex":0.0002370756,"about_ca_system_score_gemma":0.00047066459,"threshold_uncertainty_score":0.9999242},"labels":[],"label_agreement":null},{"id":"W2593211024","doi":"10.1158/2326-6074.tumimm16-a51","title":"Abstract A51: Early-life infection delays B cell precursor leukemia onset in Eu-Ret mice via an IL-23-dependent depletion of leukemia-initiating cells","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Leukemia; Medicine; Immunology; Epidemiology; Population; Disease; In utero; Internal medicine; Cancer research; Biology; Pregnancy; Fetus","score_opus":0.05886984749239877,"score_gpt":0.37392411001597525,"score_spread":0.3150542625235765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593211024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316025,0.00080912677,0.00016958296,0.00046011896,0.00047607394,0.0013322955,0.00011442101,0.00006929859,0.0034088586],"genre_scores_gemma":[0.996103,0.0018267984,0.00026028208,0.00008677008,0.00031849326,0.00039286347,0.00009865377,0.000106902764,0.0008062285],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99445647,0.0007436643,0.0009499069,0.0009790143,0.0013138553,0.0015571042],"domain_scores_gemma":[0.99540555,0.0008593796,0.00051777816,0.0016771061,0.0011396356,0.00040054298],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031352446,0.0003894448,0.00080506614,0.0009754556,0.00065951113,0.00013391832,0.0010188933,0.0008415566,0.00045323826],"category_scores_gemma":[0.0015130037,0.00038950783,0.00015203764,0.00047480818,0.001296934,0.0006541464,0.00064531685,0.0028024039,0.00036573256],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0044595986,0.0004869477,0.11977814,0.00076218706,0.00031305332,0.0003807954,0.0016210399,0.0004459178,0.858121,0.00003111336,0.0018614939,0.01173875],"study_design_scores_gemma":[0.008856548,0.0016646371,0.64164203,0.000595553,0.0000639989,0.00010205455,0.00043799603,0.003789479,0.34168062,0.0001361495,0.0006118581,0.0004190541],"about_ca_topic_score_codex":0.037821364,"about_ca_topic_score_gemma":0.002882707,"teacher_disagreement_score":0.52186394,"about_ca_system_score_codex":0.007716748,"about_ca_system_score_gemma":0.00794896,"threshold_uncertainty_score":0.9998557},"labels":[],"label_agreement":null},{"id":"W2594407313","doi":"10.1158/2326-6074.tumimm16-pr09","title":"Abstract PR09: A novel chimeric antigen receptor containing JAK-STAT signaling domains mediates superior antitumor effects","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Chimeric antigen receptor; Cancer research; CD19; Cytokine; CD28; STAT5; T cell; T-cell receptor; JAK-STAT signaling pathway; Cytokine receptor; Signal transduction; Immunology; Biology; Medicine; Tyrosine kinase; Cell biology; Antigen; Immune system","score_opus":0.08268631610408858,"score_gpt":0.4196002134770678,"score_spread":0.33691389737297917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594407313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822592,0.009577832,0.00002393453,0.0024655925,0.0008572078,0.0017844898,0.00004757858,0.000112096866,0.00287203],"genre_scores_gemma":[0.988214,0.006160513,0.00037131712,0.00011741418,0.0008595166,0.00058577076,0.000053063763,0.00013651172,0.0035018933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99518883,0.00030840983,0.0005103927,0.0009238739,0.0011319913,0.0019364747],"domain_scores_gemma":[0.9957231,0.0012487418,0.00020018248,0.0016176415,0.00082365813,0.0003866496],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026911946,0.0003873707,0.0009411599,0.00063785224,0.0016336449,0.00031073755,0.0011894173,0.00038176455,0.00583867],"category_scores_gemma":[0.0022404005,0.00034469357,0.00022297673,0.00044265683,0.0024149206,0.00033642584,0.0006129514,0.0022604417,0.00042738896],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027502119,0.00022752293,0.06103952,0.00026922786,0.0007247382,0.00031513016,0.0010541041,0.0000020976872,0.9105674,0.00006856083,0.0004629064,0.02251855],"study_design_scores_gemma":[0.008689327,0.0018423595,0.37700698,0.0010017299,0.000050950366,0.00011853015,0.0011549594,0.00007158225,0.58360624,0.000056253262,0.025908079,0.00049303024],"about_ca_topic_score_codex":0.0025195747,"about_ca_topic_score_gemma":0.0001264511,"teacher_disagreement_score":0.3269612,"about_ca_system_score_codex":0.00065402046,"about_ca_system_score_gemma":0.001597994,"threshold_uncertainty_score":0.9999005},"labels":[],"label_agreement":null},{"id":"W2594628337","doi":"10.1158/2326-6074.tumimm16-a28","title":"Abstract A28: Adenoviruses up-regulate IL17F, but not IL17A, and activate NK cells, with potential impact on oncolytic adenovirus efficacy","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Oncolytic virus; Oncolytic adenovirus; Chemokine; Biology; Cytokine; Adenoviridae; Immune system; Immunology; Cancer research; Genetic enhancement; Gene","score_opus":0.05472093910081956,"score_gpt":0.39546851840541564,"score_spread":0.3407475793045961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594628337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935301,0.0037679593,0.000006902117,0.00076115556,0.00031212898,0.0007877819,0.00016297991,0.000029997318,0.00064097653],"genre_scores_gemma":[0.99049675,0.0052647037,0.000018059302,0.00012905218,0.0005099187,0.00017642847,0.000040206804,0.000120737976,0.0032441367],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99593776,0.0003811261,0.00032504153,0.0011275919,0.0007506547,0.0014778293],"domain_scores_gemma":[0.99684674,0.00014325425,0.00021853867,0.002019585,0.0004629978,0.00030887482],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0010260466,0.00047713146,0.0004812238,0.00032072776,0.0013453439,0.00034655133,0.0014587322,0.0005241351,0.00039053507],"category_scores_gemma":[0.00020052597,0.00037757593,0.00015650764,0.00016611729,0.0022313655,0.00003562508,0.00071127317,0.001323439,0.00016238065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038073584,0.0002021913,0.0007412951,0.000038560378,0.0007290648,0.00009375653,0.00007547343,0.00026423816,0.9275237,0.000008158047,0.0009186465,0.031331353],"study_design_scores_gemma":[0.004146244,0.0069080302,0.074787654,0.00009608648,0.000027467031,0.00004011834,0.00008936949,0.000030592568,0.91093564,0.000025832529,0.0024694721,0.00044346915],"about_ca_topic_score_codex":0.0013602629,"about_ca_topic_score_gemma":0.0003920463,"teacher_disagreement_score":0.07404636,"about_ca_system_score_codex":0.00025186455,"about_ca_system_score_gemma":0.0011900292,"threshold_uncertainty_score":0.99995476},"labels":[],"label_agreement":null},{"id":"W2594697025","doi":"10.1158/2326-6074.tumimm16-a74","title":"Abstract A74: CAR-T cells harboring camelid single domain antibody as targeting agent to CEACAM6 antigen in pancreatic cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Helix Biopharma (Canada)","funders":"","keywords":"Antigen; Antibody; Cancer research; Cytotoxic T cell; Biology; CD28; Chimeric antigen receptor; T cell; Pancreatic cancer; Molecular biology; Immunology; Cancer; Immune system; In vitro; CD8; Biochemistry","score_opus":0.0871099523506898,"score_gpt":0.44197770087871424,"score_spread":0.35486774852802444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594697025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727054,0.009814563,0.0000066668827,0.004255661,0.0008124303,0.0018165241,0.000035545185,0.000061984356,0.010491218],"genre_scores_gemma":[0.9803113,0.009920112,0.00018919108,0.0001809128,0.000699361,0.0006651366,0.000024068559,0.00013017857,0.007879744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944466,0.00041208553,0.0006500999,0.0010702916,0.0011724579,0.0022485154],"domain_scores_gemma":[0.9965926,0.00037079075,0.00017754221,0.0017504671,0.00066619896,0.00044241562],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002955316,0.00038684503,0.00089826924,0.0008967265,0.0008889546,0.00026028664,0.001224664,0.00038751328,0.007778044],"category_scores_gemma":[0.0007689151,0.00037400395,0.00016945023,0.000624599,0.00087702234,0.0002393386,0.0008130729,0.0021857682,0.0005309794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013526869,0.00022059423,0.10739887,0.00016584517,0.00028759264,0.00073479913,0.0016108529,0.000025608013,0.8720008,0.000025251285,0.0010920732,0.01508499],"study_design_scores_gemma":[0.0029777386,0.00063145976,0.4143162,0.0010210495,0.000024143523,0.000024512186,0.0014532887,0.000026503374,0.5222064,0.00009070039,0.05679513,0.0004328045],"about_ca_topic_score_codex":0.038520765,"about_ca_topic_score_gemma":0.0014971272,"teacher_disagreement_score":0.3497944,"about_ca_system_score_codex":0.0021824662,"about_ca_system_score_gemma":0.0014596179,"threshold_uncertainty_score":0.9998712},"labels":[],"label_agreement":null},{"id":"W2594818459","doi":"10.1158/2326-6074.tumimm16-a68","title":"Abstract A68: Phosphodiesterase-5 inhibition modulates surgery-induced myeloid-derived suppressor cells to reduce postoperative metastatic disease","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Université de Sherbrooke","funders":"","keywords":"Medicine; Perioperative; Immunosuppression; Myeloid-derived Suppressor Cell; Immune system; Cancer; Metastasis; Immunotherapy; Pharmacology; Cancer cell; Immunology; Cancer research; Surgery; Internal medicine; Suppressor","score_opus":0.098180305023975,"score_gpt":0.3799785207298601,"score_spread":0.2817982157058851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594818459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726359,0.01362409,0.000012436121,0.0069447085,0.004304284,0.0014054538,0.0003212742,0.00011174484,0.000640104],"genre_scores_gemma":[0.99111664,0.0016142132,0.000055168817,0.00040629934,0.000104645296,0.0012940186,0.0001774229,0.000102426595,0.0051291874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949929,0.0009976688,0.0007475925,0.001230834,0.00023586839,0.0017951465],"domain_scores_gemma":[0.99510264,0.0011257958,0.0003518959,0.002236481,0.0010166309,0.00016655341],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001601118,0.0005432005,0.0009025764,0.0005475839,0.0025069923,0.0002851712,0.0012975256,0.00036131789,0.0036209575],"category_scores_gemma":[0.0013176751,0.0005191139,0.00025529048,0.00028607296,0.0018718451,0.0006003049,0.0009971574,0.0017171238,0.0026814064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025008249,0.00022575168,0.0006535603,0.00007409809,0.0006219749,0.00015144653,0.0012093567,0.000032948377,0.9690312,0.000077453944,0.015632918,0.009788452],"study_design_scores_gemma":[0.0015517485,0.00018519236,0.057934932,0.00031592592,0.000055571618,0.000020895202,0.000534216,0.0000037957914,0.9279543,0.00018957708,0.010720862,0.00053297135],"about_ca_topic_score_codex":0.00251789,"about_ca_topic_score_gemma":0.00016488509,"teacher_disagreement_score":0.057281375,"about_ca_system_score_codex":0.0006118673,"about_ca_system_score_gemma":0.0011139154,"threshold_uncertainty_score":0.99972606},"labels":[],"label_agreement":null},{"id":"W2621331192","doi":"10.1158/2326-6066.cir-17-0224","title":"Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology Keystone Symposia Meeting Summary","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Institutes for BioMedical Research; California Institute of Technology; University of California, San Francisco; Memorial Sloan-Kettering Cancer Center; University of California, San Diego; National Cancer Institute; National Institutes of Health; Cancer Research Institute","keywords":"Tumor immunology; Immunotherapy; Medicine; Cancer immunotherapy; Mainstream; Cancer; Cancer immunology; Clinical Oncology; Immunology; Oncology; Internal medicine; Political science","score_opus":0.06634672360924461,"score_gpt":0.4207497187492648,"score_spread":0.3544029951400202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621331192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8160245,0.15857887,0.0000035721184,0.013333719,0.00094657036,0.0010059297,0.000028920467,0.00007055751,0.010007367],"genre_scores_gemma":[0.8616083,0.13223748,0.00014483297,0.0005591744,0.00032680825,0.0010412667,0.00001790019,0.000097930046,0.003966308],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99543667,0.0007283686,0.0007618799,0.0009955845,0.00044731857,0.0016301634],"domain_scores_gemma":[0.9969994,0.0005111,0.0005222324,0.0014419911,0.00038461795,0.00014066469],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.002525077,0.00043731972,0.0010769899,0.00083453197,0.001270991,0.00014312478,0.0009204115,0.0008076599,0.0006992012],"category_scores_gemma":[0.0003659704,0.00040988295,0.00016439182,0.0004598402,0.0033921034,0.0003077033,0.00063720637,0.0020890352,0.000023276853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01600234,0.00031494815,0.12991953,0.0001436015,0.0014782124,0.00041455362,0.0022359455,0.0000068028917,0.5320088,0.00035788908,0.0010411863,0.3160762],"study_design_scores_gemma":[0.026625175,0.0027061147,0.7149136,0.0030083247,0.00011843555,0.00072637864,0.003386188,0.00025915142,0.03474244,0.00028088997,0.2122729,0.0009603761],"about_ca_topic_score_codex":0.02939554,"about_ca_topic_score_gemma":0.006862988,"teacher_disagreement_score":0.5849941,"about_ca_system_score_codex":0.002101221,"about_ca_system_score_gemma":0.0019432172,"threshold_uncertainty_score":0.9998353},"labels":[],"label_agreement":null},{"id":"W2740828344","doi":"10.1158/2326-6066.cir-17-0012","title":"Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Deutsche Forschungsgemeinschaft; Howard Hughes Medical Institute","keywords":"Biology; Phenotype; Antibody; Multiple myeloma; Bone marrow; Plasma cell; Lineage (genetic); Somatic cell; B cell; Immunology; Molecular biology; Genetics; Gene","score_opus":0.12933774684445906,"score_gpt":0.42897214913289894,"score_spread":0.29963440228843985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740828344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925811,0.00488329,0.0000046240507,0.00081923563,0.00015387915,0.0007075078,0.000050042177,0.0000138853475,0.00078638893],"genre_scores_gemma":[0.9973798,0.0010805028,0.00009285189,0.000010805924,0.00004583389,0.00021846336,0.000059221,0.000022264627,0.0010902674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790573,0.00024136639,0.00034911622,0.00041348944,0.00044342765,0.0006468629],"domain_scores_gemma":[0.9984284,0.00027880925,0.00011141219,0.0007250845,0.00028831567,0.00016796413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000690167,0.00016088123,0.0004962443,0.000368131,0.00036067708,0.000033870605,0.0002924684,0.00017324743,0.00022051018],"category_scores_gemma":[0.0008039762,0.00013179512,0.00005758761,0.0001459654,0.0014709055,0.00013257026,0.00054289604,0.00074009266,0.000032925782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004451492,0.0004613019,0.90795153,0.00013331675,0.00023058674,0.00048491388,0.00029144308,5.838005e-7,0.04686013,0.000038989954,0.00017244037,0.03892326],"study_design_scores_gemma":[0.008930198,0.00054014544,0.9662821,0.0004352117,0.000014569612,0.000050241335,0.00018005175,0.0009789338,0.02192629,0.000047136073,0.00052405824,0.000091008194],"about_ca_topic_score_codex":0.0028956996,"about_ca_topic_score_gemma":0.0009896787,"teacher_disagreement_score":0.058330618,"about_ca_system_score_codex":0.00022856737,"about_ca_system_score_gemma":0.00025897808,"threshold_uncertainty_score":0.54196125},"labels":[],"label_agreement":null},{"id":"W2743158281","doi":"10.1158/2326-6066.cir-16-0392","title":"Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Lung cancer; Adenocarcinoma; Hazard ratio; Gene signature; Medicine; Immune system; Oncology; Cancer; Internal medicine; Microarray; Context (archaeology); Stage (stratigraphy); Proportional hazards model; Confidence interval; Immunology; Biology; Gene; Gene expression","score_opus":0.04431057520144525,"score_gpt":0.33784700821927166,"score_spread":0.2935364330178264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743158281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837755,0.012888331,0.0000033499307,0.00044135877,0.0007662177,0.000913483,0.00024548307,0.000014968028,0.00095132756],"genre_scores_gemma":[0.9941355,0.00070161076,0.000051707644,0.000011760459,0.000042073196,0.00072943437,0.00014258586,0.000023805671,0.004161523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980201,0.0003483185,0.00037875524,0.00042416048,0.00006927613,0.0007593618],"domain_scores_gemma":[0.99825805,0.000272859,0.00021631809,0.0006913595,0.00053793885,0.000023477],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009011116,0.00015463443,0.00042954102,0.00028282258,0.00058094045,0.000022941935,0.00090910634,0.00040744332,0.0012475495],"category_scores_gemma":[0.00050262315,0.00014576467,0.00007588811,0.000121069635,0.001215542,0.000112910086,0.0004090262,0.0006159922,0.00009361416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012262749,0.00054090715,0.72782314,0.00013247828,0.00024094144,0.0000011170757,0.0007031936,5.1395676e-7,0.23989965,0.0016423763,0.0052111223,0.022578288],"study_design_scores_gemma":[0.003980601,0.00062605727,0.8399605,0.00008398902,0.000016341875,7.5605675e-7,0.00017498987,0.0000028532074,0.13970375,0.0003236516,0.014967331,0.0001591826],"about_ca_topic_score_codex":0.004325548,"about_ca_topic_score_gemma":0.0009009643,"teacher_disagreement_score":0.112137355,"about_ca_system_score_codex":0.00016792033,"about_ca_system_score_gemma":0.00021767245,"threshold_uncertainty_score":0.99966544},"labels":[],"label_agreement":null},{"id":"W2754197885","doi":"10.1158/2326-6066.cir-17-0056","title":"Immunosurveillance and Immunoediting of Breast Cancer via Class I MHC Receptors","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Ottawa","funders":"","keywords":"Immunoediting; Immunosurveillance; Biology; MHC class I; Immune system; Cancer research; Major histocompatibility complex; NKG2D; Immunology; Cancer; Granzyme B; Immunotherapy; CD8; Cytotoxic T cell","score_opus":0.04309160312057609,"score_gpt":0.36013517898809067,"score_spread":0.3170435758675146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754197885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484165,0.036809273,0.000010024636,0.0026871453,0.009135075,0.00034004494,0.000054082593,0.000059985585,0.0024878702],"genre_scores_gemma":[0.9689918,0.013082217,0.0000056815566,0.000049183313,0.00013765527,0.0001916618,0.00003450134,0.00003884641,0.017468449],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99740845,0.0005958716,0.0005223508,0.0005388323,0.000113953094,0.0008205501],"domain_scores_gemma":[0.99737245,0.0002548112,0.00046155305,0.0010421042,0.00083815533,0.000030904204],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00095916196,0.00025832313,0.0005200481,0.0003193288,0.0018337809,0.00007400178,0.00081169937,0.00048389848,0.0047830795],"category_scores_gemma":[0.00026842766,0.00024128986,0.00011471794,0.00017597013,0.002590038,0.0004049993,0.0005967326,0.0014002047,0.0002459848],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014554373,0.00008081249,0.03819579,0.000055940498,0.0005718462,0.000002779019,0.00037356524,0.0000016160831,0.9193333,0.00015077711,0.0057397797,0.034038402],"study_design_scores_gemma":[0.002906068,0.00025091335,0.6416697,0.00026725876,0.000031365922,0.0002466379,0.00092480227,0.000012478581,0.27962402,0.00006832292,0.07363651,0.00036193302],"about_ca_topic_score_codex":0.006305748,"about_ca_topic_score_gemma":0.00018193934,"teacher_disagreement_score":0.63970923,"about_ca_system_score_codex":0.0002398719,"about_ca_system_score_gemma":0.0002148318,"threshold_uncertainty_score":0.9994657},"labels":[],"label_agreement":null},{"id":"W2755137651","doi":"10.1158/2326-6066.cir-17-0102","title":"Customized Viral Immunotherapy for HPV-Associated Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario; McMaster University Medical Centre","funders":"Terry Fox Foundation","keywords":"Oncolytic virus; Immunotherapy; Cancer immunotherapy; Immunology; Immune system; Cancer; Vaccination; CD8; Virotherapy; Cancer research; Medicine; Tumor microenvironment; Cytotoxic T cell; Epitope; Priming (agriculture); Virology; Biology; Antibody; Internal medicine; In vitro","score_opus":0.0796066015998657,"score_gpt":0.4180975750450982,"score_spread":0.3384909734452325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755137651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8123315,0.17126893,0.00008992313,0.0057401657,0.005629328,0.0020035098,0.00039665436,0.00022114333,0.002318862],"genre_scores_gemma":[0.9024484,0.022907674,0.00003976886,0.00035085532,0.00018536125,0.003781299,0.00012067817,0.00013637672,0.070029594],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950159,0.0013372472,0.000665053,0.0008278331,0.00015515735,0.0019987917],"domain_scores_gemma":[0.9955003,0.0011207667,0.0004866067,0.0018846412,0.00096805615,0.000039578754],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["sts"],"category_scores_codex":[0.0026694275,0.00046976746,0.00095846306,0.00045939087,0.004878584,0.00023802239,0.0025193638,0.0010177083,0.0051001045],"category_scores_gemma":[0.0011946454,0.00042346772,0.0004246133,0.00020626707,0.0030943502,0.00042834535,0.00042486555,0.0015598948,0.00050264533],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0134313,0.0003005884,0.0024768414,0.000022922814,0.0026826265,0.000005643337,0.00075804774,0.0000028646787,0.8283388,0.0011541193,0.016056597,0.13476963],"study_design_scores_gemma":[0.02173935,0.00092720217,0.06306399,0.0001722234,0.00007133552,0.000022027813,0.0003733848,0.000014427182,0.36954573,0.001239194,0.54211515,0.000716002],"about_ca_topic_score_codex":0.0043449607,"about_ca_topic_score_gemma":0.00029371562,"teacher_disagreement_score":0.52605855,"about_ca_system_score_codex":0.0005794632,"about_ca_system_score_gemma":0.0010401148,"threshold_uncertainty_score":0.9998217},"labels":[],"label_agreement":null},{"id":"W2760662626","doi":"10.1158/2326-6066.cir-17-0131","title":"Treg Depletion Licenses T Cell–Driven HEV Neogenesis and Promotes Tumor Destruction","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"T-cell and B-cell Immunology","field":"Immunology and Microbiology","cited_by":129,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Medical Research Council; Cardiff University; Canolfan Ymchwil Canser Cymru; National Cancer Institute; National Institutes of Health; Cancer Research UK; Wellcome Trust; Deutsches Krebsforschungszentrum; Genentech; American Association for Cancer Research","keywords":"High endothelial venules; Immune system; Tumor microenvironment; Cancer research; Biology; Immunology; FOXP3; T cell; CD8; Chemokine receptor; Chemokine","score_opus":0.05112450620899809,"score_gpt":0.33041443515903307,"score_spread":0.27928992895003496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760662626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9593463,0.03539392,0.000012994915,0.0017201768,0.0014463644,0.00052852265,0.000032129617,0.00011116173,0.0014084651],"genre_scores_gemma":[0.9864482,0.005473381,0.00008113947,0.00005740738,0.00013182833,0.00030793357,0.00004253589,0.00004782416,0.0074097146],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968253,0.00077075226,0.00037983272,0.000802348,0.00009133996,0.0011304261],"domain_scores_gemma":[0.99790704,0.0002834002,0.00027104156,0.001104698,0.0003845806,0.000049262122],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["sts"],"category_scores_codex":[0.00060468045,0.0003189496,0.00050422584,0.00036686283,0.002799884,0.00013297079,0.00091916026,0.00060062594,0.000881708],"category_scores_gemma":[0.00028665012,0.00029161305,0.00010207998,0.00016227228,0.0033255862,0.00028501768,0.00069966697,0.0011246918,0.0006948765],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004917608,0.00013892517,0.02197357,0.00004621217,0.00024564017,0.00002728956,0.00034362113,8.138098e-7,0.95230716,0.00029989408,0.0015374245,0.02258769],"study_design_scores_gemma":[0.00258002,0.00068744516,0.06261024,0.00007749575,0.00006439872,0.00038129144,0.0006026494,0.0000071685045,0.88458395,0.0004915298,0.047537,0.00037680235],"about_ca_topic_score_codex":0.0028228348,"about_ca_topic_score_gemma":0.0003999508,"teacher_disagreement_score":0.06772319,"about_ca_system_score_codex":0.00015574557,"about_ca_system_score_gemma":0.0002829436,"threshold_uncertainty_score":0.9999536},"labels":[],"label_agreement":null},{"id":"W2765326687","doi":"10.1158/2326-6066.cir-17-0175","title":"Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Rosetrees Trust; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Subversion; Immune system; Tumor necrosis factor alpha; Immunotherapy; Immunology; Medicine; Cancer research; Biology; Political science","score_opus":0.058015048956315964,"score_gpt":0.3881521610682535,"score_spread":0.3301371121119375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765326687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92915136,0.06452041,0.000004207559,0.0025823715,0.00039832882,0.00039946302,0.000025927562,0.000018311846,0.002899628],"genre_scores_gemma":[0.9666458,0.03087319,0.00006588549,0.000039391005,0.00007269182,0.000053741365,0.0000075088656,0.00001965526,0.0022221538],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99826294,0.00019174349,0.0003113451,0.00039983378,0.00033140273,0.0005027036],"domain_scores_gemma":[0.9980731,0.00019570629,0.00021742783,0.0010090574,0.00042907128,0.00007563764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011621827,0.00015335677,0.00043776626,0.00020684919,0.00054904236,0.00004148475,0.0004904429,0.00013831754,0.00033583617],"category_scores_gemma":[0.00026424127,0.00013238825,0.000091308284,0.00018023053,0.0024146636,0.00013494612,0.0003282829,0.0005641572,0.000016902386],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052445354,0.00013955431,0.17154017,0.00029874942,0.00019492189,0.00003866257,0.00043372455,1.6589453e-7,0.7785404,0.000076824195,0.0010593173,0.042432997],"study_design_scores_gemma":[0.004159488,0.00086692616,0.7564965,0.0004089888,0.000016280244,0.000048102964,0.00044189687,0.000022548684,0.22700469,0.00010063564,0.01026954,0.00016443142],"about_ca_topic_score_codex":0.0019775128,"about_ca_topic_score_gemma":0.000100553465,"teacher_disagreement_score":0.5849563,"about_ca_system_score_codex":0.00013514342,"about_ca_system_score_gemma":0.00041493453,"threshold_uncertainty_score":0.88969284},"labels":[],"label_agreement":null},{"id":"W2766991138","doi":"10.1158/2326-6066.cir-17-0229","title":"Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie University; Canadian Cancer Society","keywords":"Immunotherapy; Breast cancer; Medicine; Immunogenic cell death; Metastatic breast cancer; Immunology; Cancer immunotherapy; Cancer; Natural killer cell; Chemotherapy; Immune system; Cancer research; Active immunotherapy; T cell; Cytotoxic T cell; Biology; Internal medicine","score_opus":0.037686869023074596,"score_gpt":0.3424158288692887,"score_spread":0.30472895984621406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766991138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9492743,0.037019745,0.00002450537,0.0033943497,0.0065292,0.0010433707,0.000015366806,0.0000821686,0.0026169817],"genre_scores_gemma":[0.9579575,0.007427241,0.000031024654,0.00025468474,0.00005394553,0.0006726126,0.000090454545,0.000088947134,0.033423573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99642104,0.00081911014,0.00055474485,0.0007743243,0.00019195597,0.0012388101],"domain_scores_gemma":[0.9974965,0.00020460715,0.0004220309,0.0012446718,0.00059637503,0.000035812434],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009336401,0.0004518751,0.0006354011,0.0006207536,0.0014080438,0.00016131031,0.0011575011,0.00040708602,0.0049321726],"category_scores_gemma":[0.000039307084,0.00037818804,0.00016056067,0.00032782345,0.00071473315,0.00063896773,0.00021257657,0.0022875105,0.0005721507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00499865,0.0007692118,0.011423625,0.00004187883,0.0005959976,0.000017410566,0.00087934476,0.000008087172,0.9644066,0.00013111375,0.0026869308,0.014041168],"study_design_scores_gemma":[0.022087682,0.0010965005,0.3260252,0.00023634199,0.000057893572,0.0001762109,0.0011167943,0.00006913192,0.6087955,0.00013496654,0.03937513,0.00082861923],"about_ca_topic_score_codex":0.008313961,"about_ca_topic_score_gemma":0.0005179202,"teacher_disagreement_score":0.35561103,"about_ca_system_score_codex":0.0008069574,"about_ca_system_score_gemma":0.00056630466,"threshold_uncertainty_score":0.999892},"labels":[],"label_agreement":null},{"id":"W2781496272","doi":"10.1158/2326-6066.cir-17-0383","title":"Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity <i>In Vivo</i>","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Rosetrees Trust","keywords":"Ectodomain; CD8; Cancer research; Cytotoxic T cell; Immunotherapy; Melanoma; T cell; Cytolysis; Biology; Immunology; Cancer immunotherapy; Immune system; Receptor; In vitro; Biochemistry","score_opus":0.03098202432855256,"score_gpt":0.3138554816612241,"score_spread":0.28287345733267155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781496272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97913563,0.0076514576,0.000027032738,0.00041895604,0.008689118,0.00052721484,0.000008231481,0.00008000792,0.0034623728],"genre_scores_gemma":[0.9763093,0.001247775,0.000006950945,0.00008105702,0.0001974622,0.00021465478,0.000029003553,0.000034276098,0.02187954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705386,0.00096515607,0.00031377966,0.00067210547,0.00008632253,0.0009087965],"domain_scores_gemma":[0.99873286,0.00036476637,0.0001297979,0.00042761205,0.00031114905,0.000033798355],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009607999,0.00025890162,0.00039387296,0.00049518945,0.00060598046,0.00005796626,0.00027881205,0.0006018281,0.0039533735],"category_scores_gemma":[0.00012172858,0.0002428297,0.000070592556,0.00043574598,0.0011613745,0.00042832087,0.00026711135,0.0014536629,0.0012899633],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019492637,0.000198703,0.0053665615,0.00003421698,0.00015157275,0.0000010013172,0.00023756207,3.0739807e-7,0.9636813,0.000085171385,0.01717647,0.011117869],"study_design_scores_gemma":[0.0027907828,0.0016600197,0.027284313,0.000056090357,0.000016977945,0.000011143873,0.00047978247,0.000010626749,0.8529748,0.000026382208,0.11446386,0.00022522041],"about_ca_topic_score_codex":0.0017206154,"about_ca_topic_score_gemma":0.00024075352,"teacher_disagreement_score":0.1107065,"about_ca_system_score_codex":0.00025944685,"about_ca_system_score_gemma":0.00020436794,"threshold_uncertainty_score":0.99948764},"labels":[],"label_agreement":null},{"id":"W2799597692","doi":"10.1158/2326-6066.cir-17-0475","title":"The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada)","funders":"National Cancer Institute; Dana-Farber/Harvard Cancer Center; Memorial Sloan-Kettering Cancer Center","keywords":"Renal cell carcinoma; Medicine; Immunotherapy; PD-L1; Cancer research; Internal medicine; Oncology; Cancer","score_opus":0.13248197790817184,"score_gpt":0.43656753841307966,"score_spread":0.3040855605049078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799597692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830675,0.0066154147,0.0000056710323,0.0011999762,0.0004498897,0.0009902735,0.00001086627,0.000014839419,0.007645558],"genre_scores_gemma":[0.9937583,0.0011619624,0.00011425453,0.00004378431,0.0003016882,0.00019254233,0.0000051738934,0.000045627752,0.004376626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957057,0.0013195098,0.0007143745,0.00061673555,0.00066719076,0.00097646884],"domain_scores_gemma":[0.9965664,0.0013318132,0.0001997462,0.0010824535,0.0006412933,0.00017830457],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0028843498,0.00024101218,0.0006820242,0.00035911077,0.0002636226,0.0000213374,0.0004690892,0.00024234723,0.00024266749],"category_scores_gemma":[0.00029618372,0.00016489475,0.00022061713,0.000814574,0.0027737743,0.00007741891,0.00040087613,0.0015879573,0.00021341184],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016299348,0.0018238688,0.23445751,0.00030403858,0.00038447435,0.0004946848,0.00139376,0.0000033706824,0.70336676,0.000037081754,0.0077556614,0.033679444],"study_design_scores_gemma":[0.0036028135,0.004669319,0.42499563,0.000073947245,0.00007121671,0.000017526521,0.00044897167,0.00008491137,0.5626033,0.00005688124,0.0032547372,0.000120738274],"about_ca_topic_score_codex":0.0024121262,"about_ca_topic_score_gemma":0.00047484337,"teacher_disagreement_score":0.19053812,"about_ca_system_score_codex":0.0005762579,"about_ca_system_score_gemma":0.0014406955,"threshold_uncertainty_score":0.9999401},"labels":[],"label_agreement":null},{"id":"W2883414028","doi":"10.1158/2326-6066.cir-18-0144","title":"Expanded CD56superbrightCD16+ NK Cells from Ovarian Cancer Patients Are Cytotoxic against Autologous Tumor in a Patient-Derived Xenograft Murine Model","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; McMaster University Medical Centre","funders":"","keywords":"Ovarian cancer; Cytotoxic T cell; Medicine; Immunotherapy; Cancer research; Cancer; Immunology; NK-92; Immunosuppression; Lymphokine-activated killer cell; Interleukin 21; Immune system; T cell; Biology; Internal medicine; In vitro","score_opus":0.034070945913177456,"score_gpt":0.30890500519864555,"score_spread":0.2748340592854681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883414028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98633075,0.005423319,0.00003736638,0.00048570588,0.005695187,0.00090108754,0.00014618122,0.00014316049,0.00083725114],"genre_scores_gemma":[0.9929811,0.0014898939,0.000039953007,0.0008328688,0.00013039017,0.00086348655,0.00030043145,0.00007127717,0.0032906423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99560493,0.0009983128,0.000784373,0.0010071992,0.00017278419,0.0014324032],"domain_scores_gemma":[0.99779344,0.00021528931,0.00027643435,0.00077266945,0.0008751463,0.00006703553],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00034794302,0.0004392306,0.00068301917,0.0007597705,0.0006845048,0.000052193187,0.0005802345,0.0006403763,0.005273333],"category_scores_gemma":[0.00015292667,0.00040725205,0.00015253173,0.00065748347,0.0013177411,0.00040547605,0.0004627594,0.0018055458,0.0015470654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002518091,0.0006258676,0.0062029613,0.000019597961,0.00037321847,0.00003189633,0.0020862585,0.000060259794,0.9702192,0.000022188533,0.011179436,0.0066610393],"study_design_scores_gemma":[0.0060966196,0.0009319019,0.0266129,0.00030223397,0.00003113946,0.000014248335,0.0012194267,0.0006663544,0.93276167,0.00012649233,0.030662918,0.00057406764],"about_ca_topic_score_codex":0.0050553065,"about_ca_topic_score_gemma":0.0016407765,"teacher_disagreement_score":0.03745749,"about_ca_system_score_codex":0.0008311766,"about_ca_system_score_gemma":0.0004706843,"threshold_uncertainty_score":0.99983793},"labels":[],"label_agreement":null},{"id":"W2883866956","doi":"10.1158/2326-6066.cir-18-0037","title":"Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft-Part Sarcoma","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"MedImmune","keywords":"Alveolar soft part sarcoma; Sarcoma; Medicine; Soft tissue sarcoma; Immunotherapy; Immune checkpoint; Immune system; Cancer research; Immunology; Pathology","score_opus":0.0473021969530328,"score_gpt":0.3882202883024161,"score_spread":0.34091809134938333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883866956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879543,0.0026246507,0.0000058626083,0.007636803,0.00015981839,0.0011252122,0.000018990188,0.000036218124,0.00043812496],"genre_scores_gemma":[0.9977597,0.00013160371,0.00015756905,0.0003780081,0.0001150286,0.0009142846,0.000038449092,0.000038555863,0.00046683027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744666,0.00048587806,0.00034267077,0.0004909296,0.00047802995,0.00075583893],"domain_scores_gemma":[0.9981733,0.0002621244,0.0000501609,0.00062775624,0.00074444956,0.00014220338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011906221,0.00018128325,0.0003642189,0.00061864953,0.00018954603,0.000023316765,0.00011904073,0.00010022831,0.00069862534],"category_scores_gemma":[0.00036786238,0.00014127058,0.000059104157,0.00090770377,0.0005516229,0.000087707034,0.0001974762,0.00049842626,0.0005435869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03296563,0.0019125042,0.8755868,0.000022851573,0.0002821883,0.00034158732,0.0012726369,0.0000021535695,0.06042064,0.000057792655,0.0013930845,0.025742099],"study_design_scores_gemma":[0.009202581,0.0031470112,0.89863724,0.00043931187,0.00001986625,0.000023293522,0.0001716584,0.0000054687794,0.07311833,0.00006132729,0.015034842,0.00013907655],"about_ca_topic_score_codex":0.0012076977,"about_ca_topic_score_gemma":0.000588927,"teacher_disagreement_score":0.02560302,"about_ca_system_score_codex":0.00086186576,"about_ca_system_score_gemma":0.00041332346,"threshold_uncertainty_score":0.76494575},"labels":[],"label_agreement":null},{"id":"W2891038428","doi":"10.1158/2326-6066.cir-18-0309","title":"Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; Cancer Research UK","keywords":"Oncolytic virus; Virotherapy; Antibody; Immune system; Immunotherapy; Immunology; Virology; Neutralizing antibody; Internalization; Medicine; Biology; Receptor","score_opus":0.044798546805281045,"score_gpt":0.45064326492100243,"score_spread":0.40584471811572137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891038428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849156,0.009747889,0.000037369762,0.0008184429,0.00024364726,0.0011565904,0.000026388554,0.000020617308,0.0030334431],"genre_scores_gemma":[0.98858625,0.0068298853,0.0000364423,0.0006507875,0.0005474278,0.0007918049,0.000044401328,0.00007221986,0.0024407734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960821,0.0011967457,0.00030404294,0.00084193604,0.00040348014,0.0011716671],"domain_scores_gemma":[0.9982589,0.000112543064,0.000054815973,0.0009604427,0.0005013062,0.00011199008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001811782,0.00024016025,0.00031917274,0.00043941475,0.0002660037,0.00004531793,0.0008346436,0.0004413928,0.0008544295],"category_scores_gemma":[0.00014594934,0.0002325169,0.00010759891,0.00082604465,0.0016234654,0.000009642108,0.00029717066,0.00075569365,0.00037903505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010715752,0.00013265388,0.012207801,0.000013837274,0.00020243338,0.000015794994,0.00036938302,0.0000026082414,0.95168316,0.00002364849,0.0010157411,0.023617156],"study_design_scores_gemma":[0.003234842,0.007663902,0.01922274,0.00003931931,0.0000036974352,0.000010588725,0.00009459685,0.00003146094,0.922329,0.00027748744,0.046829987,0.00026234708],"about_ca_topic_score_codex":0.0006698977,"about_ca_topic_score_gemma":0.0014539508,"teacher_disagreement_score":0.045814246,"about_ca_system_score_codex":0.00026379284,"about_ca_system_score_gemma":0.00063766254,"threshold_uncertainty_score":0.94817644},"labels":[],"label_agreement":null},{"id":"W2901601525","doi":"10.1158/2326-6066.cir-18-0136","title":"Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universität Zürich; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Melanoma; Immunotherapy; T-cell receptor; Medicine; Blockade; Oncology; Immunology; Exact test; Internal medicine; Peripheral blood mononuclear cell; Proportional hazards model; Immune system; Cancer research; T cell; Biology; Receptor","score_opus":0.08599289826017605,"score_gpt":0.38266565641827377,"score_spread":0.29667275815809774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901601525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708518,0.019703316,0.0001547282,0.0034713368,0.0007255865,0.0023022129,0.000102012484,0.00011002482,0.0025790068],"genre_scores_gemma":[0.9864783,0.0037916221,0.0011703571,0.00056979066,0.0004496965,0.0019326793,0.00015824063,0.000071981034,0.0053773182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970781,0.00027370974,0.00058737147,0.0007110341,0.00043667783,0.0009131006],"domain_scores_gemma":[0.99754953,0.00016692489,0.0001348782,0.0008666151,0.0011866783,0.00009538588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000981479,0.00026796697,0.000420076,0.00028708222,0.0007021278,0.00006602241,0.00032022226,0.00030375642,0.00058557506],"category_scores_gemma":[0.0001333244,0.00022867267,0.00020960176,0.0005413087,0.0013804797,0.00013890368,0.000062428575,0.0005386952,0.00003467235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009611737,0.00022834812,0.0028124484,0.00008354236,0.0008153506,0.000010063202,0.0021458801,0.000001008514,0.72287446,0.0001575017,0.001457609,0.25980207],"study_design_scores_gemma":[0.009962415,0.008636846,0.011425102,0.00032340875,0.00006958249,0.00008527041,0.0033009367,0.00023537254,0.79728144,0.0003004989,0.16786397,0.0005151835],"about_ca_topic_score_codex":0.00034489357,"about_ca_topic_score_gemma":0.0000948701,"teacher_disagreement_score":0.25928688,"about_ca_system_score_codex":0.00051339215,"about_ca_system_score_gemma":0.0008908359,"threshold_uncertainty_score":0.93250006},"labels":[],"label_agreement":null},{"id":"W2902041530","doi":"10.1158/2326-6074.tumimm17-a81","title":"Abstract A81: Early TLR-mediated killing of leukemia in bone marrow is correlated with durable protection against B cell precursor acute lymphoblastic leukemia","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"TLR9; Immunology; TLR7; Immune system; Innate immune system; Cancer research; TLR3; Antigen; Leukemia; Biology; Toll-like receptor; CpG Oligodeoxynucleotide; DNA methylation","score_opus":0.02269565846293876,"score_gpt":0.2776890770287185,"score_spread":0.25499341856577973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902041530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98774403,0.0044604093,0.00007726838,0.00015365648,0.0022133484,0.0008595639,0.000022597833,0.00009131963,0.004377805],"genre_scores_gemma":[0.97725904,0.0017083997,0.000015075077,0.000076586,0.000053159052,0.0002971291,0.00011441369,0.000056465058,0.020419711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702686,0.00046248545,0.0007020346,0.0006503704,0.00015639146,0.0010018303],"domain_scores_gemma":[0.9978823,0.00027045526,0.0003493494,0.0005310166,0.0009264679,0.00004039697],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00073324837,0.0003190299,0.00052931416,0.00085471896,0.00039948628,0.000031588886,0.00037404225,0.0008270859,0.0026010198],"category_scores_gemma":[0.00013770018,0.00028445487,0.000092597555,0.0011100263,0.0012818776,0.00033478322,0.00012643119,0.0019130023,0.0018581615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006866178,0.000118946286,0.0016778165,0.00006462319,0.0004203846,0.000018835617,0.0014170985,0.00007722474,0.98092955,0.00000771432,0.0051847743,0.0032168597],"study_design_scores_gemma":[0.0059466506,0.0022113323,0.021689264,0.00053292187,0.0000516887,0.00007756842,0.0008576648,0.00049318833,0.950236,0.000018542658,0.01749424,0.0003909123],"about_ca_topic_score_codex":0.0045387503,"about_ca_topic_score_gemma":0.0003488021,"teacher_disagreement_score":0.030693518,"about_ca_system_score_codex":0.002123813,"about_ca_system_score_gemma":0.0014405415,"threshold_uncertainty_score":0.9999608},"labels":[],"label_agreement":null},{"id":"W2905648583","doi":"10.1158/2326-6074.tumimm17-pr03","title":"Abstract PR03: Genetic mechanisms of immune evasion in colorectal cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Microsatellite instability; Loss of heterozygosity; Biology; Colorectal cancer; Immune checkpoint; Immune system; Cancer research; Cancer; Exome sequencing; Human leukocyte antigen; Exome; Transcriptome; Immunotherapy; Gene; Genetics; Antigen; Mutation; Allele; Microsatellite; Gene expression","score_opus":0.0740276616415938,"score_gpt":0.4108042553806031,"score_spread":0.3367765937390093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905648583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830181,0.011539555,0.000025404132,0.00078009546,0.0010847673,0.0010369257,0.000024762981,0.00003409377,0.0024563218],"genre_scores_gemma":[0.9952529,0.002798997,0.00048397,0.00006889606,0.00023422932,0.00067837676,0.0000065410004,0.000055632492,0.0004204237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693894,0.00021054444,0.0006371117,0.00058005477,0.0006993882,0.00093392725],"domain_scores_gemma":[0.99799025,0.00022826066,0.00014224627,0.00052194815,0.0010021974,0.00011508885],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009502314,0.00022913289,0.0005873813,0.00062014384,0.00012864264,0.000011897391,0.00045129145,0.00041102525,0.004699275],"category_scores_gemma":[0.00033564202,0.0002082123,0.000111909976,0.0010767869,0.001464947,0.000054491764,0.00030447857,0.0010041884,0.000107549306],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021009508,0.00017492737,0.022669619,0.00012948147,0.00015078421,0.00003250805,0.0007064568,0.000011431492,0.95308656,0.000085501546,0.00030966898,0.020542126],"study_design_scores_gemma":[0.0013135639,0.0011927412,0.47694522,0.00027389708,0.000016596257,0.000019327239,0.00020869794,0.000052900075,0.5188796,0.00062059995,0.0003656515,0.000111236295],"about_ca_topic_score_codex":0.00426844,"about_ca_topic_score_gemma":0.0014286068,"teacher_disagreement_score":0.45427558,"about_ca_system_score_codex":0.000901474,"about_ca_system_score_gemma":0.0015368874,"threshold_uncertainty_score":0.9962106},"labels":[],"label_agreement":null},{"id":"W2911247197","doi":"10.1158/2326-6074.cricimteatiaacr18-b052","title":"Abstract B052: Immunotherapy for melanoma by adenovirus-mediated full-length antibody, nivolumab","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Nivolumab; Melanoma; Immunotherapy; Medicine; Antibody; Cancer research; Cancer immunotherapy; Cancer; Immunology; Immune system; Monoclonal antibody; Virology; Oncology; Internal medicine","score_opus":0.04798463207347491,"score_gpt":0.4053823627487281,"score_spread":0.35739773067525316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911247197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531035,0.031718124,0.000026547317,0.003696251,0.00068141817,0.0034986015,0.00023861772,0.0001525231,0.0068844575],"genre_scores_gemma":[0.9140294,0.016644895,0.00010870832,0.0004193524,0.00048659125,0.0011277574,0.00067097624,0.00024982938,0.06626244],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950257,0.00027221369,0.0006130541,0.0010028679,0.0011083876,0.0019777834],"domain_scores_gemma":[0.99594283,0.0011411913,0.0001311659,0.0014411408,0.0010941396,0.00024954515],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002115522,0.0003949231,0.0008840999,0.0007275343,0.00033215532,0.00009018454,0.0009093726,0.00066210737,0.031548027],"category_scores_gemma":[0.0002583077,0.00036395,0.00029646172,0.0009667872,0.00092827243,0.00019357004,0.00022218905,0.0021063057,0.0018164413],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010582299,0.00034990808,0.011874746,0.0001818604,0.0010027318,0.000031092248,0.0002935614,0.0000010001002,0.9111278,0.000070222675,0.020895932,0.04358883],"study_design_scores_gemma":[0.019730669,0.005475961,0.059158165,0.00027917235,0.000038101232,0.000114686096,0.000820543,0.00019451289,0.19196105,0.0001876471,0.7213732,0.0006663046],"about_ca_topic_score_codex":0.0010789317,"about_ca_topic_score_gemma":0.000066976376,"teacher_disagreement_score":0.71916676,"about_ca_system_score_codex":0.00092833565,"about_ca_system_score_gemma":0.0013669012,"threshold_uncertainty_score":0.99988127},"labels":[],"label_agreement":null},{"id":"W2911283537","doi":"10.1158/2326-6074.cricimteatiaacr18-b101","title":"Abstract B101: Novel oncolytic vaccinia virus platform for systemic delivery of immunotherapeutic payloads","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Immune system; Vaccinia; Immunotherapy; Cancer immunotherapy; Medicine; Immune checkpoint; Cancer; Cancer research; Immunology; Biology; Internal medicine; Gene","score_opus":0.06529744179029018,"score_gpt":0.38105970624199254,"score_spread":0.31576226445170236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911283537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716945,0.025643405,0.00004284378,0.00020527159,0.00026618334,0.0015514492,0.000112685826,0.00001802816,0.00046558076],"genre_scores_gemma":[0.99240965,0.004921423,0.000050643917,0.00011432678,0.00017928111,0.0006019757,0.00008622771,0.00008981111,0.0015466653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971803,0.00013329225,0.0005419874,0.00066614966,0.0004472195,0.0010310567],"domain_scores_gemma":[0.9974626,0.0002598802,0.00016973467,0.0011402717,0.0008782881,0.0000892548],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015788082,0.0002686924,0.00045998264,0.0003198063,0.0001737718,0.00003282511,0.0010453525,0.0004942671,0.00041906565],"category_scores_gemma":[0.000072418894,0.00025535803,0.00022154528,0.0003581335,0.00035755057,0.000015230209,0.0002515481,0.0005739092,0.00013846873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013589828,0.0001771476,0.0007755393,0.00022307318,0.0006551009,0.0000020432888,0.00010651782,0.00008283525,0.9720993,0.00005823137,0.00036071774,0.011869651],"study_design_scores_gemma":[0.0042416696,0.0053942758,0.002388105,0.00013973711,0.00001979923,0.000034936093,0.0003223122,0.00011589867,0.9766763,0.00005916867,0.010290475,0.00031735425],"about_ca_topic_score_codex":0.00031407867,"about_ca_topic_score_gemma":0.00019537024,"teacher_disagreement_score":0.020721983,"about_ca_system_score_codex":0.0002618758,"about_ca_system_score_gemma":0.0012972594,"threshold_uncertainty_score":0.99998987},"labels":[],"label_agreement":null},{"id":"W2911359328","doi":"10.1158/2326-6074.cricimteatiaacr18-b170","title":"Abstract B170: Therapeutic implications of altered epigenetics and DNA damage responses in IDH2-mutated hematologic diseases","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"IDH2; Epigenetics; Cancer research; Biology; Myeloid; DNA methylation; Histone; Myeloid leukemia; IDH1; Haematopoiesis; Mutation; Stem cell; Genetics; Gene; Gene expression","score_opus":0.08231214431460641,"score_gpt":0.42227017969243935,"score_spread":0.3399580353778329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911359328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742993,0.01895452,0.000002936412,0.0047390237,0.00005835814,0.0011269837,0.00007937167,0.00003137635,0.0007081147],"genre_scores_gemma":[0.99340945,0.005276939,0.00005156924,0.00010548254,0.000028333849,0.00025725903,0.000037764115,0.000034528057,0.0007986413],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975678,0.0004633392,0.00042528252,0.0004787807,0.00033560558,0.0007292439],"domain_scores_gemma":[0.9971524,0.0013098205,0.000085400105,0.00084525044,0.00047425006,0.00013290721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072759675,0.0001661683,0.0005168489,0.00073052215,0.00009429687,0.000019482079,0.00038266202,0.00022981415,0.0006565686],"category_scores_gemma":[0.00049613963,0.0001413358,0.000057781097,0.0008837028,0.0011285695,0.000075300704,0.00028098785,0.0008965969,0.00008514071],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020118067,0.00018760005,0.35626057,0.00023298863,0.00017224443,0.00003943204,0.00031038927,0.0000042680354,0.63536584,0.00040605204,0.00023813682,0.0047706594],"study_design_scores_gemma":[0.0023176703,0.00045461534,0.9546445,0.00014702382,0.000021870463,0.000045566445,0.0006335243,0.00006558906,0.039886437,0.0011164983,0.0005518698,0.00011482052],"about_ca_topic_score_codex":0.00038850773,"about_ca_topic_score_gemma":0.000060288537,"teacher_disagreement_score":0.59838396,"about_ca_system_score_codex":0.00040975751,"about_ca_system_score_gemma":0.0012971925,"threshold_uncertainty_score":0.71889657},"labels":[],"label_agreement":null},{"id":"W2912011158","doi":"10.1158/2326-6074.cricimteatiaacr18-a008","title":"Abstract A008: Neoadjuvant nivolumab, gemcitabine and cisplatin in muscle-invasive bladder cancer: Study update","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Cystectomy; Medicine; Gemcitabine; Bladder cancer; Nivolumab; Oncology; Internal medicine; Cisplatin; Neoadjuvant therapy; Chemotherapy; Urology; Lymph node; Cancer; Immunotherapy; Breast cancer","score_opus":0.05267920487446963,"score_gpt":0.3912411751698508,"score_spread":0.33856197029538115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912011158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712194,0.021163303,6.072431e-7,0.0023641994,0.0004606029,0.0023598406,0.00006303941,0.00004575133,0.0023232645],"genre_scores_gemma":[0.986802,0.00899084,0.00002088408,0.00023982767,0.00016667291,0.0008737616,0.000021703263,0.00006363138,0.0028207118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969321,0.0002706633,0.00044491317,0.00083758566,0.0005406364,0.00097410363],"domain_scores_gemma":[0.9984736,0.000240097,0.00008479176,0.0006917288,0.00034229583,0.00016752262],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007309229,0.00030318942,0.0006892552,0.0005098828,0.00015755133,0.000041391246,0.00026920062,0.00023022552,0.003760544],"category_scores_gemma":[0.00008304006,0.00026164838,0.000069875045,0.00063813623,0.00037013795,0.00017349454,0.00025940978,0.001188143,0.00032233863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019728767,0.0010632885,0.84165436,0.00018726832,0.0010215557,0.00049482397,0.003066648,0.000018086466,0.037876785,0.00004383184,0.0015013354,0.11109914],"study_design_scores_gemma":[0.012011391,0.0015872604,0.9775331,0.0002882577,0.00007930395,0.000025371623,0.0026927658,0.000025882773,0.0024984966,0.000110548615,0.0028982675,0.00024933237],"about_ca_topic_score_codex":0.0128794685,"about_ca_topic_score_gemma":0.0052584982,"teacher_disagreement_score":0.13587876,"about_ca_system_score_codex":0.00059626746,"about_ca_system_score_gemma":0.0010512838,"threshold_uncertainty_score":0.99998355},"labels":[],"label_agreement":null},{"id":"W2912104291","doi":"10.1158/2326-6074.tumimm17-b41","title":"Abstract B41: Neutrophils modulate T-cell recruitment and promote hepatic metastases in lung cancer","year":2018,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Nivolumab; Tumor microenvironment; Medicine; Ipilimumab; Immune system; Immunotherapy; Docetaxel; Lung cancer; Immunology; Cancer research; Cancer; Neutrophil elastase; Internal medicine; Inflammation","score_opus":0.08936223421624875,"score_gpt":0.39917292594889975,"score_spread":0.30981069173265097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912104291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82021654,0.17403963,0.000006055546,0.0010880088,0.0017492992,0.0014844224,0.00007657911,0.000058748345,0.0012807233],"genre_scores_gemma":[0.97190565,0.021418327,0.0000539135,0.00015564452,0.00013858275,0.001960141,0.000037779726,0.000068670706,0.0042613186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99579746,0.0008654043,0.0006308257,0.0009541771,0.000145012,0.001607152],"domain_scores_gemma":[0.998155,0.00034770122,0.00017388439,0.0008373315,0.00043322166,0.000052881387],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015495216,0.00039015917,0.0006529116,0.0006203221,0.0005078559,0.000048606933,0.00070440787,0.00053494156,0.0040874495],"category_scores_gemma":[0.00010359957,0.00035932084,0.00008538658,0.0006846342,0.0025292442,0.00021089624,0.00058742904,0.001680212,0.00037784528],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090719486,0.00026105382,0.009820958,0.00020661198,0.000532621,0.000044552482,0.0015317821,0.000018520877,0.9477943,0.000114925664,0.0042681224,0.03449934],"study_design_scores_gemma":[0.0056505413,0.0008282784,0.08592856,0.0005671373,0.000102613885,0.000053597098,0.00040364685,0.000091515736,0.817184,0.0005531565,0.0879007,0.00073629565],"about_ca_topic_score_codex":0.0061171534,"about_ca_topic_score_gemma":0.0011667674,"teacher_disagreement_score":0.15262131,"about_ca_system_score_codex":0.00075317937,"about_ca_system_score_gemma":0.000621869,"threshold_uncertainty_score":0.99988586},"labels":[],"label_agreement":null},{"id":"W2912419979","doi":"10.1158/2326-6074.cricimteatiaacr18-b085","title":"Abstract B085: High mutation burden and response to immune checkpoint inhibitors in angiosarcomas of the scalp and face","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Angiosarcoma; Internal medicine; Exome; Exome sequencing; Oncology; Pathology; Biology; Mutation; Gene","score_opus":0.022701377113953584,"score_gpt":0.3323981553661915,"score_spread":0.3096967782522379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912419979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97589904,0.011389832,9.150704e-7,0.011640251,0.00011399265,0.00080858957,0.0000066321913,0.000009159291,0.00013157737],"genre_scores_gemma":[0.99867845,0.00027219628,0.00003346227,0.000034257326,0.00004727973,0.00005452323,0.0000030811136,0.000018704299,0.00085804565],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99848557,0.0002686113,0.00030014574,0.0002931615,0.00029464375,0.0003578684],"domain_scores_gemma":[0.99910325,0.00021215795,0.000056215595,0.00040942928,0.00015226241,0.000066694425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014491846,0.00011193137,0.00030882756,0.00031892792,0.0000717074,0.000014493801,0.00014858971,0.000125434,0.00007604004],"category_scores_gemma":[0.00031968686,0.00008128532,0.000068445224,0.00050338043,0.0003592468,0.00005846141,0.00022489746,0.0005026643,0.00001821286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017977993,0.000039795745,0.049196042,0.00009847146,0.00007133552,0.000034514826,0.0026894968,0.000015612595,0.934076,0.00006288741,0.000039038823,0.011878975],"study_design_scores_gemma":[0.0019659665,0.0003194044,0.9035341,0.00040323177,0.000010016989,0.0000550056,0.0019354494,0.00002472503,0.09055873,0.00008344543,0.0010295535,0.00008036275],"about_ca_topic_score_codex":0.0021672132,"about_ca_topic_score_gemma":0.00005869222,"teacher_disagreement_score":0.85433805,"about_ca_system_score_codex":0.00013439854,"about_ca_system_score_gemma":0.00022286168,"threshold_uncertainty_score":0.33147192},"labels":[],"label_agreement":null},{"id":"W2912829588","doi":"10.1158/2326-6074.cricimteatiaacr18-b035","title":"Abstract B035: Enhancing antitumoral activity of cell-based immunotherapies by modulating the JAK-STAT axis","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Priming (agriculture); Chimeric antigen receptor; Adoptive cell transfer; CD40; Immunology; Antigen; Cytotoxic T cell; T cell; Cancer research; Medicine; Immunotherapy; Interleukin 21; Antigen-presenting cell; Immune system; Biology; In vitro","score_opus":0.050236515303171025,"score_gpt":0.3845353745239244,"score_spread":0.33429885922075336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912829588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842134,0.008834584,0.000050512863,0.001681725,0.00032371064,0.0012330064,0.000035820176,0.000046188386,0.003581047],"genre_scores_gemma":[0.9875983,0.0011631115,0.00006353182,0.00008875965,0.00009192187,0.00015764823,0.000017969796,0.00007526847,0.01074346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964019,0.0005153278,0.0004263584,0.0005457795,0.001021171,0.0010894738],"domain_scores_gemma":[0.9969263,0.0009484051,0.00016593015,0.0012141117,0.0006564268,0.0000888298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002412892,0.0002520959,0.0006076673,0.00035868393,0.0003057468,0.00005085108,0.0006245154,0.00024449066,0.008882258],"category_scores_gemma":[0.00016506428,0.00018900222,0.0001987929,0.0008107036,0.0011327843,0.00014820241,0.00021521545,0.001900826,0.00014549146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022791352,0.00023485874,0.01612243,0.000287865,0.0002529182,0.00001143902,0.0006374714,0.000044678498,0.96136224,0.000014271325,0.00060355046,0.018149145],"study_design_scores_gemma":[0.0026753198,0.0006914618,0.055705786,0.00021740807,0.000013735567,0.000007823774,0.0007477297,0.0004958865,0.9337241,0.000034977922,0.0055140425,0.0001717147],"about_ca_topic_score_codex":0.0040185614,"about_ca_topic_score_gemma":0.00010364626,"teacher_disagreement_score":0.039583355,"about_ca_system_score_codex":0.0004892188,"about_ca_system_score_gemma":0.0010608616,"threshold_uncertainty_score":0.99202377},"labels":[],"label_agreement":null},{"id":"W2912834094","doi":"10.1158/2326-6074.cricimteatiaacr18-b059","title":"Abstract B059: Synergistic activation of antitumor immunity by an oncolytic virus VG161 armed with multiple immune-stimulating genes","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada); University of British Columbia","funders":"","keywords":"Oncolytic virus; Immune system; Tumor microenvironment; Cancer research; Immunotherapy; Cancer immunotherapy; Virotherapy; Immunology; Biology; Herpes simplex virus; Virus; Medicine; Virology","score_opus":0.04479246324704107,"score_gpt":0.37554749852184816,"score_spread":0.3307550352748071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912834094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931661,0.005226861,0.000072457726,0.000087224376,0.000105401945,0.0008136724,0.00007918153,0.00002258046,0.00042652365],"genre_scores_gemma":[0.99752283,0.001089372,0.000081186685,0.000030470475,0.00009675437,0.00015491244,0.00031850854,0.000076880875,0.0006291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99697185,0.0005748153,0.00043776695,0.00063496525,0.0005350624,0.00084552943],"domain_scores_gemma":[0.99747586,0.00026487588,0.00019575433,0.0012012449,0.00075036375,0.000111918824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012654163,0.0002695768,0.0004081754,0.0002490633,0.00026901037,0.000042935215,0.0008209873,0.00030709663,0.00035985812],"category_scores_gemma":[0.00028005755,0.00024613176,0.000084743704,0.0004695077,0.0007374344,0.000031379055,0.00027683008,0.00075915933,0.000049759332],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008287931,0.0003023523,0.010108097,0.00009039858,0.00029923077,0.0000040487753,0.00010482325,0.001658152,0.96970636,0.000006116841,0.00007215763,0.009360312],"study_design_scores_gemma":[0.0021714836,0.0051857987,0.015082741,0.00009393981,0.000010169172,0.000004361058,0.0003599955,0.00059300364,0.9753515,0.000014371731,0.00085676723,0.0002758688],"about_ca_topic_score_codex":0.0023501676,"about_ca_topic_score_gemma":0.00052238343,"teacher_disagreement_score":0.009084443,"about_ca_system_score_codex":0.00017430245,"about_ca_system_score_gemma":0.0008731914,"threshold_uncertainty_score":0.9999991},"labels":[],"label_agreement":null},{"id":"W2912868925","doi":"10.1158/2326-6074.cricimteatiaacr18-pr09","title":"Abstract PR09: Intratumoral delivery of engineered modified vaccinia virus Ankara expressing Flt3L and OX40L for \"in situ\" therapeutic cancer vaccination","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Modified vaccinia Ankara; Vaccinia; Virology; Medicine; Cancer research; Immune system; Vaccination; IRF3; Genetic enhancement; ELISPOT; Immunotherapy; Cancer immunotherapy; Immunology; CD8; Cancer vaccine; Biology; Innate immune system; Gene; Recombinant DNA","score_opus":0.04892804453989135,"score_gpt":0.37222510054183366,"score_spread":0.3232970560019423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912868925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9640886,0.034316868,0.000026340023,0.00024937125,0.00014969004,0.0009504466,0.000055150704,0.000009565186,0.00015393228],"genre_scores_gemma":[0.99277985,0.0061860676,0.00003510401,0.000043067823,0.00011259067,0.0005040793,0.000051805815,0.00004518893,0.00024225078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806607,0.00018449774,0.00031842972,0.000528494,0.00024037222,0.0006621204],"domain_scores_gemma":[0.9988247,0.00013771908,0.00008630441,0.0004557403,0.0004344375,0.000061079634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009012226,0.00019068498,0.00030542785,0.00030591147,0.00009129563,0.00003392265,0.0003892795,0.00032580562,0.00013516516],"category_scores_gemma":[0.000058426725,0.00018908462,0.00006686192,0.00027125422,0.00013045785,0.000021219834,0.00015359114,0.00046856143,0.0000044358208],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070277946,0.00008282497,0.0022536234,0.00013014876,0.00016472951,0.000002128656,0.00014488467,0.00061195355,0.960808,0.000032309694,0.00009300798,0.028648635],"study_design_scores_gemma":[0.002600077,0.0014862821,0.044983152,0.0000639012,0.000008288917,0.0000022280226,0.00014583595,0.00079948327,0.94917005,0.00011574955,0.00042776673,0.00019718983],"about_ca_topic_score_codex":0.00032471996,"about_ca_topic_score_gemma":0.00078875566,"teacher_disagreement_score":0.04272953,"about_ca_system_score_codex":0.0001265608,"about_ca_system_score_gemma":0.00054761325,"threshold_uncertainty_score":0.7710647},"labels":[],"label_agreement":null},{"id":"W2914404219","doi":"10.1158/2326-6074.cricimteatiaacr18-b146","title":"Abstract B146: The tumor necrosis factor superfamily member RANKL suppresses effector cytokine production in group 3 innate lymphoid cells","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"RANKL; Innate lymphoid cell; Tumor necrosis factor alpha; Cytokine; Immunology; Cancer research; Biology; C-C chemokine receptor type 6; Receptor; Chemokine; Innate immune system; Chemokine receptor; Inflammation; Activator (genetics); Immune system; Biochemistry","score_opus":0.04108454160267023,"score_gpt":0.31037854177232105,"score_spread":0.2692940001696508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914404219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820338,0.00857702,9.795351e-7,0.00054353045,0.004741103,0.0015507243,0.0011214934,0.00012297813,0.0013083941],"genre_scores_gemma":[0.99178034,0.0030150004,0.000005960034,0.00013202812,0.00017692748,0.0005928592,0.00015793752,0.00006729095,0.0040716506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99539626,0.001313404,0.000567295,0.000968521,0.00019395835,0.001560552],"domain_scores_gemma":[0.997387,0.0009233275,0.00013720489,0.0010849558,0.00042734615,0.000040164778],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015488632,0.0004171921,0.00066225824,0.00047813592,0.0005016717,0.00006371973,0.0010301479,0.00054449943,0.0021973958],"category_scores_gemma":[0.00038489894,0.0003034753,0.00014691758,0.00089832436,0.0012392227,0.0003346551,0.00041867487,0.0019319815,0.004064917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013774442,0.0002462845,0.023704315,0.00016040617,0.00028697462,0.000015942567,0.0012110374,0.000014478794,0.9628775,0.000051707342,0.007784008,0.0022699006],"study_design_scores_gemma":[0.002646599,0.00036471017,0.1442276,0.000131657,0.00001780772,0.000058866877,0.0004886828,0.0000029831763,0.7579044,0.000048726422,0.093782976,0.00032499962],"about_ca_topic_score_codex":0.003914901,"about_ca_topic_score_gemma":0.000568329,"teacher_disagreement_score":0.2049731,"about_ca_system_score_codex":0.00044524312,"about_ca_system_score_gemma":0.0005139347,"threshold_uncertainty_score":0.9999417},"labels":[],"label_agreement":null},{"id":"W2914496384","doi":"10.1158/2326-6074.cricimteatiaacr18-a147","title":"Abstract A147: AO-176, a next-generation anti-CD47 antibody, induces immunogenic cell death","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"CD47; Immunogenic cell death; Innate immune system; Immune system; Antibody; Acquired immune system; Immunology; Cytotoxic T cell; Immunotherapy; Cancer immunotherapy; Antigen; Biology; Programmed cell death; Dendritic cell; Phagocytosis; Cancer research; Apoptosis; In vitro","score_opus":0.12017062604383288,"score_gpt":0.3780008427254079,"score_spread":0.257830216681575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914496384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91693777,0.07634506,0.0000084277945,0.00044876218,0.002308427,0.00081585883,0.00003644855,0.00009974994,0.0029995255],"genre_scores_gemma":[0.9861411,0.0077778436,0.000022508475,0.00008262861,0.00017040747,0.00016677106,0.0005213243,0.000064443884,0.005053004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996164,0.0007308882,0.0006777618,0.000878698,0.00019726327,0.0013513679],"domain_scores_gemma":[0.9978384,0.00027526257,0.00025218524,0.0010589588,0.00053205073,0.000043137487],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013078176,0.0003918996,0.00065487035,0.0005984424,0.0006953842,0.00012742364,0.00091691565,0.00089748023,0.0050649215],"category_scores_gemma":[0.000081991384,0.00036262601,0.00022207291,0.0006380377,0.00055742305,0.0006392781,0.0004042709,0.0016209615,0.0051681497],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022089871,0.00024431478,0.008485528,0.00004477073,0.00038116958,0.0000048505945,0.00035693226,0.000027779399,0.9784523,0.00035797808,0.001609793,0.009813651],"study_design_scores_gemma":[0.002305902,0.00036374337,0.21709913,0.000085044456,0.000032472613,0.000040371237,0.00036901174,0.00003954594,0.75930405,0.00013070217,0.019827902,0.0004021195],"about_ca_topic_score_codex":0.0012484742,"about_ca_topic_score_gemma":0.00002759851,"teacher_disagreement_score":0.21914828,"about_ca_system_score_codex":0.00034436156,"about_ca_system_score_gemma":0.00063100614,"threshold_uncertainty_score":0.9998826},"labels":[],"label_agreement":null},{"id":"W2921210767","doi":"10.1158/2326-6066.cir-18-0517","title":"A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":262,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"Universitair Medisch Centrum Groningen; Wellcome Trust; Ministry of Earth Sciences; Academy of Medical Sciences; KWF Kankerbestrijding; National Institute for Health and Care Research; Jan Kornelis de Cock Stichting","keywords":"CXCL13; CD8; Biology; B cell; Immunology; T cell; Tumor microenvironment; Cancer research; Acquired immune system; Chemokine; CXCR5; Immune system; Population; Antibody; Chemokine receptor; Medicine","score_opus":0.09239662447523743,"score_gpt":0.3867133403020323,"score_spread":0.29431671582679486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921210767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750977,0.018417735,0.0000022363529,0.0020091853,0.00018295384,0.0018136278,0.000062575346,0.00003569026,0.0023782607],"genre_scores_gemma":[0.98046446,0.0035723213,0.000014782375,0.00033721403,0.000057684327,0.0006562094,0.00010364686,0.00004626555,0.014747391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974011,0.00027047965,0.0003921829,0.0006068456,0.00063310174,0.0006962855],"domain_scores_gemma":[0.9989577,0.000100677746,0.00011789414,0.0003811861,0.00035410793,0.000088453475],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009261543,0.00023970942,0.00047933075,0.00032472805,0.00019760466,0.000038865073,0.00018712654,0.0002701665,0.002422738],"category_scores_gemma":[0.000018643543,0.00020098174,0.00008025221,0.00067020213,0.0003445351,0.00011922435,0.0000539949,0.0007500843,0.000022695744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044858446,0.00038824722,0.5179476,0.00015551996,0.00034116308,0.000033114,0.0014871866,0.000004806615,0.46698838,0.000019224766,0.0008569347,0.0072919796],"study_design_scores_gemma":[0.013613656,0.0014585746,0.9548168,0.00072194816,0.00006480907,0.000014790184,0.00035055206,0.000058891896,0.016169613,0.00007780848,0.012339793,0.00031274563],"about_ca_topic_score_codex":0.0136406515,"about_ca_topic_score_gemma":0.0051941425,"teacher_disagreement_score":0.45081878,"about_ca_system_score_codex":0.0016464574,"about_ca_system_score_gemma":0.0007457608,"threshold_uncertainty_score":0.9984892},"labels":[],"label_agreement":null},{"id":"W2924812697","doi":"10.1158/2326-6066.cir-18-0499","title":"Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Foundation","funders":"National Cancer Institute","keywords":"Immune system; Tumor microenvironment; Cytotoxic T cell; Tumor-infiltrating lymphocytes; Immunohistochemistry; CD8; Cancer research; Immune checkpoint; PD-L1; Immunotherapy; Cancer; T cell; Medicine; Immunology; Biology; Internal medicine","score_opus":0.040802647508878714,"score_gpt":0.35138590238406125,"score_spread":0.31058325487518257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924812697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96780926,0.025198182,0.000013758698,0.0018554631,0.00066557305,0.0012690625,0.000019786065,0.00004721658,0.0031217046],"genre_scores_gemma":[0.99123245,0.001903493,0.00013093837,0.00022949025,0.000077323966,0.0003318649,0.000030460873,0.000051187282,0.0060127904],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972337,0.00031599368,0.00042826234,0.00058262533,0.00047158648,0.0009678716],"domain_scores_gemma":[0.99837905,0.00031211914,0.0000778511,0.00085835316,0.00028850813,0.00008410303],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009307881,0.00021946609,0.0005320659,0.000579908,0.00012137488,0.00002749546,0.0004061779,0.00036684025,0.0029953804],"category_scores_gemma":[0.00011890831,0.00019630384,0.00016351031,0.00084073463,0.00038559202,0.00011864476,0.0002237989,0.0011561501,0.00042280782],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007190585,0.00013968852,0.10179657,0.00011541599,0.00022311194,0.000103545644,0.00073537935,0.0000062026675,0.88004136,0.00026003917,0.0005915907,0.008796537],"study_design_scores_gemma":[0.014492441,0.0016781554,0.52505744,0.00047351193,0.00002440563,0.00011901773,0.002274679,0.0004323702,0.4322335,0.00056623784,0.022259992,0.00038822633],"about_ca_topic_score_codex":0.0027863958,"about_ca_topic_score_gemma":0.00015722212,"teacher_disagreement_score":0.44780782,"about_ca_system_score_codex":0.0006430953,"about_ca_system_score_gemma":0.00067543366,"threshold_uncertainty_score":0.99791604},"labels":[],"label_agreement":null},{"id":"W2928326859","doi":"10.1158/2326-6066.cir-18-0013","title":"Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Institutes of Health; Oncolytics Biotech; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Phenotype; Immunotherapy; Cancer research; Cell culture; Cell; Biology; Immunology; Medicine; Cancer; Genetics; Gene","score_opus":0.0742356342109851,"score_gpt":0.36868867120983173,"score_spread":0.2944530369988466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928326859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93924093,0.046728782,0.000005189068,0.0023516826,0.00040755924,0.0028630411,0.00008109289,0.000118601856,0.008203099],"genre_scores_gemma":[0.93425435,0.02286146,0.00023756346,0.00015086547,0.00044167828,0.0007968325,0.00012715453,0.00015201248,0.040978055],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955298,0.00051243923,0.000388662,0.0010943258,0.0009515389,0.0015232557],"domain_scores_gemma":[0.9967718,0.00082509365,0.00010948977,0.0014618853,0.00054002233,0.0002917104],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006451968,0.00045903272,0.0008581168,0.00034973546,0.00028596213,0.00009024985,0.0006326946,0.00032073498,0.046413124],"category_scores_gemma":[0.000047233236,0.00035663068,0.00026452602,0.0005670205,0.0007362441,0.00017058612,0.0002594203,0.0011219621,0.0016634546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008330393,0.0016035811,0.050203145,0.00009704343,0.0006633862,0.0001912535,0.0022538512,0.000010885389,0.9068409,0.000011446959,0.00082763657,0.028966468],"study_design_scores_gemma":[0.016387617,0.009216626,0.025009817,0.00014573235,0.000056343055,0.000028309583,0.0013440336,0.00046311706,0.8580321,0.0001621319,0.08869642,0.000457722],"about_ca_topic_score_codex":0.007389186,"about_ca_topic_score_gemma":0.00046861882,"teacher_disagreement_score":0.08786878,"about_ca_system_score_codex":0.0013423448,"about_ca_system_score_gemma":0.0013021397,"threshold_uncertainty_score":0.99988854},"labels":[],"label_agreement":null},{"id":"W2945184742","doi":"10.1158/2326-6066.cir-18-0657","title":"Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health; Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Immune checkpoint; Immune system; Cancer research; Tumor microenvironment; Melanoma; Immunotherapy; Blockade; PD-L1; Tumor hypoxia; Hypoxia (environmental); Biology; Medicine; Immunology; Chemistry; Internal medicine; Receptor; Radiation therapy","score_opus":0.02197598036315715,"score_gpt":0.30964866186925105,"score_spread":0.28767268150609393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945184742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726542,0.024287734,0.0000574175,0.00055941567,0.00048336538,0.0004212844,0.00000644571,0.000026935015,0.0015031708],"genre_scores_gemma":[0.99409264,0.0027308376,0.00004491077,0.00010508685,0.00026467862,0.00014893245,0.000051190906,0.00003160427,0.002530143],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788207,0.00033642925,0.00035523667,0.0005963185,0.0002336874,0.00059628114],"domain_scores_gemma":[0.9989782,0.000053195847,0.00009330947,0.0004487263,0.00033843733,0.00008816262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087995525,0.00018333904,0.00024789828,0.000128038,0.00018386911,0.000045293757,0.00025175087,0.00036588268,0.00019108385],"category_scores_gemma":[0.00021468982,0.00017259535,0.00007343516,0.00020147175,0.00026952155,0.000011562954,0.00030797513,0.0005551696,0.00009478043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028520072,0.000034788147,0.00082341203,0.00006767322,0.00009370564,0.0000035128228,0.00006791476,0.000012300301,0.99749523,0.00005591414,0.00048766375,0.00057270925],"study_design_scores_gemma":[0.000992558,0.00072240905,0.0012630693,0.00012751675,0.0000089970345,0.000028945857,0.00053070823,0.00012187684,0.9898263,0.000039131242,0.006115825,0.00022264074],"about_ca_topic_score_codex":0.00026205857,"about_ca_topic_score_gemma":0.00003025249,"teacher_disagreement_score":0.021556897,"about_ca_system_score_codex":0.000088255794,"about_ca_system_score_gemma":0.0003020508,"threshold_uncertainty_score":0.70382345},"labels":[],"label_agreement":null},{"id":"W2948733916","doi":"10.1158/2326-6066.cir-18-0891","title":"Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Labex Immuno-Oncology; Sorbonne Université; Institut National de la Santé et de la Recherche Médicale; Ligue Contre le Cancer; Les Laboratories Pierre Fabre; Institute of Cancer Research; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Complement system; Tumor microenvironment; Cancer research; Immune system; Tumor progression; Inflammation; Cancer; Biology; Immunotherapy; Clear cell renal cell carcinoma; Alternative complement pathway; Immunology; Medicine; Renal cell carcinoma; Pathology","score_opus":0.05467390408719436,"score_gpt":0.362362333252701,"score_spread":0.30768842916550665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948733916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818408,0.007084499,0.000007585401,0.0020951165,0.0030726735,0.003685686,0.00043924004,0.0001805081,0.0015939141],"genre_scores_gemma":[0.9862716,0.000078082965,0.000086701904,0.00050330156,0.00013787847,0.001325441,0.00014803118,0.000081338716,0.011367613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9943822,0.0012853163,0.0007453517,0.0013088972,0.00027194063,0.0020062753],"domain_scores_gemma":[0.9970237,0.00032740683,0.0001740053,0.0015136234,0.0008378309,0.00012340558],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001550376,0.0004262776,0.0007527343,0.0006280191,0.0005176687,0.00006653047,0.0016638715,0.00016043465,0.031155903],"category_scores_gemma":[0.00021924812,0.00040288884,0.00016889292,0.00085193757,0.0005304566,0.00012922278,0.001422297,0.0010454728,0.031948447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008003219,0.00026965392,0.0119397035,0.00017453442,0.00047541037,0.0000452134,0.00044936134,0.0000073171645,0.9128712,0.000884848,0.07034457,0.0017378652],"study_design_scores_gemma":[0.0028682246,0.0010792203,0.02221754,0.00021958783,0.00003328041,0.00006082948,0.0007833793,0.000004838479,0.7353278,0.0002256831,0.2366805,0.00049917755],"about_ca_topic_score_codex":0.0010850965,"about_ca_topic_score_gemma":0.00008767146,"teacher_disagreement_score":0.17754346,"about_ca_system_score_codex":0.0006765533,"about_ca_system_score_gemma":0.0005717657,"threshold_uncertainty_score":0.9998423},"labels":[],"label_agreement":null},{"id":"W2961898921","doi":"10.1158/2326-6066.cir-18-0691","title":"TGFβ Programs Central Memory Differentiation in <i>Ex Vivo</i> –Stimulated Human T Cells","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; BC Children's Hospital; University of British Columbia; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"Leukemia and Lymphoma Society of Canada","keywords":"Cytotoxic T cell; Adoptive cell transfer; Ex vivo; Biology; Immunology; T cell; CD8; Memory T cell; Cell biology; Immunotherapy; Cancer research; In vivo; Immune system; In vitro","score_opus":0.06344752022462088,"score_gpt":0.39404221541498,"score_spread":0.3305946951903591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961898921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986497,0.001841166,0.0000024890373,0.000769394,0.00047173767,0.0024187742,0.000007207061,0.00008409254,0.007908147],"genre_scores_gemma":[0.94738805,0.0007336561,0.000015529506,0.000079282225,0.00017680002,0.00025273935,0.00008479306,0.00006696289,0.051202208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99587494,0.0005845803,0.00042586683,0.0006641053,0.0008507866,0.0015997363],"domain_scores_gemma":[0.998308,0.00017787977,0.00006145733,0.00083071186,0.00043593548,0.00018601587],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010098432,0.0002272934,0.00052508333,0.00068840815,0.00013594353,0.000058058788,0.00043588603,0.00038045473,0.017938202],"category_scores_gemma":[0.00004938112,0.00021009822,0.00012525854,0.0010928033,0.0005073184,0.00011491928,0.000259459,0.0018651508,0.00054060074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012677663,0.00043178973,0.094915256,0.00013446328,0.000183987,0.000056617617,0.0007111403,0.000025594463,0.8822546,0.000057292036,0.00070319267,0.019258311],"study_design_scores_gemma":[0.014609663,0.0026040187,0.3255374,0.00057051925,0.00004005162,0.00003485674,0.00094573473,0.0013247782,0.6289227,0.0002537322,0.024646057,0.0005104529],"about_ca_topic_score_codex":0.0024054924,"about_ca_topic_score_gemma":0.00042047235,"teacher_disagreement_score":0.25333187,"about_ca_system_score_codex":0.0011890327,"about_ca_system_score_gemma":0.000513224,"threshold_uncertainty_score":0.9829595},"labels":[],"label_agreement":null},{"id":"W2987656669","doi":"10.1158/2326-6066.cir-19-0144","title":"IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition","year":2019,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"KWF Kankerbestrijding; Landsteiner Foundation for Blood Transfusion Research","keywords":"CD47; Cancer research; Cancer immunotherapy; Immunology; Immunotherapy; Antibody; Biology; Chemistry; Cell biology; Immune system","score_opus":0.023930129426210815,"score_gpt":0.30845955820054627,"score_spread":0.28452942877433546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987656669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610548,0.03559462,0.00004464858,0.00062920613,0.000901395,0.0006984518,0.00037093426,0.000055323897,0.0006506157],"genre_scores_gemma":[0.98976475,0.004136778,0.000010271493,0.00016316738,0.000031565007,0.00016338698,0.0006324382,0.00004617633,0.0050514834],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968921,0.0006246392,0.00070917583,0.00064729137,0.00015983045,0.00096696935],"domain_scores_gemma":[0.99815327,0.00031735594,0.00031811846,0.0006536652,0.0005197168,0.000037867325],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00082902034,0.00028260046,0.0006427149,0.0003187254,0.00023550984,0.000021429749,0.00043712454,0.00051990425,0.0034691854],"category_scores_gemma":[0.00006611314,0.00026744464,0.00015817158,0.0005696259,0.0008287645,0.00022584383,0.0002420649,0.0010615931,0.0014479319],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048412223,0.00018710183,0.00027380732,0.000057066238,0.00027477785,7.4124756e-7,0.0004671481,0.000004760034,0.97276616,0.000048176233,0.023178969,0.0022571427],"study_design_scores_gemma":[0.0023225879,0.000515438,0.0010369632,0.00014227783,0.000018318226,0.000006156667,0.00033389652,0.000017369835,0.95795435,0.00008806697,0.03732297,0.00024158046],"about_ca_topic_score_codex":0.00059312436,"about_ca_topic_score_gemma":0.000005485082,"teacher_disagreement_score":0.03145784,"about_ca_system_score_codex":0.00027646834,"about_ca_system_score_gemma":0.000247063,"threshold_uncertainty_score":0.99997777},"labels":[],"label_agreement":null},{"id":"W3001787418","doi":"10.1158/2326-6066.cir-19-0521","title":"IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada); Vector Institute; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"CD8; Cytotoxic T cell; Biology; Chimeric antigen receptor; T-cell receptor; Cancer research; Cytokine; Immunology; Immunotherapy; T cell; Cell biology; Antigen; Immune system; Genetics","score_opus":0.13213537955766047,"score_gpt":0.39498686672623684,"score_spread":0.26285148716857637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001787418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97948205,0.0042324173,0.000040063725,0.0094553055,0.00020709111,0.000992096,0.00002332788,0.00012297594,0.005444648],"genre_scores_gemma":[0.98856604,0.0018953483,0.00007444545,0.00077877194,0.0005899093,0.00027344745,0.0000634258,0.0000809523,0.007677685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99639606,0.0005151325,0.00027375246,0.00076532614,0.0010043192,0.0010454275],"domain_scores_gemma":[0.9978442,0.00014450347,0.000058131387,0.00071322086,0.000822185,0.00041772312],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000878003,0.00023263,0.00045097264,0.00036435685,0.00030479216,0.00007108536,0.00045278913,0.00024368784,0.00795475],"category_scores_gemma":[0.00011810486,0.00018539953,0.00007814858,0.0012467285,0.0008957593,0.0002067145,0.00020873485,0.0019323482,0.0003576369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009372066,0.00027416667,0.012188239,0.00012829778,0.0002802352,0.0002629784,0.0009789747,0.00001119418,0.9511977,0.000070643866,0.0044943383,0.020741198],"study_design_scores_gemma":[0.012073243,0.022316497,0.06303466,0.0002274736,0.00014044222,0.00024921566,0.0068497886,0.0003782443,0.7097733,0.00011532704,0.1841605,0.00068130513],"about_ca_topic_score_codex":0.00070701295,"about_ca_topic_score_gemma":0.00010951122,"teacher_disagreement_score":0.24142437,"about_ca_system_score_codex":0.00032712333,"about_ca_system_score_gemma":0.0011772302,"threshold_uncertainty_score":0.9929521},"labels":[],"label_agreement":null},{"id":"W3006446512","doi":"10.1158/2326-6066.cir-19-0541","title":"Proteogenomics Uncovers a Vast Repertoire of Shared Tumor-Specific Antigens in Ovarian Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Terry Fox Research Institute","keywords":"Biology; Ovarian cancer; Immunotherapy; Antigen; Cancer; Genetics; Cancer research","score_opus":0.08396748384329009,"score_gpt":0.3402985964987779,"score_spread":0.2563311126554878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006446512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.851873,0.14087285,0.00002521377,0.004701165,0.0007013426,0.001065752,0.00022429037,0.00005228037,0.0004840999],"genre_scores_gemma":[0.98073107,0.016474245,0.000060213686,0.0003781785,0.0000752937,0.0005759101,0.000058621583,0.00006970203,0.0015767774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959434,0.0012608318,0.00076608657,0.0007420932,0.00013275883,0.0011548114],"domain_scores_gemma":[0.9983137,0.00035257923,0.00021969069,0.0006826803,0.0003881793,0.00004316032],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008931214,0.00032141342,0.0007730175,0.00048082345,0.00033667218,0.000028369743,0.0010084496,0.0004527242,0.004164883],"category_scores_gemma":[0.00026974213,0.00030879854,0.00017779128,0.0012594091,0.0014591026,0.00018638387,0.00036037154,0.0016049315,0.0002625837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007366215,0.00015823738,0.0121688945,0.00006889752,0.00052199344,0.000044614007,0.004131879,0.00003953823,0.96330285,0.00030357472,0.00317717,0.008716156],"study_design_scores_gemma":[0.005274104,0.0006924951,0.038120694,0.0002835807,0.000016478321,0.000046606852,0.0020278438,0.000008735849,0.71484494,0.00007559126,0.23817213,0.00043677693],"about_ca_topic_score_codex":0.0024183413,"about_ca_topic_score_gemma":0.00017007747,"teacher_disagreement_score":0.24845786,"about_ca_system_score_codex":0.0003717918,"about_ca_system_score_gemma":0.0011769034,"threshold_uncertainty_score":0.9999364},"labels":[],"label_agreement":null},{"id":"W3009949817","doi":"10.1158/2326-6066.cir-19-0703","title":"Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University; University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Alberta Innovates - Health Solutions; Government of Canada","keywords":"Oncolytic virus; Vaccinia; Immune system; Virus; Immunology; Breast cancer; Virology; Cancer; Immunotherapy; Medicine; Virotherapy; Cancer immunotherapy; Biology; Recombinant DNA; Gene; Internal medicine","score_opus":0.04842172544349591,"score_gpt":0.3854856642971151,"score_spread":0.3370639388536192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009949817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544046,0.014376821,0.000059916787,0.02960038,0.00019341965,0.001119001,0.00014881101,0.000016870732,0.00008016263],"genre_scores_gemma":[0.99488145,0.0016558332,0.000031064064,0.001511548,0.0003431176,0.0010376457,0.0000042981587,0.000067983245,0.00046706243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955766,0.0016583815,0.0004646268,0.00071477256,0.0005863993,0.0009991986],"domain_scores_gemma":[0.99711937,0.00030735685,0.00009996177,0.0014875466,0.00076644437,0.00021931602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028786373,0.0002681048,0.0003617991,0.00012286536,0.0005088637,0.000050562732,0.0021909142,0.00021341999,0.00039630485],"category_scores_gemma":[0.00064335804,0.00018781867,0.00015210631,0.0011306921,0.00066566106,0.000009999711,0.0012192783,0.00092440663,0.00012495494],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037640657,0.000048957867,0.0003401112,0.000018814138,0.00032898627,0.000003569534,0.0013246231,0.00067469175,0.94070625,0.000007915351,0.0012805206,0.017624894],"study_design_scores_gemma":[0.0005037108,0.0028456422,0.029706672,0.000050086175,0.000011930535,0.000010033733,0.00042672013,0.00004218393,0.94332427,0.000012206485,0.022848278,0.00021826048],"about_ca_topic_score_codex":0.0015471606,"about_ca_topic_score_gemma":0.0010855126,"teacher_disagreement_score":0.04047683,"about_ca_system_score_codex":0.00027162718,"about_ca_system_score_gemma":0.0012311129,"threshold_uncertainty_score":0.76590234},"labels":[],"label_agreement":null},{"id":"W3013133988","doi":"10.1158/2326-6074.tumimm19-b16","title":"Abstract B16: Identification of tumor-specific antigens shared by induced pluripotent stem cells","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Induced pluripotent stem cell; Cancer stem cell; Cancer immunotherapy; Biology; Stem cell; Cancer research; Embryonic stem cell; Cancer; Immunotherapy; Antigen; Immunology; Cell biology; Genetics; Gene","score_opus":0.0569917876543167,"score_gpt":0.3631866938506854,"score_spread":0.3061949061963687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013133988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825458,0.015891165,0.0004566552,0.00044780414,0.00020545645,0.00024953356,0.00010258002,0.000012645497,0.000088350615],"genre_scores_gemma":[0.9968737,0.0026186896,0.000024633602,0.000039485014,0.00012641781,0.000055180077,0.000056746285,0.000025529964,0.00017965934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998657,0.00006720613,0.00031686656,0.00040405677,0.00020074614,0.00035413873],"domain_scores_gemma":[0.9992195,0.000018224622,0.000075164004,0.00036647017,0.00024014004,0.00008052952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002456958,0.00011973552,0.00016717,0.000060864124,0.00007391494,0.000022415164,0.0003841537,0.00014522413,0.00009804914],"category_scores_gemma":[0.000023859515,0.0001269875,0.000063767635,0.00021255034,0.00013706433,0.000004313516,0.0001597449,0.00028751223,0.00003662466],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102553226,0.000030257586,0.00034083356,0.000046444064,0.00007338617,0.00000298677,0.00015564196,0.00011022921,0.9881442,0.000006458017,0.006711107,0.004275908],"study_design_scores_gemma":[0.00033769954,0.00015899802,0.0058575743,0.0000132517525,0.000003755182,0.0000017400962,0.00033369404,0.000045427634,0.9710982,0.000003253509,0.022031873,0.0001145209],"about_ca_topic_score_codex":0.0000432006,"about_ca_topic_score_gemma":0.0000048074935,"teacher_disagreement_score":0.017045982,"about_ca_system_score_codex":0.000030284371,"about_ca_system_score_gemma":0.00010614931,"threshold_uncertainty_score":0.51784},"labels":[],"label_agreement":null},{"id":"W3013248902","doi":"10.1158/2326-6074.tumimm19-a59","title":"Abstract A59: Inhibition of Glycogen Synthase Kinase 3 (GSK-3) synergizes with anti-PD-1 by potentiating tumor-infiltrated CD8+ T-cells","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Fluidigm (Canada); McGill University Health Centre; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Cancer research; CD8; Cytotoxic T cell; Immune checkpoint; Melanoma; Blockade; Immunotherapy; PD-L1; Medicine; Perforin; Tumor microenvironment; Tumor-infiltrating lymphocytes; Immune system; Chemistry; Immunology; Internal medicine; Receptor; Biochemistry","score_opus":0.03330822633405862,"score_gpt":0.30292046428008945,"score_spread":0.26961223794603084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013248902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94670296,0.050083183,0.00005292326,0.0012743755,0.00033166542,0.00062018307,0.00032176872,0.00012765943,0.0004852851],"genre_scores_gemma":[0.9955289,0.0028975322,0.0000373222,0.0002820081,0.00004432345,0.00015493827,0.00024305366,0.00007829944,0.00073364755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960064,0.0010954151,0.0007747861,0.00073553034,0.00020292007,0.0011849096],"domain_scores_gemma":[0.9976586,0.0006894495,0.00038211697,0.0005938612,0.0006091619,0.00006682239],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00088268274,0.0004200431,0.00079161604,0.00034254967,0.00064084237,0.00005002105,0.00062955223,0.0004670811,0.0027642555],"category_scores_gemma":[0.00032459607,0.00036421712,0.00016678341,0.0009766939,0.0019169083,0.000298062,0.00021489373,0.0015530098,0.00040073504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006526238,0.00031049104,0.00064664555,0.00013292834,0.0010092504,0.00009445148,0.0007971599,0.000033547145,0.9808721,0.00006099865,0.0058377343,0.0036784434],"study_design_scores_gemma":[0.0036430373,0.0012450673,0.0024579337,0.00028915156,0.000050839302,0.000063042964,0.0014552103,0.000008033419,0.97571427,0.000013843952,0.014673692,0.0003858979],"about_ca_topic_score_codex":0.0012338946,"about_ca_topic_score_gemma":0.000014123031,"teacher_disagreement_score":0.048825916,"about_ca_system_score_codex":0.00012970137,"about_ca_system_score_gemma":0.0006701344,"threshold_uncertainty_score":0.99988097},"labels":[],"label_agreement":null},{"id":"W3013332782","doi":"10.1158/2326-6074.tumimm19-b88","title":"Abstract B88: GPNMB expression modulates the tumor immune microenvironment in mouse models of breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University","funders":"","keywords":"Immune system; Tumor microenvironment; Granzyme B; Cancer research; CD8; Biology; Cytotoxic T cell; Immunology; Immunotherapy; Acquired immune system; Breast cancer; T cell; Cancer; In vitro","score_opus":0.050569529708301766,"score_gpt":0.31617392874241246,"score_spread":0.2656043990341107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013332782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8683311,0.123860225,0.00001930439,0.0056570135,0.0005846262,0.0008255385,0.0002814233,0.000044398726,0.00039641804],"genre_scores_gemma":[0.9855917,0.012226402,0.000020099185,0.0002984855,0.000072421,0.0006893008,0.000034439585,0.00007062268,0.0009965263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962743,0.00072233577,0.00084501546,0.00075069856,0.00020001894,0.0012076531],"domain_scores_gemma":[0.99814075,0.00038758593,0.00027906994,0.00092901697,0.0002191807,0.000044420747],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000897121,0.00036436538,0.0006909929,0.00023442152,0.0003389847,0.0000219805,0.0015558823,0.00041643484,0.0041856845],"category_scores_gemma":[0.00006484147,0.00027725042,0.00016910268,0.0005319235,0.002159548,0.0002276864,0.0009435649,0.0022612838,0.00024833862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001596884,0.00019316199,0.002639915,0.00009834235,0.00027217038,0.0000125434435,0.0022224279,0.0024754037,0.98336256,0.000083826555,0.0021710151,0.004871769],"study_design_scores_gemma":[0.0023267113,0.00013418245,0.043021798,0.00024676824,0.000019078612,0.00002513069,0.0013149853,0.00012357543,0.94783807,0.00015640563,0.004489623,0.00030369178],"about_ca_topic_score_codex":0.0034090208,"about_ca_topic_score_gemma":0.000076822136,"teacher_disagreement_score":0.11726065,"about_ca_system_score_codex":0.00047581655,"about_ca_system_score_gemma":0.0004136896,"threshold_uncertainty_score":0.999968},"labels":[],"label_agreement":null},{"id":"W3013420908","doi":"10.1158/2326-6074.tumimm19-a53","title":"Abstract A53: Phosphorylation of eIF4E promotes phenotype switching and MDSC-mediated immunosuppression in melanoma","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Melanoma; Cancer research; Immunotherapy; EIF4E; Cytokine; Immune system; Microphthalmia-associated transcription factor; Immunology; Biology; Medicine; Transcription factor; Gene","score_opus":0.04469111608526693,"score_gpt":0.3249136380126815,"score_spread":0.2802225219274146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013420908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824807,0.0157598,0.000022333788,0.0005558143,0.000086814835,0.00026956503,0.00001861076,0.000008865684,0.00079747254],"genre_scores_gemma":[0.99786675,0.0017441154,0.00007655863,0.00004357934,0.000088432986,0.000051319515,0.00007560135,0.00001846426,0.000035199326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987796,0.00014253033,0.0002576183,0.00034983738,0.00014898326,0.00032143318],"domain_scores_gemma":[0.9994501,0.00006380286,0.000076110446,0.0002212902,0.00012737152,0.000061345476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039117038,0.000117049305,0.00019640084,0.00008807613,0.00007574839,0.0000126857785,0.00022050455,0.00023695253,0.00007444617],"category_scores_gemma":[0.0003402243,0.000108465916,0.00003052715,0.00020258345,0.00016030355,0.0000081522185,0.0002363793,0.00036525377,0.000010674361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000535958,0.00004195996,0.017545199,0.00006542065,0.00004486636,0.000006462379,0.00050533,0.0000054000425,0.97122246,0.000058308782,0.00018695921,0.009781701],"study_design_scores_gemma":[0.0010987503,0.0006772849,0.1504667,0.000073122574,0.0000051014435,0.000003284747,0.00029000035,0.000119349344,0.8439674,0.00012539137,0.0030279423,0.0001457244],"about_ca_topic_score_codex":0.0002934793,"about_ca_topic_score_gemma":0.00005303855,"teacher_disagreement_score":0.1329215,"about_ca_system_score_codex":0.000020956688,"about_ca_system_score_gemma":0.00018501485,"threshold_uncertainty_score":0.44231117},"labels":[],"label_agreement":null},{"id":"W3013453726","doi":"10.1158/2326-6074.tumimm19-b62","title":"Abstract B62: Development of novel chimeric antigen receptor T cells for immunotherapy of hepatocellular carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Epitope; Monoclonal antibody; Antigen; Immunotherapy; Effector; Cancer immunotherapy; Immunohistochemistry; Cancer research; Hepatocellular carcinoma; Antibody; Adoptive cell transfer; Molecular biology; T cell; Biology; Immunology; Immune system","score_opus":0.1458943262138125,"score_gpt":0.39103270112138505,"score_spread":0.24513837490757256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013453726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854594,0.010075123,0.0004015121,0.0012732474,0.00018545955,0.001991083,0.000084449566,0.000028594388,0.0005011682],"genre_scores_gemma":[0.9910414,0.0025434787,0.004318699,0.0000892091,0.0001779204,0.00040552928,0.000058450656,0.00009421136,0.0012710573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969256,0.00011757737,0.0007859907,0.00054649456,0.00076775823,0.0008566157],"domain_scores_gemma":[0.99753326,0.0003646761,0.00019700051,0.0006053393,0.0011158535,0.00018383925],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012250745,0.00024026426,0.00081207865,0.000384159,0.00015745814,0.0000115848725,0.00061283685,0.00026645118,0.0045477212],"category_scores_gemma":[0.00014626844,0.00022447358,0.0002265992,0.0009034806,0.0007889404,0.00005992011,0.00018672526,0.000768898,0.00004076722],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052346033,0.00039016665,0.015153579,0.00053982716,0.00070688763,0.0000054517477,0.0029257366,0.0000028320196,0.9293572,0.000023364331,0.00081218744,0.04484819],"study_design_scores_gemma":[0.004583401,0.0010147971,0.028734164,0.00011445402,0.0000118777025,0.0000035908058,0.00057779875,0.00020904906,0.91352195,0.0000059220724,0.051056445,0.00016655351],"about_ca_topic_score_codex":0.00036510525,"about_ca_topic_score_gemma":0.000006418824,"teacher_disagreement_score":0.050244257,"about_ca_system_score_codex":0.0002832588,"about_ca_system_score_gemma":0.0022182893,"threshold_uncertainty_score":0.99636227},"labels":[],"label_agreement":null},{"id":"W3014079509","doi":"10.1158/2326-6074.tumimm19-b103","title":"Abstract B103: Molecular heterogeneity of gastric cancer explained by methylation-driven key regulators","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Epigenetics; DNA methylation; Tumor microenvironment; Biology; Methylation; Stromal cell; Cancer; Cancer research; Computational biology; Genetics; Gene; Gene expression","score_opus":0.08158889648798251,"score_gpt":0.3876243804889234,"score_spread":0.3060354840009409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014079509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548659,0.033860657,0.00007288568,0.009847888,0.00013624839,0.0005949743,0.000103445214,0.000048692476,0.00046932523],"genre_scores_gemma":[0.99331003,0.0052710962,0.00015227142,0.00044399773,0.00012718706,0.0005077219,0.00004317216,0.0000491922,0.000095337506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974575,0.00021795175,0.00046349864,0.00056641555,0.0006538611,0.00064074085],"domain_scores_gemma":[0.9983975,0.00010820639,0.00014954602,0.00045440206,0.0006441005,0.00024622373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038159854,0.00021308065,0.00056910585,0.00021291942,0.00012943971,0.000017214385,0.00035236785,0.00024467576,0.0014583729],"category_scores_gemma":[0.0001870214,0.00019575804,0.00017574705,0.0010509297,0.00049731834,0.00009464285,0.00017076766,0.00073632697,0.00002906866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086226186,0.00012797056,0.056391522,0.00021503879,0.0007000049,0.0000183385,0.0004598431,0.00010373597,0.91880614,0.00007489353,0.00850094,0.013739307],"study_design_scores_gemma":[0.0022421614,0.000804739,0.090408765,0.00018277031,0.00010619405,0.0000055496726,0.00032576002,0.00026152842,0.8940086,0.000027133989,0.011401058,0.00022574983],"about_ca_topic_score_codex":0.000953668,"about_ca_topic_score_gemma":0.000036736972,"teacher_disagreement_score":0.03844414,"about_ca_system_score_codex":0.0003166176,"about_ca_system_score_gemma":0.0006214692,"threshold_uncertainty_score":0.99945444},"labels":[],"label_agreement":null},{"id":"W3016847734","doi":"10.1158/2326-6074.tumimm18-b65","title":"Abstract B65: Mathematical modeling studies on spatial profiles of tumor-infiltrating T cells","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cytotoxic T cell; Tumor microenvironment; Stromal cell; Infiltration (HVAC); CD8; T cell; Cell; Biology; Chemistry; Cancer research; Antigen; Immune system; Tumor cells; Immunology; Materials science; In vitro; Biochemistry","score_opus":0.14759933396227182,"score_gpt":0.3955689120957886,"score_spread":0.24796957813351678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016847734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561511,0.03997107,0.00010060553,0.0013243238,0.0005124644,0.000583491,0.000049907016,0.0000866197,0.0012204013],"genre_scores_gemma":[0.9973486,0.001332978,0.00007029277,0.00018003846,0.000086627435,0.00018287764,0.000014033593,0.000045102064,0.0007394399],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693805,0.0007774641,0.00081315753,0.0005050369,0.00016165964,0.00080465805],"domain_scores_gemma":[0.9976059,0.0012145848,0.00020845058,0.0004608153,0.00047850987,0.000031705153],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011440866,0.0002923735,0.0007401447,0.00024167511,0.00042701326,0.000019972698,0.0006462578,0.00029861333,0.0026926002],"category_scores_gemma":[0.0009904192,0.00024275901,0.00016653423,0.00035297094,0.0012812683,0.00010811479,0.00025246647,0.0014680133,0.0013147012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038093354,0.00016764342,0.000053910167,0.00021511863,0.00091929303,0.000014118463,0.003365653,0.00045335124,0.9826353,0.00081588846,0.00070965505,0.0068406877],"study_design_scores_gemma":[0.0014574121,0.0013799182,0.00018106864,0.0003649623,0.000024157847,0.000016852788,0.0041106986,0.0004191453,0.9894572,0.00034224917,0.0019905497,0.00025576924],"about_ca_topic_score_codex":0.0001602169,"about_ca_topic_score_gemma":0.000004737887,"teacher_disagreement_score":0.04119749,"about_ca_system_score_codex":0.00010312227,"about_ca_system_score_gemma":0.0003821948,"threshold_uncertainty_score":0.9994629},"labels":[],"label_agreement":null},{"id":"W3017464623","doi":"10.1158/2326-6066.cir-18-0508","title":"Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Ontario Institute for Cancer Research","keywords":"Chimeric antigen receptor; T cell; Immunology; Immunotherapy; Adoptive cell transfer; Cytotoxic T cell; Cell therapy; Biology; T-cell receptor; Cancer research; Medicine; Immune system; Stem cell; Cell biology; In vitro","score_opus":0.09584839896265963,"score_gpt":0.3678044325559333,"score_spread":0.2719560335932737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017464623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95104223,0.015346204,0.00012242385,0.028000731,0.0001555111,0.004252702,0.00007756654,0.00003123181,0.00097142544],"genre_scores_gemma":[0.96788186,0.017131474,0.0006715828,0.00181845,0.00036883497,0.0013481365,0.000033939636,0.00010046077,0.01064526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966038,0.0007276632,0.00045441557,0.00066434767,0.00068954116,0.0008602686],"domain_scores_gemma":[0.9968395,0.0012310079,0.000114804876,0.0006190791,0.0009519979,0.00024359445],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00149508,0.00025137543,0.00064266764,0.0002839685,0.0003395435,0.000036678794,0.000527778,0.00029991995,0.0014326725],"category_scores_gemma":[0.00018380639,0.00018370825,0.0001659349,0.0008293947,0.0013091605,0.000053234868,0.0003337372,0.000825887,0.0000249346],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013200722,0.0001595916,0.0007613784,0.00015272162,0.00028602176,0.000003883579,0.0061543714,0.000084865365,0.96149856,0.00007467424,0.010323919,0.0072992966],"study_design_scores_gemma":[0.010336668,0.0032234113,0.00058330974,0.000029642879,0.000031846193,0.0000026898722,0.0014701004,0.00046807065,0.75932664,0.00006398096,0.22431125,0.00015240254],"about_ca_topic_score_codex":0.000334216,"about_ca_topic_score_gemma":0.00004419301,"teacher_disagreement_score":0.21398732,"about_ca_system_score_codex":0.0002621786,"about_ca_system_score_gemma":0.00079278136,"threshold_uncertainty_score":0.9994801},"labels":[],"label_agreement":null},{"id":"W3021897149","doi":"10.1158/2326-6074.tumimm18-b63","title":"Abstract B63: Immune gene expression profiling of acute myeloid leukemia identifies predictors of survival and actionable targets for treatment","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Immune system; Myeloid; Immunotherapy; Immune checkpoint; Cancer immunotherapy; Biology; Gene expression profiling; Tumor microenvironment; Immunology; Cancer research; Innate immune system; Medicine; Gene; Gene expression; Genetics","score_opus":0.06833407773161575,"score_gpt":0.37581714269050154,"score_spread":0.3074830649588858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021897149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98415864,0.011738773,0.000100577396,0.001439943,0.00023612184,0.0016570748,0.00033355394,0.000038732323,0.0002965632],"genre_scores_gemma":[0.98369914,0.012572266,0.0012123629,0.000013864596,0.00027752365,0.00065167254,0.00022608075,0.000058592836,0.0012885024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744195,0.00016501715,0.00058680755,0.00054182834,0.0005783536,0.0006860665],"domain_scores_gemma":[0.9977562,0.00051598035,0.00018380009,0.00044371927,0.00091728236,0.00018305024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008041782,0.00022085012,0.0007956854,0.00031516424,0.00021428583,0.000016386608,0.00029141913,0.0002835164,0.00021432237],"category_scores_gemma":[0.00040290775,0.00018121989,0.00015519859,0.0004277089,0.0008567217,0.0001638597,0.00030190658,0.0004972454,0.000008109909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056317206,0.00009760195,0.009233135,0.0005917752,0.0012725462,0.000024129204,0.0008775352,0.000019364397,0.97909385,0.000039079707,0.0008816915,0.0022375882],"study_design_scores_gemma":[0.0041707866,0.0014470615,0.028588483,0.00014027717,0.00011129715,0.000012731986,0.0011092224,0.00018234582,0.9627033,0.000051027342,0.0013703243,0.00011317285],"about_ca_topic_score_codex":0.0005518284,"about_ca_topic_score_gemma":0.000008117403,"teacher_disagreement_score":0.019355347,"about_ca_system_score_codex":0.0009172309,"about_ca_system_score_gemma":0.001971101,"threshold_uncertainty_score":0.7389933},"labels":[],"label_agreement":null},{"id":"W3031072535","doi":"10.1158/2326-6074.tumimm18-a20","title":"Abstract A20: Enhancing checkpoint inhibitor therapy with ultrasound stimulated microbubbles","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Microbubbles; Ultrasound; Radiation therapy; Immunotherapy; Chemotherapy; Colorectal cancer; Cancer research; Cancer; Pharmacology; Oncology; Internal medicine; Radiology","score_opus":0.05365946276296409,"score_gpt":0.31198822522056163,"score_spread":0.25832876245759756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031072535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98554736,0.011064893,0.00026512195,0.0009385732,0.00007877157,0.00037958656,0.000022812645,0.00032140344,0.0013814876],"genre_scores_gemma":[0.9954442,0.003681658,0.0001748902,0.00011249024,0.00018855806,0.00022771802,0.000024606856,0.00006794277,0.00007793294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986672,0.00004295195,0.00023072516,0.00030960407,0.00019210037,0.0005574424],"domain_scores_gemma":[0.99910605,0.00025890555,0.000024368215,0.00028575005,0.00021328202,0.00011166047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018569618,0.0001831462,0.00022881397,0.00009496581,0.00021444795,0.00006986332,0.0003300985,0.00015654134,0.00076139654],"category_scores_gemma":[0.00004275469,0.00015426597,0.00003961458,0.00060068566,0.0002847158,0.000106792475,0.000029397079,0.00081679504,0.00023016162],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010135532,0.000030753738,0.0007307663,0.000037861148,0.00019718843,0.000005643493,0.0010645918,0.0017288708,0.99094933,0.0000286502,0.0007120414,0.004412971],"study_design_scores_gemma":[0.0012966929,0.0002018804,0.022872148,0.00008742622,0.0000100095285,0.00001986461,0.00058999995,0.0003708195,0.9410214,0.000059832746,0.033106856,0.0003630888],"about_ca_topic_score_codex":0.00021642062,"about_ca_topic_score_gemma":0.00012922974,"teacher_disagreement_score":0.049927924,"about_ca_system_score_codex":0.00012880046,"about_ca_system_score_gemma":0.00016842608,"threshold_uncertainty_score":0.83367586},"labels":[],"label_agreement":null},{"id":"W3035392729","doi":"10.1158/2326-6074.tumimm18-b15","title":"Abstract B15: The oral Chk1 inhibitor, SRA737, synergizes with immune checkpoint blockade in small-cell lung cancer (SCLC)","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living Society of British Columbia","funders":"","keywords":"Immune checkpoint; Cancer research; Immunotherapy; Cancer; CHEK1; Immune system; In vivo; Blockade; Medicine; Lung cancer; T cell; Cancer immunotherapy; Immunology; Biology; Cell cycle checkpoint; Cell cycle; Oncology; Internal medicine; Receptor","score_opus":0.0738198577910945,"score_gpt":0.3948078948909215,"score_spread":0.320988037099827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035392729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81040347,0.119832955,0.0000037919008,0.06452083,0.00024390087,0.0020127874,0.000035362213,0.00010116718,0.0028457146],"genre_scores_gemma":[0.9716261,0.022057775,0.000056816018,0.000517656,0.00067638763,0.0024277715,0.000015572808,0.000110701345,0.002511196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9949153,0.00047026257,0.00069981883,0.0009816253,0.0010373304,0.0018956591],"domain_scores_gemma":[0.9973003,0.00053972675,0.00015380657,0.00090059213,0.00080212706,0.00030342644],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016064115,0.0004538519,0.0009431737,0.0003818244,0.0004990415,0.00008983086,0.0009597874,0.0002842224,0.0010555116],"category_scores_gemma":[0.0005186725,0.00028938882,0.00017390086,0.0019159323,0.0019617819,0.00015683437,0.00090362405,0.0038643277,0.00008823563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01832417,0.00086011516,0.16216306,0.0029407602,0.0034850214,0.0016690519,0.014994239,0.0004236551,0.75455755,0.00009955605,0.016763872,0.023718977],"study_design_scores_gemma":[0.021141792,0.003129724,0.43215832,0.0025709074,0.00032114782,0.00007806376,0.008928006,0.0007406541,0.47588742,0.0000747309,0.05386019,0.0011090407],"about_ca_topic_score_codex":0.012364846,"about_ca_topic_score_gemma":0.003187593,"teacher_disagreement_score":0.2786701,"about_ca_system_score_codex":0.0014306804,"about_ca_system_score_gemma":0.0027826412,"threshold_uncertainty_score":0.99995583},"labels":[],"label_agreement":null},{"id":"W3036965359","doi":"10.1158/2326-6074.tumimm18-b49","title":"Abstract B49: Development and characterization of a novel CA9 targeting dual-antibody T-cell engager for renal cell carcinoma","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cancer research; Antigen; Flow cytometry; T cell; Immunotherapy; Biology; Antibody; Clear cell renal cell carcinoma; Immunology; Medicine; Immune system; Renal cell carcinoma; Pathology","score_opus":0.10713529950958542,"score_gpt":0.37959568119280607,"score_spread":0.2724603816832206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036965359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916124,0.0031567204,0.00016348841,0.0032758322,0.00007400334,0.00076149474,0.00010249528,0.000016356425,0.0008372294],"genre_scores_gemma":[0.99537593,0.0006752841,0.0010580195,0.00016839677,0.00025969362,0.00015168813,0.00034013012,0.000033892844,0.0019369408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979747,0.00009416697,0.00042854215,0.00042979605,0.000437886,0.0006349345],"domain_scores_gemma":[0.99862605,0.00031669287,0.00010528698,0.00015437313,0.0005987449,0.00019883332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000809072,0.00017013773,0.0003949284,0.00019398367,0.00029385934,0.000020693718,0.00015918304,0.00016517428,0.00024548892],"category_scores_gemma":[0.00016596854,0.00014567311,0.00006985143,0.00030222503,0.0003522086,0.00007335626,0.00023072478,0.0007804262,0.000017560573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016771777,0.000189442,0.0098515935,0.0010672633,0.00008253451,0.000029096967,0.002123299,0.0000013371525,0.9810045,0.000045978482,0.0003762628,0.0035515183],"study_design_scores_gemma":[0.0024662465,0.00056608627,0.14323494,0.000085520944,0.000018197854,0.000010286764,0.00038918993,0.00035714352,0.8117724,0.0000033803176,0.04094429,0.00015230919],"about_ca_topic_score_codex":0.00018431935,"about_ca_topic_score_gemma":0.0000042645934,"teacher_disagreement_score":0.16923209,"about_ca_system_score_codex":0.000078913916,"about_ca_system_score_gemma":0.0008031771,"threshold_uncertainty_score":0.5940377},"labels":[],"label_agreement":null},{"id":"W3036992533","doi":"10.1158/2326-6074.tumimm18-pr03","title":"Abstract PR03: Immuno-mass spectrometric identification of serum biomarkers of response and toxicity to pembrolizumab","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Autoantibody; Pembrolizumab; Immunotherapy; Immunology; Medicine; Immune system; Antigen; Antibody; Immune checkpoint; Cancer; Cancer immunotherapy; Internal medicine","score_opus":0.07018959431744651,"score_gpt":0.3897958769316217,"score_spread":0.31960628261417523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036992533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97512275,0.014144814,0.000035584948,0.0093503175,0.00013109247,0.00078224443,0.00011340899,0.000026741678,0.00029301885],"genre_scores_gemma":[0.99648446,0.0028915447,0.00009037401,0.00015055752,0.000047486414,0.00006931327,0.0000062625595,0.000027464263,0.00023253704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99757624,0.00031853945,0.0006826156,0.0004472649,0.0005091272,0.00046621944],"domain_scores_gemma":[0.9981835,0.0004162558,0.00020691837,0.00050885533,0.0005383355,0.00014612832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019463274,0.00016344896,0.0004944548,0.000895212,0.000102102305,0.000018159404,0.00032216217,0.00018994373,0.00052785914],"category_scores_gemma":[0.0009417174,0.00015349477,0.00011853558,0.00254952,0.0007467925,0.00009423396,0.00013259995,0.0004292428,0.000016713813],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049072318,0.00009179689,0.0076532736,0.00026232254,0.00062715734,0.000011290577,0.00079192827,0.0000015324895,0.91907096,0.000019803501,0.0004420233,0.021955593],"study_design_scores_gemma":[0.0019208224,0.0011434141,0.5087238,0.00008443781,0.000022798005,0.000010201481,0.0004048984,0.000014726597,0.4867333,0.000019104216,0.00084335444,0.000079163314],"about_ca_topic_score_codex":0.00032589262,"about_ca_topic_score_gemma":0.0000074685786,"teacher_disagreement_score":0.5010705,"about_ca_system_score_codex":0.00029320776,"about_ca_system_score_gemma":0.0006184015,"threshold_uncertainty_score":0.6259335},"labels":[],"label_agreement":null},{"id":"W3040953901","doi":"10.1158/2326-6074.tumimm18-a75","title":"Abstract A75: The role of eosinophils in the lung tumor microenvironment","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Immune system; Lung cancer; Immunology; Tumor microenvironment; Cytotoxic T cell; Lewis lung carcinoma; Cancer research; Population; Lung; Immunotherapy; Metastasis; Biology; Medicine; Cancer; Pathology; Internal medicine","score_opus":0.037563942209326705,"score_gpt":0.31560181990609054,"score_spread":0.27803787769676386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040953901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9061672,0.07452474,0.000003936396,0.013477891,0.00083505287,0.0005827865,0.000009457157,0.000017775712,0.004381178],"genre_scores_gemma":[0.9966006,0.0014316199,0.0000015608928,0.0010187774,0.000051097904,0.00016635098,0.000020195323,0.000012844345,0.0006969543],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811685,0.0007320392,0.00034201724,0.00026328382,0.00008662374,0.00045918569],"domain_scores_gemma":[0.99900866,0.00041258012,0.00010350649,0.00038754242,0.00007655319,0.000011179525],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00079275767,0.00012650092,0.0002046906,0.000103192564,0.00026500065,0.000016504111,0.0007153008,0.00014100409,0.0031914895],"category_scores_gemma":[0.00012644375,0.00007708285,0.00008335594,0.00031577703,0.00076481013,0.0000789418,0.0001649674,0.001449294,0.0006365069],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000596261,0.000105470586,0.0034123005,0.000014934517,0.00013034833,0.0000040288,0.0029191195,0.000012173871,0.9664058,0.00039726455,0.022337934,0.0036643615],"study_design_scores_gemma":[0.0010347132,0.00031066738,0.11399998,0.000045807883,0.000018359447,0.00004011561,0.010677614,0.000019437119,0.37226135,0.00012801458,0.50133604,0.00012789246],"about_ca_topic_score_codex":0.00064139103,"about_ca_topic_score_gemma":0.000016510423,"teacher_disagreement_score":0.59414446,"about_ca_system_score_codex":0.00010684796,"about_ca_system_score_gemma":0.00009931729,"threshold_uncertainty_score":0.9977197},"labels":[],"label_agreement":null},{"id":"W3044111226","doi":"10.1158/2326-6066.cir-20-0196","title":"The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":300,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal","funders":"Cancéropôle Ile de France; Institut National Du Cancer; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche; Labex Immuno-Oncology; Seerave Foundation; Japan Society for the Promotion of Science London; Association pour la Recherche sur le Cancer","keywords":"Microbiome; Gut microbiome; Lung cancer; Immune system; Immune checkpoint; Medicine; Immunology; Immunotherapy; Pembrolizumab; Cancer; Cancer immunotherapy; Cancer research; Biology; Oncology; Bioinformatics; Gut flora; Internal medicine","score_opus":0.0142274996646788,"score_gpt":0.3081915938968357,"score_spread":0.2939640942321569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044111226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869152,0.008266091,0.0000116449755,0.0036382822,0.00009237792,0.00088452885,0.000071814684,0.000010937684,0.000109166125],"genre_scores_gemma":[0.9958062,0.0026184274,0.00007955258,0.00031913418,0.000052675612,0.00035794408,0.00013066753,0.000043346925,0.00059202116],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980416,0.00019826577,0.00030071053,0.0004997538,0.00016132406,0.0007983458],"domain_scores_gemma":[0.99898237,0.00004286089,0.00013837633,0.00034413172,0.000412506,0.00007972976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033592628,0.00021380567,0.00029188234,0.00007579004,0.00032734033,0.00004034094,0.00033418628,0.00020889116,0.000028394294],"category_scores_gemma":[0.00004271289,0.00014027323,0.000053802458,0.00036992133,0.00035027842,0.0000094594725,0.0002447608,0.0006087475,0.0000098382025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010650597,0.000092499395,0.2969707,0.000057363246,0.00012272177,0.0000027923652,0.00031086092,0.000026617185,0.70041156,0.0000023952807,0.0003196026,0.0006178644],"study_design_scores_gemma":[0.0051515736,0.001313337,0.73714423,0.00010682799,0.000017941717,9.659653e-7,0.0003783436,0.000008778371,0.25187242,0.0000032759872,0.0037299152,0.0002723659],"about_ca_topic_score_codex":0.0005500252,"about_ca_topic_score_gemma":0.001172004,"teacher_disagreement_score":0.4485391,"about_ca_system_score_codex":0.00022644445,"about_ca_system_score_gemma":0.0006395835,"threshold_uncertainty_score":0.5720176},"labels":[],"label_agreement":null},{"id":"W3047711886","doi":"10.1158/2326-6074.tumimm18-pr15","title":"Abstract PR15: A novel NK cell-targeted therapeutic strategy against pancreatic cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"","keywords":"Pancreatic cancer; Cancer research; Immunotherapy; Cytotoxic T cell; Tumor microenvironment; Immune system; Immunology; Cancer immunotherapy; CD8; Memory T cell; Medicine; Biology; Cancer; Internal medicine; In vitro","score_opus":0.14931097674022706,"score_gpt":0.4141424449200402,"score_spread":0.2648314681798132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047711886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9069329,0.06031284,0.000038196675,0.012899722,0.00026767887,0.0020591195,0.000104519546,0.00019955209,0.01718551],"genre_scores_gemma":[0.96588254,0.020688497,0.000056904497,0.001647479,0.00069850957,0.0010327172,0.00006254554,0.00014876673,0.00978205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952176,0.00032815812,0.0005588895,0.0009707073,0.0011690551,0.0017555886],"domain_scores_gemma":[0.9971473,0.00046889842,0.00011305854,0.00085221895,0.000906399,0.000512104],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091138046,0.0003985928,0.00080358743,0.00039758455,0.0003401894,0.00009621061,0.00075082615,0.00044755242,0.019069117],"category_scores_gemma":[0.00018786658,0.00034969024,0.00022144835,0.0015466241,0.0009929511,0.00014803659,0.0002647958,0.002969687,0.00048027706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029064878,0.0003108755,0.0051153647,0.0004398351,0.0008192092,0.00014144761,0.00095872924,0.00007401895,0.92964745,0.000049248698,0.0026878817,0.056849483],"study_design_scores_gemma":[0.017746342,0.0038798202,0.17030317,0.0007381422,0.00025305068,0.00006461898,0.0041566915,0.0028293433,0.64791346,0.00018015283,0.1506774,0.0012578109],"about_ca_topic_score_codex":0.0020450524,"about_ca_topic_score_gemma":0.00012923888,"teacher_disagreement_score":0.28173396,"about_ca_system_score_codex":0.00080471765,"about_ca_system_score_gemma":0.00294099,"threshold_uncertainty_score":0.9998955},"labels":[],"label_agreement":null},{"id":"W3082159235","doi":"10.1158/2326-6074.tumimm18-b60","title":"Abstract B60: Functional genomic landscape of T-cell mediated cytotoxicity","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Biology; CTL*; Cancer immunotherapy; Immunotherapy; CRISPR; Cytotoxic T cell; Computational biology; Gene; Cancer; Genetics","score_opus":0.10345025057284551,"score_gpt":0.3694555785910577,"score_spread":0.2660053280182122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082159235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97307646,0.0056022303,0.000011379413,0.0047867787,0.00012715757,0.00062712864,0.00005991843,0.00005513957,0.01565379],"genre_scores_gemma":[0.99350893,0.0024182273,0.000033438886,0.00031027917,0.00038445144,0.00012150475,0.00008066943,0.00004669592,0.0030958226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99742335,0.00021656757,0.00037938135,0.0004679372,0.00079822494,0.0007145343],"domain_scores_gemma":[0.99802846,0.0005264223,0.000075767995,0.0004403369,0.00066742965,0.00026159934],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087514566,0.0001625846,0.0004612372,0.00032364728,0.000122063,0.00001528258,0.00035474778,0.00026893665,0.039933015],"category_scores_gemma":[0.00036220177,0.00014718615,0.00013770218,0.0008296846,0.000692728,0.000058196387,0.00024656855,0.0015645832,0.0006415206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004118865,0.00017432345,0.02253158,0.00017742407,0.0002722804,0.000056652712,0.0003405338,0.00001198814,0.9631587,0.000026042851,0.007187906,0.001943679],"study_design_scores_gemma":[0.0057674088,0.0012451957,0.3936466,0.000057605663,0.00002764883,0.000027629565,0.00048225236,0.00028272855,0.57767004,0.000058043388,0.020535583,0.00019926917],"about_ca_topic_score_codex":0.00029805585,"about_ca_topic_score_gemma":0.000023626775,"teacher_disagreement_score":0.3854887,"about_ca_system_score_codex":0.00024607507,"about_ca_system_score_gemma":0.0013003921,"threshold_uncertainty_score":0.9609446},"labels":[],"label_agreement":null},{"id":"W3084364727","doi":"10.1158/2326-6074.tumimm18-b85","title":"Abstract B85: Anticancer efficacy of a novel immune-stimulating oncolytic virus: VG161 in gastrointestinal cancers","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Immune system; ELISPOT; Cancer; Cancer research; Virotherapy; Immunotherapy; Herpes simplex virus; Immunology; Immunogenic cell death; Medicine; Cancer immunotherapy; Virus; Biology; T cell; Internal medicine","score_opus":0.09335631015325443,"score_gpt":0.41129960111078084,"score_spread":0.3179432909575264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084364727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139285,0.005943228,0.00011309494,0.0010403432,0.000069219124,0.0006437122,0.00007126178,0.000018056737,0.00070824346],"genre_scores_gemma":[0.9978772,0.0009816047,0.00037262283,0.00017192605,0.0002641481,0.00013318507,0.00003678007,0.00006636632,0.000096183925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99670607,0.00026285136,0.0006223283,0.00076297746,0.0005392682,0.0011065358],"domain_scores_gemma":[0.9983391,0.0002452399,0.0001519219,0.00061405316,0.00047145056,0.00017821495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010601371,0.00026868185,0.00046259692,0.00024884628,0.00013186234,0.00002796005,0.00090875034,0.00020380126,0.0003634966],"category_scores_gemma":[0.0010155409,0.00027980312,0.00014571809,0.00087706523,0.00096750504,0.0000129567525,0.00045436545,0.001097637,0.00003251289],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009279641,0.00019902748,0.006979156,0.00008667156,0.00013243963,0.000023112687,0.00026115426,0.0053457315,0.9710303,0.000014994354,0.00017080437,0.006476947],"study_design_scores_gemma":[0.009178912,0.00901814,0.052302893,0.00061190117,0.000015927188,0.000032039745,0.0006014975,0.0033715698,0.9223575,0.000018691877,0.0019422994,0.0005486472],"about_ca_topic_score_codex":0.0018597973,"about_ca_topic_score_gemma":0.00090409355,"teacher_disagreement_score":0.04867284,"about_ca_system_score_codex":0.0003589166,"about_ca_system_score_gemma":0.00214252,"threshold_uncertainty_score":0.9999654},"labels":[],"label_agreement":null},{"id":"W3092226358","doi":"10.1158/2326-6066.cir-20-0527","title":"The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":236,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Gary Bennett Family Fund; Suomen Kulttuurirahasto; Stand Up To Cancer; Uehara Memorial Foundation; National Institutes of Health; Orionin Tutkimussäätiö; American Institute for Cancer Research; National Cancer Institute; Entertainment Industry Foundation; Mitsukoshi Health and Welfare Foundation; American Association for Cancer Research; American Society of Clinical Oncology; Japan Society for the Promotion of Science; Cancer Research UK; Conquer Cancer Foundation","keywords":"Tumor microenvironment; Colorectal cancer; Medicine; Cancer research; Macrophage polarization; Cancer; Macrophage; Immunology; Oncology; Immune system; Internal medicine; Biology; In vitro","score_opus":0.027447630629549757,"score_gpt":0.3126443706912673,"score_spread":0.2851967400617176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092226358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8123021,0.17928897,0.000005948219,0.0065407814,0.00048263356,0.000880755,0.000045411933,0.000016365038,0.0004370202],"genre_scores_gemma":[0.9889821,0.009141236,0.000006125691,0.00027585446,0.000059083824,0.0008700974,0.000027175796,0.000027053911,0.00061126426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996743,0.0014974113,0.00042312988,0.0003848563,0.00014529232,0.00080628914],"domain_scores_gemma":[0.99841124,0.000902248,0.00013664599,0.00039235473,0.0001401318,0.000017403387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010549843,0.00017900557,0.00027337263,0.00009301484,0.000508752,0.000025527477,0.0012493689,0.00028760027,0.00070052803],"category_scores_gemma":[0.00030100747,0.00011541831,0.00007452734,0.000655435,0.0020523022,0.000063214,0.00038228385,0.0014806672,0.00019851515],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006640929,0.00008056112,0.053189643,0.000022640015,0.0001902868,0.0000049752653,0.0036786266,0.000029784007,0.92512757,0.00043393116,0.0013872788,0.015190607],"study_design_scores_gemma":[0.0016460255,0.0005371337,0.2504882,0.00006918133,0.00003744504,0.000019486173,0.004793204,0.000033142296,0.61582917,0.00022905316,0.12611255,0.00020541243],"about_ca_topic_score_codex":0.0011673409,"about_ca_topic_score_gemma":0.00026866162,"teacher_disagreement_score":0.3092984,"about_ca_system_score_codex":0.0002439813,"about_ca_system_score_gemma":0.00034455236,"threshold_uncertainty_score":0.7670291},"labels":[],"label_agreement":null},{"id":"W3105835028","doi":"10.1158/2326-6066.cir-20-0138","title":"A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Academisch Medisch Centrum; Vrije Universiteit Amsterdam","keywords":"CD40; Cancer research; T cell; Chronic lymphocytic leukemia; B cell; Jurkat cells; Antibody; Cytotoxic T cell; Immunology; Biology; Leukemia; Medicine; In vitro; Immune system","score_opus":0.10189720866426633,"score_gpt":0.402953893935271,"score_spread":0.30105668527100465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105835028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97236305,0.019294068,0.000005751669,0.0049034986,0.0001051958,0.0018321334,0.00005634126,0.000118530435,0.0013214154],"genre_scores_gemma":[0.98803824,0.0055987802,0.00010059433,0.00016311028,0.0002650724,0.00024462718,0.00007690056,0.00010160645,0.005411079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948837,0.0011359215,0.0006118023,0.0010234073,0.0008969602,0.0014481718],"domain_scores_gemma":[0.99759096,0.00083577266,0.00010322282,0.00056458876,0.0005855698,0.00031986964],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021111255,0.00035207288,0.00082251086,0.00089740194,0.00040400308,0.00013606172,0.0004968894,0.00031824523,0.001886904],"category_scores_gemma":[0.00064390677,0.00032266098,0.00010192059,0.0018651907,0.0016725519,0.00016762046,0.0004932503,0.001988902,0.00008731317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041070133,0.00031267828,0.12702295,0.0005251216,0.00008228426,0.0007363533,0.0020496072,0.0000013735936,0.86411333,0.000044189503,0.00031083476,0.0006942814],"study_design_scores_gemma":[0.0064622583,0.0028718421,0.04306762,0.0003506706,0.000023594528,0.000061521765,0.002535766,0.00017797886,0.9366136,0.00005936584,0.007399215,0.000376521],"about_ca_topic_score_codex":0.0007382396,"about_ca_topic_score_gemma":0.00006776034,"teacher_disagreement_score":0.08395533,"about_ca_system_score_codex":0.00028909493,"about_ca_system_score_gemma":0.0013584542,"threshold_uncertainty_score":0.9999226},"labels":[],"label_agreement":null},{"id":"W3108724287","doi":"10.1158/2326-6074.tumimm18-pr19","title":"Abstract PR19: Utilizing novel oncolytic vaccinia virus for selective expression of immunotherapeutic payloads in metastatic tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Vaccinia; Immune system; Immune checkpoint; Immunotherapy; Cancer; Medicine; Cancer research; Cancer immunotherapy; Immunology; Virus; Biology; Gene; Internal medicine","score_opus":0.11398960278472821,"score_gpt":0.4195886685095294,"score_spread":0.3055990657248012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108724287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844222,0.012969404,0.00014852917,0.00070589513,0.00006346281,0.0013249485,0.000095669326,0.000014714207,0.00025516303],"genre_scores_gemma":[0.99703956,0.0014297741,0.00022086166,0.00019576169,0.00010216396,0.0008124329,0.000046262336,0.00007336771,0.00007979951],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99716586,0.00035805142,0.000525556,0.00068775273,0.00036958282,0.00089321274],"domain_scores_gemma":[0.99846405,0.000279174,0.00014735924,0.0004972571,0.00049835414,0.000113804825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001226194,0.00024425818,0.00045504342,0.00026685343,0.00015051672,0.000023780818,0.00073987886,0.00021926168,0.00011752805],"category_scores_gemma":[0.00045277533,0.00023479637,0.0001425164,0.00068415527,0.00035676177,0.000014316002,0.00025566827,0.00070335116,0.000013077635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016041286,0.00022592422,0.00059690146,0.00013694268,0.00022451427,0.0000047418102,0.00054587587,0.0001260871,0.9746601,0.000017648792,0.00023427512,0.0071856757],"study_design_scores_gemma":[0.0032801873,0.004194688,0.003377426,0.00009406007,0.000011318518,0.0000037047485,0.00058328715,0.00018928364,0.98640656,0.000071175076,0.0015729401,0.0002153818],"about_ca_topic_score_codex":0.00021882103,"about_ca_topic_score_gemma":0.00028680696,"teacher_disagreement_score":0.012761099,"about_ca_system_score_codex":0.00016981964,"about_ca_system_score_gemma":0.001180766,"threshold_uncertainty_score":0.95747185},"labels":[],"label_agreement":null},{"id":"W3118944735","doi":"10.1158/2326-6074.tumimm18-a26","title":"Abstract A26: Immune profiling and organoids generation of a rare case of prostate cancer liver metastasis","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Metastasis; Immunotherapy; Cancer; Pathology; Immunophenotyping; Oncology; Internal medicine; Immunology; Antigen","score_opus":0.15677542524079074,"score_gpt":0.41524590447679954,"score_spread":0.2584704792360088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118944735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88454056,0.110917024,0.0000042177703,0.0030370867,0.000067849556,0.0010759761,0.00020099238,0.000019033965,0.00013724745],"genre_scores_gemma":[0.9706897,0.028091017,0.00021911925,0.0000413856,0.00012774032,0.00035083987,0.00005913633,0.000035177338,0.00038588562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980479,0.00018850969,0.0004470709,0.0004296966,0.00037972155,0.00050711783],"domain_scores_gemma":[0.9982102,0.00012220778,0.00013210239,0.0003026526,0.0010751373,0.00015772773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005690675,0.00017457425,0.0005456593,0.0002652813,0.00016542301,0.000016655447,0.0001365642,0.00015542665,0.00066805934],"category_scores_gemma":[0.00019709731,0.000137687,0.00008036283,0.0007432287,0.0008466162,0.00013382672,0.00020856428,0.0006567562,0.0000068042214],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024930413,0.00013760057,0.021631662,0.0012947957,0.0008730942,0.0010041539,0.0035369254,0.000009747392,0.92000616,0.000065395165,0.0003603812,0.048587065],"study_design_scores_gemma":[0.0035915892,0.001026374,0.011245718,0.00023127545,0.00013119706,0.00017274382,0.0018522188,0.00047266207,0.98066425,0.000013722991,0.0004620738,0.00013616895],"about_ca_topic_score_codex":0.002594239,"about_ca_topic_score_gemma":0.000095021525,"teacher_disagreement_score":0.08614913,"about_ca_system_score_codex":0.0001871909,"about_ca_system_score_gemma":0.0010738757,"threshold_uncertainty_score":0.7314781},"labels":[],"label_agreement":null},{"id":"W3126199907","doi":"10.1158/2326-6074.tumimm20-po081","title":"Abstract PO081: Systematic Generation of Allogeneic Immune-targeting Modalities for Glioblastoma","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medicine; Population; Haematopoiesis; Immune system; Progenitor cell; Chimeric antigen receptor; Stem cell; Chemoradiotherapy; Oncology; Immunotherapy; Cancer research; Cancer; Immunology; Internal medicine; Biology","score_opus":0.13009358589491676,"score_gpt":0.41780739091948677,"score_spread":0.28771380502457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126199907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9372614,0.05829698,0.00008592498,0.0013560315,0.0003540789,0.0016456542,0.000039289967,0.000037506237,0.0009231191],"genre_scores_gemma":[0.9826487,0.0024241945,0.00027941246,0.000045736473,0.00038517095,0.0011983513,0.00008408733,0.00006346241,0.012870911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967824,0.0005108794,0.00073990494,0.00045523542,0.0007018612,0.00080972083],"domain_scores_gemma":[0.9958113,0.0008266292,0.0001404945,0.00073326955,0.0023957842,0.0000925481],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025567163,0.00018023993,0.0007637335,0.00039264138,0.00024688622,0.0000427541,0.00028783185,0.00026418874,0.0032909086],"category_scores_gemma":[0.0013593846,0.00016510178,0.00024304831,0.0005475641,0.0004591978,0.00008958994,0.00017525756,0.0006378491,0.000041943626],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009055025,0.00013549853,0.0005042598,0.009320689,0.00071505323,0.000042801646,0.00058396783,0.00003258869,0.98503757,0.0004589469,0.0007050148,0.0015580893],"study_design_scores_gemma":[0.0020708619,0.0006265555,0.0021453784,0.0016518718,0.00006211159,0.00007883313,0.0024299787,0.00055465475,0.98889685,0.0001798139,0.0011485637,0.00015455727],"about_ca_topic_score_codex":0.0002482602,"about_ca_topic_score_gemma":0.00007354591,"teacher_disagreement_score":0.055872783,"about_ca_system_score_codex":0.0004640825,"about_ca_system_score_gemma":0.0013791437,"threshold_uncertainty_score":0.9976202},"labels":[],"label_agreement":null},{"id":"W3128382343","doi":"10.1158/2326-6074.tumimm20-pr009","title":"Abstract PR009: The functional genomic landscape of recurrent glioblastoma","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; McMaster University","funders":"","keywords":"Temozolomide; Cancer research; Biology; Stem cell; Regulator; Glioblastoma; Gene; Medicine; Genetics","score_opus":0.052074732079787474,"score_gpt":0.36706898798161386,"score_spread":0.3149942559018264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128382343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96804625,0.028085047,0.000021301144,0.0013911754,0.00023011175,0.00014661276,0.000049539856,0.000005102727,0.0020248806],"genre_scores_gemma":[0.99227846,0.004483694,0.000013808696,0.000049269733,0.00035330845,0.00011428242,0.000072013085,0.000018127408,0.002617027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844027,0.00025401305,0.00019970247,0.00034896543,0.00030784804,0.00044922507],"domain_scores_gemma":[0.9986661,0.00011088829,0.000047272755,0.00053827104,0.00058506295,0.000052415067],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000572557,0.00010131027,0.0001389552,0.00007537998,0.00021162617,0.000021678361,0.00035696005,0.00015838607,0.0013252037],"category_scores_gemma":[0.00022674813,0.00006844607,0.000100488294,0.0002862353,0.0005044844,0.0000036663007,0.00043395808,0.00046430857,0.00006525562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007665002,0.00009341573,0.0030923127,0.000025889918,0.0002072993,0.000015523066,0.00003311065,0.000027580698,0.96750224,0.00010750197,0.012192331,0.015936302],"study_design_scores_gemma":[0.00061938376,0.0004743577,0.06921276,0.000031743628,0.000008366751,0.000022603233,0.0004316686,0.000022400905,0.82427496,0.0001007036,0.10468298,0.000118063435],"about_ca_topic_score_codex":0.000033439283,"about_ca_topic_score_gemma":0.00014928998,"teacher_disagreement_score":0.14322726,"about_ca_system_score_codex":0.000034947887,"about_ca_system_score_gemma":0.00090972404,"threshold_uncertainty_score":0.9995877},"labels":[],"label_agreement":null},{"id":"W3137608926","doi":"10.1158/2326-6066.cir-20-0800","title":"Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Institute of Health Services and Policy Research; Deutsche Forschungsgemeinschaft; Rosetrees Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Canadian Institutes of Health Research; Melanoma Research Alliance; International Development Research Centre; Government of Canada; Azrieli Foundation; Israel Science Foundation; Israel Cancer Research Fund","keywords":"Cytotoxic T cell; Immune checkpoint; Cancer immunotherapy; Alternative splicing; Biology; Cancer research; Gene isoform; Cell biology; Immune system; T cell; splice; Receptor; Immunotherapy; Effector; Immunology; Genetics; Gene; In vitro","score_opus":0.028152558349800166,"score_gpt":0.3100179988044744,"score_spread":0.2818654404546742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137608926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95798606,0.025487062,0.00017545899,0.0011134392,0.010572673,0.00058806874,0.00005055969,0.000037152153,0.003989503],"genre_scores_gemma":[0.9503244,0.0013748511,0.000024003612,0.000088321984,0.00017438966,0.00026854553,0.00017273793,0.000040972296,0.04753176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963645,0.001587933,0.0006436281,0.00053713145,0.00013282131,0.00073398545],"domain_scores_gemma":[0.99698895,0.0007532499,0.00032115268,0.00064413477,0.0012682133,0.00002430652],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009819252,0.00025958463,0.00045724123,0.00024875565,0.0009801907,0.000032489213,0.00041274948,0.0003615767,0.0026316477],"category_scores_gemma":[0.0005071693,0.00020036391,0.00030068227,0.00066565204,0.00087870477,0.00018990332,0.0005780735,0.0017254268,0.00082175445],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006628804,0.0002129568,0.00076645875,0.000046202502,0.0004767313,0.000004389979,0.0014416146,0.000030355584,0.9888981,0.00011828437,0.005172921,0.0021691252],"study_design_scores_gemma":[0.0017532872,0.00032624174,0.0032877943,0.00029952012,0.000046412068,0.00007665641,0.002362811,0.000027408205,0.96608233,0.00003248968,0.025517097,0.00018797794],"about_ca_topic_score_codex":0.0017214746,"about_ca_topic_score_gemma":0.00008521614,"teacher_disagreement_score":0.04354226,"about_ca_system_score_codex":0.0005088081,"about_ca_system_score_gemma":0.0005711408,"threshold_uncertainty_score":0.99995625},"labels":[],"label_agreement":null},{"id":"W3173022732","doi":"10.1158/2326-6074.tumimm18-a38","title":"Abstract A38: Oncogenes drive production of immunosuppressive cytokines to facilitate lung cancer progression","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Cancer research; Carcinogenesis; KRAS; Immune system; Biology; Cytokine; Immunology; Lung cancer; Oncogene; Chemokine; Cancer; Medicine; Cell cycle; Pathology","score_opus":0.13618006315326206,"score_gpt":0.4293497468823965,"score_spread":0.29316968372913443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173022732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92735875,0.03837295,0.0000113694205,0.031188583,0.000624949,0.0017581901,0.00008364189,0.000071986,0.00052956614],"genre_scores_gemma":[0.9872996,0.008758824,0.00016613043,0.00025971272,0.00050367817,0.0022372848,0.000025322195,0.000047342928,0.0007020764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99714756,0.00018044138,0.00051800575,0.0007564411,0.0006896634,0.000707895],"domain_scores_gemma":[0.9975317,0.00008943991,0.00015572223,0.0004974327,0.0014968822,0.00022880617],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042908167,0.00024743032,0.0006089203,0.00028177944,0.0002431944,0.000023152239,0.00036751878,0.00020934037,0.0009838394],"category_scores_gemma":[0.00042886444,0.00020151261,0.0001450014,0.0010791249,0.0005653937,0.00015459898,0.00030055788,0.0007556101,0.000045837263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032686135,0.00018748616,0.049644466,0.00075303984,0.00056986173,0.0000205196,0.0047641667,0.00010277416,0.82931787,0.000018162638,0.01690982,0.094443224],"study_design_scores_gemma":[0.001460154,0.0013553464,0.16788262,0.0013662264,0.00011660977,0.0000102093945,0.0016606391,0.00007192352,0.79237556,0.000014408647,0.033412743,0.0002735303],"about_ca_topic_score_codex":0.0010627393,"about_ca_topic_score_gemma":0.00006268798,"teacher_disagreement_score":0.11823815,"about_ca_system_score_codex":0.00035776568,"about_ca_system_score_gemma":0.00082151,"threshold_uncertainty_score":0.99992937},"labels":[],"label_agreement":null},{"id":"W3199446885","doi":"10.1158/2326-6066.cir-21-0519","title":"Supporting the Next Generation of Scientists to Lead Cancer Immunology Research","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Engineering ethics; Field (mathematics); Cancer immunotherapy; Publishing; Political science; Immunology; Medicine; Immunotherapy; Engineering; Immune system","score_opus":0.3417155636439009,"score_gpt":0.5241351132805301,"score_spread":0.1824195496366292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199446885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9260556,0.037591133,0.000030097308,0.03020634,0.0009513747,0.0013822366,0.000032449116,0.000036320085,0.0037144455],"genre_scores_gemma":[0.89935136,0.010883424,0.00017263961,0.00041961132,0.00095601665,0.0013908225,0.000058190737,0.000087441185,0.08668049],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99153906,0.0024706328,0.00072703423,0.0010199741,0.0020036546,0.0022396385],"domain_scores_gemma":[0.99087644,0.0011039063,0.00010956455,0.0017609413,0.0059380867,0.00021108393],"candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008331576,0.00022998505,0.00062530604,0.0010951194,0.001012021,0.0001456593,0.001020493,0.00037525425,0.014244776],"category_scores_gemma":[0.0027211993,0.00018450171,0.00017246333,0.0044787093,0.002930552,0.00016096998,0.0013069321,0.0029779153,0.0003181683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007870575,0.00017116508,0.0054348377,0.000088569075,0.00041896245,0.0001403712,0.0016920291,0.000017294695,0.882949,0.0006197063,0.017925788,0.08975521],"study_design_scores_gemma":[0.0016147078,0.00080855837,0.017194213,0.00022883287,0.000027047969,0.00016636628,0.0031976635,0.0003067875,0.83515257,0.00020946219,0.14090464,0.00018917007],"about_ca_topic_score_codex":0.0047701686,"about_ca_topic_score_gemma":0.002571042,"teacher_disagreement_score":0.122978844,"about_ca_system_score_codex":0.0012893053,"about_ca_system_score_gemma":0.005392414,"threshold_uncertainty_score":0.9997829},"labels":[],"label_agreement":null},{"id":"W3212747176","doi":"10.1158/2326-6066.cir-21-0445","title":"Imaging α-GalCer–Activated iNKT Cells in a Hepatic Metastatic Environment","year":2021,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"Canadian Cancer Society; Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Metastasis; Cytokine; Immunotherapy; Liver transplantation; Primary tumor; Cancer; Liver tumor; Colorectal cancer; Immune system","score_opus":0.041644585124124195,"score_gpt":0.3314237682964186,"score_spread":0.28977918317229445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212747176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491951,0.04019883,0.00013161436,0.0020480254,0.004056962,0.00047055562,0.000012574207,0.00007606378,0.0038102993],"genre_scores_gemma":[0.9682237,0.0040684384,0.00004075058,0.00025995928,0.000025216039,0.0002987699,0.00012467279,0.000035295416,0.026923196],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964676,0.00158186,0.00045152928,0.0005547872,0.00009815725,0.000846064],"domain_scores_gemma":[0.9988332,0.00032773006,0.0000896592,0.00052496174,0.00019949941,0.000024956631],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00074816967,0.00020441551,0.00036848112,0.00048146961,0.00027936348,0.00003418754,0.00027296421,0.00017587165,0.014503884],"category_scores_gemma":[0.000170788,0.00020507205,0.00009550744,0.00055645476,0.00048843777,0.00019877934,0.0002780059,0.0015353619,0.0030798458],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031871954,0.000282308,0.0019916804,0.000021959813,0.00024564055,0.00008044661,0.0005278135,0.000038120408,0.9808061,0.00009843902,0.0047685015,0.010820246],"study_design_scores_gemma":[0.0018060728,0.00009632903,0.0075708614,0.000077421595,0.000020631076,0.00010975505,0.0018547443,0.000043439668,0.84465694,0.00012026291,0.14344685,0.00019667861],"about_ca_topic_score_codex":0.0012466066,"about_ca_topic_score_gemma":0.00008239941,"teacher_disagreement_score":0.13867836,"about_ca_system_score_codex":0.00062105723,"about_ca_system_score_gemma":0.00034079686,"threshold_uncertainty_score":0.9976964},"labels":[],"label_agreement":null},{"id":"W4205365572","doi":"10.1158/2326-6074.tumimm21-p008","title":"Abstract P008: Effect of route of Bacillus Calmette Guérin administration on the tumor immune microenvironment in a mouse model of non-muscle invasive bladder cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Bladder cancer; Medicine; Immunotherapy; Immune system; Urology; Tumor microenvironment; Cancer; Flow cytometry; Saline; Internal medicine; Immunology","score_opus":0.049497589969809325,"score_gpt":0.3508672274035879,"score_spread":0.30136963743377854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205365572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926773,0.00350114,0.0000025433299,0.0011686402,0.00008844073,0.0014518521,0.0005579338,0.000005436953,0.00054672593],"genre_scores_gemma":[0.9960987,0.0012759579,0.000014049826,0.000087011686,0.000022894097,0.0017028971,0.000025278556,0.000033200828,0.0007400204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976624,0.00038284727,0.00055007637,0.00035247498,0.00062393106,0.0004282596],"domain_scores_gemma":[0.9985542,0.0004234843,0.00023246474,0.000624169,0.00011798067,0.000047689424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009046421,0.00019655222,0.00059426314,0.00027881147,0.00012016973,0.000003790468,0.00034662714,0.00008080232,0.0011428156],"category_scores_gemma":[0.00009116238,0.00014584465,0.00014615989,0.0003637473,0.0005606772,0.000043039578,0.00022759463,0.0008079714,0.000005259853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005854991,0.00062010536,0.009958456,0.00024435922,0.0005422003,0.000027842843,0.0011495689,0.0023347442,0.9732683,0.000021347032,0.00019630104,0.0057818415],"study_design_scores_gemma":[0.004145235,0.004029166,0.08506699,0.00017494986,0.00007144233,0.0000052867717,0.0005489808,0.000294538,0.9054594,0.000023195393,0.000079366015,0.00010145354],"about_ca_topic_score_codex":0.0053737476,"about_ca_topic_score_gemma":0.00035567864,"teacher_disagreement_score":0.07510853,"about_ca_system_score_codex":0.00078089494,"about_ca_system_score_gemma":0.001155215,"threshold_uncertainty_score":0.9997703},"labels":[],"label_agreement":null},{"id":"W4205464259","doi":"10.1158/2326-6074.tumimm21-p001","title":"Abstract P001: The gut microbiome-prostate tumor crosstalk is modulated by dietary polyunsaturated fatty acids","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval","funders":"","keywords":"Prostate cancer; Eicosapentaenoic acid; PTEN; Gut flora; Polyunsaturated fatty acid; Cancer; Gastroenterology; Prostate; Internal medicine; Medicine; Cancer research; Biology; Oncology; Immunology; Fatty acid; Biochemistry; PI3K/AKT/mTOR pathway; Apoptosis","score_opus":0.02772733896355184,"score_gpt":0.32999613121093146,"score_spread":0.3022687922473796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205464259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92318326,0.06716883,0.0000038486583,0.0026309455,0.0046893624,0.00056110136,0.0013880404,0.00003221518,0.00034236562],"genre_scores_gemma":[0.9790935,0.0059019453,0.000014940073,0.0013963627,0.0017890524,0.0006379682,0.0008400554,0.000076274955,0.010249922],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.996966,0.00042303503,0.00036466672,0.00078524963,0.00037718227,0.0010838826],"domain_scores_gemma":[0.9984255,0.00004238914,0.00012289966,0.0009597909,0.00034627956,0.00010315571],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008269238,0.0002872153,0.00030251086,0.00014294848,0.0012575639,0.00008938547,0.0010134149,0.00018747865,0.0011344345],"category_scores_gemma":[0.00005747071,0.00023998396,0.0001642508,0.0006567894,0.0011240164,0.000012233343,0.00090557826,0.0011276908,0.00003996728],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008370677,0.00007928965,0.00058006524,0.000013121032,0.0002551061,0.0000017009515,0.00029992714,0.000029060635,0.77766645,0.0000038037786,0.21584456,0.0043898476],"study_design_scores_gemma":[0.0011065507,0.00023913139,0.020660967,0.0000073192155,0.000015868127,0.000044810786,0.00059225236,0.00001687009,0.21598157,0.000035301127,0.76104146,0.00025786922],"about_ca_topic_score_codex":0.0018333925,"about_ca_topic_score_gemma":0.00008984087,"teacher_disagreement_score":0.5616849,"about_ca_system_score_codex":0.00018015175,"about_ca_system_score_gemma":0.0006708354,"threshold_uncertainty_score":0.9997787},"labels":[],"label_agreement":null},{"id":"W4205606019","doi":"10.1158/2326-6074.tumimm21-p038","title":"Abstract P038: Identification and functional evaluation of monoclonal antibodies specifically targeting human Carbonic Anhydrase IX","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Enzyme function and inhibition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; National Research Council Canada","funders":"","keywords":"Tumor hypoxia; Monoclonal antibody; Cancer research; Hypoxia (environmental); Carbonic anhydrase; Biology; Antibody; Chemistry; Biochemistry; Radiation therapy; Enzyme; Medicine; Immunology; Internal medicine","score_opus":0.09562450883257141,"score_gpt":0.38601229145727783,"score_spread":0.29038778262470644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205606019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045354,0.007620068,0.000035762103,0.00031212243,0.00027555827,0.00022260816,0.00003889218,0.000007766492,0.0010336525],"genre_scores_gemma":[0.9979908,0.00048760322,0.000014989592,0.000026602265,0.00018112911,0.00021464544,0.00055281224,0.000012422577,0.00051901606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831665,0.00036402306,0.00026690506,0.00034162548,0.00049581967,0.00021495398],"domain_scores_gemma":[0.9990296,0.000026837604,0.00010866415,0.00020940199,0.0005958345,0.000029699471],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002254117,0.000081924656,0.00010010563,0.00015323111,0.00049790874,0.000017858869,0.000103064966,0.00008511764,0.0011061465],"category_scores_gemma":[0.00015299395,0.000090709225,0.000043011063,0.00016283274,0.00030718243,0.000009848695,0.00018321845,0.0003206216,0.0000039893753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017963415,0.000071646384,0.0038219204,0.000011131443,0.00005933917,5.649085e-7,0.000059844453,0.00030558588,0.9882417,0.00025660574,0.005538225,0.001453849],"study_design_scores_gemma":[0.001262105,0.0003888759,0.2861179,0.00001287248,0.000027011945,0.000012752784,0.0010707164,0.0002728382,0.7029269,0.0007219365,0.007014948,0.0001711721],"about_ca_topic_score_codex":0.00012273515,"about_ca_topic_score_gemma":0.000035011974,"teacher_disagreement_score":0.2853148,"about_ca_system_score_codex":0.00011709565,"about_ca_system_score_gemma":0.00025449824,"threshold_uncertainty_score":0.999807},"labels":[],"label_agreement":null},{"id":"W4205984988","doi":"10.1158/2326-6074.tumimm21-p045","title":"Abstract P045: Preclinical transcriptome-based evaluation of the translatable potential of new treatments in Triple-Negative Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Transcriptome; Cancer research; Gene expression profiling; Gene signature; Triple-negative breast cancer; CD44; Breast cancer; Biology; Cancer; Gene expression; Significance analysis of microarrays; Gene; In vitro; Genetics","score_opus":0.08245404925804785,"score_gpt":0.42460060505243963,"score_spread":0.3421465557943918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205984988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98472494,0.011500873,0.000013442156,0.0013551571,0.00045737057,0.0007983631,0.0009837546,0.0000019282484,0.00016415578],"genre_scores_gemma":[0.99767935,0.0013502326,0.000019876707,0.00004642939,0.00007751007,0.000501483,0.00005445075,0.0000182257,0.0002524524],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979448,0.0004836492,0.00038353913,0.00033930142,0.0005213766,0.00032737947],"domain_scores_gemma":[0.9989942,0.000083292645,0.00013253231,0.00040652262,0.0003418441,0.000041640287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011688177,0.00011630705,0.0002327891,0.00011860166,0.00012684896,0.0000061984815,0.0004481614,0.00012490683,0.00084670633],"category_scores_gemma":[0.00010813697,0.00010230075,0.00014153826,0.00039660675,0.00032951927,0.0000048545735,0.000114326125,0.00038060048,6.036135e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041561676,0.000619752,0.020362653,0.000040153638,0.00039952286,0.0000017471818,0.0004502895,0.025584584,0.9033486,0.000019077474,0.0016160377,0.043401387],"study_design_scores_gemma":[0.0138820335,0.0007933277,0.6265405,0.000074595264,0.00017718218,0.0000062339413,0.00056049787,0.0009793665,0.35395652,0.0005277619,0.0022779051,0.0002240985],"about_ca_topic_score_codex":0.0077764387,"about_ca_topic_score_gemma":0.002038745,"teacher_disagreement_score":0.6061778,"about_ca_system_score_codex":0.00026686324,"about_ca_system_score_gemma":0.0033941944,"threshold_uncertainty_score":0.99883085},"labels":[],"label_agreement":null},{"id":"W4206062949","doi":"10.1158/2326-6066.cir-21-0332","title":"An <i>In Vivo</i> Screen to Identify Short Peptide Mimotopes with Enhanced Antitumor Immunogenicity","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institutes of Health; McGill University","keywords":"Epitope; Immunogenicity; Peptide; Adjuvant; Peptide vaccine; Antigen; Mimotope; Peptide library; Cytotoxic T cell","score_opus":0.04164043390786948,"score_gpt":0.37923803936803574,"score_spread":0.33759760546016626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206062949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723307,0.02327881,0.00008750422,0.0006964803,0.0007249211,0.0013635474,0.00020939844,0.00012829171,0.001180368],"genre_scores_gemma":[0.98901993,0.0011021578,0.0000666669,0.00048151586,0.000042901196,0.002058201,0.00009852543,0.00009023999,0.0070398794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9928644,0.0033137891,0.00065104145,0.0010723263,0.0002938191,0.0018046395],"domain_scores_gemma":[0.99766016,0.00039955752,0.00009760665,0.0014284123,0.00035334902,0.000060917446],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027017088,0.00041869647,0.0007292008,0.0011417486,0.0016698836,0.000071052054,0.0020703098,0.0002628351,0.007429537],"category_scores_gemma":[0.00010480071,0.00039840568,0.00013780154,0.001797677,0.0010693046,0.00035055686,0.0008163209,0.0023512612,0.0003145085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012746145,0.0005365195,0.004620465,0.000011764607,0.0004847054,0.000068662055,0.001857687,0.00019587004,0.97009087,0.00016591453,0.0019527691,0.0072686435],"study_design_scores_gemma":[0.0027174822,0.003166254,0.046646718,0.00007387056,0.000021952239,0.00020459444,0.0036101397,0.000002738202,0.8432913,0.00004296144,0.09967014,0.00055184384],"about_ca_topic_score_codex":0.005030195,"about_ca_topic_score_gemma":0.00085976993,"teacher_disagreement_score":0.12679955,"about_ca_system_score_codex":0.000639842,"about_ca_system_score_gemma":0.0008156891,"threshold_uncertainty_score":0.99995035},"labels":[],"label_agreement":null},{"id":"W4206202786","doi":"10.1158/2326-6074.tumimm21-p013","title":"Abstract P013: Germinal center hypoxia in tumor-draining lymph nodes negatively regulates humoral immune responses and affects the activation of tumor-infiltrating T cells","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Germinal center; Immune system; Tumor hypoxia; Cancer research; Lymph; Immunology; Antibody; Immunoglobulin class switching; Biology; Hypoxia (environmental); Lymph node; Medicine; B cell; Pathology; Chemistry; Internal medicine; Radiation therapy","score_opus":0.05903517423731405,"score_gpt":0.3599433665381531,"score_spread":0.3009081923008391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206202786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99016106,0.006304384,8.767861e-7,0.0021669974,0.00017646317,0.0006350202,0.000035397778,0.000023172515,0.0004966443],"genre_scores_gemma":[0.9985815,0.0003436234,0.00005468802,0.00019809036,0.000067416455,0.0003262107,0.000014228023,0.000034458375,0.00037974791],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99715084,0.0008324068,0.00047712727,0.00040574453,0.0005096495,0.0006242295],"domain_scores_gemma":[0.9979051,0.0012351848,0.00025380924,0.00039362052,0.00016873336,0.000043553347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025185924,0.00020254066,0.00043165352,0.00049502245,0.0005771478,0.000037161044,0.0003116531,0.00007094429,0.0004602315],"category_scores_gemma":[0.00025639017,0.00016336578,0.0000957205,0.00084295485,0.0011583301,0.00015123968,0.00028485747,0.0009960732,0.0000017642411],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011595733,0.00013805972,0.031225612,0.00011588051,0.00017259666,0.000074635296,0.0028977056,0.000023876582,0.9414499,0.000042645235,0.00013080686,0.012132555],"study_design_scores_gemma":[0.0030024045,0.0003882302,0.66117877,0.0003244459,0.000011088337,0.00014576923,0.006648185,0.000085120046,0.32740104,0.00006123196,0.0006230516,0.00013069292],"about_ca_topic_score_codex":0.001913731,"about_ca_topic_score_gemma":0.000024461748,"teacher_disagreement_score":0.62995315,"about_ca_system_score_codex":0.00054608774,"about_ca_system_score_gemma":0.00073738315,"threshold_uncertainty_score":0.66618633},"labels":[],"label_agreement":null},{"id":"W4206500679","doi":"10.1158/2326-6066.cir-21-1083","title":"Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; University of Texas MD Anderson Cancer Center; American Association for Cancer Research","keywords":"Melanoma; Immunotherapy; Stromal cell; Cancer; MHC class I; Tumor-infiltrating lymphocytes; Antigen; Cytotoxic T cell; Major histocompatibility complex","score_opus":0.047796247781921916,"score_gpt":0.37120881998169686,"score_spread":0.32341257219977493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206500679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978965,0.010592364,0.0000014580635,0.009001437,0.00023546378,0.00057702133,0.00004693789,0.0000421989,0.0005381192],"genre_scores_gemma":[0.9935886,0.0004227248,0.000050224233,0.0005235069,0.000076512835,0.001136461,0.000030486564,0.00003905216,0.0041323933],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9962664,0.0014291799,0.00030980486,0.00046625096,0.0007704792,0.0007578339],"domain_scores_gemma":[0.9985994,0.0006230671,0.00008506603,0.00042875748,0.00018601242,0.000077661825],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002699307,0.00016438533,0.0003557613,0.0005966899,0.00045998843,0.000020032408,0.00034858717,0.0001065825,0.0033386634],"category_scores_gemma":[0.00018130413,0.00013387688,0.000075964475,0.0008852563,0.0005764958,0.000077315504,0.00031070173,0.0015307481,0.000020718218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20247383,0.00044016363,0.08427101,0.00003595555,0.0002579727,0.0007424573,0.0015020015,0.000023383496,0.69543314,0.00004621661,0.008836495,0.005937349],"study_design_scores_gemma":[0.0115710925,0.006130169,0.7889246,0.00034658296,0.00002097462,0.00042494995,0.00441924,0.0000548541,0.06474862,0.00012355435,0.122903556,0.00033180072],"about_ca_topic_score_codex":0.0005773249,"about_ca_topic_score_gemma":0.0001669244,"teacher_disagreement_score":0.7046536,"about_ca_system_score_codex":0.0018359359,"about_ca_system_score_gemma":0.0016543446,"threshold_uncertainty_score":0.9975724},"labels":[],"label_agreement":null},{"id":"W4206729345","doi":"10.1158/2326-6074.tumimm21-p014","title":"Abstract P014: Driving immune-dependent metabolic vulnerabilities in the breast tumor microenvironment","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Tumor microenvironment; Immune system; Inflammation; Cancer research; Immunology; Immunotherapy; Cancer; Breast cancer; Biology; Medicine; Internal medicine","score_opus":0.030611492571380756,"score_gpt":0.31556064803124484,"score_spread":0.2849491554598641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206729345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82714486,0.16471186,0.0000026866094,0.0030238326,0.002173482,0.00092322065,0.00012893557,0.000053472635,0.0018376329],"genre_scores_gemma":[0.9880186,0.0028013492,0.000009280425,0.00036085755,0.00008358677,0.003404676,0.0000704114,0.00006479099,0.005186496],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99285305,0.0034765638,0.000770291,0.00082754565,0.0003565554,0.0017160218],"domain_scores_gemma":[0.9972178,0.0010418785,0.00019146319,0.0014208881,0.00010489842,0.000023112209],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0052587385,0.00036319057,0.0005916862,0.0005580081,0.001769238,0.000058216017,0.0022612885,0.00019919722,0.018086834],"category_scores_gemma":[0.00011111036,0.0003056326,0.00019285483,0.00066136755,0.0018656487,0.00015372904,0.0016714339,0.0047935955,0.00072831253],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007543732,0.00075193,0.020297179,0.000043303084,0.00055127835,0.00012126152,0.006516287,0.00039633244,0.9497313,0.0015458555,0.005513078,0.013777836],"study_design_scores_gemma":[0.004056245,0.00043352056,0.45213747,0.00007593853,0.000055469736,0.0018427235,0.03277799,0.0000045810675,0.10445196,0.0008030107,0.40260872,0.00075237657],"about_ca_topic_score_codex":0.0033656787,"about_ca_topic_score_gemma":0.0002624073,"teacher_disagreement_score":0.84527934,"about_ca_system_score_codex":0.0010830752,"about_ca_system_score_gemma":0.00050607626,"threshold_uncertainty_score":0.99993956},"labels":[],"label_agreement":null},{"id":"W4213219040","doi":"10.1158/2326-6066.cir-20-0973","title":"Overproduction of IFNγ by Cbl-b–Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Immune system; Ubiquitin ligase; Cytotoxic T cell; Cytokine; IL-2 receptor; Function (biology); T cell; Immunotherapy; Interleukin 21; Acquired immune system","score_opus":0.03512501272261518,"score_gpt":0.32311491335468334,"score_spread":0.28798990063206814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213219040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92763406,0.06762587,0.0000022230038,0.002032093,0.0007211119,0.0008894721,0.00016060528,0.000037395937,0.00089714275],"genre_scores_gemma":[0.9826818,0.01027794,0.00004878634,0.00020491995,0.0000734297,0.00029806094,0.00004288535,0.00003785577,0.006334314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99685585,0.00065324234,0.0004927749,0.0006043601,0.00077900355,0.00061477907],"domain_scores_gemma":[0.99840003,0.000134514,0.00022009239,0.0008048351,0.00035987207,0.00008066409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020107422,0.00021039248,0.00045697216,0.0004027444,0.00073064386,0.000025956757,0.00034793958,0.00012842569,0.00034304682],"category_scores_gemma":[0.00005858678,0.0002021081,0.00010752446,0.0008648548,0.0014472404,0.000110030494,0.0003954609,0.0011078679,0.0000034850577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051785884,0.00036473974,0.0007174151,0.0002420959,0.00026858973,0.000016116073,0.0008478667,0.000015637746,0.96267897,0.000042815635,0.015826497,0.0138006415],"study_design_scores_gemma":[0.0024212035,0.000986776,0.015982788,0.00017953909,0.00004015033,0.000022374115,0.0033951122,0.000013518244,0.8582879,0.000045593693,0.11838458,0.00024047724],"about_ca_topic_score_codex":0.0010973297,"about_ca_topic_score_gemma":0.000039841852,"teacher_disagreement_score":0.104391105,"about_ca_system_score_codex":0.00081435643,"about_ca_system_score_gemma":0.00080565555,"threshold_uncertainty_score":0.8241729},"labels":[],"label_agreement":null},{"id":"W4220853501","doi":"10.1158/2326-6066.cir-22-0112","title":"Tumor-Associated High Endothelial Venules: Inroads Enabling Immune Control of Cancer Progression","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Cancer Research UK; Wellcome Trust","keywords":"Immune system; Tumor microenvironment; Immunotherapy; Peripheral blood; Circulating tumor cell; Cancer immunotherapy; Infiltration (HVAC)","score_opus":0.029117328631029907,"score_gpt":0.36399954309347377,"score_spread":0.3348822144624439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220853501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8915271,0.10644198,0.000026934538,0.0004025184,0.00064545684,0.00039453633,0.00044005056,0.000014367055,0.000107010244],"genre_scores_gemma":[0.99284357,0.0040354044,0.000015189649,0.0001299931,0.0003123472,0.0016473545,0.00010220444,0.000048011192,0.0008659066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997422,0.0006301117,0.00036567866,0.00047020233,0.0004498693,0.0006621422],"domain_scores_gemma":[0.99878275,0.00006233368,0.0002196146,0.0004559127,0.00042520976,0.00005418524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010606671,0.00017174028,0.00034004007,0.0001663505,0.000511094,0.00001422926,0.00061362784,0.00015423575,0.0007845268],"category_scores_gemma":[0.00014052214,0.00016741295,0.00015647503,0.0004114711,0.00046773595,0.000005319021,0.00055200316,0.0004996623,0.000004625774],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012090985,0.00017553361,0.0179397,0.000023913932,0.0004605314,0.000010069817,0.0001158222,0.00031323297,0.9654361,0.000108250584,0.0009569712,0.013250755],"study_design_scores_gemma":[0.0041218037,0.0014598392,0.0197692,0.00009268602,0.000053923304,0.000010942718,0.00055060355,0.000073116054,0.8684735,0.00009594845,0.104961716,0.00033675472],"about_ca_topic_score_codex":0.0012917835,"about_ca_topic_score_gemma":0.000089789646,"teacher_disagreement_score":0.10400475,"about_ca_system_score_codex":0.00026228762,"about_ca_system_score_gemma":0.00082532346,"threshold_uncertainty_score":0.8590018},"labels":[],"label_agreement":null},{"id":"W4224217383","doi":"10.1158/2326-6066.cir-21-0171","title":"Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HealthForceOntario","funders":"Imperial Experimental Cancer Medicine Centre; Rosetrees Trust; National Institute for Health and Care Research; Department of Health and Social Care; Cancer Research UK","keywords":"Oncolytic virus; Medicine; Vaccinia; Immunotherapy; Cancer; Melanoma; Oncology; Virus; Internal medicine; Immunology; Cancer research; Biology","score_opus":0.044125128087930884,"score_gpt":0.37026466762813803,"score_spread":0.32613953954020714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224217383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98239136,0.015048594,0.0000016347503,0.0006033379,0.00027764516,0.0011768166,0.00009126308,0.000019971321,0.00038940873],"genre_scores_gemma":[0.9914041,0.005941573,0.000012210352,0.00025649436,0.00013151321,0.0014110326,0.00014758203,0.00007409739,0.0006214016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99503785,0.0019237578,0.00039210758,0.0007185602,0.0007089657,0.0012187805],"domain_scores_gemma":[0.99827754,0.00009306665,0.00008687601,0.001040587,0.00039691504,0.0001050018],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020610637,0.00025284066,0.00034570132,0.00043478413,0.00064305495,0.000040092847,0.0012820854,0.00019756814,0.0012795649],"category_scores_gemma":[0.00015937176,0.00025728947,0.00009638721,0.00091547944,0.00045386015,0.000009934469,0.0010884677,0.0016079864,0.00004130745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020064749,0.0013506642,0.025527934,0.000015419784,0.00027242835,0.00002407815,0.0006685454,0.000118332086,0.8424843,0.000014353504,0.0010651844,0.108394],"study_design_scores_gemma":[0.011347209,0.042511985,0.14814784,0.000036270816,0.00000938666,0.000016872558,0.0007309995,0.000104216924,0.7559381,0.00045157375,0.03989697,0.0008086041],"about_ca_topic_score_codex":0.0014039482,"about_ca_topic_score_gemma":0.00081618445,"teacher_disagreement_score":0.1226199,"about_ca_system_score_codex":0.0005920433,"about_ca_system_score_gemma":0.0012777648,"threshold_uncertainty_score":0.99998796},"labels":[],"label_agreement":null},{"id":"W4225003254","doi":"10.1158/2326-6066.cir-21-0931","title":"Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Medicine; Immunotherapy; Adjuvant; CD8; Immune system; Immunology; T cell; Immunoediting; Hepatocellular carcinoma; Dendritic cell; Adjuvant therapy; Adoptive cell transfer; Oncology; Internal medicine; Cancer","score_opus":0.0460332441837773,"score_gpt":0.3094296325806096,"score_spread":0.2633963883968323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225003254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8980857,0.099603504,0.00008426097,0.00033759055,0.0006293074,0.00076845224,0.00015635477,0.00003800724,0.00029678943],"genre_scores_gemma":[0.9941695,0.003111415,0.000014748054,0.00007992505,0.000010703295,0.0004694072,0.00018499704,0.00004030872,0.0019190029],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99348384,0.004453774,0.00054209545,0.00057378545,0.00020644313,0.00074006757],"domain_scores_gemma":[0.9977191,0.0010970077,0.0001456328,0.00049042853,0.0005212529,0.00002657215],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021190299,0.0002748402,0.00048344838,0.0009659768,0.0011806276,0.000026630645,0.00063749094,0.00026725465,0.0011718095],"category_scores_gemma":[0.00013941078,0.0002929153,0.000116771356,0.0008513902,0.0008659369,0.00016984456,0.0002298834,0.0014043974,0.000034508652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045613293,0.00067907455,0.013386499,0.00010623935,0.0001104939,0.000024800875,0.0016981937,0.00001842873,0.9716684,0.0002582632,0.00023247441,0.0072557637],"study_design_scores_gemma":[0.0046911887,0.0018900257,0.042024184,0.000045853918,0.000031976248,0.000030104293,0.002567635,0.00010625085,0.94234926,0.000064838576,0.0058943876,0.00030428043],"about_ca_topic_score_codex":0.00033898902,"about_ca_topic_score_gemma":0.0000063356915,"teacher_disagreement_score":0.09649209,"about_ca_system_score_codex":0.00025965364,"about_ca_system_score_gemma":0.00097054703,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W4285672705","doi":"10.1158/2326-6066.723.8.6","title":"A Sampling of Highlights from the Literature","year":2020,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sampling (signal processing); Medicine; Computer science; Computational biology; Biology","score_opus":0.09914347380315007,"score_gpt":0.3762141187227381,"score_spread":0.277070644919588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285672705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79289246,0.18436629,0.000036246245,0.020846408,0.0007133911,0.00026954454,0.00016429761,0.000046938167,0.00066445034],"genre_scores_gemma":[0.9932891,0.004179745,0.000022954475,0.0006392291,0.00012059912,0.00006661997,0.000074510936,0.000019457635,0.0015877977],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977292,0.0010529611,0.00030233405,0.00033544423,0.000072269264,0.00050782703],"domain_scores_gemma":[0.9979338,0.0011591429,0.00007727237,0.00044720544,0.00036182208,0.000020761508],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039620607,0.00014936506,0.00031736682,0.00008940378,0.00030853716,0.000026556445,0.0008884478,0.0003301954,0.002129556],"category_scores_gemma":[0.00049037253,0.0000952062,0.00011028659,0.0005069819,0.0010234904,0.00007029315,0.00036603655,0.0012817514,0.0005889106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002033014,0.00003593494,0.00059115625,0.00001455928,0.00047547353,0.0000049074147,0.006857216,0.0000011564425,0.9680498,0.0022058284,0.014653757,0.005077149],"study_design_scores_gemma":[0.0010012329,0.00038679436,0.009008959,0.00017267995,0.00001833557,0.000011496607,0.0013545997,0.0000017383692,0.60979486,0.00023235142,0.37789673,0.00012023127],"about_ca_topic_score_codex":0.000510081,"about_ca_topic_score_gemma":0.000022404363,"teacher_disagreement_score":0.36324295,"about_ca_system_score_codex":0.000044435576,"about_ca_system_score_gemma":0.00021414804,"threshold_uncertainty_score":0.99878263},"labels":[],"label_agreement":null},{"id":"W4296301767","doi":"10.1158/2326-6066.cir-22-0434","title":"Immune Phenotypes and Target Antigens of Clonally Expanded Bone Marrow T Cells in Treatment-Naïve Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Deutschen Konsortium für Translationale Krebsforschung; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft","keywords":"Bone marrow; Immune system; Antigen; Multiple myeloma; Immunology; Phenotype; Immunotherapy; Medicine; Cancer research; Biology; Gene; Genetics","score_opus":0.05314186102276201,"score_gpt":0.3621803626410768,"score_spread":0.30903850161831475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296301767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669682,0.028874641,0.0000017696452,0.0012864006,0.00017345611,0.0011939582,0.00011353358,0.000026522,0.0013615428],"genre_scores_gemma":[0.9744443,0.0063206963,0.00019158723,0.000036428548,0.00007341575,0.00073335634,0.000062991654,0.00005597191,0.018081218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965948,0.0007727017,0.00046429838,0.0005486563,0.00069552386,0.0009240479],"domain_scores_gemma":[0.99830645,0.0005606204,0.00008499125,0.0006420121,0.00028876885,0.000117145726],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013295147,0.00021073862,0.0007052784,0.0010497236,0.00028286438,0.000015054142,0.00029330654,0.00014447933,0.008183791],"category_scores_gemma":[0.000116307696,0.00019900894,0.000117161406,0.0011474952,0.00087360555,0.000059918588,0.0005088736,0.0010572158,0.000018477354],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005305496,0.00052999135,0.077695824,0.00006814892,0.00034299417,0.00017125085,0.0017570801,0.000024696401,0.8928014,0.000047859572,0.00023317673,0.021022053],"study_design_scores_gemma":[0.012755427,0.004089004,0.18333505,0.000073984564,0.000029820008,0.000121250865,0.0030767513,0.00036120357,0.74881834,0.00022925399,0.046839025,0.00027090107],"about_ca_topic_score_codex":0.00306948,"about_ca_topic_score_gemma":0.0003827191,"teacher_disagreement_score":0.1439831,"about_ca_system_score_codex":0.0008409416,"about_ca_system_score_gemma":0.00090651773,"threshold_uncertainty_score":0.99272287},"labels":[],"label_agreement":null},{"id":"W4306721717","doi":"10.1158/2326-6066.cir-22-0095","title":"Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; American Association for Cancer Research; Children's Hospital of Philadelphia; Stand Up To Cancer; Entertainment Industry Foundation; Doris Duke Charitable Foundation","keywords":"CD19; Chimeric antigen receptor; Medicine; Context (archaeology); Immunotherapy; Immunology; Oncology; Cancer research; Antigen; Biology; Immune system","score_opus":0.07989112111024521,"score_gpt":0.3691113198757585,"score_spread":0.2892201987655133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306721717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97907823,0.015111041,0.00006054989,0.0016912678,0.00030514837,0.0016320709,0.000073148934,0.00005529503,0.0019932513],"genre_scores_gemma":[0.96047974,0.008420794,0.00019369202,0.00049198593,0.00018775367,0.0012181586,0.00013692467,0.0001012903,0.028769638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960631,0.00089211663,0.00047334284,0.0006412506,0.00096242776,0.0009677573],"domain_scores_gemma":[0.9979366,0.00020308001,0.00011898541,0.0009609932,0.000660234,0.00012012441],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014533455,0.00020585,0.00052036374,0.0005760144,0.0004886154,0.000020365103,0.000661422,0.00014310899,0.008250862],"category_scores_gemma":[0.000090339316,0.00021350289,0.0001227569,0.0016721026,0.00042161017,0.00009802899,0.0004579929,0.001459258,0.000056792982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048158173,0.00010731305,0.0020809788,0.00008185647,0.00019203553,0.00004700162,0.0045722406,0.00005818081,0.983792,0.00009354086,0.00041141588,0.003747589],"study_design_scores_gemma":[0.0030484346,0.0012187973,0.014605378,0.00005108806,0.000013475632,0.00003045486,0.0017301742,0.000075987795,0.8897942,0.00015168946,0.08906082,0.00021952252],"about_ca_topic_score_codex":0.00088157074,"about_ca_topic_score_gemma":0.00007963007,"teacher_disagreement_score":0.09399785,"about_ca_system_score_codex":0.0035481653,"about_ca_system_score_gemma":0.0020844787,"threshold_uncertainty_score":0.99265575},"labels":[],"label_agreement":null},{"id":"W4309656465","doi":"10.1158/2326-6066.cir-22-0260","title":"CD73 Inhibits cGAS–STING and Cooperates with CD39 to Promote Pancreatic Cancer","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Vector Institute; Hôpital de l'Enfant-Jésus; Université de Montréal; University of Toronto; University Health Network; Artificial Intelligence in Medicine (Canada); Centre Hospitalier de l’Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Université de Montréal; Terry Fox Research Institute","keywords":"Sting; Pancreatic cancer; Medicine; Cancer; Cancer research; Cancer immunotherapy; Immunotherapy; Immunology; Internal medicine","score_opus":0.04895646800022256,"score_gpt":0.3561988983489186,"score_spread":0.307242430348696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309656465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94168293,0.05302372,0.0000068152494,0.0030864591,0.00047501927,0.00079143676,0.00008476045,0.00007876782,0.00077008945],"genre_scores_gemma":[0.9716873,0.0012737915,0.00003345021,0.0004201444,0.000039068316,0.0021124987,0.000032730026,0.00005203067,0.024348974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965755,0.0012205008,0.00031585837,0.0006425111,0.00012981422,0.0011158631],"domain_scores_gemma":[0.9987244,0.00032969654,0.00007340629,0.0004343879,0.00038669677,0.000051419265],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010338925,0.00026047876,0.0004556908,0.00048032522,0.0015126867,0.000050566276,0.0005082111,0.00015905297,0.0043606716],"category_scores_gemma":[0.0002180308,0.00021744128,0.000040186336,0.00080578716,0.00082756375,0.00009987646,0.0009968574,0.0015573824,0.00020594517],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046146247,0.000111966074,0.0049865586,0.000038120845,0.00057036727,0.000029892877,0.0029176057,0.00004733343,0.9628666,0.00035892954,0.004864107,0.018593917],"study_design_scores_gemma":[0.003540549,0.0044397907,0.011720946,0.00030992815,0.000064845706,0.00062899885,0.004919427,0.00001803735,0.6576782,0.00004892718,0.31602675,0.0006036147],"about_ca_topic_score_codex":0.0023101636,"about_ca_topic_score_gemma":0.00026508796,"teacher_disagreement_score":0.31116262,"about_ca_system_score_codex":0.00036692995,"about_ca_system_score_gemma":0.0006801203,"threshold_uncertainty_score":0.9997872},"labels":[],"label_agreement":null},{"id":"W4311098518","doi":"10.1158/2326-6074.tumimm22-a09","title":"Abstract A09: Immune checkpoint inhibitor-induced polyarthritis: a case series","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nivolumab; Polyarthritis; Prednisone; Ipilimumab; Arthritis; Internal medicine; Cancer; Rash; Synovitis; Dermatology; Surgery; Oncology; Immunotherapy","score_opus":0.06990754541223117,"score_gpt":0.37819605054656996,"score_spread":0.3082885051343388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311098518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9308275,0.05637498,5.9759935e-7,0.007920539,0.0011355644,0.00087008596,0.00008574879,0.00012524973,0.0026597593],"genre_scores_gemma":[0.9906498,0.0030293614,0.000029356514,0.0002886806,0.0003348433,0.0015067807,0.000043206714,0.000070227055,0.00404775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966107,0.00038716797,0.0006211642,0.0006098341,0.0007123494,0.0010587567],"domain_scores_gemma":[0.99841464,0.00013719503,0.00012544221,0.00085323665,0.00032970813,0.00013977358],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018541653,0.00026132638,0.0005120116,0.00054505613,0.0013293036,0.00005416444,0.00034988575,0.00019344199,0.009225079],"category_scores_gemma":[0.00011267529,0.00026134888,0.0002642391,0.0011184952,0.00074368436,0.00017974207,0.00052520866,0.0021708286,0.000075128766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009948448,0.0003327928,0.0010113446,0.0000953492,0.00063404546,0.008430006,0.0012690343,0.0000016081395,0.89067113,0.00008480828,0.002378329,0.085143104],"study_design_scores_gemma":[0.019318752,0.007884994,0.07522157,0.0005001213,0.00010645682,0.090046234,0.02629238,0.000016366625,0.51300836,0.00030506702,0.26620054,0.001099141],"about_ca_topic_score_codex":0.0056206337,"about_ca_topic_score_gemma":0.00036252267,"teacher_disagreement_score":0.37766275,"about_ca_system_score_codex":0.0011719071,"about_ca_system_score_gemma":0.0013517777,"threshold_uncertainty_score":0.99998385},"labels":[],"label_agreement":null},{"id":"W4311098665","doi":"10.1158/2326-6074.tumimm22-a03","title":"Abstract A03: Estimating scenarios for survival time in patients with metastatic melanoma receiving immunotherapy or targeted therapy","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Interquartile range; Immunotherapy; Oncology; Internal medicine; Clinical trial; Melanoma; Survival analysis; Targeted therapy; Randomized controlled trial; Cancer","score_opus":0.36514786188021325,"score_gpt":0.477485829104555,"score_spread":0.11233796722434175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311098665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983672,0.00596653,0.00031802367,0.005996161,0.0006680061,0.0026461543,0.0005000034,0.0000441218,0.000188975],"genre_scores_gemma":[0.98539007,0.00024246701,0.0058642197,0.0013199348,0.00017769459,0.0054749013,0.00024239444,0.00015456528,0.0011337373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493736,0.0009483291,0.0021981827,0.0007174009,0.00024142036,0.0009573318],"domain_scores_gemma":[0.9951017,0.0030096737,0.0010097412,0.00058753346,0.00021476345,0.000076569166],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01835321,0.00022819598,0.0010173375,0.00079610513,0.00080473605,0.00008124968,0.0006628664,0.00009649718,0.005003632],"category_scores_gemma":[0.0017163896,0.00023859259,0.00008390918,0.0006813112,0.00018960821,0.00033349483,0.00012444796,0.00076275464,0.00020414196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010367966,0.0017587116,0.9240498,0.00058183126,0.0020590117,0.000013430072,0.011553277,0.015793666,0.00035091315,0.003773516,0.009193024,0.02050486],"study_design_scores_gemma":[0.01584929,0.0023606513,0.9338677,0.00015883682,0.0000056189338,0.0000039673037,0.0020255065,0.017118448,0.000024150806,0.0048479913,0.022904407,0.000833421],"about_ca_topic_score_codex":0.0028178217,"about_ca_topic_score_gemma":0.00043324384,"teacher_disagreement_score":0.01967144,"about_ca_system_score_codex":0.0018059668,"about_ca_system_score_gemma":0.0007794083,"threshold_uncertainty_score":0.99590594},"labels":[],"label_agreement":null},{"id":"W4311098666","doi":"10.1158/2326-6074.tumimm22-a51","title":"Abstract A51: STING activation overcomes immune escape in osteosarcoma metastasis","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Sting; Stimulator of interferon genes; Cancer research; Metastasis; Immune system; Cancer; Tumor microenvironment; Cancer cell; Immunotherapy; Medicine; Downregulation and upregulation; Innate immune system; Immunology; Biology; Internal medicine; Gene","score_opus":0.0800805621876029,"score_gpt":0.37718980849216177,"score_spread":0.29710924630455887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311098666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655679,0.027379699,0.000006026964,0.0018327299,0.0010974371,0.00053742586,0.000063766405,0.00008479276,0.0034302175],"genre_scores_gemma":[0.9922064,0.0007242413,0.000014247022,0.00011869405,0.000029002504,0.00082941813,0.00013145943,0.00004686868,0.0058996654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99446136,0.0028491244,0.000649129,0.00059873407,0.00018998745,0.0012516726],"domain_scores_gemma":[0.9976322,0.0013096032,0.0001704129,0.0006537318,0.00021117645,0.000022867594],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033388843,0.0002686259,0.0005291022,0.0011727719,0.0010836064,0.000038802285,0.0009652418,0.0002511785,0.014377598],"category_scores_gemma":[0.0005673545,0.0002748289,0.00015675198,0.0010542742,0.000619494,0.00024197681,0.0010866661,0.0029745114,0.0004327469],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027118858,0.00030271092,0.0037633765,0.000025845304,0.00038166062,0.000029649802,0.0011303856,0.000038941802,0.9360052,0.00088307407,0.0018572654,0.052870054],"study_design_scores_gemma":[0.0039236895,0.00084639265,0.19065271,0.000108569635,0.000020207803,0.00014568752,0.008783354,0.000011155029,0.6546249,0.00029622304,0.14009741,0.0004897232],"about_ca_topic_score_codex":0.0025053439,"about_ca_topic_score_gemma":0.000078394696,"teacher_disagreement_score":0.28138027,"about_ca_system_score_codex":0.00088222517,"about_ca_system_score_gemma":0.00052872614,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W4311934208","doi":"10.1158/2326-6066.cir-22-0174","title":"Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome–Positive C3 Cancers in Mice","year":2022,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Universiteit Leiden; National Institutes of Health; Eurostars; Bundesministerium für Bildung und Forschung; Institut de recherche en santé mentale; European Commission","keywords":"Medicine; Virology; Cisplatin; Immunotherapy; Genome; Cancer research; Immunology; Biology; Immune system; Internal medicine; Chemotherapy; Gene; Genetics","score_opus":0.026674317863691798,"score_gpt":0.3423913271875536,"score_spread":0.3157170093238618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311934208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97043914,0.028149964,0.000006624971,0.00029928001,0.000054860197,0.0006411857,0.000103279715,0.000009388087,0.00029630464],"genre_scores_gemma":[0.99544525,0.003224556,0.000025259305,0.00016651953,0.00007145463,0.00055016077,0.00016223536,0.00006024391,0.00029433242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99662954,0.0011834872,0.0002890131,0.00069753604,0.0004328379,0.00076761347],"domain_scores_gemma":[0.9988556,0.000110861154,0.00009493857,0.000569251,0.00026566949,0.0001036609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009956963,0.00021951355,0.0003362728,0.00039586946,0.00031057934,0.000020105204,0.00065495115,0.00015013099,0.00021383216],"category_scores_gemma":[0.000041044368,0.00021024009,0.000038621478,0.0007814784,0.0005184997,0.000010853521,0.00046445755,0.00080571487,0.000002057579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025714492,0.00017250508,0.0011108072,0.000020530475,0.00038535066,0.000039218827,0.0005854208,0.0025554253,0.9403105,0.000017536797,0.000021936645,0.02906632],"study_design_scores_gemma":[0.012994427,0.030405771,0.07636286,0.000050444327,0.000034829707,0.00006837168,0.0027181893,0.00048417415,0.87182266,0.000057774774,0.004304215,0.00069626607],"about_ca_topic_score_codex":0.0013611629,"about_ca_topic_score_gemma":0.0034291567,"teacher_disagreement_score":0.075252056,"about_ca_system_score_codex":0.00039963305,"about_ca_system_score_gemma":0.001087312,"threshold_uncertainty_score":0.85733426},"labels":[],"label_agreement":null},{"id":"W4360813826","doi":"10.1158/2326-6066.cir-22-0621","title":"The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"Genome British Columbia; Infrastruktura PL-Grid; Imperial Experimental Cancer Medicine Centre; Cancerfonden; Agence Nationale de la Recherche; European Regional Development Fund; Fundacja na rzecz Nauki Polskiej; European Commission; UK Research and Innovation; Horizon 2020 Framework Programme; Cancer Research UK; NuCana; Medical Research Council; Swedish Cancer Foundation; Fundação para a Ciência e a Tecnologia; Genome Canada","keywords":"MHC class I; Computational biology; Biology; Major histocompatibility complex; Human leukocyte antigen; Genome; Cancer immunotherapy; Antigen; Cancer; Genetics; Immunotherapy; Gene","score_opus":0.044769820431042634,"score_gpt":0.34525456298662566,"score_spread":0.300484742555583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360813826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713611,0.023099916,0.0000057407647,0.0027497285,0.00026266626,0.0003293786,0.00007836166,0.000020790425,0.002092334],"genre_scores_gemma":[0.9864177,0.010953155,0.000012616508,0.00005078817,0.0001974354,0.00019609356,0.0001382277,0.00003277663,0.0020011882],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99795145,0.00041356156,0.000373343,0.00030193242,0.00027948557,0.00068020914],"domain_scores_gemma":[0.9977992,0.0006839527,0.00014835504,0.00082704425,0.0005051359,0.000036300706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018568231,0.00016209825,0.0002332188,0.00009424988,0.0007402262,0.00013377558,0.0012462041,0.00023684968,0.000038233997],"category_scores_gemma":[0.0012751974,0.00009949272,0.00013912086,0.0006140786,0.0006682024,0.000013778977,0.0009529196,0.0006628303,0.000045440684],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007352815,0.00007549376,0.0073478017,0.000014131868,0.0014450144,0.0000031188501,0.0024044288,0.00019811411,0.9539982,0.0015026557,0.026892219,0.005383508],"study_design_scores_gemma":[0.0064978357,0.0019010004,0.54251575,0.00027138586,0.00015784598,0.000029819545,0.10011533,0.0048701447,0.11598609,0.0041452814,0.22238089,0.0011286156],"about_ca_topic_score_codex":0.0012866074,"about_ca_topic_score_gemma":0.00043157185,"teacher_disagreement_score":0.83801216,"about_ca_system_score_codex":0.00011011593,"about_ca_system_score_gemma":0.0005284855,"threshold_uncertainty_score":0.5693296},"labels":[],"label_agreement":null},{"id":"W4380357935","doi":"10.1158/2326-6066.cir-22-0465","title":"Aerobic Exercise Alters the Melanoma Microenvironment and Modulates ERK5 S496 Phosphorylation","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"NHLBI Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Division of Cancer Epidemiology and Genetics, National Cancer Institute; University of Texas MD Anderson Cancer Center; Cancer Prevention and Research Institute of Texas","keywords":"Tumor microenvironment; Immune system; Cancer research; CD8; Cytotoxic T cell; Population; Melanoma; Macrophage polarization; Biology; Phosphorylation; Immunology; Phenotype; Medicine; Endocrinology; Cell biology","score_opus":0.03871444760019662,"score_gpt":0.31733138965066304,"score_spread":0.27861694205046644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380357935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.864401,0.12950025,0.000007797789,0.0033493303,0.001531484,0.0007120951,0.000020001846,0.00011614937,0.0003619109],"genre_scores_gemma":[0.9425752,0.040772695,0.000013892617,0.00012250582,0.000049986465,0.000714271,0.000092796356,0.000052119452,0.01560651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972747,0.0005757602,0.00033872714,0.0006044375,0.00011486961,0.0010914962],"domain_scores_gemma":[0.9984962,0.00049977406,0.00009006314,0.000780513,0.00010664942,0.000026796843],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012688215,0.00024805966,0.00033033418,0.00030361343,0.0009376043,0.000042287586,0.0006734247,0.0003800609,0.0013062557],"category_scores_gemma":[0.000066450484,0.00019172848,0.00007750913,0.00061762345,0.0023741645,0.000107769,0.0007143255,0.0011317166,0.0024804715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048207416,0.00004690255,0.0057095005,0.000036394722,0.00041369343,0.000013191702,0.0020526398,0.000092125796,0.90731543,0.00026956003,0.029118026,0.054450486],"study_design_scores_gemma":[0.00242445,0.0003144019,0.13658783,0.0001824606,0.00007646814,0.0000710726,0.0023634743,0.00007497659,0.6609296,0.001037703,0.19547668,0.0004608548],"about_ca_topic_score_codex":0.0005679699,"about_ca_topic_score_gemma":0.000037528964,"teacher_disagreement_score":0.24638578,"about_ca_system_score_codex":0.0002842347,"about_ca_system_score_gemma":0.00013216915,"threshold_uncertainty_score":0.99960667},"labels":[],"label_agreement":null},{"id":"W4380450183","doi":"10.1158/2326-6066.cir-22-0140","title":"HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer; McGill University; Université de Montréal; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Tumor microenvironment; Immune system; Cancer research; Breast cancer; Biology; Carcinogenesis; Immunotherapy; Cancer; Tumor progression; Tumor initiation; Gene knockdown; Immunology; Cell culture","score_opus":0.049542272113119894,"score_gpt":0.3641174741742652,"score_spread":0.3145752020611453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380450183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93959355,0.04954633,0.0000027864046,0.0077295946,0.0012979391,0.0012286081,0.00020145811,0.00022157299,0.00017813101],"genre_scores_gemma":[0.95385474,0.022883618,0.000021701062,0.00039501544,0.00009784036,0.0025963553,0.000099743185,0.00012305437,0.019927954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9937479,0.0020882525,0.00071168685,0.001025916,0.0001871708,0.0022391032],"domain_scores_gemma":[0.9980317,0.00036580634,0.00010896295,0.0012261118,0.00019341361,0.000074046395],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0028560627,0.00045178193,0.00070788956,0.0014105813,0.0008160065,0.00006409654,0.0013972966,0.00065546035,0.0048256023],"category_scores_gemma":[0.00010134764,0.00042966648,0.00015157176,0.0019039297,0.0010178544,0.0002974885,0.00069765036,0.0021605268,0.0039706794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002711355,0.00033740792,0.00667248,0.000030397148,0.00039401057,0.00005103954,0.0032520562,0.000057529574,0.93381464,0.000120961035,0.0035351187,0.049023002],"study_design_scores_gemma":[0.002628975,0.0005822882,0.33696926,0.00025874437,0.000015291764,0.000076762226,0.0016735852,0.00000551391,0.4630615,0.000054746855,0.19416931,0.0005040178],"about_ca_topic_score_codex":0.004216246,"about_ca_topic_score_gemma":0.00028717314,"teacher_disagreement_score":0.47075313,"about_ca_system_score_codex":0.0007569539,"about_ca_system_score_gemma":0.0005304673,"threshold_uncertainty_score":0.9998155},"labels":[],"label_agreement":null},{"id":"W4382240403","doi":"10.1158/2326-6066.cir-23-0189","title":"A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Landsteiner Foundation for Blood Transfusion Research","keywords":"Cancer research; CD8; T cell; Cytotoxic T cell; Immune system; Immunotherapy; In vivo; Effector; Peripheral blood mononuclear cell; CD3; Antibody; Ex vivo; Immunology; Biology; In vitro","score_opus":0.07868281163372867,"score_gpt":0.3782674942303921,"score_spread":0.2995846825966634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382240403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96878606,0.016577415,0.000008821689,0.0055099996,0.0005751097,0.0017668369,0.000056574772,0.000546219,0.006172953],"genre_scores_gemma":[0.93046683,0.009989597,0.00011842215,0.00017664679,0.00048365782,0.0009446305,0.00025604927,0.00028953797,0.0572746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9886678,0.0038841704,0.0010055127,0.0014087021,0.001826041,0.003207763],"domain_scores_gemma":[0.9919721,0.0044935094,0.00022570562,0.0016453154,0.0011722748,0.0004910908],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.009356413,0.00058617664,0.0010725881,0.0024841272,0.0013133168,0.00020613219,0.0011047104,0.00062693417,0.004183963],"category_scores_gemma":[0.0027230491,0.0005446633,0.00037505,0.004489066,0.001595349,0.00025162954,0.0011565983,0.00527915,0.0018922117],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013318133,0.00038694128,0.0020905554,0.00025154196,0.0002819085,0.001334624,0.0028285622,0.000065294815,0.9584829,0.0000051039256,0.011151333,0.009803107],"study_design_scores_gemma":[0.0061796093,0.0009588062,0.01686267,0.00056700764,0.000029044073,0.00004146918,0.008180514,0.00090258935,0.8810648,0.000037339065,0.084615365,0.00056082354],"about_ca_topic_score_codex":0.0006278063,"about_ca_topic_score_gemma":0.000007832999,"teacher_disagreement_score":0.077418126,"about_ca_system_score_codex":0.0020265414,"about_ca_system_score_gemma":0.0023754765,"threshold_uncertainty_score":0.9999868},"labels":[],"label_agreement":null},{"id":"W4385064061","doi":"10.1158/2326-6066.cir-22-0912","title":"Tumor Cell–Intrinsic c-Myb Upregulation Stimulates Antitumor Immunity in a Murine Colorectal Cancer Model","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; European Commission; Deutsches Krebsforschungszentrum; Swiss Cancer Research Foundation; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Cancer research; Downregulation and upregulation; Cytotoxic T cell; Biology; Tumor microenvironment; Carcinogenesis; CD8; Tumor progression; Cancer; Immune system; Immunology","score_opus":0.06070083626266562,"score_gpt":0.3709813163964048,"score_spread":0.3102804801337392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385064061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619773,0.032611746,0.000014414841,0.00082718424,0.0020390053,0.0010679365,0.00015945784,0.00026853685,0.0010344124],"genre_scores_gemma":[0.98261833,0.005810837,0.000035711022,0.000083530744,0.00008795499,0.0014996552,0.00025443896,0.00010102615,0.00950849],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99489003,0.001123195,0.0007657168,0.00093618414,0.00021989143,0.0020649775],"domain_scores_gemma":[0.9975827,0.00073274504,0.00019241915,0.0008749732,0.0005669875,0.00005022139],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018680062,0.0004474099,0.0007670223,0.0013951386,0.00071019784,0.000048177186,0.0011827783,0.00059120974,0.002088535],"category_scores_gemma":[0.00025864388,0.00045451368,0.00015736846,0.0025415174,0.0017158746,0.0002825536,0.0010761779,0.0026119156,0.0017196547],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015742971,0.0003168391,0.02127534,0.00012548851,0.00025854039,0.000066526794,0.0014928351,0.009816478,0.9504421,0.00023382936,0.00677304,0.0076246806],"study_design_scores_gemma":[0.008134898,0.00042346862,0.2030488,0.0003421738,0.00005050158,0.000048780275,0.0010457003,0.0064106686,0.77004975,0.0013433832,0.008231172,0.00087071105],"about_ca_topic_score_codex":0.004849838,"about_ca_topic_score_gemma":0.00092587114,"teacher_disagreement_score":0.18177345,"about_ca_system_score_codex":0.0010955101,"about_ca_system_score_gemma":0.0012867018,"threshold_uncertainty_score":0.99979067},"labels":[],"label_agreement":null},{"id":"W4388013818","doi":"10.1158/2326-6066.cir-23-0321","title":"Determinants for Antitumor and Protumor Effects of Programmed Cell Death","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Cancer Research Society","keywords":"Immunosurveillance; Tumor microenvironment; Programmed cell death; Biology; Immune system; Epigenetics; Immunology; Cancer; Context (archaeology); Immunotherapy; Chemokine; Immunogenic cell death; Cancer research; Apoptosis; Genetics; Gene","score_opus":0.07155914524658015,"score_gpt":0.4224807868041451,"score_spread":0.35092164155756495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388013818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98645514,0.009628594,0.0000068024588,0.0004828003,0.0002071492,0.0030287125,0.000016002872,0.000057738533,0.000117060066],"genre_scores_gemma":[0.98966974,0.00433884,0.00017904236,0.00004596841,0.00007766316,0.0027227192,0.000012245928,0.000034768993,0.0029189927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985032,0.000100139165,0.00023646303,0.00032012578,0.00021817765,0.0006218904],"domain_scores_gemma":[0.9989106,0.000385836,0.00006478683,0.00029725183,0.00027476822,0.000066766435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074542715,0.00012310833,0.00035810255,0.0003446073,0.00014690889,0.0000136082745,0.00014693964,0.00012502287,0.000023852317],"category_scores_gemma":[0.00019298278,0.0001002468,0.00008237008,0.0006010447,0.0005522592,0.000042410997,0.00009770551,0.0002445976,0.000009140587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005645142,0.00017339498,0.08070798,0.0030106113,0.00019675183,0.000087826855,0.00038425642,7.5043374e-8,0.78838646,0.00003689628,0.0014010885,0.119969524],"study_design_scores_gemma":[0.007046272,0.0029813352,0.29062822,0.0005091929,0.0000486158,0.000041156152,0.00022256609,0.000098496836,0.68779767,0.00013477687,0.010354862,0.0001368151],"about_ca_topic_score_codex":0.0002188558,"about_ca_topic_score_gemma":0.000017727465,"teacher_disagreement_score":0.20992024,"about_ca_system_score_codex":0.000086837004,"about_ca_system_score_gemma":0.00039093778,"threshold_uncertainty_score":0.40879455},"labels":[],"label_agreement":null},{"id":"W4388041288","doi":"10.1158/2326-6066.cir-23-0522","title":"Lessons for the Next Generation of Scientists from the Second Annual Arthur and Sandra Irving Cancer Immunology Symposium","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Cancer Institute","keywords":"Publishing; Scientific publishing; Engineering ethics; Political science; Engineering","score_opus":0.1869273419889362,"score_gpt":0.4251396820144746,"score_spread":0.2382123400255384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388041288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8649015,0.08823294,0.000026299509,0.043824933,0.0013523444,0.00094944565,0.0005845321,0.000032623644,0.00009542038],"genre_scores_gemma":[0.955883,0.036494534,0.000021572712,0.0005063008,0.00059694756,0.001063637,0.000083986044,0.000035885605,0.0053141154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99804425,0.00026721018,0.0003344797,0.0004377584,0.00029655593,0.00061973685],"domain_scores_gemma":[0.99743223,0.0013065153,0.00011330349,0.0005998709,0.0005084471,0.00003960186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014398572,0.0001598451,0.0003223547,0.00020390532,0.0008460949,0.000066155764,0.00041238833,0.0002023994,0.0006691285],"category_scores_gemma":[0.00014901656,0.00009924347,0.000107910455,0.00081135595,0.0019636808,0.00013008033,0.00025112476,0.000524004,0.00001018696],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018404516,0.000031117244,0.0031590643,0.00005489986,0.001037664,0.000004349124,0.0033261448,0.000007610968,0.9089961,0.00036592974,0.028100438,0.05307625],"study_design_scores_gemma":[0.0081090825,0.0010195879,0.44798937,0.00042278308,0.00022844135,0.00005807338,0.010291523,0.0020296546,0.18027735,0.00050978444,0.348685,0.00037934075],"about_ca_topic_score_codex":0.0027694593,"about_ca_topic_score_gemma":0.004030677,"teacher_disagreement_score":0.72871876,"about_ca_system_score_codex":0.00018556905,"about_ca_system_score_gemma":0.00070524076,"threshold_uncertainty_score":0.73264873},"labels":[],"label_agreement":null},{"id":"W4388621780","doi":"10.1158/2326-6066.cir-23-0205","title":"The Tautomerase Activity of Tumor Exosomal MIF Promotes Pancreatic Cancer Progression by Modulating MDSC Differentiation","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pancreas Centre (Canada)","funders":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","keywords":"Pancreatic cancer; Tumor microenvironment; Cancer research; Macrophage migration inhibitory factor; Exosome; Microvesicles; Tumor progression; Cancer immunotherapy; Cancer; Biology; Immunotherapy; Immune system; Immunology; Cytokine; microRNA; Biochemistry","score_opus":0.04572977854645075,"score_gpt":0.3741826503556524,"score_spread":0.32845287180920163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388621780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817457,0.014840884,0.000022172148,0.001202744,0.0009433947,0.0008763352,0.00016930616,0.00014412876,0.000055314824],"genre_scores_gemma":[0.9928481,0.00095553044,0.000009994045,0.000011166264,0.000069883514,0.0014360575,0.00010299933,0.000035806705,0.0045304885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663115,0.0013825889,0.00042662135,0.00048032939,0.00019819419,0.00088113116],"domain_scores_gemma":[0.99774736,0.0009766216,0.00028329418,0.00051687006,0.00044414937,0.000031678384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009438918,0.00022207065,0.00036705687,0.00025005333,0.0010995541,0.00004315181,0.00048261564,0.00026723964,0.00077835907],"category_scores_gemma":[0.00051765837,0.0001582454,0.00009424156,0.00081635534,0.0011080775,0.00014852571,0.00031531486,0.0008922174,0.00017428606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039797317,0.000100086145,0.01905984,0.00007100717,0.00027075634,0.000003356075,0.0005876787,0.000007141217,0.94224554,0.00007741926,0.006897388,0.030281788],"study_design_scores_gemma":[0.0010353486,0.00024154078,0.080592625,0.00015139695,0.000026071155,0.0000057574125,0.0003182004,0.00038042624,0.9132887,0.000112804955,0.003675379,0.00017173002],"about_ca_topic_score_codex":0.00087193324,"about_ca_topic_score_gemma":0.00019832587,"teacher_disagreement_score":0.061532784,"about_ca_system_score_codex":0.00021816732,"about_ca_system_score_gemma":0.00039762107,"threshold_uncertainty_score":0.8522486},"labels":[],"label_agreement":null},{"id":"W4389227565","doi":"10.1158/2326-6074.tumimm23-a039","title":"Abstract A039: Detection of immune cell glycosylation as an indicator of metabolic activity in the tumor tissue microenvironment using multimodal mass spectrometry imaging","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Glycan; Tumor microenvironment; Biology; Glycosylation; Cancer research; Immunology; Molecular biology; Biochemistry; Glycoprotein","score_opus":0.02756899991615742,"score_gpt":0.3586619397464903,"score_spread":0.3310929398303329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994832,0.0040591694,0.00020048028,0.00012303767,0.0000666558,0.000559956,0.000025860807,0.0000064328738,0.0001264042],"genre_scores_gemma":[0.998585,0.0010118161,0.00011805472,0.000007822182,0.0000595916,0.00009718198,0.00003614103,0.000022087015,0.00006230583],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978464,0.0005428329,0.00031955203,0.00037750462,0.00043250874,0.0004811772],"domain_scores_gemma":[0.9990854,0.00006735358,0.00016248036,0.0005288305,0.00011319386,0.000042734704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017583402,0.00013073102,0.00021485586,0.0005883804,0.00014141611,0.000018303632,0.00043913294,0.00013158614,0.00012314781],"category_scores_gemma":[0.00012937281,0.000116560645,0.00006673838,0.0007975747,0.00039941462,0.000021539474,0.00017421247,0.00049596507,0.000027476777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043811195,0.00013954751,0.007022389,0.000045801426,0.000033733453,0.000008852778,0.00016558719,0.00017740966,0.9838241,0.0000115248495,0.000002918366,0.008130035],"study_design_scores_gemma":[0.00052004337,0.00016467646,0.2801739,0.000010461341,0.00000449647,0.0000055381,0.0003729365,0.00048336026,0.71770203,0.00003426232,0.00045837302,0.000069884605],"about_ca_topic_score_codex":0.0025317485,"about_ca_topic_score_gemma":0.00011407598,"teacher_disagreement_score":0.27315152,"about_ca_system_score_codex":0.00007792555,"about_ca_system_score_gemma":0.00022249157,"threshold_uncertainty_score":0.47532052},"labels":[],"label_agreement":null},{"id":"W4389227574","doi":"10.1158/2326-6074.tumimm23-pr04","title":"Abstract PR04: Temporal single cell profiling identifies B-cell specific checkpoint molecules that regulate anti-tumor immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Acquired immune system; Cancer immunotherapy; TIGIT; Immune checkpoint; Immunotherapy; Antigen presentation; T cell; Cancer research; B cell; Immunology; Immunity; Antigen; Immune system; Antibody","score_opus":0.11737914931982456,"score_gpt":0.3683198197744457,"score_spread":0.25094067045462115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9601594,0.03133569,0.00000802273,0.0016100247,0.0009212576,0.0010931928,0.000048164613,0.00028571652,0.0045385086],"genre_scores_gemma":[0.9819424,0.008097947,0.00011920629,0.0000901696,0.00022898453,0.00026066694,0.00017520113,0.00010426656,0.0089811245],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99611974,0.0003346579,0.00063138426,0.00076612114,0.0007947809,0.0013532917],"domain_scores_gemma":[0.99777114,0.00024352135,0.00021741465,0.0011544174,0.00046866224,0.00014481886],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022125475,0.0003624359,0.00061764073,0.00081932725,0.00060079386,0.0001506609,0.00061136484,0.0002995519,0.0009713663],"category_scores_gemma":[0.00007271698,0.00032881164,0.00029709103,0.0015266796,0.0012945253,0.0002160855,0.00038222162,0.001472768,0.00053681195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021901785,0.0003855886,0.0076810787,0.00042646835,0.00022262303,0.00034713067,0.00059098785,0.0000081507615,0.9771444,0.00001029456,0.007981026,0.0030120478],"study_design_scores_gemma":[0.0029772879,0.0003889093,0.1287921,0.00030836157,0.000024467618,0.00004691258,0.002836939,0.00003280516,0.8475725,0.00012554479,0.016583484,0.00031068752],"about_ca_topic_score_codex":0.0011889172,"about_ca_topic_score_gemma":0.000045055498,"teacher_disagreement_score":0.12957193,"about_ca_system_score_codex":0.0005904094,"about_ca_system_score_gemma":0.00066838315,"threshold_uncertainty_score":0.9999419},"labels":[],"label_agreement":null},{"id":"W4389227587","doi":"10.1158/2326-6074.tumimm23-b009","title":"Abstract B009: GBM cells mimic regulatory T cell function to protect the CSC pool from immune surveillance in recurrent GBM","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer research; FOXP3; Tumor microenvironment; Biology; Cancer stem cell; Glioma; Cancer; T cell; Stem cell; Immunology; Cell biology; Genetics","score_opus":0.05937206859392809,"score_gpt":0.3611547826674185,"score_spread":0.30178271407349044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731938,0.016233321,0.0000012836886,0.007147155,0.0008485217,0.0019867755,0.000062086765,0.00008006476,0.00044694424],"genre_scores_gemma":[0.99387306,0.002913203,0.000010540393,0.00010428813,0.00018295052,0.0020421734,0.00007723228,0.00004331948,0.00075325655],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972355,0.00038949374,0.00040677082,0.00060975656,0.00051213545,0.00084634736],"domain_scores_gemma":[0.9980759,0.00055331405,0.00007935348,0.0009334769,0.00024789266,0.00011006582],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013913526,0.00021891021,0.0004141907,0.0005109471,0.0002298102,0.000036515332,0.0002795403,0.00021256763,0.0006593541],"category_scores_gemma":[0.00014320819,0.0001580163,0.00011657614,0.001367937,0.00023619506,0.0000507399,0.00022814976,0.0009813226,0.001266573],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024808403,0.0006239658,0.025037752,0.00010861207,0.00033295678,0.0003242132,0.00088967243,0.00014475758,0.8856059,0.000023597613,0.019386502,0.065041244],"study_design_scores_gemma":[0.001948636,0.00051793724,0.8510984,0.0002040511,0.000016818667,0.000003996812,0.00040336643,0.000049596827,0.13438402,0.00010422997,0.0111354105,0.00013353353],"about_ca_topic_score_codex":0.003930863,"about_ca_topic_score_gemma":0.0008311774,"teacher_disagreement_score":0.82606065,"about_ca_system_score_codex":0.0006573265,"about_ca_system_score_gemma":0.0003733986,"threshold_uncertainty_score":0.99951106},"labels":[],"label_agreement":null},{"id":"W4389227629","doi":"10.1158/2326-6074.tumimm23-a036","title":"Abstract A036: Development of a stirred-tank bioreactor scale-up approach to allogeneic natural killer cell culture","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Immunology; Immunotherapy; K562 cells; Immune system; Flow cytometry; Transplantation; Cell therapy; Cancer immunotherapy; Biology; Cancer research; Medicine; Stem cell; Cell biology; Leukemia; Internal medicine","score_opus":0.061332372972011086,"score_gpt":0.3458579716181284,"score_spread":0.2845255986461173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95228237,0.012736134,0.000043442018,0.0005722389,0.02488006,0.00090840197,0.00002009216,0.00022524997,0.008332035],"genre_scores_gemma":[0.8654002,0.0006533936,0.00011443027,0.00008935548,0.00013072512,0.0003790359,0.00045441758,0.000041182448,0.13273726],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732274,0.00031103703,0.00057166175,0.00062161486,0.00018268925,0.0009902486],"domain_scores_gemma":[0.99856687,0.00015540732,0.00013918077,0.0005179897,0.00057071296,0.000049860664],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000902338,0.0002801137,0.000434729,0.0007882935,0.0004694236,0.000026837066,0.00064842607,0.0005898661,0.0012413384],"category_scores_gemma":[0.000118470634,0.00023508714,0.00013991164,0.0011545721,0.0004536444,0.0001324134,0.00038959668,0.0015243819,0.0041035945],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067231525,0.0001717094,0.00040580475,0.000056818142,0.00028268603,0.0000012688577,0.0035282262,0.000008215333,0.79115814,0.00002433598,0.19553088,0.0081595825],"study_design_scores_gemma":[0.0010165457,0.00013766951,0.025802815,0.00005471183,0.000012737937,0.000012853203,0.002847838,0.0000030579668,0.4522065,0.000007991739,0.5176646,0.00023270112],"about_ca_topic_score_codex":0.0002136152,"about_ca_topic_score_gemma":0.000041633677,"teacher_disagreement_score":0.33895168,"about_ca_system_score_codex":0.00031906777,"about_ca_system_score_gemma":0.00046320216,"threshold_uncertainty_score":0.99967164},"labels":[],"label_agreement":null},{"id":"W4389227639","doi":"10.1158/2326-6074.tumimm23-a006","title":"Abstract A006: Understanding the Potential of Human IL-12 and Chimeric IL-15 Combination for Cancer Immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Interleukin 15; Cancer immunotherapy; Immunology; Cytotoxic T cell; Chimeric antigen receptor; CD8; T cell; Cancer research; STAT4; Biology; Immune system; Medicine; Cytokine; Interleukin; In vitro; stat; STAT3; Cell biology; Signal transduction","score_opus":0.15433649951523956,"score_gpt":0.4428773898484035,"score_spread":0.288540890333164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842798,0.0062150178,0.00008242505,0.0064581903,0.00036449812,0.0017206051,0.00007126751,0.00009252213,0.000715649],"genre_scores_gemma":[0.98213863,0.011500875,0.000008731474,0.00006497721,0.00020408863,0.0007583815,0.000042771713,0.0000854691,0.0051960843],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99759686,0.00022703204,0.00034836982,0.00039628867,0.0006342714,0.00079716416],"domain_scores_gemma":[0.9983662,0.0005277847,0.00010406568,0.00050188415,0.0004284472,0.00007166845],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002012846,0.00017064966,0.00039861485,0.00059604115,0.000556069,0.000047924008,0.0003480041,0.00020071544,0.0013427216],"category_scores_gemma":[0.000096378,0.00013247626,0.00012634679,0.0008794849,0.0013789164,0.0000859736,0.00015508824,0.0008267097,0.000009998557],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017262024,0.00008924712,0.0031831644,0.00017123706,0.0006488573,0.000009659433,0.0011632987,0.000012271245,0.9570907,0.0011524879,0.00216924,0.032583684],"study_design_scores_gemma":[0.020187523,0.004063702,0.76152223,0.00058865553,0.00014383034,0.000056009703,0.014089239,0.0012552477,0.15351903,0.015897522,0.028079692,0.0005973093],"about_ca_topic_score_codex":0.0014271103,"about_ca_topic_score_gemma":0.00019699716,"teacher_disagreement_score":0.80357164,"about_ca_system_score_codex":0.00057789584,"about_ca_system_score_gemma":0.00046049125,"threshold_uncertainty_score":0.9995702},"labels":[],"label_agreement":null},{"id":"W4389227651","doi":"10.1158/2326-6074.tumimm23-b047","title":"Abstract B047: Tertiary lymphoid structures and B cells signatures determine clinically relevant T cell phenotype in ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Germinal center; CD8; Immunotherapy; Biology; Follicular dendritic cells; Immunosurveillance; Cancer research; Immunology; T cell; Immune system; B cell; Antigen-presenting cell; Antibody","score_opus":0.050372601418938595,"score_gpt":0.38741373420365127,"score_spread":0.3370411327847127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579483,0.036072694,0.0000013733178,0.003534437,0.00082371494,0.0007420578,0.00006403486,0.00008365344,0.0007296897],"genre_scores_gemma":[0.95548666,0.04119821,0.000079382,0.0007452391,0.00030391855,0.00027146237,0.00003188748,0.00006447887,0.001818744],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968529,0.00025141795,0.0006653656,0.0007372987,0.00046417603,0.00102885],"domain_scores_gemma":[0.9982667,0.00065149297,0.0001239042,0.0005829358,0.00022340401,0.00015158487],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013760763,0.0002860728,0.00053960783,0.00068608084,0.00020572371,0.00004981777,0.00037059205,0.00051614543,0.0011508978],"category_scores_gemma":[0.00013618633,0.0002376229,0.00011634817,0.0010218159,0.0008660101,0.00010465103,0.00024281842,0.0013195882,0.000052045154],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053467522,0.00010380445,0.043496937,0.0002495496,0.00023500672,0.00032804208,0.00063616654,0.000021662338,0.86006945,0.000013791976,0.0052647595,0.08423406],"study_design_scores_gemma":[0.0063353484,0.0004498798,0.87964934,0.00035519208,0.00003835455,0.000026045682,0.0004022294,0.000116518175,0.100665025,0.0004194968,0.011217876,0.0003247108],"about_ca_topic_score_codex":0.0040825945,"about_ca_topic_score_gemma":0.00057924713,"teacher_disagreement_score":0.8361524,"about_ca_system_score_codex":0.00040454595,"about_ca_system_score_gemma":0.0010610862,"threshold_uncertainty_score":0.9997622},"labels":[],"label_agreement":null},{"id":"W4389227659","doi":"10.1158/2326-6074.tumimm23-a041","title":"Abstract A041: Rejuvenation: Innovative technology to improve T-cell antitumor properties through partial reprogramming","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reprogramming; Induced pluripotent stem cell; Epigenetics; Biology; Cell potency; Immunotherapy; Embryonic stem cell; T cell; Cytotoxic T cell; Stem cell; Cell therapy; Cell; Phenotype; Cancer research; Immunology; Cell biology; Immune system; Genetics; In vitro","score_opus":0.06679651810333476,"score_gpt":0.38924516370498413,"score_spread":0.3224486456016494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846283,0.0040063257,0.00008556449,0.006860958,0.000465136,0.0011676245,0.000033452165,0.00013704842,0.0026155494],"genre_scores_gemma":[0.98918885,0.0016409027,0.0002237571,0.00011312629,0.00030820112,0.0015831112,0.00008318753,0.00006245559,0.006796416],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964117,0.00020615273,0.00041780423,0.0010583518,0.0005282659,0.0013777362],"domain_scores_gemma":[0.99737734,0.000045104673,0.000089994675,0.0009967298,0.0014001079,0.00009071644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013763155,0.00023728514,0.00028720428,0.0006454503,0.00044666292,0.00007722927,0.0009447887,0.0004495776,0.0000766299],"category_scores_gemma":[0.0007654287,0.00022026112,0.000067146764,0.0033554044,0.0009312991,0.00002086445,0.001362613,0.00087535474,0.00068318314],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040746084,0.000090816444,0.0013929422,0.000077011624,0.00011971914,0.000055697557,0.0002086199,0.00004132369,0.97656375,0.00017262767,0.0072863144,0.013583742],"study_design_scores_gemma":[0.0006176322,0.0006131139,0.0014212575,0.000050479328,0.0000030736412,0.000009078759,0.0007683158,0.000022230077,0.85978395,0.00012959339,0.13635582,0.00022545239],"about_ca_topic_score_codex":0.00023490492,"about_ca_topic_score_gemma":0.000050121103,"teacher_disagreement_score":0.12906949,"about_ca_system_score_codex":0.00015442962,"about_ca_system_score_gemma":0.0007291555,"threshold_uncertainty_score":0.8981988},"labels":[],"label_agreement":null},{"id":"W4389227671","doi":"10.1158/2326-6074.tumimm23-b046","title":"Abstract B046: Analyzing heterogeneity of tumor microenvironment of TNBC patients by meta-analysis of 7 breast cancer scRNAseq studies","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Stromal cell; Breast cancer; Triple-negative breast cancer; Cancer research; Immunotherapy; Immune system; CD8; Medicine; Estrogen receptor; Immune checkpoint; Cancer; T cell; Oncology; Biology; Internal medicine; Immunology","score_opus":0.16784164586879086,"score_gpt":0.43705841957133656,"score_spread":0.2692167737025457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89684373,0.100138076,9.61672e-7,0.00084815745,0.00009331854,0.00039442957,0.0016472851,0.000011957903,0.00002207756],"genre_scores_gemma":[0.9724951,0.026810775,0.000013715582,0.00005601333,0.000016698912,0.00021348226,0.00008897567,0.000025068417,0.00028021482],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971792,0.00025254374,0.00088886346,0.00045054618,0.0006977745,0.00053104863],"domain_scores_gemma":[0.9978295,0.00027958292,0.00045804292,0.0006631135,0.00070507167,0.00006470738],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012549155,0.00021782125,0.001706908,0.0009930378,0.000098973775,0.0000046494424,0.00032239995,0.00011033322,0.0012295146],"category_scores_gemma":[0.0000676467,0.00016834652,0.0009275506,0.0023874766,0.0014095006,0.000062533996,0.00021724861,0.00032545082,0.0000054330117],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024212447,0.00036588756,0.1848705,0.0003572513,0.24836269,0.000008117559,0.00038400566,0.00006430766,0.5574535,0.0000013502715,0.0022263026,0.0034848491],"study_design_scores_gemma":[0.0014704446,0.00028219805,0.7544804,0.000082955965,0.019235289,0.0000013938833,0.0005392255,0.000012166018,0.22328746,0.0000038341595,0.0004862796,0.00011834757],"about_ca_topic_score_codex":0.0044003935,"about_ca_topic_score_gemma":0.00045304562,"teacher_disagreement_score":0.5696099,"about_ca_system_score_codex":0.00038405752,"about_ca_system_score_gemma":0.00022504324,"threshold_uncertainty_score":0.9996835},"labels":[],"label_agreement":null},{"id":"W4389227682","doi":"10.1158/2326-6074.tumimm23-b028","title":"Abstract B028: WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wee1; Cancer research; Immune checkpoint; Cell cycle checkpoint; Blockade; Immunotherapy; Cell cycle; Medicine; Biology; Immunology; Immune system; Cancer; Cyclin-dependent kinase 1; Internal medicine","score_opus":0.07118017525727223,"score_gpt":0.4046953547627054,"score_spread":0.3335151795054332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.957073,0.019246314,0.0000052132555,0.021328526,0.0001399383,0.0017897388,0.00010513205,0.00004242336,0.00026976573],"genre_scores_gemma":[0.9878576,0.009351233,0.00001148396,0.000108782064,0.00009755159,0.0014387895,0.000015341808,0.00003571254,0.00108353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99672127,0.00076626375,0.00051532564,0.00047936125,0.0006066802,0.0009110773],"domain_scores_gemma":[0.9959851,0.0027302871,0.00015323803,0.00050574343,0.00054374133,0.00008190808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045817476,0.00020463293,0.00044400393,0.00047135787,0.00049285666,0.00004594089,0.00033560334,0.000127809,0.00008805184],"category_scores_gemma":[0.0014926307,0.00013048353,0.000056884215,0.0016397991,0.0010234375,0.000113936185,0.00050841586,0.001282441,0.000012186281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004981936,0.00006507736,0.00791556,0.00032635653,0.00015874453,0.00003274244,0.0067628953,0.00004033915,0.9730589,0.000018739434,0.002754024,0.003884714],"study_design_scores_gemma":[0.0018335555,0.00041660146,0.34839466,0.0009014665,0.000021814349,0.0000048886454,0.007266309,0.00014066325,0.6391489,0.00005784271,0.0016836841,0.00012961411],"about_ca_topic_score_codex":0.0066858134,"about_ca_topic_score_gemma":0.0007237814,"teacher_disagreement_score":0.3404791,"about_ca_system_score_codex":0.0009993522,"about_ca_system_score_gemma":0.0014705854,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W4389227694","doi":"10.1158/2326-6074.tumimm23-b025","title":"Abstract B025: Neutrophil depletion enhances the anti-tumor activity of CAR-T cells in an autochthonous model of non-small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; T cell; CD8; Immunotherapy; Medicine; Infiltration (HVAC); Cell; Lung cancer; Cancer immunotherapy; Immune system; Immunology; Pathology; Biology","score_opus":0.08007744742955278,"score_gpt":0.4022435364212251,"score_spread":0.3221660889916723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943529,0.0021457325,0.000026501893,0.00082741963,0.00024230887,0.00162433,0.000098281715,0.00004272163,0.00063981296],"genre_scores_gemma":[0.9896539,0.007624071,0.000030308087,0.000028747281,0.00013446198,0.000739109,0.000013901406,0.00006649765,0.0017090074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99650586,0.00047358134,0.00051279424,0.0006182937,0.0007998403,0.0010896488],"domain_scores_gemma":[0.9973843,0.00052906625,0.00019237677,0.0010151681,0.0007585008,0.0001205671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021715816,0.00024302452,0.0007174666,0.00082001695,0.0001682936,0.000022200737,0.00074265193,0.0002640713,0.0006734994],"category_scores_gemma":[0.00006905297,0.00019370519,0.00015517938,0.001640236,0.0010059442,0.00014395372,0.0003066648,0.0016788513,0.000018387962],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016138649,0.00035017828,0.013850313,0.00058944395,0.00013263634,0.00004358806,0.0015949752,0.0053411922,0.97039497,0.00000864022,0.0002454149,0.0058348095],"study_design_scores_gemma":[0.0015164505,0.00041928518,0.17703763,0.00020077275,0.000027449129,0.0000031728976,0.00047860513,0.02700421,0.7930596,0.000032750264,0.00008373239,0.00013633195],"about_ca_topic_score_codex":0.011214337,"about_ca_topic_score_gemma":0.0020025133,"teacher_disagreement_score":0.17733534,"about_ca_system_score_codex":0.00052767684,"about_ca_system_score_gemma":0.0021663036,"threshold_uncertainty_score":0.9953701},"labels":[],"label_agreement":null},{"id":"W4389227697","doi":"10.1158/2326-6074.tumimm23-a017","title":"Abstract A017: Exploring the interplay between macrophage subtypes and colorectal cancer cell growth","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Cancer research; Stromal cell; Immune system; Biology; Macrophage; Colorectal cancer; Cell culture; Tumor progression; Cell; Cancer cell; Cancer; Immunology; In vitro","score_opus":0.07314657446558576,"score_gpt":0.3727645151303189,"score_spread":0.29961794066473313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9167093,0.07545569,0.0000021353358,0.0015489373,0.0030262358,0.00052322977,0.00012825242,0.00018227196,0.0024239593],"genre_scores_gemma":[0.95444304,0.03783309,0.0000042073757,0.00006882457,0.00023230158,0.001402894,0.000060359587,0.00007372575,0.00588154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965156,0.00064732373,0.00043977154,0.00072925084,0.0001524233,0.0015156469],"domain_scores_gemma":[0.99732864,0.0016116919,0.00012031404,0.0005555951,0.00033800726,0.000045750898],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0016682805,0.0003301794,0.00047567044,0.000298542,0.00107225,0.00007097442,0.0011126713,0.0004354287,0.0023378322],"category_scores_gemma":[0.00018107226,0.0002540762,0.000107714215,0.00083390484,0.0023225816,0.0002647004,0.0010602584,0.0021776718,0.0014904189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054477353,0.000045555716,0.03895962,0.00012603153,0.0007401463,0.000038275313,0.0035467688,0.000005339126,0.8987733,0.00024542035,0.019312745,0.03766201],"study_design_scores_gemma":[0.0012598734,0.00019696963,0.34641486,0.00011419789,0.000044470395,0.000017900446,0.002128387,0.000002312989,0.606102,0.00025965186,0.0431265,0.00033290774],"about_ca_topic_score_codex":0.0059737284,"about_ca_topic_score_gemma":0.00053463783,"teacher_disagreement_score":0.30745524,"about_ca_system_score_codex":0.00044667014,"about_ca_system_score_gemma":0.00037533487,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W4389227701","doi":"10.1158/2326-6074.tumimm23-a029","title":"Abstract A029: Treatment-Specific Immune Phenotypes Identified by nELISA High-Throughput Proteomics Reveal Actionable Insights for Drug Discovery","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Proteomics; Immune system; Biology; Cytokine; Phenotype; Computational biology; Proteases; Immunotherapy; Tumor microenvironment; Chemokine; Peripheral blood mononuclear cell; Drug discovery; Immunology; Bioinformatics; Gene; Genetics; In vitro; Enzyme; Biochemistry","score_opus":0.04862144729291532,"score_gpt":0.3739854669666774,"score_spread":0.32536401967376205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986182,0.007089025,0.0023810077,0.0018838143,0.00031917068,0.0014951614,0.0003458309,0.000114104965,0.00018990897],"genre_scores_gemma":[0.9499966,0.019275755,0.0017825856,0.00004515137,0.00044903328,0.0024077506,0.0019742227,0.00007026178,0.02399865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998326,0.00007087801,0.0002710218,0.00062460563,0.00014409178,0.00056337443],"domain_scores_gemma":[0.9988748,0.00007777358,0.00009460005,0.00065502495,0.00025156818,0.000046243968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026737817,0.00019273837,0.00021769741,0.0001099087,0.00054993265,0.00007883265,0.0003330521,0.00022901614,0.00001615863],"category_scores_gemma":[0.000042397693,0.00017437576,0.0001045987,0.0003430507,0.0003777286,0.000025286714,0.00019178835,0.00022650712,0.000040573756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030940084,0.00008778246,0.000022025171,0.00001652257,0.00011396537,0.0000015200097,0.00004731531,0.00002350935,0.94392836,0.0007492968,0.049785204,0.0049151084],"study_design_scores_gemma":[0.00057485956,0.00015255266,0.0008789005,0.00001788785,0.0000070991036,0.0000019475397,0.00013866302,0.0000075952116,0.7484945,0.0028042477,0.2467617,0.00016006346],"about_ca_topic_score_codex":0.00037770177,"about_ca_topic_score_gemma":0.000060621576,"teacher_disagreement_score":0.19697648,"about_ca_system_score_codex":0.00019195255,"about_ca_system_score_gemma":0.00019144123,"threshold_uncertainty_score":0.7110837},"labels":[],"label_agreement":null},{"id":"W4389227707","doi":"10.1158/2326-6074.tumimm23-a034","title":"Abstract A034: VV-iVP55: A Superior Vaccinia Virus Platform with Enhanced Oncolytic Potency and Immunogenicity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Vaccinia; Biology; Immunogenicity; Virology; Population; Immune system; CD8; Virus; Immunology; Cancer research; Medicine","score_opus":0.04840830391638313,"score_gpt":0.37576277820827836,"score_spread":0.32735447429189524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861748,0.011167163,0.0000099179215,0.0005909212,0.000119201744,0.0007266122,0.00006990073,0.000066053195,0.0010753806],"genre_scores_gemma":[0.9821313,0.014660257,0.0000261452,0.00008469783,0.00019727073,0.0005932296,0.00009629495,0.00008523128,0.0021255452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966492,0.00021721168,0.00034649158,0.00087851007,0.000529848,0.0013787625],"domain_scores_gemma":[0.9982069,0.00012215023,0.00007054614,0.0009446739,0.00047064637,0.00018507335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013581939,0.00031312244,0.0003688979,0.00038082185,0.00052788446,0.00008516615,0.0007320803,0.00041501905,0.00041206123],"category_scores_gemma":[0.00017048481,0.0002737102,0.00009421702,0.0009018748,0.000805486,0.00002170193,0.00056947354,0.00091533543,0.0002511996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010520897,0.00007497583,0.0006700322,0.000044138345,0.00039476555,0.00004631713,0.00023544542,0.000021111997,0.9442453,0.000010599711,0.00045598278,0.043280464],"study_design_scores_gemma":[0.002627263,0.0058103194,0.026729893,0.00005919208,0.000014752761,0.00003932055,0.00046621545,0.00004190829,0.9589799,0.00010812895,0.0047287606,0.00039436307],"about_ca_topic_score_codex":0.0007612849,"about_ca_topic_score_gemma":0.0020390197,"teacher_disagreement_score":0.0428861,"about_ca_system_score_codex":0.00017081748,"about_ca_system_score_gemma":0.0011161743,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W4389227714","doi":"10.1158/2326-6074.tumimm23-a020","title":"Abstract A020: Neutralizing oxidative damage at telomeres prevents T cell dysfunction and improves adoptive cell therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telomere; DNA damage; Reactive oxygen species; Oxidative stress; Tumor microenvironment; Biology; Cancer research; Cell; Adoptive cell transfer; Cell biology; T cell; Immune system; Immunology; DNA; Genetics; Biochemistry","score_opus":0.04674682155867603,"score_gpt":0.34355372245467763,"score_spread":0.2968069008960016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627057,0.034222793,0.0000035238022,0.00016366104,0.0008371623,0.000472455,0.00006140552,0.00003148641,0.001501819],"genre_scores_gemma":[0.91195667,0.07703306,0.000026476913,0.00007546551,0.0006274712,0.0002684101,0.00016615364,0.000045627097,0.009800679],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980478,0.00021454615,0.00020694146,0.0006270731,0.0002084052,0.00069517613],"domain_scores_gemma":[0.9991352,0.00006178211,0.00009077503,0.0004110039,0.00020366185,0.00009756336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051168166,0.00021346704,0.00022673022,0.0001969418,0.00036295655,0.000041346524,0.00028196172,0.0002871428,0.00013654493],"category_scores_gemma":[0.000034174176,0.00019945086,0.000079752346,0.0003441455,0.00047694653,0.000017320706,0.0004018694,0.00042021318,0.00005823743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006105952,0.000056501838,0.0009065335,0.00003812204,0.00010611951,0.0000029125677,0.00042546605,0.000010976242,0.97001576,0.0000074768705,0.008866116,0.018953415],"study_design_scores_gemma":[0.0014069851,0.00035539595,0.10375286,0.0000144552605,0.000010113445,0.0000028157142,0.0007717399,0.000005200343,0.7575466,0.000055299326,0.13588025,0.00019830886],"about_ca_topic_score_codex":0.0003566346,"about_ca_topic_score_gemma":0.0001382188,"teacher_disagreement_score":0.21246919,"about_ca_system_score_codex":0.00007467917,"about_ca_system_score_gemma":0.00022349285,"threshold_uncertainty_score":0.813337},"labels":[],"label_agreement":null},{"id":"W4389227721","doi":"10.1158/2326-6074.tumimm23-b024","title":"Abstract B024: TrkB.T1 receptor promotes an immunosuppressive microenvironment driven by neutrophil recruitment in gliomas","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tropomyosin receptor kinase B; Glioma; Tumor microenvironment; Cancer research; Immune system; Neurotrophic factors; Biology; Paracrine signalling; Downregulation and upregulation; Brain-derived neurotrophic factor; Immunology; Tropomyosin receptor kinase A; Medicine; Receptor; Neurotrophin; Internal medicine","score_opus":0.18318923831139722,"score_gpt":0.4003265696749317,"score_spread":0.21713733136353447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917661,0.00041113567,0.0000038158714,0.0050747907,0.0006654527,0.001551298,0.00011135609,0.00019052575,0.00022552107],"genre_scores_gemma":[0.9886453,0.005436419,0.000034727822,0.00032884633,0.00010711591,0.002027932,0.000082868224,0.00007751682,0.0032592562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957273,0.0011391101,0.000500682,0.0010312353,0.00062370487,0.0009779386],"domain_scores_gemma":[0.99859375,0.0003364335,0.0001313235,0.0007266517,0.00007154558,0.00014029973],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006472376,0.00025823354,0.0002828125,0.0006613353,0.00045801268,0.00012757545,0.0008218049,0.00018380211,0.0012607911],"category_scores_gemma":[0.0002756218,0.000255962,0.000064854394,0.0011486257,0.00044879006,0.0003692964,0.0003470627,0.0009296137,0.0013653158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019359434,0.00018651658,0.000110472865,0.000015404587,0.000008998047,0.00011409528,0.00058654044,0.00014193171,0.9901101,0.00032899986,0.0031174761,0.005085894],"study_design_scores_gemma":[0.0009884827,0.00039704476,0.0041067973,0.000035444427,0.000002323326,0.000012819385,0.00017198647,0.00032035346,0.97641194,0.00018123252,0.017154569,0.00021699513],"about_ca_topic_score_codex":0.000061086816,"about_ca_topic_score_gemma":0.00002814086,"teacher_disagreement_score":0.014037091,"about_ca_system_score_codex":0.00031710902,"about_ca_system_score_gemma":0.00016524516,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W4389227733","doi":"10.1158/2326-6074.tumimm23-b027","title":"Abstract B027: ATR inhibition upregulates PD-L1 and potentiates the antitumor immune response to chemoimmunotherapy in small-cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Blockade; Lung cancer; Immune system; Medicine; Immunology; Chemoimmunotherapy; Immunotherapy; Biology; Pharmacology; Oncology; Internal medicine; Receptor","score_opus":0.05111201229879783,"score_gpt":0.4114197291463439,"score_spread":0.36030771684754603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8763567,0.08229943,0.0000014650636,0.038843937,0.00024725543,0.0018835356,0.000039195842,0.00011211033,0.00021633871],"genre_scores_gemma":[0.9521362,0.03940428,0.00002366663,0.00025956778,0.00017076469,0.0020682784,0.000021100379,0.000078512414,0.0058376086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9961663,0.0005443718,0.00050864724,0.0007330289,0.00060621195,0.0014414368],"domain_scores_gemma":[0.99744976,0.00096945814,0.000086176646,0.00079264,0.0005622749,0.00013968557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037907218,0.0003080513,0.0005817152,0.0010231207,0.0005977257,0.00010381367,0.00042535868,0.00021465478,0.00036376162],"category_scores_gemma":[0.0005351852,0.00023036177,0.00010948058,0.0023708986,0.0010497995,0.00014301602,0.00070840016,0.0014295814,0.000113032],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010592639,0.00012392316,0.054479785,0.0004151072,0.00044623954,0.00023471353,0.0034951363,0.000081479906,0.9179082,0.000021516264,0.0057672975,0.006433968],"study_design_scores_gemma":[0.0035418537,0.0003706447,0.8865933,0.000870888,0.000031013722,0.000021727972,0.0022362492,0.00018668086,0.102158785,0.00010879642,0.0036424971,0.00023755354],"about_ca_topic_score_codex":0.0061707688,"about_ca_topic_score_gemma":0.0006838071,"teacher_disagreement_score":0.8321135,"about_ca_system_score_codex":0.00093891163,"about_ca_system_score_gemma":0.0009583689,"threshold_uncertainty_score":0.939388},"labels":[],"label_agreement":null},{"id":"W4389227749","doi":"10.1158/2326-6074.tumimm23-a023","title":"Abstract A023: Nicotinamide Phosphoribosyltransferase (NAMPT) is required for trained macrophage-mediated antitumor immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune responses and vaccinations","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nicotinamide phosphoribosyltransferase; Cancer research; NAD+ kinase; Immune system; Innate immune system; Nicotinamide mononucleotide; Nicotinamide adenine dinucleotide; Immunity; Cancer immunotherapy; PI3K/AKT/mTOR pathway; Medicine; Immunotherapy; Immunology; Biology; Biochemistry; Apoptosis; Enzyme","score_opus":0.07881101901085927,"score_gpt":0.39078295239183025,"score_spread":0.31197193338097096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96451885,0.024053497,0.0000657303,0.0054405094,0.001841684,0.0016100567,0.0014185228,0.00045046865,0.0006007022],"genre_scores_gemma":[0.9694846,0.007639771,0.00002518655,0.00017230655,0.00008304232,0.0013469479,0.0013174475,0.00009934839,0.019831328],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955273,0.00074278447,0.00074934395,0.0007873389,0.00015741024,0.0020357918],"domain_scores_gemma":[0.99546176,0.0024427678,0.000136021,0.001011636,0.0008751478,0.000072675],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0025995248,0.00040385957,0.0006744524,0.00093546655,0.0017143026,0.00007009441,0.0011278642,0.00075314613,0.0041789194],"category_scores_gemma":[0.0012802664,0.00039182903,0.00034238258,0.0018573289,0.0009818365,0.00022815575,0.00028750903,0.0016656996,0.003059187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031090959,0.0002511845,0.00077498093,0.00010631295,0.0007929929,0.000036306134,0.0011774203,0.0000063197767,0.9441545,0.00090779405,0.033256855,0.015426242],"study_design_scores_gemma":[0.009354253,0.0009101916,0.13634397,0.00016037353,0.00007430283,0.000065372675,0.0023974588,0.000071392744,0.6346808,0.0007857242,0.21444148,0.000714688],"about_ca_topic_score_codex":0.0014838375,"about_ca_topic_score_gemma":0.0001350355,"teacher_disagreement_score":0.3094737,"about_ca_system_score_codex":0.00033677384,"about_ca_system_score_gemma":0.00090729014,"threshold_uncertainty_score":0.9998534},"labels":[],"label_agreement":null},{"id":"W4389227750","doi":"10.1158/2326-6074.tumimm23-b034","title":"Abstract B034: CD27 is a new promising T cell co-stimulatory target for cancer immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer immunotherapy; Monoclonal antibody; T cell; Immunotherapy; CD8; Immunology; Cancer research; Immune system; Biology; Tumor necrosis factor alpha; Antibody; Cell biology","score_opus":0.09209846402742795,"score_gpt":0.4146756453279528,"score_spread":0.3225771813005249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71625227,0.2723987,0.00010318519,0.0040422822,0.0028755928,0.0022412576,0.0003930131,0.00075158797,0.0009421452],"genre_scores_gemma":[0.76895344,0.064457126,0.00023607754,0.0013282885,0.0006111165,0.0036683136,0.00050138263,0.00061418675,0.15963005],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.994904,0.0006672049,0.0008061655,0.0010348323,0.00021195957,0.002375881],"domain_scores_gemma":[0.9965359,0.0014577202,0.00026727674,0.001125554,0.00054014334,0.00007339141],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0020922725,0.0005565777,0.00086832873,0.0010229456,0.0012171936,0.00010409571,0.0013076066,0.001011535,0.007191401],"category_scores_gemma":[0.00019000628,0.0005287252,0.0004071314,0.0011528532,0.0012263671,0.0002954059,0.00021273877,0.001721487,0.001992671],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051302435,0.0001540987,0.00081952004,0.000095053554,0.001034087,0.000009301395,0.0024987266,0.000039940678,0.81027824,0.00007892578,0.11339143,0.06647042],"study_design_scores_gemma":[0.00455024,0.00045227073,0.0070568183,0.00011448603,0.000017736036,0.000010540511,0.00046923629,0.000012786356,0.4460834,0.0004362699,0.5404029,0.0003933372],"about_ca_topic_score_codex":0.0019302885,"about_ca_topic_score_gemma":0.000029621533,"teacher_disagreement_score":0.42701146,"about_ca_system_score_codex":0.00046953867,"about_ca_system_score_gemma":0.0024177406,"threshold_uncertainty_score":0.9997164},"labels":[],"label_agreement":null},{"id":"W4389227754","doi":"10.1158/2326-6074.tumimm23-b001","title":"Abstract B001: Harnessing invariant natural killer T cell cytotoxicity for cancer therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Cytotoxic T cell; Biology; Natural killer T cell; Immunology; Adoptive cell transfer; Cancer research; Population; Interleukin 21; Lymphokine-activated killer cell; Antigen; T cell; CD8; Immune system; Medicine; In vitro","score_opus":0.09172463458641776,"score_gpt":0.3831439119877658,"score_spread":0.29141927740134804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9234653,0.04654229,0.000039834576,0.0042330218,0.021606233,0.001230152,0.000032993248,0.0003517002,0.0024984672],"genre_scores_gemma":[0.888607,0.009924491,0.00001006881,0.00034812937,0.00020879782,0.0013349561,0.00025273004,0.000058058682,0.09925572],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973043,0.00039415434,0.00041302282,0.0006063926,0.00010351595,0.0011785963],"domain_scores_gemma":[0.998196,0.0006793424,0.00014259011,0.00045863254,0.00049323065,0.000030221378],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011224733,0.00026492396,0.000382832,0.0005592722,0.0010469535,0.000069484086,0.00050290744,0.00051214197,0.0057738014],"category_scores_gemma":[0.00016017428,0.00022870887,0.00018509485,0.00070854614,0.0005657823,0.00026354537,0.00017641523,0.0015702726,0.001899389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014832747,0.000104821396,0.0005465929,0.000036469355,0.0002951455,0.000004565365,0.0005293036,0.00002038401,0.8613808,0.00014643875,0.12238439,0.0130678],"study_design_scores_gemma":[0.002678869,0.0001971394,0.027132759,0.00007217957,0.0000110591145,0.000011262486,0.00072582875,0.00005576259,0.5321507,0.000114286995,0.4365792,0.00027097456],"about_ca_topic_score_codex":0.0014421205,"about_ca_topic_score_gemma":0.00011454848,"teacher_disagreement_score":0.32923013,"about_ca_system_score_codex":0.00034770658,"about_ca_system_score_gemma":0.000446426,"threshold_uncertainty_score":0.99887776},"labels":[],"label_agreement":null},{"id":"W4389227756","doi":"10.1158/2326-6074.tumimm23-a050","title":"Abstract A050: Enhancing immune checkpoint inhibitor efficacy by targeting neurotrophic receptor tyrosine kinase 1 signaling in immune resistant non-small cell lung cancer patients","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer research; Medicine; Cancer; Receptor tyrosine kinase; Immunotherapy; Lung cancer; Immunology; Receptor; Internal medicine","score_opus":0.028009205499139326,"score_gpt":0.3293710504655176,"score_spread":0.3013618449663783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493051,0.045923583,9.648978e-7,0.0016990225,0.000813421,0.0019318749,0.00010475541,0.00011729689,0.00010398337],"genre_scores_gemma":[0.9883949,0.008468861,0.00006033075,0.000048470723,0.00026354328,0.0017794928,0.00038213027,0.00014527443,0.00045696963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99486715,0.00033221257,0.0012549857,0.0010300587,0.000733015,0.0017825793],"domain_scores_gemma":[0.9975237,0.00059899833,0.00029811962,0.0006786469,0.00066832645,0.00023216975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015524502,0.00047616428,0.00090545655,0.00094918674,0.0004638793,0.00008050629,0.00041228512,0.0003567043,0.0006720806],"category_scores_gemma":[0.0005714697,0.0004373194,0.00024728314,0.0020670376,0.0002911331,0.00013315654,0.00043665658,0.0017027438,0.000210166],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001501112,0.0012600467,0.03350376,0.00048748724,0.00020536811,0.00029397942,0.000854966,0.00013274724,0.9575321,0.0000017299363,0.0022213159,0.0020053696],"study_design_scores_gemma":[0.007325321,0.0005899102,0.22715133,0.0017610436,0.00005531766,0.0000013229252,0.0003586247,0.00011769253,0.7615482,0.0000039103425,0.00077414693,0.00031318233],"about_ca_topic_score_codex":0.0066463947,"about_ca_topic_score_gemma":0.00013486666,"teacher_disagreement_score":0.19598392,"about_ca_system_score_codex":0.0015105127,"about_ca_system_score_gemma":0.0006504925,"threshold_uncertainty_score":0.9999684},"labels":[],"label_agreement":null},{"id":"W4389227764","doi":"10.1158/2326-6074.tumimm23-b026","title":"Abstract B026: The senescent tumor cells evade the immune system by secreting SASPs in colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer research; Immunotherapy; CD8; Biology; Colorectal cancer; Cancer cell; Tumor microenvironment; Cytokine; Cancer; Cancer immunotherapy; Tumor progression; Immunology","score_opus":0.037296221061185346,"score_gpt":0.33998373927142556,"score_spread":0.3026875182102402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82766,0.15899922,0.0000015365148,0.0045069456,0.0054574055,0.0015199468,0.0002172575,0.00022566212,0.0014119862],"genre_scores_gemma":[0.9849656,0.007681199,0.0000017209389,0.00014599401,0.0001833431,0.0026293183,0.0001047992,0.00010253132,0.0041854526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9933745,0.002134678,0.0009228197,0.00088813907,0.00030227914,0.0023775713],"domain_scores_gemma":[0.99604356,0.0021772883,0.00029564515,0.00106353,0.00038223396,0.00003776585],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0048798695,0.00046090918,0.00067963573,0.0003990546,0.0015137743,0.00009157512,0.0023055733,0.0005821663,0.0015814954],"category_scores_gemma":[0.00022134956,0.00030249107,0.00020687505,0.0019747454,0.002685706,0.00012589374,0.0010668539,0.0039460366,0.002435628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006476006,0.00006558206,0.0024892464,0.00013005879,0.00044983882,0.000051489675,0.0020178754,0.00014732737,0.96007264,0.00020314177,0.028472506,0.0052527143],"study_design_scores_gemma":[0.0018230386,0.00011546988,0.043713603,0.00043898774,0.00003506402,0.00006478276,0.0102457795,0.00006708477,0.85174304,0.00002916899,0.09132839,0.00039561058],"about_ca_topic_score_codex":0.01090814,"about_ca_topic_score_gemma":0.0008264598,"teacher_disagreement_score":0.1573056,"about_ca_system_score_codex":0.0016832994,"about_ca_system_score_gemma":0.0010556586,"threshold_uncertainty_score":0.9999427},"labels":[],"label_agreement":null},{"id":"W4389227766","doi":"10.1158/2326-6074.tumimm23-a031","title":"Abstract A031: Discovery and characterization of a novel, immunoproteasome activator that modulates the immunopeptidome, increases MHC class I antigenic presentation and enhances antitumor immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MHC class I; Cytotoxic T cell; Antigen presentation; Biology; Cancer immunotherapy; Antigen processing; CD8; Antigen; Immunotherapy; Major histocompatibility complex; Antigen-presenting cell; T cell; Immune system; Cell biology; Immunology; Biochemistry; In vitro","score_opus":0.053643369274040585,"score_gpt":0.33869999929725747,"score_spread":0.2850566300232169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99189425,0.0066902973,0.000024011646,0.0002559245,0.00012244996,0.00073061505,0.00019006236,0.000022671731,0.000069705355],"genre_scores_gemma":[0.9767393,0.02191504,0.000012644132,0.000024995361,0.00009860535,0.00032732857,0.00031734683,0.000029894978,0.0005348396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825174,0.00035878818,0.00027560283,0.00040894072,0.00025113104,0.0004538045],"domain_scores_gemma":[0.9988812,0.00018925047,0.0001793071,0.0004962997,0.00020947719,0.0000444627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011309849,0.00019472186,0.00025390496,0.00018246452,0.00045281902,0.000111983856,0.00037145134,0.00019879051,0.000029007939],"category_scores_gemma":[0.00024378506,0.00015254659,0.000057583107,0.00040098597,0.0010612521,0.00007302478,0.00057507947,0.00038774838,0.0000052354103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056804606,0.00008040894,0.008397787,0.00010661031,0.00020491898,0.0000015548957,0.00022714121,0.0000023316566,0.98689616,0.000081631006,0.000027611797,0.0034057975],"study_design_scores_gemma":[0.00049650593,0.00015801123,0.34946644,0.00007433533,0.000008470831,0.000010265976,0.00048585734,0.000035258246,0.64849555,0.00004332823,0.00060990884,0.000116034826],"about_ca_topic_score_codex":0.0010771367,"about_ca_topic_score_gemma":0.000048656002,"teacher_disagreement_score":0.34106866,"about_ca_system_score_codex":0.000024680798,"about_ca_system_score_gemma":0.00019833834,"threshold_uncertainty_score":0.622067},"labels":[],"label_agreement":null},{"id":"W4389227770","doi":"10.1158/2326-6074.tumimm23-b003","title":"Abstract B003: Communication is key: Understanding the modulating effect of immune cell crosstalk on T cell therapy function","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Crosstalk; T cell; Immune system; Interactome; CD8; Immunotherapy; Cancer immunotherapy; Cancer research; Cell; Biology; Computational biology; Cell biology; Immunology; Genetics","score_opus":0.15349428235421014,"score_gpt":0.42722960022174505,"score_spread":0.2737353178675349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724585,0.009772616,0.000020902766,0.002592176,0.00022009572,0.0014368222,0.000014748606,0.000095002,0.013389147],"genre_scores_gemma":[0.98023707,0.011043326,0.00000567815,0.00007605509,0.00009663217,0.00030810817,0.000049642458,0.000075216296,0.008108261],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964095,0.0009429347,0.00045980868,0.00042430664,0.0009292663,0.0008341904],"domain_scores_gemma":[0.99532104,0.0026019148,0.00016141724,0.0014866214,0.00035744527,0.0000715924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047258576,0.00022735524,0.00044926524,0.000582746,0.00078467705,0.00006564279,0.0005922314,0.0002773936,0.0027352227],"category_scores_gemma":[0.0001515012,0.00015973454,0.0002140252,0.001615459,0.0010226234,0.000095145304,0.0002689668,0.0019134894,0.0002227604],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057326993,0.00012486927,0.004479016,0.0002163034,0.0002582108,0.000009205297,0.0021395418,0.00013264561,0.96266425,0.00009573685,0.0018245113,0.022323016],"study_design_scores_gemma":[0.0069587533,0.0038429056,0.08871749,0.00034808918,0.000034437806,0.0000062785107,0.0035241286,0.00086043833,0.88843477,0.0008374104,0.0062098536,0.00022545546],"about_ca_topic_score_codex":0.0010380939,"about_ca_topic_score_gemma":0.000019049676,"teacher_disagreement_score":0.08423848,"about_ca_system_score_codex":0.00077614747,"about_ca_system_score_gemma":0.00031022597,"threshold_uncertainty_score":0.9981764},"labels":[],"label_agreement":null},{"id":"W4389227786","doi":"10.1158/2326-6074.tumimm23-b021","title":"Abstract B021: In vivo gain-of-function screen identifies CREB5, a novel ECM modulator that promotes immunotherapy resistance via the Collagen-Lair1 axis","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Immune system; Cancer immunotherapy; Cancer research; In vivo; Biology; Immune checkpoint; Stromal cell; Cancer cell; Downregulation and upregulation; Cell biology; Cancer; Immunology; Medicine; Gene; Genetics","score_opus":0.08539948952769882,"score_gpt":0.3718062214813789,"score_spread":0.28640673195368005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96135104,0.028536085,0.00006913975,0.0060504046,0.0006832914,0.0018043967,0.000099934434,0.0001213235,0.0012843603],"genre_scores_gemma":[0.9797689,0.00812488,0.00004125032,0.00018921313,0.0001600065,0.00066299725,0.000032201053,0.00007705046,0.010943532],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996589,0.0002889514,0.0006584814,0.00064030377,0.0008616397,0.0009616143],"domain_scores_gemma":[0.997463,0.0006282651,0.00021405914,0.0011443668,0.0004850481,0.00006527157],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00292666,0.00029918546,0.0005869582,0.0008113841,0.00043009582,0.00006522361,0.0006464594,0.00034886404,0.0011515025],"category_scores_gemma":[0.00017143367,0.00022794408,0.00022204524,0.00259173,0.001422367,0.00019920015,0.00017153424,0.00074044225,0.000060720806],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012642882,0.00021799142,0.006083949,0.00020328563,0.0008585957,0.00003368977,0.0016814724,0.000015234035,0.9579178,0.00007325917,0.006266084,0.014005748],"study_design_scores_gemma":[0.007436125,0.0006704649,0.6592401,0.00095109263,0.000044881963,0.000026947899,0.0026837746,0.00021287231,0.2830782,0.0006510181,0.044609435,0.00039509797],"about_ca_topic_score_codex":0.004034609,"about_ca_topic_score_gemma":0.0026033414,"teacher_disagreement_score":0.6748396,"about_ca_system_score_codex":0.00054792105,"about_ca_system_score_gemma":0.0007901013,"threshold_uncertainty_score":0.9997616},"labels":[],"label_agreement":null},{"id":"W4389227791","doi":"10.1158/2326-6074.tumimm23-pr03","title":"Abstract PR03: Hypoxia promotes inflammatory fibroblast formation in pancreatic cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Stromal cell; Pancreatic cancer; Cancer research; Hypoxia (environmental); Cancer-Associated Fibroblasts; Immune system; Chemokine; Cancer cell; Stroma; Immunotherapy; Biology; Cancer immunotherapy; Cancer; Medicine; Immunology; Chemistry; Internal medicine; Immunohistochemistry","score_opus":0.03971138302073033,"score_gpt":0.3450460202357461,"score_spread":0.30533463721501575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97899485,0.01828948,0.0000060040306,0.0006306399,0.0006791049,0.0005842637,0.000052050986,0.00004615277,0.0007174537],"genre_scores_gemma":[0.96837175,0.02604411,0.000021757942,0.00006263212,0.001112139,0.0014166427,0.00014207687,0.000049547616,0.0027793266],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978445,0.0001907335,0.0003544691,0.00046377687,0.00028246417,0.0008640241],"domain_scores_gemma":[0.99903667,0.00005991528,0.00008703277,0.00047990284,0.00025353956,0.00008293539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007443012,0.00019373602,0.0002589041,0.00039022262,0.00017661518,0.000040451607,0.00039273244,0.00032255214,0.00018120997],"category_scores_gemma":[0.00020821279,0.00019160485,0.0000785937,0.00066948414,0.0003319826,0.000026111153,0.00026382532,0.00049482787,0.0001391442],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026789372,0.000033620297,0.0030153617,0.00014535146,0.00008397012,0.0000067533615,0.00036323367,0.00012364068,0.96863115,0.000043562537,0.009879746,0.017405692],"study_design_scores_gemma":[0.001990154,0.00021625275,0.40387917,0.00033076786,0.000016012369,0.000019917243,0.0006457057,0.00014941672,0.38674158,0.0003174631,0.20525193,0.0004416418],"about_ca_topic_score_codex":0.00071007083,"about_ca_topic_score_gemma":0.0016966125,"teacher_disagreement_score":0.58188957,"about_ca_system_score_codex":0.00014444174,"about_ca_system_score_gemma":0.00052191026,"threshold_uncertainty_score":0.7813419},"labels":[],"label_agreement":null},{"id":"W4389227797","doi":"10.1158/2326-6074.tumimm23-a047","title":"Abstract A047: Tumor specific γδ T cells expand and respond to PD-1 blockade","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; TIGIT; T cell; T-cell receptor; Blockade; Immunology; Cancer immunotherapy; Tumor-infiltrating lymphocytes; Immunotherapy; Biology; Cancer research; Medicine; Immune system; Receptor; Internal medicine","score_opus":0.12411425987828946,"score_gpt":0.4345827140921795,"score_spread":0.3104684542138901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97901756,0.006439998,0.0000013369531,0.007480425,0.00040618246,0.0012341504,0.00004331235,0.00014065292,0.005236377],"genre_scores_gemma":[0.87761086,0.009686793,0.00007557194,0.0002811564,0.0007803058,0.0006286568,0.000025009816,0.00012759253,0.11078403],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960081,0.00030099959,0.00037352098,0.0008307386,0.0009505073,0.0015361295],"domain_scores_gemma":[0.9972001,0.0008766485,0.000039105056,0.0009823614,0.00047297296,0.00042886243],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0024449772,0.00024017895,0.0005049801,0.0014445399,0.00041035973,0.00012619022,0.00045455078,0.00022562154,0.010349008],"category_scores_gemma":[0.00028233786,0.00022091187,0.00009124141,0.0021231712,0.0010622065,0.00008020851,0.00055958243,0.0016345475,0.0025950354],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037542947,0.00007314934,0.0019223462,0.000091968635,0.00015288063,0.000716126,0.0010717666,0.0000040759146,0.9209263,0.000032673768,0.041481078,0.029773362],"study_design_scores_gemma":[0.0022097793,0.00076529564,0.12439683,0.00015661416,0.000009368594,0.00008327786,0.0012495402,0.000013595328,0.39248052,0.00013603538,0.47828633,0.0002128082],"about_ca_topic_score_codex":0.0005101557,"about_ca_topic_score_gemma":0.00007911891,"teacher_disagreement_score":0.5284458,"about_ca_system_score_codex":0.00045607027,"about_ca_system_score_gemma":0.0007716668,"threshold_uncertainty_score":0.9981816},"labels":[],"label_agreement":null},{"id":"W4389227799","doi":"10.1158/2326-6074.tumimm23-b039","title":"Abstract B039: T cell recruitment dynamics at different stages of primary and metastatic colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Medicine; Metastasis; Tumor microenvironment; KRAS; FOXP3; Cancer research; Oncology; Immunotherapy; Cancer; Pathology; Internal medicine; Immune system; Immunology","score_opus":0.129604609222508,"score_gpt":0.410922813002028,"score_spread":0.28131820377952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96238536,0.03288868,0.0000013367081,0.002072834,0.0003456787,0.001170599,0.00024406367,0.000053262163,0.0008382033],"genre_scores_gemma":[0.9308465,0.062449086,0.000018749395,0.00007798367,0.000046922763,0.00093979755,0.0001265044,0.000041052623,0.0054533994],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99787325,0.00017061067,0.00039307584,0.00042086127,0.00048258103,0.0006595991],"domain_scores_gemma":[0.9988109,0.00041183367,0.00012161084,0.0003301525,0.00022352932,0.00010195744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006434119,0.00020534897,0.00055324147,0.00040819478,0.00018892587,0.000015399168,0.00018815309,0.00014293268,0.00086155924],"category_scores_gemma":[0.000035424688,0.00016340149,0.00010952762,0.0005988798,0.0009340787,0.000051351508,0.000284592,0.0005046971,0.00002218292],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068045817,0.00023393269,0.0662418,0.0009152928,0.00100787,0.000075932854,0.0008122322,0.0000051970455,0.83865744,0.000036024292,0.0033492565,0.08186043],"study_design_scores_gemma":[0.004142287,0.00092133984,0.8241728,0.00029272708,0.00009203808,0.000020098698,0.00075900904,0.000099911216,0.16420354,0.000060549188,0.0050403103,0.00019538653],"about_ca_topic_score_codex":0.0013924502,"about_ca_topic_score_gemma":0.0009188579,"teacher_disagreement_score":0.757931,"about_ca_system_score_codex":0.0016098791,"about_ca_system_score_gemma":0.00043757676,"threshold_uncertainty_score":0.943347},"labels":[],"label_agreement":null},{"id":"W4389227813","doi":"10.1158/2326-6074.tumimm23-b035","title":"Abstract B035: The contribution of inflammasomes and cGAS-STING in RT-induced cell fate","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Inflammasome; AIM2; Pyrin domain; Biology; Innate immune system; Cytokine; Cancer research; Pyroptosis; Cell biology; Immunology; Immune system; Inflammation","score_opus":0.06907600309833052,"score_gpt":0.3741322705198751,"score_spread":0.30505626742154457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805489,0.016361227,7.9776083e-7,0.001397994,0.00044307866,0.00035448113,0.000014370055,0.000042131618,0.00083701126],"genre_scores_gemma":[0.9944635,0.0034353097,9.697967e-7,0.000025031402,0.000019946787,0.00012911526,0.000028420016,0.000015374368,0.0018823398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977087,0.000792021,0.00039453883,0.00028030336,0.00006777399,0.0007566668],"domain_scores_gemma":[0.9979793,0.0013072276,0.000105650026,0.00033042385,0.00026439963,0.00001302828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002049835,0.00014158801,0.0003126661,0.00048730877,0.0002948391,0.00001774276,0.00038809393,0.00032617289,0.0002956203],"category_scores_gemma":[0.00064100086,0.0001049043,0.000053203432,0.0006395534,0.000882281,0.0000864842,0.0003424752,0.0011028942,0.00031134376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084380736,0.000033493267,0.008716094,0.000024274545,0.000097055134,0.000010340167,0.0009585078,0.0000033834438,0.97890496,0.0005403065,0.0005859479,0.0092818225],"study_design_scores_gemma":[0.001496569,0.0002141426,0.3007158,0.000094510084,0.00000628081,0.000012970332,0.0019506457,0.0000073124347,0.6883313,0.00015784244,0.0069123274,0.00010026356],"about_ca_topic_score_codex":0.0010134882,"about_ca_topic_score_gemma":0.00022635583,"teacher_disagreement_score":0.2919997,"about_ca_system_score_codex":0.000096024414,"about_ca_system_score_gemma":0.00023806145,"threshold_uncertainty_score":0.4791588},"labels":[],"label_agreement":null},{"id":"W4389227919","doi":"10.1158/2326-6074.tumimm23-a026","title":"Abstract A026: Administration of preoperative ketorolac prevents osteosarcoma recurrence by promoting T cell memory and inhibiting immunosuppression","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ketorolac; Medicine; Immune system; Immunosuppression; Osteosarcoma; Cyclooxygenase; Metastasis; Immunotherapy; Cancer; Immunology; Pharmacology; Cancer research; Internal medicine; Biology; Analgesic","score_opus":0.03980411047910442,"score_gpt":0.3754176781044063,"score_spread":0.33561356762530187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916696,0.00577133,0.0000012303077,0.00034018065,0.00019506128,0.0010329077,0.000030479376,0.00005250607,0.00090669637],"genre_scores_gemma":[0.997655,0.0010555973,0.000022676302,0.000011603904,0.00009945668,0.0002699397,0.00006640024,0.000027598406,0.0007917293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976937,0.0005039799,0.0004344383,0.00039653576,0.00042846313,0.00054286607],"domain_scores_gemma":[0.9986771,0.00050423015,0.00016554612,0.00023316393,0.00030916475,0.00011083418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023443748,0.00016400022,0.00033836835,0.00023330025,0.00025853686,0.000022444903,0.00014510339,0.0002253177,0.000118729804],"category_scores_gemma":[0.00060176855,0.00014390789,0.00004738858,0.0003391704,0.0003939983,0.000172331,0.00019782834,0.00085032266,0.00003043386],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006849086,0.00010064167,0.012730545,0.00084899785,0.000051373016,0.00005519496,0.0022874218,6.6289886e-7,0.9578449,0.0000065352033,0.0013108011,0.024078002],"study_design_scores_gemma":[0.0014139924,0.0009131313,0.08108328,0.001102713,0.000017654149,0.00002261281,0.0010315147,0.00022288422,0.91379255,0.000022439493,0.00025409856,0.00012311699],"about_ca_topic_score_codex":0.0000857971,"about_ca_topic_score_gemma":0.000006809363,"teacher_disagreement_score":0.06835274,"about_ca_system_score_codex":0.000110597815,"about_ca_system_score_gemma":0.00048449176,"threshold_uncertainty_score":0.5868393},"labels":[],"label_agreement":null},{"id":"W4389227931","doi":"10.1158/2326-6074.tumimm23-b008","title":"Abstract B008: GPR64-targeting single-domain CAR-T cells for immunotherapy in Ewing sarcoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Cancer research; Cancer; FLI1; Context (archaeology); Transcriptome; Medicine; Sarcoma; Mesenchymal stem cell; Cancer immunotherapy; Biology; Computational biology; Bioinformatics; Transcription factor; Internal medicine; Pathology; Gene expression; Genetics; Gene","score_opus":0.12010739287825663,"score_gpt":0.42062158504169206,"score_spread":0.30051419216343545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97930294,0.0097421985,0.000024379719,0.0048720385,0.0006343467,0.0023129634,0.000042693402,0.00020468785,0.0028637238],"genre_scores_gemma":[0.97676164,0.006323234,0.00046714727,0.00026907882,0.00072107936,0.0018114473,0.00013254202,0.00025067414,0.013263142],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946935,0.0004742665,0.0007051501,0.000866426,0.00090922543,0.0023514123],"domain_scores_gemma":[0.9964216,0.0018198721,0.00009403719,0.0008762604,0.00061086804,0.0001773601],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00522195,0.00032441222,0.00073807716,0.0016120789,0.00041807818,0.00008793565,0.00067723036,0.00044987103,0.0029592316],"category_scores_gemma":[0.0004468515,0.00031971352,0.00026294118,0.0023268277,0.00074170233,0.00014984782,0.00028396345,0.0019529966,0.0003316449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003032221,0.00021453331,0.00447842,0.00021856655,0.0002809328,0.00020795637,0.001641143,0.000023736624,0.9185914,0.00006853633,0.006123595,0.065118976],"study_design_scores_gemma":[0.012075991,0.0015778221,0.046221107,0.00064232986,0.000015736652,0.00004123462,0.005136231,0.00031911163,0.678258,0.0015339211,0.25358826,0.00059027004],"about_ca_topic_score_codex":0.0012190626,"about_ca_topic_score_gemma":0.00020922419,"teacher_disagreement_score":0.24746466,"about_ca_system_score_codex":0.0014404083,"about_ca_system_score_gemma":0.0008993654,"threshold_uncertainty_score":0.9999255},"labels":[],"label_agreement":null},{"id":"W4389227944","doi":"10.1158/2326-6074.tumimm23-a028","title":"Abstract A028: Defining immune pathways involved in the depletion of B-cell precursor acute lymphoblastic leukemia-initiating cells following early-life cytomegalovirus (CMV) infection in mice","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunology; Immune system; Biology; Leukemia; B cell; Antibody; Chemokine; Medicine; Cancer research; Virology","score_opus":0.053619627169509645,"score_gpt":0.3394182277089818,"score_spread":0.28579860053947215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944477,0.001978626,0.00004099205,0.00029856447,0.00039287936,0.0013206142,0.000036389254,0.000106168416,0.0013780417],"genre_scores_gemma":[0.9955939,0.003016348,0.00008910984,0.00009338513,0.00010538294,0.0008081228,0.00008746203,0.00009310329,0.00011319244],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9941414,0.001013656,0.0011430895,0.00074682117,0.0012872925,0.0016677509],"domain_scores_gemma":[0.9947792,0.0037083474,0.00026571486,0.0007142166,0.00038834807,0.00014415056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0050700833,0.00035207777,0.0008066993,0.00204487,0.00029444872,0.000067397006,0.0006907802,0.0005544203,0.00006874361],"category_scores_gemma":[0.0019852293,0.00030472197,0.00024202559,0.0043202834,0.000617779,0.0003201331,0.00046178198,0.0022521496,0.00040954424],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016501372,0.00024498603,0.0640134,0.00043055363,0.00029873505,0.0007095828,0.0055155125,0.0004688052,0.924714,0.000060702754,0.00031660017,0.001576976],"study_design_scores_gemma":[0.014166968,0.0010835468,0.70947003,0.0015839539,0.00010131984,0.0000431573,0.004885256,0.0049798037,0.26293984,0.0002030988,0.00010599075,0.0004370277],"about_ca_topic_score_codex":0.011032088,"about_ca_topic_score_gemma":0.00081204495,"teacher_disagreement_score":0.66177416,"about_ca_system_score_codex":0.003943799,"about_ca_system_score_gemma":0.004504622,"threshold_uncertainty_score":0.9999405},"labels":[],"label_agreement":null},{"id":"W4389227945","doi":"10.1158/2326-6074.tumimm23-a022","title":"Abstract A022: Immunotherapy of IL-6R Prevents Relapse and Metastasis of Triple-Negative Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Cancer research; Triple-negative breast cancer; Metastasis; Breast cancer; Tumor microenvironment; Cancer; Cytotoxic T cell; Immunology; Oncology; Internal medicine; Biology","score_opus":0.04981593190187377,"score_gpt":0.40484699882325814,"score_spread":0.35503106692138436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783726,0.018810246,0.0000026075413,0.00046286703,0.00014245273,0.0005278792,0.0014283928,0.00001061673,0.00024234607],"genre_scores_gemma":[0.9379423,0.05970461,0.000028268538,0.000013440896,0.000058746184,0.0004604878,0.00007469051,0.000033852237,0.001683552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797493,0.00026415466,0.00032979652,0.00045224995,0.00037576424,0.00060308067],"domain_scores_gemma":[0.9987514,0.000096606826,0.00013641137,0.0004922792,0.00043474865,0.00008857881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006853883,0.0001764932,0.00035315935,0.00030629276,0.00013366142,0.0000127895055,0.00037028687,0.00018451607,0.00035144857],"category_scores_gemma":[0.00010875841,0.00015684981,0.000116925985,0.00065108034,0.00089081546,0.000013291021,0.0003119523,0.000314144,0.000008619487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029761551,0.00018325774,0.020751756,0.00012240451,0.0018629899,0.000011713335,0.000281117,0.000010389202,0.89538896,0.000030855146,0.0033547515,0.07502566],"study_design_scores_gemma":[0.004200164,0.000774351,0.3479268,0.00013805447,0.000031009666,0.000015112615,0.0004282691,0.000007771405,0.6405769,0.00040192928,0.005299739,0.00019989586],"about_ca_topic_score_codex":0.0064559723,"about_ca_topic_score_gemma":0.00064758613,"teacher_disagreement_score":0.32717505,"about_ca_system_score_codex":0.0000909795,"about_ca_system_score_gemma":0.0005707566,"threshold_uncertainty_score":0.9759542},"labels":[],"label_agreement":null},{"id":"W4389227987","doi":"10.1158/2326-6074.tumimm23-a010","title":"Abstract A010: Assay development to assess the efficiency and stability of candidate molecules for transcriptional gene silencing of FOXP3, using a human tumor-derived cell line","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gene silencing; Biology; FOXP3; Transcription factor; Cell biology; Transcriptional regulation; Epigenetics; Effector; Cancer research; Therapeutic gene modulation; Gene expression; Immune system; Gene; Immunology; Genetics; Regulator gene","score_opus":0.22277501408679942,"score_gpt":0.4421814979584126,"score_spread":0.21940648387161318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389227987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956354,0.0015504141,0.0007254035,0.00042267833,0.000072298906,0.0013907404,0.000076552926,0.000018801507,0.000107739106],"genre_scores_gemma":[0.99873215,0.00018555264,0.0005112772,0.000021416732,0.000046611414,0.00028913526,0.000035095985,0.000030958145,0.00014777394],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975339,0.00027845873,0.00048475183,0.00040184043,0.0006521357,0.0006489042],"domain_scores_gemma":[0.9977914,0.00071671465,0.00008498543,0.00039881637,0.0009061532,0.000101897574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003932715,0.00014518999,0.0004043317,0.00041420187,0.00032129115,0.000019519057,0.00030874385,0.00009687148,0.0004227149],"category_scores_gemma":[0.00026450946,0.00011345085,0.00008021474,0.0007530917,0.0007570448,0.00004477982,0.0001789456,0.0004844191,0.0000029833004],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092841405,0.00014217758,0.0030769482,0.0004885336,0.00013592065,0.000010165753,0.0023352369,0.00009674374,0.99024147,0.000017221308,0.00001840474,0.0025087867],"study_design_scores_gemma":[0.0013982404,0.00042192577,0.076174214,0.00013246435,0.0000177072,0.000008617831,0.0014901003,0.000505263,0.9195677,0.000040266827,0.00015307027,0.000090417394],"about_ca_topic_score_codex":0.0010531032,"about_ca_topic_score_gemma":0.0001928515,"teacher_disagreement_score":0.073097266,"about_ca_system_score_codex":0.0003390958,"about_ca_system_score_gemma":0.0014053907,"threshold_uncertainty_score":0.46284318},"labels":[],"label_agreement":null},{"id":"W4389228010","doi":"10.1158/2326-6074.tumimm23-a003","title":"Abstract A003: High-throughput TCR sequencing demonstrates induction of long-lasting HPV16-specific T cell responses in VB10.16 vaccinated advanced cervical cancer patients","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"ELISPOT; T-cell receptor; Peripheral blood mononuclear cell; T cell; Immunotherapy; Medicine; Immunology; Biology; Immune system; Genetics","score_opus":0.05035878388481703,"score_gpt":0.347053994624171,"score_spread":0.296695210739354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98880565,0.009440514,0.000014315001,0.00021283199,0.0006824661,0.00041592564,0.0001559198,0.000024746065,0.0002476092],"genre_scores_gemma":[0.98214465,0.016732149,0.00005926785,0.000027383967,0.00019416843,0.00024353151,0.00022500103,0.000050780654,0.00032303517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974416,0.00022929389,0.00054029137,0.0006856364,0.000287476,0.0008157387],"domain_scores_gemma":[0.99836797,0.00029275293,0.00018437862,0.00043598536,0.0006357129,0.00008322741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006407683,0.00023168643,0.0003309331,0.0004047812,0.0001841929,0.00003314355,0.00040949482,0.00039441176,0.00017390135],"category_scores_gemma":[0.00034877704,0.00024489043,0.000072662006,0.0009952661,0.00030994424,0.000019937966,0.00035734253,0.00062167586,0.00002554263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012422134,0.00012583977,0.09812908,0.0001027431,0.00007287707,0.000021710594,0.00018061796,0.0017712598,0.87609667,0.000025072533,0.0010454014,0.021186542],"study_design_scores_gemma":[0.0018140147,0.00040418474,0.39741787,0.00013289756,0.000007984644,0.0000023981986,0.0005297429,0.000033776854,0.59790456,0.0001467988,0.001356177,0.00024955862],"about_ca_topic_score_codex":0.0024882497,"about_ca_topic_score_gemma":0.001997949,"teacher_disagreement_score":0.2992888,"about_ca_system_score_codex":0.00054871454,"about_ca_system_score_gemma":0.000862289,"threshold_uncertainty_score":0.99863416},"labels":[],"label_agreement":null},{"id":"W4389228033","doi":"10.1158/2326-6074.tumimm23-a018","title":"Abstract A018: Characterization of macrophage population in head and neck squamous cell carcinoma and renal cell carcinoma and their role in modulating immune checkpoint blockade response","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Tumor microenvironment; Medicine; Nivolumab; Renal cell carcinoma; Immune system; Cancer research; Population; Immune checkpoint; Immunotherapy; Cytokine; Tumor necrosis factor alpha; Cancer; Internal medicine; Head and neck cancer; Immunology","score_opus":0.03612479526620541,"score_gpt":0.31801589618779136,"score_spread":0.2818911009215859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98912436,0.009424009,5.365374e-7,0.0006524368,0.00004785615,0.0006205823,0.000033713197,0.000018651728,0.00007784689],"genre_scores_gemma":[0.99850005,0.0010191767,0.000018020475,0.000013145581,0.000040305327,0.0001580416,0.0000622558,0.000035682562,0.00015333256],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979564,0.0003237024,0.00053022563,0.0004671706,0.00020198304,0.0005205455],"domain_scores_gemma":[0.9991927,0.00019837484,0.00012877704,0.0002787862,0.00012192567,0.00007940749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012554572,0.0001866419,0.00045370555,0.0007091236,0.000115351715,0.000025352821,0.00009307484,0.00023001604,0.00003758759],"category_scores_gemma":[0.00009850207,0.0001725102,0.000036643472,0.00073864363,0.00024614212,0.00011577118,0.00020753084,0.00062648545,0.0000018888428],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019119289,0.00006246368,0.3806893,0.00021979421,0.000005333803,0.00002274168,0.0019828933,0.000008669491,0.60922253,0.0000012358915,0.0000011220442,0.0058720107],"study_design_scores_gemma":[0.0024274793,0.00042814188,0.6992957,0.0001189153,0.000006030206,0.000009118853,0.0008856799,0.0014111336,0.29528847,0.000018296216,0.00001790671,0.00009314793],"about_ca_topic_score_codex":0.004861543,"about_ca_topic_score_gemma":0.00022542146,"teacher_disagreement_score":0.3186064,"about_ca_system_score_codex":0.0002054773,"about_ca_system_score_gemma":0.00015558334,"threshold_uncertainty_score":0.7349231},"labels":[],"label_agreement":null},{"id":"W4389228053","doi":"10.1158/2326-6074.tumimm23-a004","title":"Abstract A004: Immune response to sub-ablative radiation before surgery in pleural mesothelioma – Results from the SMARTER trial","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Occupational and environmental lung diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Mesothelioma; Radiology; Surgery; Nuclear medicine; Pathology","score_opus":0.08277757359573512,"score_gpt":0.38857470126811866,"score_spread":0.30579712767238354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728312,0.00161817,2.1980391e-7,0.02369857,0.0003894292,0.0008715987,0.00045071536,0.000040317904,0.00009981183],"genre_scores_gemma":[0.9969108,0.000512623,0.0000033589874,0.0002209101,0.00034241797,0.00043100215,0.00047459634,0.000023598563,0.0010806873],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976327,0.0005842051,0.00042686504,0.00037136345,0.00048587748,0.00049901824],"domain_scores_gemma":[0.99601614,0.0033379835,0.000063804466,0.0004207458,0.00007163351,0.00008970907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002125404,0.00013178126,0.00027643595,0.00042962623,0.00018215335,0.000022851986,0.00018482762,0.00013016448,0.00030820764],"category_scores_gemma":[0.0018600072,0.000094348274,0.000109039785,0.0009618114,0.000308102,0.000096115,0.0001380934,0.00046146123,0.0007164772],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7181135,0.0002766654,0.13508831,0.000015474709,0.00032743602,0.0002269888,0.0030884484,0.00008396944,0.08079247,0.00001097719,0.021007229,0.04096853],"study_design_scores_gemma":[0.010820211,0.00036716455,0.98116297,0.000120744175,0.0000126318555,0.0000018814321,0.0004831155,0.000029667179,0.002933931,0.00015940737,0.003823596,0.0000846793],"about_ca_topic_score_codex":0.0022060142,"about_ca_topic_score_gemma":0.00025874324,"teacher_disagreement_score":0.84607464,"about_ca_system_score_codex":0.0004495214,"about_ca_system_score_gemma":0.00039106075,"threshold_uncertainty_score":0.9209104},"labels":[],"label_agreement":null},{"id":"W4389228096","doi":"10.1158/2326-6074.tumimm23-a002","title":"Abstract A002: Analysis of tumor microenvironments in ovarian cancer patients receiving anti-BTN1A1 immunotherapy combined with standard-of-care therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Immune system; Medicine; Tumor microenvironment; Cancer; Ovarian cancer; Multiplex; Antibody; Oncology; Immunofluorescence; Clinical trial; Cancer research; Cancer immunotherapy; Mass cytometry; Internal medicine; Immunology; Bioinformatics; Biology","score_opus":0.030192311363762055,"score_gpt":0.33452821421615886,"score_spread":0.3043359028523968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389228096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94664586,0.051252272,0.0000045079055,0.00019925159,0.00042014132,0.00090501015,0.0003907592,0.000045286564,0.00013692667],"genre_scores_gemma":[0.96518165,0.03346679,0.000021073804,0.000043768217,0.000009728542,0.0003808197,0.00030003622,0.00007431838,0.00052183366],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958255,0.0010829759,0.00096223294,0.00067375874,0.00028401962,0.0011714607],"domain_scores_gemma":[0.99735266,0.0006927328,0.00046112295,0.00091456826,0.0005532018,0.0000257096],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011999111,0.00040476624,0.0014042829,0.002399181,0.00032844386,0.000021707498,0.00094202603,0.00039140342,0.002148483],"category_scores_gemma":[0.00008404246,0.00034083088,0.0002779642,0.003867692,0.0015146526,0.00018183181,0.00018943075,0.0010258696,0.000051068997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022976011,0.00039544082,0.30968934,0.00005876735,0.0055812187,0.000010214229,0.003930713,0.00013486533,0.63365626,0.000022909648,0.00016818811,0.023376072],"study_design_scores_gemma":[0.007720468,0.0017123455,0.7183803,0.00024237616,0.000069673384,0.000001196848,0.0014828854,0.0000026629023,0.26579428,0.000008821853,0.004331475,0.00025354256],"about_ca_topic_score_codex":0.002944629,"about_ca_topic_score_gemma":0.00045938703,"teacher_disagreement_score":0.40869093,"about_ca_system_score_codex":0.00049626315,"about_ca_system_score_gemma":0.00055296574,"threshold_uncertainty_score":0.9999044},"labels":[],"label_agreement":null},{"id":"W4389239891","doi":"10.1158/2326-6074.tumimm23-b030","title":"Abstract B030: Characterizing MAIT cells in lung cancer: Insights from NSCLC and murine models","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Granzyme B; Cytotoxic T cell; Granzyme; Immune system; Biology; T-cell receptor; Cancer research; Ex vivo; Tumor microenvironment; Immunology; Lung cancer; T cell; In vivo; Immunotherapy; CD8; Pathology; Medicine; In vitro; Perforin","score_opus":0.05391378213233809,"score_gpt":0.3382651749986699,"score_spread":0.2843513928663318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556586,0.036728285,0.000010330566,0.0011622914,0.0042794775,0.0004066049,0.000045842862,0.0001352231,0.0015733375],"genre_scores_gemma":[0.9633489,0.026037008,0.0000060076436,0.00016186069,0.00010445784,0.00041734788,0.00024197546,0.000041615564,0.009640826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761015,0.00038564132,0.00044618084,0.000629873,0.00009022866,0.00083792553],"domain_scores_gemma":[0.998865,0.0004111515,0.0001050016,0.00039936954,0.00018517286,0.000034320572],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00042528939,0.0002394861,0.00040638115,0.000806396,0.0003823412,0.00005036844,0.00034034066,0.0004868318,0.0028578576],"category_scores_gemma":[0.00004676756,0.0002315621,0.00006550265,0.00067006995,0.00044400428,0.0004066723,0.00033988812,0.0016297547,0.0008624016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071341434,0.000065792534,0.0013703721,0.000039085106,0.00025743936,0.000026940415,0.0014207191,0.000050953906,0.9734275,0.00018118281,0.00924656,0.013200054],"study_design_scores_gemma":[0.004992379,0.00021640964,0.21074799,0.0006923597,0.0000398116,0.000019751249,0.0026645197,0.00094210857,0.5809271,0.0007885662,0.1972715,0.000697552],"about_ca_topic_score_codex":0.008515343,"about_ca_topic_score_gemma":0.00054080936,"teacher_disagreement_score":0.39250043,"about_ca_system_score_codex":0.0003148478,"about_ca_system_score_gemma":0.0002037163,"threshold_uncertainty_score":0.99991554},"labels":[],"label_agreement":null},{"id":"W4389239901","doi":"10.1158/2326-6074.tumimm23-b033","title":"Abstract B033: Multiplex analysis of the tumor immune microenvironment during treatment with atezolizumab/pelareorep/letrozole reveals novel immune-tumor interactions","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Atezolizumab; Tumor microenvironment; Immune system; Cancer research; Immunotherapy; Medicine; Cytotoxic T cell; Immunology; Biology; Nivolumab","score_opus":0.03899828271051024,"score_gpt":0.3539340456493098,"score_spread":0.31493576293879955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919835,0.0060797464,0.0000053376907,0.00041494012,0.0001119287,0.00072954874,0.00045202128,0.00001966756,0.00020332122],"genre_scores_gemma":[0.99246216,0.0030735382,0.00003084889,0.000014382352,0.00006112125,0.00089289225,0.0002576792,0.000045946235,0.003161457],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99739987,0.00018141458,0.000445209,0.0006485107,0.0004254731,0.0008995062],"domain_scores_gemma":[0.9981901,0.00007504853,0.0001985199,0.0012337038,0.00020231793,0.00010029238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003289063,0.0002756444,0.00045738768,0.0005049093,0.0004739424,0.00003637099,0.0005958957,0.00008614317,0.0002721396],"category_scores_gemma":[0.00006605288,0.000191567,0.00036912342,0.001425838,0.000741869,0.00001184181,0.0005438901,0.0003763393,0.00004771393],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013074225,0.000319623,0.037686955,0.000032428055,0.0052325404,0.000039810446,0.00014020338,0.00058233406,0.953241,0.0000067743313,0.00008418046,0.0013267298],"study_design_scores_gemma":[0.001963251,0.00040919858,0.5307954,0.00006216718,0.0001576836,0.000020381618,0.00029566884,0.000038582464,0.4635235,0.0000049282794,0.0025906162,0.0001385922],"about_ca_topic_score_codex":0.004739879,"about_ca_topic_score_gemma":0.0017009698,"teacher_disagreement_score":0.49310845,"about_ca_system_score_codex":0.0006207885,"about_ca_system_score_gemma":0.0003303626,"threshold_uncertainty_score":0.7811876},"labels":[],"label_agreement":null},{"id":"W4389239913","doi":"10.1158/2326-6074.tumimm23-a013","title":"Abstract A013: Targeting perivascular macrophages with an orally bioavailable heme oxygenase-1 inhibitor improves responses to chemotherapeutic drugs in cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Heme Oxygenase-1 and Carbon Monoxide","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Tumor microenvironment; Stromal cell; Heme oxygenase; Immune system; Angiogenesis; Cancer; Cancer cell; Immunotherapy; Cancer immunotherapy; Ferroportin; Biology; Immunology; Chemistry; Heme; Medicine; Inflammation; Internal medicine; Biochemistry; Enzyme","score_opus":0.037996206869306375,"score_gpt":0.3591688728274037,"score_spread":0.3211726659580973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98605806,0.011515734,0.000003036731,0.0013882995,0.00016493308,0.0006027059,0.00005535429,0.00006497028,0.00014691838],"genre_scores_gemma":[0.9896898,0.0042866087,0.00018238073,0.0003723214,0.00035175748,0.0009325782,0.00009096369,0.00010944444,0.00398413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966107,0.00034592827,0.00036037105,0.0009794049,0.00040587204,0.0012977358],"domain_scores_gemma":[0.99855626,0.00005780668,0.000066894754,0.00076171267,0.0003489846,0.00020836087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014096224,0.0003176389,0.00034616934,0.00043790558,0.00025212648,0.00009047656,0.0006348605,0.00032954774,0.0002429237],"category_scores_gemma":[0.00014478031,0.00028352105,0.00008710522,0.0011082143,0.00040468128,0.000024041981,0.00032061437,0.00053850125,0.00010865853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017116787,0.00008476823,0.0036163991,0.00006171403,0.00017222638,0.00004227068,0.00049367646,0.000055816814,0.9846193,0.000004757515,0.0021033539,0.007034033],"study_design_scores_gemma":[0.0012726205,0.0009158146,0.035581406,0.00009170341,0.000009857867,0.000006370465,0.0019578827,0.000039463303,0.93441784,0.000017365986,0.025250623,0.00043905416],"about_ca_topic_score_codex":0.00210617,"about_ca_topic_score_gemma":0.0009681505,"teacher_disagreement_score":0.05020147,"about_ca_system_score_codex":0.00018293601,"about_ca_system_score_gemma":0.0009135662,"threshold_uncertainty_score":0.9999617},"labels":[],"label_agreement":null},{"id":"W4389239921","doi":"10.1158/2326-6074.tumimm23-a015","title":"Abstract A015: Rapid mitochondrial reactive oxygen species production precedes NF-κB activation and pro-inflammatory responses in macrophages","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reactive oxygen species; Proinflammatory cytokine; Chemistry; Cell biology; Mitochondrial ROS; Lipopolysaccharide; Inflammation; NF-κB; Context (archaeology); Pharmacology; Signal transduction; Biochemistry; Immunology; Biology","score_opus":0.0801465144568929,"score_gpt":0.34463482955673336,"score_spread":0.26448831509984044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990256,0.0035129075,0.0000020813677,0.0027696684,0.0013859918,0.0010494884,0.000049296617,0.00014555697,0.001182436],"genre_scores_gemma":[0.98488694,0.0032095497,0.00001895121,0.000016573207,0.00024642196,0.0007049155,0.0002299151,0.000032493284,0.01065426],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712294,0.00094697886,0.00043188964,0.0006229932,0.00012969277,0.0007455302],"domain_scores_gemma":[0.99841946,0.000665404,0.00014976057,0.00038239572,0.0003569335,0.000026022723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016095694,0.00022154326,0.00030837324,0.0009967707,0.0005770081,0.000049696933,0.00026137126,0.00050143176,0.00041709674],"category_scores_gemma":[0.0010012629,0.00020743135,0.000053663174,0.000791213,0.0010535787,0.0003566115,0.00019786248,0.00092414353,0.0003865002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038228487,0.000047730675,0.00507185,0.00006923559,0.00019113037,0.000017344968,0.0024300495,0.0000049186506,0.96843857,0.00029868758,0.006209476,0.013398159],"study_design_scores_gemma":[0.00096720475,0.00013041314,0.3721599,0.00011067828,0.000005547783,0.000017900278,0.0017541758,0.0000019343238,0.60110885,0.00031756322,0.023261216,0.00016458616],"about_ca_topic_score_codex":0.00019032696,"about_ca_topic_score_gemma":0.00015506895,"teacher_disagreement_score":0.3673297,"about_ca_system_score_codex":0.00026678806,"about_ca_system_score_gemma":0.00037219567,"threshold_uncertainty_score":0.8458805},"labels":[],"label_agreement":null},{"id":"W4389239946","doi":"10.1158/2326-6074.tumimm23-a024","title":"Abstract A024: Systemic administration of CD3-redirected lentiviral vector efficiently targets CD19-CAR delivery to human T cells in vivo","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD19; IL-2 receptor; Tropism; CD3; In vivo; Ex vivo; T cell; LDL receptor; Viral vector; Antibody; Biology; Cell biology; Molecular biology; Immunology; Antigen; Recombinant DNA; Immune system; CD8; Virus; Lipoprotein","score_opus":0.04491017351373862,"score_gpt":0.37345859563846934,"score_spread":0.32854842212473073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566,0.0025635415,0.0000033013264,0.00020688184,0.00029542547,0.00077317446,0.00016182526,0.00003410559,0.0003017099],"genre_scores_gemma":[0.9968807,0.00091791997,0.000008006761,0.000022648972,0.00015597804,0.00035223554,0.000117660085,0.00004832326,0.0014965414],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99697137,0.0005024365,0.0004516992,0.00065402256,0.0004981752,0.0009222861],"domain_scores_gemma":[0.99857146,0.00008588465,0.00008349229,0.0006491788,0.0005020197,0.00010796796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014782504,0.00020208873,0.0003112322,0.0006699998,0.00016860866,0.000029345447,0.00066353794,0.0003231874,0.00019640246],"category_scores_gemma":[0.0001275989,0.00021413338,0.00010009968,0.0011139282,0.00034860763,0.000008942987,0.00031482015,0.00047764304,0.00014158308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033914216,0.00012747505,0.0011077402,0.000091449365,0.000121478275,0.00003977162,0.00019004146,0.00031413115,0.9899207,0.0000075706484,0.0039212387,0.00076699397],"study_design_scores_gemma":[0.0010444276,0.0023678362,0.00975386,0.000099102755,0.0000045551183,0.000004210077,0.00025691823,0.000037102945,0.9847474,0.000009168018,0.0014899559,0.00018545079],"about_ca_topic_score_codex":0.00041219153,"about_ca_topic_score_gemma":0.0014457143,"teacher_disagreement_score":0.008646119,"about_ca_system_score_codex":0.00019215197,"about_ca_system_score_gemma":0.00070396095,"threshold_uncertainty_score":0.8732106},"labels":[],"label_agreement":null},{"id":"W4389239965","doi":"10.1158/2326-6074.tumimm23-b020","title":"Abstract B020: Hypoxia as tumor-intrinsic regulator of Flt3L production by NK cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biology; Immunotherapy; Cancer research; Lymphokine-activated killer cell; Cytokine; Tumor microenvironment; Natural killer cell; Chemokine; Immune system; Cell biology; Cancer immunotherapy; Interleukin 12; Interleukin 21; Immunology; Cytotoxic T cell; T cell; In vitro","score_opus":0.03968215534722751,"score_gpt":0.33277334051829544,"score_spread":0.2930911851710679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975315,0.00981515,0.0000021200328,0.0015107146,0.009355947,0.0005161719,0.000022151551,0.00020899442,0.0032537866],"genre_scores_gemma":[0.90001315,0.0031578515,0.0000034587952,0.000079884776,0.00011276644,0.00019527289,0.00018476998,0.000043894026,0.09620898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736226,0.00047689077,0.0005440066,0.0006072237,0.00014861864,0.0008610307],"domain_scores_gemma":[0.9981177,0.00035739422,0.0002049989,0.00068105623,0.00060679205,0.000032068587],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011130739,0.00022631654,0.0004129303,0.0006647312,0.00042170633,0.000021303427,0.00044635197,0.0003916596,0.0068757003],"category_scores_gemma":[0.00049693324,0.00021811906,0.0001342906,0.0010597477,0.00095871487,0.00021479838,0.0002146651,0.0012966619,0.010122477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066688104,0.000110224115,0.00015930645,0.000043147826,0.00021559201,0.0000044795283,0.00019695023,0.000006604413,0.6864571,0.00012385187,0.30580372,0.006212128],"study_design_scores_gemma":[0.0006495739,0.00029755905,0.0066505647,0.000066539156,0.000012904318,0.000038049653,0.0007500106,0.0000015339223,0.71164095,0.00010220683,0.27964458,0.0001455045],"about_ca_topic_score_codex":0.0009885626,"about_ca_topic_score_gemma":0.000019285662,"teacher_disagreement_score":0.092955194,"about_ca_system_score_codex":0.0002501055,"about_ca_system_score_gemma":0.00031890892,"threshold_uncertainty_score":0.99403214},"labels":[],"label_agreement":null},{"id":"W4389239981","doi":"10.1158/2326-6074.tumimm23-a045","title":"Abstract A045: Development of automated deep learning-based off-target distribution prediction system for CRISPR-Cas13 system","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Genome editing; Computational biology; Computer science; RNA; Gene; Biology; Genetics","score_opus":0.027281087744333306,"score_gpt":0.3724679905078316,"score_spread":0.3451869027634983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95359373,0.0050807344,0.039236035,0.000059940474,0.00063182955,0.00072360464,0.00021941018,0.00036120118,0.00009352048],"genre_scores_gemma":[0.9972868,0.00011999561,0.00024845876,0.0000015095815,0.00010954509,0.0006218507,0.0014537707,0.000031165095,0.00012692751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846536,0.00009921414,0.00036935994,0.00034867713,0.000213128,0.0005042764],"domain_scores_gemma":[0.9990658,0.00006532305,0.00008294649,0.00026541617,0.00046502307,0.000055504588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009750856,0.00013903576,0.00020478142,0.00014893251,0.00025499234,0.0000150602655,0.00021165003,0.00027163164,0.0000074509044],"category_scores_gemma":[0.00014820055,0.00014209263,0.000074915195,0.00033027504,0.00010061568,0.0000034760303,0.000094012066,0.00021008663,0.000016233893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038899257,0.000036775582,0.0016947967,0.0012875783,0.000270894,0.000003956629,0.00014110592,0.033993542,0.95388454,0.000032351338,0.0017833202,0.0064821257],"study_design_scores_gemma":[0.0010144456,0.00027690842,0.032930557,0.00020216365,0.000015542675,0.00000550644,0.0011614466,0.0681689,0.874279,0.0000010952205,0.02178284,0.00016159409],"about_ca_topic_score_codex":0.000026234837,"about_ca_topic_score_gemma":0.00001655828,"teacher_disagreement_score":0.07960556,"about_ca_system_score_codex":0.00023379739,"about_ca_system_score_gemma":0.00032381443,"threshold_uncertainty_score":0.57943696},"labels":[],"label_agreement":null},{"id":"W4389239988","doi":"10.1158/2326-6074.tumimm23-b052","title":"Abstract B052: Single-cell analysis of multiple cancers in the upper gastrointestinal tract uncovers immune characteristics of tumor microenvironments linked to the predictive biomarkers for immunotherapy in esophageal cancers","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Cancer; Immune system; Medicine; Stromal cell; Cancer research; Adenocarcinoma; Esophageal cancer; Cell; Cancer cell; Oncology; Internal medicine; Immunology; Biology","score_opus":0.04764231119001107,"score_gpt":0.35189254125083835,"score_spread":0.3042502300608273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389239988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891497,0.0056440528,0.000019538238,0.0013886462,0.000113316644,0.0027492717,0.001076774,0.000014308605,0.0000791248],"genre_scores_gemma":[0.99632335,0.0013634623,0.0001065547,0.000100806996,0.00004953001,0.001661134,0.0002329878,0.000043807886,0.00011835669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963582,0.00039934705,0.00081017887,0.00055189326,0.00077989924,0.001100455],"domain_scores_gemma":[0.99696904,0.0016423702,0.00025833372,0.0007503077,0.0002741035,0.000105824605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021459975,0.0002802556,0.0008238814,0.0014508896,0.00016395797,0.000021127427,0.0006980205,0.00009991951,0.00014494747],"category_scores_gemma":[0.0004252378,0.00019326317,0.00032254425,0.0033886984,0.00085255125,0.00007941593,0.00012177078,0.000815194,0.000008368994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014993027,0.0006435727,0.8442434,0.00020811553,0.001818286,0.00024330156,0.003612692,0.002400877,0.1240902,0.000004178072,0.00026684464,0.007475506],"study_design_scores_gemma":[0.004715742,0.0022670296,0.9786459,0.0002544117,0.00016059044,0.000009380511,0.0031533467,0.000952182,0.009521476,0.000008770542,0.00019529411,0.00011585524],"about_ca_topic_score_codex":0.016971497,"about_ca_topic_score_gemma":0.0021496518,"teacher_disagreement_score":0.13440253,"about_ca_system_score_codex":0.0028142738,"about_ca_system_score_gemma":0.0011920591,"threshold_uncertainty_score":0.98957455},"labels":[],"label_agreement":null},{"id":"W4389240018","doi":"10.1158/2326-6074.tumimm23-a033","title":"Abstract A033: Secretogranin V as a Potential Biomarker for Esophageal Squamous Cell Carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gene knockdown; Biomarker; Cancer research; Medicine; Cancer; Esophageal squamous cell carcinoma; Esophageal cancer; Small interfering RNA; Oncology; Immunotherapy; Cell; Cell culture; Transcription factor; Internal medicine; Biology; Gene; Transfection","score_opus":0.036486499083017765,"score_gpt":0.3538197098311396,"score_spread":0.3173332107481218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858875,0.010921705,0.000110746165,0.0006805939,0.0007402895,0.0007401294,0.000114244234,0.00005013517,0.0007546444],"genre_scores_gemma":[0.9911712,0.0005718341,0.00003592615,0.0000384681,0.0005297283,0.0006005443,0.00063903746,0.000068096866,0.006345184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779713,0.00014600263,0.0002662451,0.00064418925,0.00027814522,0.00086829154],"domain_scores_gemma":[0.9988314,0.00007374478,0.00007510205,0.0005333638,0.0003886957,0.000097704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006751516,0.00019365016,0.00019066017,0.00030934272,0.00032441143,0.000040959883,0.00039750643,0.0005118407,0.00025308342],"category_scores_gemma":[0.00012568639,0.0002073506,0.00016976315,0.00056121394,0.00036343656,0.0000071983372,0.00024620508,0.00032757415,0.00018487568],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011073862,0.00004293251,0.0011059981,0.00006074994,0.00008494483,0.000022086588,0.00007458558,0.00029978418,0.9639393,0.000024815537,0.021773368,0.011464047],"study_design_scores_gemma":[0.004105542,0.0010321436,0.169178,0.000017434602,0.000040414718,0.0000433002,0.00031430606,0.00093690574,0.77078557,0.00041289025,0.05268836,0.0004451112],"about_ca_topic_score_codex":0.000538123,"about_ca_topic_score_gemma":0.00011135307,"teacher_disagreement_score":0.19315371,"about_ca_system_score_codex":0.00012268222,"about_ca_system_score_gemma":0.00059835106,"threshold_uncertainty_score":0.8455512},"labels":[],"label_agreement":null},{"id":"W4389240026","doi":"10.1158/2326-6074.tumimm23-a011","title":"Abstract A011: Targeting the FES tyrosine kinase in antigen presenting cells to enhance anti-tumor cytotoxic lymphocyte responses","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Cytotoxic T cell; CTL*; Immune system; Immunology; Cancer research; Immunotherapy; Cancer immunotherapy; Innate immune system; Inflammation; Medicine; Biology; CD8","score_opus":0.06120850725847581,"score_gpt":0.4099252004221392,"score_spread":0.3487166931636634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868442,0.008174099,0.0000036788228,0.0033080317,0.0003558301,0.0008264543,0.00001663164,0.00009811812,0.00037300182],"genre_scores_gemma":[0.9930477,0.0035654798,0.000058736106,0.00016181271,0.00039399753,0.00027061606,0.000015869018,0.000055467524,0.0024303352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968383,0.00034382837,0.00048293167,0.00058369746,0.00053695077,0.001214336],"domain_scores_gemma":[0.9979069,0.001030102,0.00008767484,0.00053174276,0.00032117983,0.00012238201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030782633,0.00020903915,0.00044455417,0.00065980287,0.00041884356,0.00006945925,0.0004530213,0.00013856705,0.00041568754],"category_scores_gemma":[0.0012562149,0.00015976408,0.000100745,0.0021501556,0.0003513502,0.0000893333,0.0004513527,0.00091926724,0.00035937587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065359345,0.00005946813,0.03278268,0.00010478176,0.000055992212,0.0003215229,0.00092258817,0.000085967215,0.95784503,0.0000075379985,0.003374419,0.003786443],"study_design_scores_gemma":[0.0005879765,0.000082995415,0.15986131,0.00036493674,0.000006369161,0.000012759288,0.0008395327,0.00013667486,0.82877153,0.000018282728,0.00917435,0.00014329482],"about_ca_topic_score_codex":0.0010235689,"about_ca_topic_score_gemma":0.00006425261,"teacher_disagreement_score":0.12907349,"about_ca_system_score_codex":0.00040174698,"about_ca_system_score_gemma":0.00067572127,"threshold_uncertainty_score":0.651499},"labels":[],"label_agreement":null},{"id":"W4389240058","doi":"10.1158/2326-6074.tumimm23-b036","title":"Abstract B036: cGAS-STING activation promotes anti-tumor inflammatory response in osteosarcoma: Implications for tumor microenvironment reprogramming and tumor progression in patients","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"","keywords":"Tumor microenvironment; Sting; Stimulator of interferon genes; Innate immune system; Cancer research; Immune system; Tumor necrosis factor alpha; Macrophage polarization; Immunology; Macrophage; Reprogramming; Biology; Medicine; Cell; In vitro","score_opus":0.04514764148239905,"score_gpt":0.365085682048669,"score_spread":0.31993804056626995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322206,0.002738816,0.0000036079614,0.0014171426,0.00020657253,0.0022549895,0.000047824473,0.00009057041,0.000018438692],"genre_scores_gemma":[0.9969113,0.000133753,0.00006879685,0.000043246117,0.000019004163,0.0024014846,0.0001318991,0.000049742288,0.00024077427],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963438,0.0009877309,0.00069436256,0.00073752727,0.00008850908,0.0011480675],"domain_scores_gemma":[0.99776924,0.0012938266,0.00022029827,0.0004977892,0.00018473291,0.00003410719],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027889574,0.00026143686,0.00041244552,0.0010988528,0.0004588377,0.00004684782,0.00037970644,0.00021356731,0.00005254885],"category_scores_gemma":[0.0016282189,0.00025183478,0.000066465334,0.0006673755,0.0007207611,0.0002235497,0.00042545056,0.0009572064,0.00008368739],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068546906,0.0002701377,0.20918104,0.00009551749,0.000052526582,0.000012412655,0.0007986477,0.0000033276956,0.76443875,0.000039594746,0.0001935335,0.018059833],"study_design_scores_gemma":[0.0028980249,0.00071444473,0.80844283,0.00043478105,0.000004279837,0.000017305973,0.00080372754,0.000007766378,0.18329959,0.0000922496,0.0030890794,0.0001959016],"about_ca_topic_score_codex":0.00015855626,"about_ca_topic_score_gemma":0.000040779476,"teacher_disagreement_score":0.5992618,"about_ca_system_score_codex":0.00048269593,"about_ca_system_score_gemma":0.0003023234,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W4389240069","doi":"10.1158/2326-6074.tumimm23-a053","title":"Abstract A053: Notch completes CD4 T cell help in CD8 T cells and ensures timely departure","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Priming (agriculture); Cytotoxic T cell; CD8; Antigen-presenting cell; T cell; Cell biology; CD40; IL-2 receptor; Lymph node; Biology; Immunology; Chemistry; Antigen; Immune system; Biochemistry","score_opus":0.10310504523726723,"score_gpt":0.4104980381016099,"score_spread":0.3073929928643427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97571075,0.009905484,5.270044e-7,0.0041031577,0.00022656268,0.0009571278,0.00005882375,0.00011122148,0.008926359],"genre_scores_gemma":[0.96560705,0.010014142,0.000036841553,0.00015254556,0.00023484473,0.000295685,0.00006338981,0.00007635339,0.023519134],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99630886,0.00037414356,0.00038048442,0.00069562776,0.0007873066,0.0014535884],"domain_scores_gemma":[0.9974711,0.0011933455,0.000047640806,0.00068475713,0.00038815918,0.00021499516],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019113317,0.00024883577,0.0005594259,0.0010364379,0.00022200789,0.000064500506,0.00040789717,0.00039328236,0.0049089557],"category_scores_gemma":[0.00019492059,0.00022755281,0.000091483016,0.0011984342,0.00096915907,0.00008318285,0.00041801718,0.0021663352,0.0009277456],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011044153,0.00012925574,0.028224913,0.00024254639,0.00011551775,0.0004777298,0.0006995266,0.0000126413215,0.9375999,0.000035728688,0.015987664,0.015370135],"study_design_scores_gemma":[0.0044762692,0.0007276456,0.4571661,0.0002524271,0.000018811317,0.00005509213,0.0013016333,0.00025677064,0.40728498,0.00033475997,0.12777337,0.00035214264],"about_ca_topic_score_codex":0.0017261878,"about_ca_topic_score_gemma":0.0005863257,"teacher_disagreement_score":0.530315,"about_ca_system_score_codex":0.00032320857,"about_ca_system_score_gemma":0.0005592145,"threshold_uncertainty_score":0.99985015},"labels":[],"label_agreement":null},{"id":"W4389240132","doi":"10.1158/2326-6074.tumimm23-b013","title":"Abstract B013: Investigating the role of LINE-1 ORF1 protein in a syngeneic mouse melanoma model","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transposable element; Biology; Cancer research; Cell culture; Cancer; Melanoma; Cell growth; Genome; Genetics; Gene","score_opus":0.0704131324677263,"score_gpt":0.34318599144591855,"score_spread":0.27277285897819226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929293,0.0052782507,0.0000071865793,0.0004896246,0.00002529861,0.00045900937,0.000021350212,0.000012898242,0.0007770918],"genre_scores_gemma":[0.99737525,0.0010593074,0.000127188,0.000026034988,0.00005028545,0.00044461864,0.00005198071,0.000025277188,0.00084003346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986244,0.00010697162,0.00035603618,0.00023018676,0.00018404199,0.0004983956],"domain_scores_gemma":[0.9991321,0.000037279682,0.00009328901,0.0005302723,0.00017294796,0.000034108838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001018598,0.00012793146,0.00017803849,0.00017078579,0.0001341963,0.00002253479,0.00057492463,0.00020193352,0.000013709612],"category_scores_gemma":[0.00025667288,0.0000959427,0.00005879838,0.0004915497,0.00027773218,0.000009116214,0.0004517794,0.00044960677,0.000020607418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073236144,0.000028891325,0.0023069873,0.000053333137,0.000067946465,7.529411e-7,0.00044234018,0.0020871514,0.98858374,0.0002782017,0.00021308452,0.0058643045],"study_design_scores_gemma":[0.000605028,0.00021395614,0.007099927,0.00006787128,0.000004419536,0.0000035702749,0.0020753068,0.02478253,0.96217406,0.0012828872,0.0015250196,0.00016541874],"about_ca_topic_score_codex":0.0003858305,"about_ca_topic_score_gemma":0.00014873038,"teacher_disagreement_score":0.026409704,"about_ca_system_score_codex":0.00003435014,"about_ca_system_score_gemma":0.00037162768,"threshold_uncertainty_score":0.39124295},"labels":[],"label_agreement":null},{"id":"W4389240136","doi":"10.1158/2326-6074.tumimm23-a025","title":"Abstract A025: Combination of anti-CTLA4 and radiation induce synergistic tumor control in radiorecurrent prostate cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Prostate cancer; Tramp; Immune system; Cancer; Immunotherapy; Cancer research; Radiation therapy; Immune checkpoint; Oncology; Immunology; Internal medicine","score_opus":0.05905890052005738,"score_gpt":0.4087926179580436,"score_spread":0.34973371743798626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96642745,0.027180728,0.0000011073062,0.004412919,0.00029773018,0.0013518548,0.00009530823,0.000039009625,0.00019386811],"genre_scores_gemma":[0.9692524,0.029043218,0.0000025380652,0.000033408396,0.000068331865,0.0009394245,0.00008354011,0.000026866719,0.00055028195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781066,0.0002335511,0.00037350334,0.00040102136,0.00048953557,0.00069174176],"domain_scores_gemma":[0.99870694,0.0003787235,0.000099565405,0.00024999125,0.00045887887,0.0001058747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011454736,0.00015511726,0.00044966952,0.0009817625,0.00012610719,0.000023573011,0.00013939358,0.00014255384,0.00013873885],"category_scores_gemma":[0.00027708517,0.00013139598,0.00004391761,0.0013215147,0.00063792296,0.00013050779,0.00008179831,0.00085901807,0.000024244611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002972513,0.00048595946,0.4905991,0.0009363049,0.0004539511,0.0002775345,0.0018505276,0.00008180117,0.3764082,0.00035532657,0.0025128908,0.12306591],"study_design_scores_gemma":[0.009428162,0.0005177328,0.9586018,0.0005138986,0.00003239259,0.0000069726143,0.00045821586,0.0008812485,0.02794435,0.0002398309,0.0012451299,0.00013030897],"about_ca_topic_score_codex":0.001621219,"about_ca_topic_score_gemma":0.00010051639,"teacher_disagreement_score":0.46800268,"about_ca_system_score_codex":0.0006065254,"about_ca_system_score_gemma":0.0010513194,"threshold_uncertainty_score":0.53581727},"labels":[],"label_agreement":null},{"id":"W4389240145","doi":"10.1158/2326-6074.tumimm23-a035","title":"Abstract A035: Comparing the clinical and genomic landscapes of acral, mucosal, and cutaneous metastatic melanomas treated with immune checkpoint inhibitors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Melanoma; Mucosal melanoma; Oncology; Malignancy; Internal medicine; Metastatic melanoma; Cancer; Immunotherapy; Immune checkpoint; Cohort; Pembrolizumab; Cancer research","score_opus":0.10236977837228804,"score_gpt":0.402273994166284,"score_spread":0.29990421579399595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9586196,0.03798426,4.6151348e-7,0.002461016,0.00011848439,0.00060823525,0.000010869202,0.000045124467,0.00015197918],"genre_scores_gemma":[0.95739424,0.042062026,0.000023876102,0.000034738292,0.00006484463,0.00008845038,0.000018990997,0.00003119821,0.0002816437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998076,0.0002412405,0.0005741746,0.00036477984,0.00026360594,0.00048018698],"domain_scores_gemma":[0.9985589,0.00066100346,0.00013952905,0.00039307863,0.00017181988,0.00007570915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015226854,0.00017819469,0.0005866405,0.0002596397,0.00022554834,0.000053402007,0.00017571644,0.000120384604,0.00009503471],"category_scores_gemma":[0.00008235703,0.00010791274,0.000088511966,0.0005773607,0.0018162413,0.0000866501,0.00017339147,0.0006861832,0.000011845702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019437667,0.00023422335,0.45793843,0.00049540173,0.00392276,0.00039675483,0.0019123978,0.000011505888,0.4444116,0.000037012407,0.0008149606,0.07038727],"study_design_scores_gemma":[0.0057343156,0.0014991779,0.96663505,0.00047566745,0.00015907697,0.0005169165,0.0039724642,0.00019501126,0.017972538,0.00004827517,0.0026101153,0.00018137194],"about_ca_topic_score_codex":0.0014970072,"about_ca_topic_score_gemma":0.0003215324,"teacher_disagreement_score":0.5086966,"about_ca_system_score_codex":0.00006812493,"about_ca_system_score_gemma":0.0002922627,"threshold_uncertainty_score":0.6692017},"labels":[],"label_agreement":null},{"id":"W4389240156","doi":"10.1158/2326-6074.tumimm23-b051","title":"Abstract B051: GSTT2 modulates the bladder tumor environment and response to BCG Immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Bladder cancer; Cancer research; Immunology; Gene expression; Gene; Immune system; Cancer; Biology; Internal medicine","score_opus":0.06729804768618665,"score_gpt":0.3874945738633544,"score_spread":0.32019652617716776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639478,0.011299912,0.000003199459,0.02284002,0.0001854641,0.0010289205,0.000040493676,0.00008152404,0.00057267945],"genre_scores_gemma":[0.9834399,0.006405976,0.000030996103,0.00087600393,0.00014584386,0.00096002576,0.000010314133,0.000058185204,0.00807272],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99778086,0.00028958693,0.00023568842,0.0004793693,0.00045046068,0.00076403795],"domain_scores_gemma":[0.9985368,0.00048397886,0.000033247143,0.0007115951,0.000095534626,0.00013884596],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0012506478,0.0001987876,0.00029274297,0.00031474855,0.00041405336,0.000043541768,0.0002651738,0.000112270805,0.0013480134],"category_scores_gemma":[0.00011141006,0.00013389163,0.000070643946,0.0005232709,0.0005970301,0.000054816952,0.00021396385,0.0006016472,0.0010042307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018532388,0.00024615094,0.016629923,0.00004887163,0.0015444746,0.00038408578,0.0060512726,0.00006133384,0.83820015,0.00007341213,0.01650719,0.10172075],"study_design_scores_gemma":[0.002672274,0.0010156531,0.8757237,0.00007135206,0.000030890067,0.000058464455,0.0009266207,0.000027520411,0.021605836,0.00031997618,0.0973811,0.00016661329],"about_ca_topic_score_codex":0.00079443824,"about_ca_topic_score_gemma":0.000020658717,"teacher_disagreement_score":0.8590938,"about_ca_system_score_codex":0.00033481288,"about_ca_system_score_gemma":0.00034624393,"threshold_uncertainty_score":0.9997736},"labels":[],"label_agreement":null},{"id":"W4389240203","doi":"10.1158/2326-6074.tumimm23-a005","title":"Abstract A005: Synergistically Engaging a b-Selective IL-2 Agonist with PD1/PDL-1 Blockade in a Bifunctional Superkine, MDNA223","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; In vivo; Cancer research; Pharmacology; Flow cytometry; Cancer immunotherapy; Peripheral blood mononuclear cell; Tumor-infiltrating lymphocytes; Chemistry; Immunotherapy; Agonist; Blockade; T cell; In vitro; Medicine; Receptor; Immunology; Immune system; Biology; Biochemistry","score_opus":0.03985302018752771,"score_gpt":0.34393564231748563,"score_spread":0.3040826221299579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837956,0.008648684,0.00005606232,0.0012736882,0.0007957786,0.00044189623,0.00012443223,0.00005969802,0.0048041577],"genre_scores_gemma":[0.98637736,0.0054500094,0.00007164035,0.000102304,0.0014865459,0.0006857824,0.00019303351,0.00006335055,0.0055699483],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719006,0.00024673506,0.0002940756,0.00077843317,0.00040022956,0.0010904592],"domain_scores_gemma":[0.9987583,0.00015437546,0.00005194782,0.0004738442,0.00043842717,0.0001230824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009439006,0.0002460747,0.00031302264,0.00044771086,0.00033510308,0.00005370676,0.0004164037,0.00031457227,0.00019152889],"category_scores_gemma":[0.00036686513,0.0002268649,0.000086623615,0.001150455,0.00079938094,0.00001123023,0.0002521657,0.0010510776,0.00008531118],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016228952,0.00013575243,0.0027080134,0.0000454613,0.00033702902,0.000047980473,0.00023369977,0.0003190298,0.96724665,0.0003041903,0.012134105,0.0148652075],"study_design_scores_gemma":[0.0038831213,0.0008269583,0.19866595,0.00013012375,0.00003930965,0.00009411224,0.0010208588,0.00011863017,0.1229743,0.00029451915,0.6712806,0.0006715221],"about_ca_topic_score_codex":0.0010424667,"about_ca_topic_score_gemma":0.0017149049,"teacher_disagreement_score":0.8442723,"about_ca_system_score_codex":0.00015930533,"about_ca_system_score_gemma":0.0011959127,"threshold_uncertainty_score":0.9251282},"labels":[],"label_agreement":null},{"id":"W4389240410","doi":"10.1158/2326-6074.tumimm23-pr05","title":"Abstract PR05: Dgat1 camouflages sexual dimorphism in anti-tumor CD8+ T cell immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; Tumor microenvironment; Biology; Cytotoxic T cell; T cell; Immunotherapy; Cancer immunotherapy; Immunology; Immune system; Cancer research; Biochemistry; In vitro","score_opus":0.04975814404255782,"score_gpt":0.3622263831629061,"score_spread":0.31246823912034827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750116,0.017995672,0.0000032528258,0.00058549317,0.0043047676,0.00041507208,0.00008971861,0.000048738566,0.0015457039],"genre_scores_gemma":[0.9787036,0.010587238,0.00001613244,0.000116488016,0.0037160455,0.00037410881,0.00018673742,0.00006109001,0.00623856],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99710196,0.00036428063,0.00036933884,0.0006771227,0.0003205882,0.001166729],"domain_scores_gemma":[0.9985846,0.00009294268,0.00008321389,0.0008671948,0.00025624305,0.00011577332],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013809522,0.0002506167,0.0003682183,0.00042930935,0.00027212553,0.000043355856,0.00074859016,0.0003479172,0.00023743782],"category_scores_gemma":[0.0002188616,0.0002546269,0.000091049624,0.0008065636,0.00066991686,0.000013779984,0.00061213574,0.0010005101,0.00024312659],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019771006,0.00010440467,0.007847266,0.00006749502,0.00006274106,0.0000067486194,0.00027245056,0.00005583322,0.9349453,0.0000274913,0.05199689,0.004415679],"study_design_scores_gemma":[0.0018324729,0.00026029852,0.28447545,0.000038583406,0.000011186463,0.000015991878,0.0015662544,0.000016154194,0.20879377,0.00009332132,0.50248647,0.00041004564],"about_ca_topic_score_codex":0.0030029968,"about_ca_topic_score_gemma":0.0011900575,"teacher_disagreement_score":0.7261515,"about_ca_system_score_codex":0.00010713588,"about_ca_system_score_gemma":0.00072700967,"threshold_uncertainty_score":0.9999906},"labels":[],"label_agreement":null},{"id":"W4389240413","doi":"10.1158/2326-6074.tumimm23-b014","title":"Abstract B014: Spatial genomics identifies cancer cell cytokines regulating ovarian cancer immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Ovarian cancer; Immunotherapy; Cancer research; Cancer; Immune system; Biology; Immune checkpoint; Cancer immunotherapy; T cell; CRISPR; Immunology; Gene; Genetics","score_opus":0.06805472660407133,"score_gpt":0.3542901432539164,"score_spread":0.2862354166498451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98009735,0.015642248,0.000053400807,0.00074861787,0.0016901637,0.00038128564,0.00021580885,0.000072156596,0.0010989616],"genre_scores_gemma":[0.9671905,0.026497385,0.000039380764,0.000094168194,0.0010832552,0.00045293794,0.00023190925,0.0000885731,0.004321858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972107,0.0002588974,0.00044149836,0.0006974999,0.00033220567,0.0010592252],"domain_scores_gemma":[0.9984098,0.00008934527,0.00013237084,0.00074493204,0.0005117144,0.0001118235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008623462,0.00029819648,0.00033891285,0.00018071644,0.0006955758,0.000108139524,0.0007980878,0.0004847737,0.00068160176],"category_scores_gemma":[0.00009690639,0.00030484307,0.0001561779,0.0004442944,0.00059005886,0.000020151554,0.00045931237,0.0007147966,0.000062655796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000428961,0.00006491624,0.009501618,0.00010024217,0.00022835226,0.000009723753,0.00043029326,0.00053625397,0.97088575,0.000013157826,0.0030826125,0.014718134],"study_design_scores_gemma":[0.0012950745,0.00013794821,0.105232835,0.000085030035,0.00003064256,0.00000407083,0.00065096735,0.00029532844,0.86475307,0.000137397,0.026941098,0.00043652861],"about_ca_topic_score_codex":0.04674422,"about_ca_topic_score_gemma":0.016844535,"teacher_disagreement_score":0.10613266,"about_ca_system_score_codex":0.00028366252,"about_ca_system_score_gemma":0.00083751255,"threshold_uncertainty_score":0.9999404},"labels":[],"label_agreement":null},{"id":"W4389240415","doi":"10.1158/2326-6074.tumimm23-b041","title":"Abstract B041: Defining the Determinants of Immune Response in DNA Homologous Recombination Deficient Tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune checkpoint; CXCL10; Tumor microenvironment; Immune system; Immunotherapy; Cancer research; Chemokine; CXCR3; Cancer immunotherapy; Biology; Cancer; Immunology; Chemokine receptor; Medicine; Genetics","score_opus":0.06969010939385277,"score_gpt":0.40386602749732037,"score_spread":0.3341759181034676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98359287,0.011998191,3.500493e-7,0.0028877633,0.00037236526,0.00058832165,0.000016160044,0.000045464207,0.0004985196],"genre_scores_gemma":[0.9957044,0.002917983,0.0000085021875,0.000056174966,0.000018781062,0.0002483681,0.000014156986,0.000029256324,0.0010023889],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972743,0.00058304396,0.0006457495,0.0003476701,0.0004340813,0.00071517046],"domain_scores_gemma":[0.99768925,0.0012347616,0.00015926293,0.000605671,0.0002737723,0.000037271366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062528765,0.00014796117,0.0003946493,0.0008937199,0.00021029069,0.000016807895,0.0003929469,0.00019456126,0.00025460037],"category_scores_gemma":[0.0008928369,0.000110753615,0.00012843382,0.002047592,0.00090668007,0.00006270298,0.00017119966,0.00077184284,0.00010954407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043990303,0.00035540227,0.079889484,0.00020664577,0.00022677622,0.0003913367,0.0038655417,0.000034527853,0.74356216,0.00016832624,0.0011098734,0.12619965],"study_design_scores_gemma":[0.0023716874,0.0007902401,0.9281762,0.00044943066,0.0000096156855,0.000075935284,0.0019756602,0.000103013735,0.0649058,0.00015140041,0.00088673696,0.00010423644],"about_ca_topic_score_codex":0.0014170258,"about_ca_topic_score_gemma":0.0001830779,"teacher_disagreement_score":0.84828675,"about_ca_system_score_codex":0.0004906945,"about_ca_system_score_gemma":0.0008383644,"threshold_uncertainty_score":0.45164013},"labels":[],"label_agreement":null},{"id":"W4389240416","doi":"10.1158/2326-6074.tumimm23-b031","title":"Abstract B031: A tale of cancer cell death and immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"","keywords":"Necroptosis; Pyroptosis; Programmed cell death; Immunogenic cell death; Cytotoxic T cell; Immunotherapy; Cancer; Cancer research; Cancer immunotherapy; Biology; Immune system; Cancer cell; Apoptosis; Immunology; In vitro","score_opus":0.06960302290979067,"score_gpt":0.385671473663472,"score_spread":0.3160684507536813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79871213,0.19764666,0.0000011180774,0.00039798763,0.00062094716,0.00033503614,0.00010279021,0.000096302014,0.0020870054],"genre_scores_gemma":[0.9058981,0.08014656,0.000007991797,0.00004228726,0.00002757577,0.00033248114,0.00005314393,0.000043306707,0.013448549],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971345,0.0007641335,0.0004787905,0.00044729523,0.00011259511,0.0010626537],"domain_scores_gemma":[0.9978146,0.0009379387,0.00015366932,0.0006969259,0.0003679059,0.000028951767],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014960305,0.00025799326,0.0005224829,0.00045692024,0.0006215253,0.000023081475,0.00066644745,0.00042837873,0.0035916788],"category_scores_gemma":[0.00015370577,0.00023431118,0.00012082254,0.0007478496,0.0016215368,0.00018479634,0.00047012503,0.001157958,0.0004479358],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014176667,0.00014176518,0.008025689,0.0001013692,0.0005291413,0.000011411611,0.0012476878,0.0000035843386,0.95770377,0.00028576274,0.0027437306,0.027788432],"study_design_scores_gemma":[0.0022689176,0.00041760705,0.3000264,0.0001449143,0.000027794524,0.000023179267,0.002096948,0.0000028189713,0.6389705,0.00023870659,0.05551265,0.00026955284],"about_ca_topic_score_codex":0.014938094,"about_ca_topic_score_gemma":0.00035829304,"teacher_disagreement_score":0.31873325,"about_ca_system_score_codex":0.00016070396,"about_ca_system_score_gemma":0.00049753767,"threshold_uncertainty_score":0.99731916},"labels":[],"label_agreement":null},{"id":"W4389240426","doi":"10.1158/2326-6074.tumimm23-b004","title":"Abstract B004: Neoantigen adenoviral cancer vaccine generates improved CD8+ T-cell responses compared to adjuvanted peptide vaccine","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Peptide vaccine; Immune system; CD8; Immunology; Cancer vaccine; T cell; Cancer immunotherapy; Vaccination; Epitope; Virology; Immunotherapy; Biology; Antigen; Medicine","score_opus":0.06228367985435414,"score_gpt":0.3741527830259748,"score_spread":0.3118691031716207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.892238,0.09779477,0.0000105294075,0.00515302,0.0022984014,0.0013404158,0.0003660132,0.00049579877,0.00030301922],"genre_scores_gemma":[0.9126907,0.017508838,0.00003848409,0.0005256886,0.00023348688,0.0013896135,0.00037268415,0.00016590494,0.06707458],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9929468,0.0016773733,0.0010948523,0.0012862147,0.00023339782,0.0027613335],"domain_scores_gemma":[0.99579865,0.0014478295,0.00025613658,0.001446501,0.00092919695,0.00012169997],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0021729332,0.0007074189,0.001171233,0.001839924,0.0013953566,0.000120469456,0.0017778643,0.00081487605,0.007464742],"category_scores_gemma":[0.0005412309,0.00064509903,0.00028765402,0.0027199772,0.00048466484,0.000292899,0.0008351907,0.0021409905,0.0068898275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021518184,0.00023013451,0.00569524,0.000062806495,0.0010013719,0.00006077854,0.0011660205,0.000078443256,0.901631,0.00002367447,0.055178948,0.013353432],"study_design_scores_gemma":[0.006223428,0.000821349,0.1581368,0.00019902694,0.000048260747,0.000043953805,0.0013034464,0.000033613356,0.6662995,0.000039384362,0.16616017,0.0006910415],"about_ca_topic_score_codex":0.005730644,"about_ca_topic_score_gemma":0.0008459725,"teacher_disagreement_score":0.23533143,"about_ca_system_score_codex":0.00046851372,"about_ca_system_score_gemma":0.0014068346,"threshold_uncertainty_score":0.9999047},"labels":[],"label_agreement":null},{"id":"W4389240480","doi":"10.1158/2326-6074.tumimm23-b049","title":"Abstract B049: Lipid nanoparticle-delivered toll-like receptor agonists are highly effective in cancer immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Medicine; Tumor microenvironment; Cancer; Immune system; Melanoma; CpG Oligodeoxynucleotide; Cancer immunotherapy; Cancer research; CpG site; Dosing; Immunology; Pharmacology; Internal medicine; Chemistry","score_opus":0.03809409247362991,"score_gpt":0.3372456088245331,"score_spread":0.2991515163509032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97268087,0.020887207,0.000007090041,0.0006042656,0.0033241634,0.0011104457,0.00015574702,0.00095247396,0.00027774353],"genre_scores_gemma":[0.96954614,0.026662147,0.000022043881,0.00006763502,0.0003212884,0.0025006512,0.00002841616,0.00024101832,0.0006106576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996513,0.00015907113,0.00053451525,0.000585276,0.0005341095,0.0016739902],"domain_scores_gemma":[0.99822676,0.0005606465,0.00007874128,0.0007125055,0.0002899357,0.00013140049],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089768,0.00039493886,0.00059753674,0.00076325797,0.0002271911,0.00008734886,0.0007699958,0.00042555804,0.0006364934],"category_scores_gemma":[0.00008699666,0.00040203767,0.00012656173,0.0022075465,0.00043480896,0.00032628115,0.000165899,0.0014418706,0.00076816196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072977756,0.00006735867,0.006370919,0.00016767747,0.0004699013,0.00007709014,0.0013314799,0.0048244526,0.9140417,0.0000358636,0.008078925,0.06380485],"study_design_scores_gemma":[0.0074401256,0.0004786602,0.21261802,0.0009912287,0.000026066564,0.00001105252,0.0015539634,0.0025349671,0.6544612,0.00057472993,0.117971115,0.0013388285],"about_ca_topic_score_codex":0.0015764848,"about_ca_topic_score_gemma":0.001351812,"teacher_disagreement_score":0.25958046,"about_ca_system_score_codex":0.0021009378,"about_ca_system_score_gemma":0.00029068263,"threshold_uncertainty_score":0.9998431},"labels":[],"label_agreement":null},{"id":"W4389240568","doi":"10.1158/2326-6074.tumimm23-pr01","title":"Abstract PR01: Regulation of exhausted CD8+ T cell differentiation by IKZF transcription factors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Immunology; Cancer immunotherapy; CD8; Biology; Immunotherapy; T cell; Cytokine; Progenitor cell; Transcription factor; Cancer research; Stem cell; Immune system; Cell biology; Genetics; Gene","score_opus":0.06386997535943507,"score_gpt":0.34039160081341263,"score_spread":0.27652162545397757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389240568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97806555,0.019344227,0.000040092276,0.0003328235,0.0010399565,0.00051784515,0.00012383703,0.00015674156,0.00037895393],"genre_scores_gemma":[0.98016775,0.004719024,0.0000027184074,0.000011370169,0.000021188573,0.00014261313,0.0009912343,0.000042195716,0.013901918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997251,0.0008023941,0.00056679867,0.00042557434,0.00015443048,0.00079981127],"domain_scores_gemma":[0.99839395,0.0005243193,0.00020371094,0.0005054143,0.0003526552,0.00001994035],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00091589434,0.00024178514,0.00041374855,0.0007225111,0.00044163925,0.000022803455,0.0004578514,0.0006242584,0.002952174],"category_scores_gemma":[0.000106678584,0.00022032693,0.00015374325,0.0009772929,0.0007304007,0.00022766777,0.00007962784,0.0008271605,0.0004833505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013064761,0.00017552894,0.0029791654,0.00006919645,0.00028682232,7.273353e-7,0.0014134428,0.000010547074,0.978146,0.00009346039,0.0082114665,0.0073071676],"study_design_scores_gemma":[0.0014067643,0.00023346985,0.27934903,0.000052133037,0.000016607191,0.0000018881717,0.0007787833,0.000005773411,0.70486,0.000110086316,0.013036121,0.00014935494],"about_ca_topic_score_codex":0.00067256385,"about_ca_topic_score_gemma":0.000019553217,"teacher_disagreement_score":0.27636987,"about_ca_system_score_codex":0.00016739864,"about_ca_system_score_gemma":0.00018539841,"threshold_uncertainty_score":0.99795926},"labels":[],"label_agreement":null},{"id":"W4389241326","doi":"10.1158/2326-6074.tumimm23-b043","title":"Abstract B043: A core inflammatory gene network associated with poor prognosis serves chemokine production in cancer associated fibroblasts in pancreatic ductal adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Transcriptome; Chemokine; Cancer-Associated Fibroblasts; Cancer research; Pancreatic cancer; Cancer; Pancreatic ductal adenocarcinoma; Gene signature; Adenocarcinoma; Biology; Gene expression; Gene; Medicine; Inflammation; Immunology; Internal medicine; Tumor cells","score_opus":0.09791905113859348,"score_gpt":0.38460295732029376,"score_spread":0.28668390618170025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867204,0.006268684,1.642422e-7,0.003929046,0.00021570656,0.0023631884,0.00003516247,0.00016796948,0.0002996819],"genre_scores_gemma":[0.98889405,0.0036247128,0.000029651042,0.000058243997,0.0003405782,0.0035202447,0.00027522322,0.00008918364,0.003168094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947306,0.00065245415,0.0007516939,0.00090593274,0.0009355275,0.0020238007],"domain_scores_gemma":[0.99749815,0.0008012046,0.00022138949,0.00046298275,0.0008235656,0.00019272543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035010083,0.0003571699,0.0011522784,0.0010832761,0.00027180667,0.000029798523,0.00035950198,0.0006423952,0.00041111195],"category_scores_gemma":[0.002204676,0.00031012224,0.00008640116,0.0046645612,0.0009795234,0.00018845954,0.0002485723,0.0020001838,0.00005594888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002335336,0.00047044762,0.9659366,0.0002406386,0.0009895572,0.0009843244,0.0009342592,0.00024724792,0.023453651,0.000008834395,0.0037606128,0.000638493],"study_design_scores_gemma":[0.004514972,0.00083484105,0.98802215,0.0022842842,0.00010293003,0.00004274268,0.0005514348,0.000788366,0.0024127343,0.000121046935,0.000053662337,0.00027084313],"about_ca_topic_score_codex":0.004064551,"about_ca_topic_score_gemma":0.014879671,"teacher_disagreement_score":0.022085546,"about_ca_system_score_codex":0.0025176024,"about_ca_system_score_gemma":0.0026817364,"threshold_uncertainty_score":0.9999351},"labels":[],"label_agreement":null},{"id":"W4389241345","doi":"10.1158/2326-6074.tumimm23-a037","title":"Abstract A037: Prostate Specific Membrane Antigen Targeted Photodynamic Therapy Agent for the Treatment of Breast Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Photodynamic therapy; Breast cancer; Cancer; Prostate; Cancer research; Glutamate carboxypeptidase II; Immunotherapy; Antigen; Pathology; Oncology; Internal medicine; Immunology; Chemistry","score_opus":0.06213209408112459,"score_gpt":0.3445584552434887,"score_spread":0.28242636116236414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92385274,0.07086862,0.000023436849,0.00048053372,0.001394174,0.0019527687,0.0011321921,0.00020835295,0.00008715437],"genre_scores_gemma":[0.65662307,0.34063497,0.000011548781,0.000009037312,0.00015823457,0.001946627,0.00005557828,0.00008661884,0.0004742899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99804664,0.00003392361,0.00035827537,0.0003149206,0.00032094013,0.00092530693],"domain_scores_gemma":[0.9986207,0.00042322418,0.00005889985,0.00058077736,0.0002650811,0.000051349052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037613418,0.00026080888,0.00036817917,0.0003035973,0.00025380153,0.000034650875,0.00048047965,0.00015679045,0.0005555741],"category_scores_gemma":[0.00000675781,0.00018140087,0.00015947339,0.0009180181,0.00039069142,0.00009165853,0.00003274646,0.00028823328,0.000060337326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000808486,0.00007278007,0.00043303365,0.00009083105,0.001038089,0.000009318778,0.0012641586,0.006781264,0.8672384,0.000020429428,0.0016701034,0.1205731],"study_design_scores_gemma":[0.0038958814,0.00047449087,0.08507124,0.00010881143,0.000025987267,0.000006618098,0.0005666662,0.0036006875,0.73541856,0.00021055757,0.17025208,0.00036844108],"about_ca_topic_score_codex":0.0007572354,"about_ca_topic_score_gemma":0.00021353834,"teacher_disagreement_score":0.26976636,"about_ca_system_score_codex":0.0007459883,"about_ca_system_score_gemma":0.00022578891,"threshold_uncertainty_score":0.7397313},"labels":[],"label_agreement":null},{"id":"W4389241358","doi":"10.1158/2326-6074.tumimm23-a016","title":"Abstract A016: Reprogramming of immune-enhancing neutrophils by subclinical low-dose endotoxin for the treatment of cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Innate immune system; Reprogramming; Immunotherapy; Immunology; Cancer immunotherapy; Medicine; Cancer; Cancer research; Cancer cell; Subclinical infection; Biology; Cell; Internal medicine","score_opus":0.08005832439318357,"score_gpt":0.4560578932807521,"score_spread":0.3759995688875685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92522615,0.07229976,0.000015197232,0.00063027104,0.00022337779,0.0011963227,0.00035135084,0.00001321813,0.00004432581],"genre_scores_gemma":[0.91882825,0.07671112,0.000019751233,0.000010007838,0.00018406843,0.0028630046,0.00015186745,0.000038235816,0.0011937002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767494,0.00014570307,0.00052017526,0.0005259227,0.00030302908,0.00083021313],"domain_scores_gemma":[0.99806315,0.0004981118,0.00016445952,0.0007831387,0.00041033293,0.00008079153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080386776,0.00018694525,0.00037366283,0.00013430815,0.00023464415,0.000019239167,0.0004765866,0.00020303798,0.00007911227],"category_scores_gemma":[0.00022290925,0.00013481005,0.0002982568,0.00043790723,0.0007741796,0.0000064941464,0.00016274671,0.00021441549,0.000009589744],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020211241,0.00035760942,0.0045758164,0.000088340414,0.0010226377,0.0000063469633,0.000137337,0.000037446684,0.9050963,0.000013594274,0.0012536499,0.08538984],"study_design_scores_gemma":[0.0028503179,0.002038903,0.014841101,0.00006514957,0.000034817072,0.0000015709519,0.0002694127,0.000023359937,0.9534006,0.00004285177,0.026316755,0.000115163304],"about_ca_topic_score_codex":0.0063831317,"about_ca_topic_score_gemma":0.0014929617,"teacher_disagreement_score":0.085274674,"about_ca_system_score_codex":0.00016151955,"about_ca_system_score_gemma":0.00060733664,"threshold_uncertainty_score":0.9649428},"labels":[],"label_agreement":null},{"id":"W4389241389","doi":"10.1158/2326-6074.tumimm23-b002","title":"Abstract B002: Vidutolimod, an immunostimulatory virus-like particle, reduces proliferation but enhances the activation of tumor-specific T cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; T cell; CD8; Biology; Population; Immune system; Cytotoxic T cell; Splenocyte; Cancer research; Molecular biology; Immunology; Medicine; In vitro","score_opus":0.07310221273367039,"score_gpt":0.3595919720579775,"score_spread":0.2864897593243071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713728,0.025227414,0.000010243462,0.0006902423,0.0014489215,0.0008571847,0.000058661237,0.0001706825,0.00016385979],"genre_scores_gemma":[0.987645,0.008982325,0.000007851715,0.00009759305,0.00010432412,0.0005232078,0.000112018344,0.000055009543,0.0024726847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99558586,0.0017310176,0.0007577567,0.0006041169,0.00023597314,0.0010853064],"domain_scores_gemma":[0.9967031,0.0013623238,0.00029710098,0.0010220801,0.00058610673,0.000029287608],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002491178,0.0003182694,0.0004789553,0.0004465526,0.0011841668,0.00007711225,0.0010754475,0.00039220505,0.0013019341],"category_scores_gemma":[0.00018188152,0.00024345351,0.00014993329,0.0011644794,0.0021338607,0.000555083,0.0002226588,0.0012410037,0.0009951288],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003337183,0.00024185791,0.00018810971,0.00003131082,0.0003918635,0.000004649348,0.002428001,0.00009891521,0.9756644,0.0003088421,0.0025282889,0.01477662],"study_design_scores_gemma":[0.0011252771,0.00051528745,0.04163277,0.000102826496,0.000013779673,0.000012448189,0.0025176005,0.000024858435,0.93100226,0.00015428424,0.022661112,0.00023751256],"about_ca_topic_score_codex":0.0006536224,"about_ca_topic_score_gemma":0.000028852426,"teacher_disagreement_score":0.044662118,"about_ca_system_score_codex":0.00016154033,"about_ca_system_score_gemma":0.00053801894,"threshold_uncertainty_score":0.99978274},"labels":[],"label_agreement":null},{"id":"W4389241392","doi":"10.1158/2326-6074.tumimm23-b007","title":"Abstract B007: Phenotypic Signatures of Circulating Neoantigen-Reactive CD8+ T Cells in Patients with Metastatic Cancers","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD8; T-cell receptor; Cytotoxic T cell; Immunotherapy; T cell; Biology; Antigen; Cancer immunotherapy; Immunology; Circulating tumor cell; Cancer research; Phenotype; Cancer; Immune system; Metastasis; Gene; In vitro; Genetics","score_opus":0.06538773514156315,"score_gpt":0.38750745095334577,"score_spread":0.3221197158117826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944211,0.0017040806,0.0000028999877,0.00024928054,0.0001765342,0.0013964222,0.000047248523,0.00004846099,0.0019539623],"genre_scores_gemma":[0.9973974,0.00052907236,0.0000496665,0.000034384044,0.000060058544,0.0002567028,0.0000604076,0.00007083912,0.0015414424],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99642074,0.00034061456,0.00043872907,0.0005578581,0.0011108476,0.0011311863],"domain_scores_gemma":[0.99750376,0.0008124789,0.00013098349,0.0006019711,0.0008250204,0.00012578012],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013462973,0.00022412672,0.00062446477,0.0012211523,0.00013424699,0.000019679357,0.0003558771,0.00017697008,0.002470825],"category_scores_gemma":[0.00024409637,0.00018716768,0.00009157779,0.002509393,0.00080563064,0.00011946209,0.0001655377,0.0016735472,0.00009615782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067698783,0.00030541146,0.13419038,0.00039148313,0.0010730521,0.00020986426,0.0024231223,0.0014854929,0.8208587,0.000043233704,0.00072165823,0.03152773],"study_design_scores_gemma":[0.0064220587,0.00096757745,0.91998374,0.00046478127,0.00003498264,0.0000025847467,0.0014720608,0.00022933663,0.06934047,0.0001419456,0.00072227645,0.00021821188],"about_ca_topic_score_codex":0.0036246039,"about_ca_topic_score_gemma":0.00036208227,"teacher_disagreement_score":0.7857933,"about_ca_system_score_codex":0.001072753,"about_ca_system_score_gemma":0.0015103066,"threshold_uncertainty_score":0.99844104},"labels":[],"label_agreement":null},{"id":"W4389241393","doi":"10.1158/2326-6074.tumimm23-a030","title":"Abstract A030: Blood-based screening panel for lung cancer based on clonal hematopoietic mutations in tumor infiltrating immune cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Cancer; Immune system; Medicine; Circulating tumor cell; Somatic evolution in cancer; Haematopoiesis; Immunology; Oncology; Cancer research; Internal medicine; Biology; Metastasis; Stem cell; Genetics","score_opus":0.0600768943612152,"score_gpt":0.3735269915377564,"score_spread":0.3134500971765412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99145734,0.0044624787,0.0003945805,0.0017101027,0.00042978578,0.00087406876,0.0004750496,0.000031060084,0.00016555126],"genre_scores_gemma":[0.9956436,0.00053921744,0.00045133755,0.00033421133,0.00031781787,0.0020202987,0.00043501437,0.00006486886,0.00019361154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977776,0.00011129753,0.00041593594,0.0005843217,0.000252395,0.0008584675],"domain_scores_gemma":[0.9983495,0.00067650375,0.0001133968,0.0004675975,0.0003085263,0.00008451623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084149116,0.00021742495,0.00027199174,0.00037722854,0.00032180033,0.000065903245,0.0003974025,0.00021499452,0.00010031388],"category_scores_gemma":[0.00040805087,0.00023740096,0.00013658995,0.0005852574,0.00029699857,0.000006495166,0.00011966508,0.00048935495,0.00000912938],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060931174,0.00015200867,0.008301118,0.00019426794,0.0001290619,0.000036152618,0.00011909407,0.094246924,0.8920029,0.0000697234,0.0020398742,0.0020995608],"study_design_scores_gemma":[0.0055237953,0.0007042622,0.03990112,0.00048396626,0.00005563766,0.000004348852,0.0005950071,0.047324825,0.89986545,0.00011348395,0.0048311623,0.00059693813],"about_ca_topic_score_codex":0.0009544569,"about_ca_topic_score_gemma":0.0006169586,"teacher_disagreement_score":0.0469221,"about_ca_system_score_codex":0.00012775265,"about_ca_system_score_gemma":0.0012473725,"threshold_uncertainty_score":0.96809304},"labels":[],"label_agreement":null},{"id":"W4389241397","doi":"10.1158/2326-6074.tumimm23-a032","title":"Abstract A032: Antitumor activities of different RIG-I agonists in a murine model of kidney adenocarcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Kidney; Adjuvant; TLR9; CpG site; Cancer research; CpG Oligodeoxynucleotide; Internal medicine; Pharmacology; Immunology; Biology; Gene; Gene expression","score_opus":0.06922599686079035,"score_gpt":0.3876212511225661,"score_spread":0.3183952542617758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943663,0.0040271045,0.00000407592,0.0003864755,0.00006724993,0.00031195176,0.0002572182,0.000008859118,0.00057078246],"genre_scores_gemma":[0.9928759,0.0056982692,0.00001457556,0.000018862831,0.00004135343,0.00025969435,0.0001297328,0.000024112625,0.00093751],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982966,0.00011892308,0.0002716499,0.00036893747,0.00032049048,0.0006233555],"domain_scores_gemma":[0.99913096,0.000049403316,0.000068628986,0.0004748913,0.00015725111,0.00011886777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032780922,0.00014441586,0.00030854362,0.0004033303,0.00006525589,0.000009446047,0.00037796723,0.00014896017,0.000077336306],"category_scores_gemma":[0.00019342577,0.000129981,0.000092920134,0.00038914077,0.00061454275,0.0000075642165,0.00039578186,0.00030928565,0.00000889122],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010056194,0.00023170824,0.061899755,0.00018206374,0.0002291965,0.000025188188,0.0001464188,0.00012128174,0.93190527,0.00006625116,0.0024748086,0.0017124228],"study_design_scores_gemma":[0.0017498381,0.000488722,0.15033005,0.00010252256,0.000006168537,0.0000034651337,0.00017754606,0.00023864965,0.84614956,0.00029527425,0.00033982386,0.00011835956],"about_ca_topic_score_codex":0.0014670996,"about_ca_topic_score_gemma":0.0007511158,"teacher_disagreement_score":0.0884303,"about_ca_system_score_codex":0.00010053804,"about_ca_system_score_gemma":0.00087415153,"threshold_uncertainty_score":0.5300471},"labels":[],"label_agreement":null},{"id":"W4389241441","doi":"10.1158/2326-6074.tumimm23-b029","title":"Abstract B029: Investigating therapeutic strategies to promote immune rejection of KRAS G12C inhibitor-resistant sub-populations in lung cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KRAS; Immune system; Cancer research; Cancer; Lung cancer; Tumor microenvironment; Immunotherapy; Population; Immunology; Cancer cell; Biology; Medicine; Oncology; Colorectal cancer; Internal medicine","score_opus":0.16407142773062766,"score_gpt":0.46741755157289805,"score_spread":0.3033461238422704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778046,0.011632397,0.0000034810578,0.008300547,0.00029726798,0.0010553848,0.000044668483,0.00006585647,0.0007958002],"genre_scores_gemma":[0.99480057,0.0028337764,0.0000648483,0.000052883337,0.00019540114,0.00046457603,0.00005036984,0.0000409533,0.0014966363],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969777,0.0002586331,0.0006272574,0.00045695156,0.0007499214,0.00092956086],"domain_scores_gemma":[0.9985054,0.00025304584,0.000097769414,0.00039272028,0.0006036883,0.00014734225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014396497,0.0002021737,0.00048105404,0.00109886,0.0002939726,0.000042786298,0.00027785212,0.00021116273,0.0002877154],"category_scores_gemma":[0.0002735044,0.00017405373,0.00010241527,0.0026761694,0.0005679581,0.00016097385,0.00024022751,0.0011991137,0.00005568685],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093748036,0.00009212265,0.059371565,0.0005491876,0.00019247274,0.00004971025,0.0017459476,0.00031148252,0.9229451,0.0009474172,0.0006128748,0.012244654],"study_design_scores_gemma":[0.00080325955,0.00038625492,0.88547784,0.0010681066,0.000019341482,0.000007329793,0.0014840288,0.0006108999,0.10739037,0.0010759633,0.0015062245,0.00017037193],"about_ca_topic_score_codex":0.016999556,"about_ca_topic_score_gemma":0.0033825152,"teacher_disagreement_score":0.8261063,"about_ca_system_score_codex":0.00047922513,"about_ca_system_score_gemma":0.0014000433,"threshold_uncertainty_score":0.98954636},"labels":[],"label_agreement":null},{"id":"W4389241446","doi":"10.1158/2326-6074.tumimm23-b012","title":"Abstract B012: Transcriptional activation of mouse LINE-1 promoter by transcription factor YY1","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chromosomal and Genetic Variations","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"YY1; Transcription factor; Biology; Promoter; Molecular biology; Response element; Transcription (linguistics); Gene knockdown; Chromatin immunoprecipitation; Electrophoretic mobility shift assay; General transcription factor; Genetics; Gene; Gene expression","score_opus":0.11607551148955102,"score_gpt":0.3437398097800102,"score_spread":0.22766429829045914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308187,0.00038253004,0.0000040865366,0.005447109,0.00011742895,0.0002787317,0.00048520757,0.000059161655,0.00014387768],"genre_scores_gemma":[0.9969572,0.0005718042,0.0000067931082,0.000022968912,0.00012696623,0.00013193907,0.00037424147,0.0000017800484,0.0018062961],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875027,0.00010977232,0.00022332615,0.0002549917,0.00031210572,0.0003495262],"domain_scores_gemma":[0.9994666,0.00016005982,0.000033708726,0.00006467096,0.00022799395,0.000046969315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025782295,0.00009378973,0.00013472995,0.000049774186,0.00021724265,0.000022873604,0.00023531466,0.00016831406,0.0023921279],"category_scores_gemma":[0.0000388601,0.000044369113,0.00007287268,0.0006776567,0.00016812856,0.00011979286,0.000026977097,0.0002815665,0.00009298085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072132025,0.00009192723,0.0011014168,0.0000114354625,0.00003441735,3.092395e-7,0.00023460084,0.000012430166,0.97606874,0.000111977846,0.00075437,0.021506269],"study_design_scores_gemma":[0.00032162937,0.00029788777,0.34720507,0.000027250855,0.0000043090345,9.695561e-7,0.00028718464,0.000077955876,0.6320478,0.0005416034,0.01906561,0.00012272803],"about_ca_topic_score_codex":0.0005318389,"about_ca_topic_score_gemma":0.00020901629,"teacher_disagreement_score":0.34610367,"about_ca_system_score_codex":0.000054120304,"about_ca_system_score_gemma":0.000040351086,"threshold_uncertainty_score":0.99851984},"labels":[],"label_agreement":null},{"id":"W4389241501","doi":"10.1158/2326-6074.tumimm23-b010","title":"Abstract B010: Revealing the Influence of the Infantile Immune System on the Developmental Origins of Childhood Ependymoma: An Integrative Multi-Omic Investigation of Supratentorial Ependymoma Tumorigenesis Driven by ZFTA-RELA Fusion","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ependymoma; Biology; Immune system; Neuroscience; Cancer research; Immunology; Pathology; Medicine","score_opus":0.043145817827848765,"score_gpt":0.33973470422725477,"score_spread":0.296588886399406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959126,0.0009307016,3.7430493e-7,0.00113597,0.00037229524,0.0014272663,0.00015174353,0.000023144737,0.000045903205],"genre_scores_gemma":[0.9989034,0.00044852638,0.00002138295,0.000017717943,0.000055078246,0.00042304047,0.000064052074,0.000026694377,0.00004012662],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997261,0.00063688675,0.00069077115,0.0003409882,0.0006709477,0.0003994357],"domain_scores_gemma":[0.9974886,0.00082196563,0.00041022126,0.00063866575,0.0005849125,0.000055621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013930532,0.00021545003,0.0004826181,0.00024068638,0.00040660004,0.000015562822,0.0006220765,0.0001650543,0.000045326367],"category_scores_gemma":[0.0004424956,0.00010407235,0.00013718911,0.0011250002,0.0009201259,0.00009415986,0.000258422,0.00062003126,0.000019246883],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004893094,0.00036089553,0.080467656,0.00011887605,0.0005529595,0.000030382747,0.0057633193,0.00022343246,0.90970737,0.001210381,0.00031600887,0.0007594148],"study_design_scores_gemma":[0.0011168227,0.00024914293,0.5428787,0.000755375,0.000041390304,0.000021005982,0.0034457159,0.000052975665,0.4513372,0.00001344374,0.000034216402,0.000054039094],"about_ca_topic_score_codex":0.0073090377,"about_ca_topic_score_gemma":0.00029400017,"teacher_disagreement_score":0.46241105,"about_ca_system_score_codex":0.0006272344,"about_ca_system_score_gemma":0.00083237624,"threshold_uncertainty_score":0.9993014},"labels":[],"label_agreement":null},{"id":"W4389241535","doi":"10.1158/2326-6074.tumimm23-a001","title":"Abstract A001: Reshaping the immune microenvironment after temozolomide priming in metastatic colorectal cancer patients in ARETHUSA clinical trial","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Immune system; Immune checkpoint; Immunotherapy; MSH6; Medicine; DNA mismatch repair; Colorectal cancer; Cancer research; Oncology; Tumor microenvironment; Cancer; Immunology; Internal medicine; Biology; Chemotherapy","score_opus":0.08686040538991975,"score_gpt":0.4098916356056458,"score_spread":0.32303123021572605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819066,0.015102962,0.0000011017878,0.00090648135,0.00083552394,0.0010807379,0.00008545891,0.000007227167,0.0000739128],"genre_scores_gemma":[0.9744833,0.023097815,0.000015518764,0.00018041879,0.00024829298,0.0017143248,0.00008906508,0.000037751866,0.00013350851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970925,0.00047220432,0.0007418746,0.0006050117,0.00025395228,0.00083449925],"domain_scores_gemma":[0.99883103,0.00045682443,0.0001286566,0.0004308955,0.00009185603,0.00006073139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002237257,0.00019148986,0.0003392588,0.00022274342,0.00013271884,0.000039888873,0.0005028559,0.00023790427,0.00010247791],"category_scores_gemma":[0.0006925325,0.00016395087,0.0001242181,0.00042859427,0.00063658075,0.000007664866,0.000624991,0.00086652616,0.00004400534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07176846,0.0011978976,0.52484095,0.00011602542,0.00065369246,0.00018793556,0.0013660478,0.0010786577,0.319303,0.000035826066,0.0048721246,0.074579395],"study_design_scores_gemma":[0.015823921,0.00067388883,0.9467981,0.00010401839,0.000015283447,0.000001289817,0.0003326319,0.000046892106,0.024246981,0.00007727244,0.011643154,0.00023660634],"about_ca_topic_score_codex":0.0025542926,"about_ca_topic_score_gemma":0.0062029134,"teacher_disagreement_score":0.42195714,"about_ca_system_score_codex":0.00032937856,"about_ca_system_score_gemma":0.00051960855,"threshold_uncertainty_score":0.66857225},"labels":[],"label_agreement":null},{"id":"W4389241566","doi":"10.1158/2326-6074.tumimm23-b054","title":"Abstract B054: Immunological control by PARP inhibitors for successful immunotherapy in metastatic ovarian carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer research; Immunotherapy; Cytotoxic T cell; DNA repair; DNA damage; Cancer; Immunology; Biology; Ovarian cancer; Immune system; Medicine; Internal medicine; DNA; In vitro; Genetics","score_opus":0.10298796408779382,"score_gpt":0.43308032806995667,"score_spread":0.33009236398216285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493593,0.031200754,0.00013911231,0.014246102,0.00080776366,0.0028996407,0.00035610268,0.00024240115,0.0007488014],"genre_scores_gemma":[0.98635453,0.005704808,0.000089315254,0.0006126651,0.00025061725,0.005420746,0.00020963339,0.00010388211,0.0012538203],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.995434,0.00053079944,0.0008731608,0.0008526218,0.00063645816,0.0016729652],"domain_scores_gemma":[0.99684936,0.0014895528,0.00016408725,0.00079419406,0.0005526905,0.00015010424],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00270285,0.00037037273,0.00092668174,0.0010405896,0.00034444578,0.00006488405,0.00055075367,0.0004178717,0.0013974634],"category_scores_gemma":[0.00036194175,0.00033303283,0.00024842587,0.001845825,0.0010945416,0.0001946443,0.000095615775,0.0015305971,0.00024760055],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012351514,0.0006134745,0.058375545,0.00023209707,0.0010797102,0.00027405642,0.00088843034,0.000040445062,0.8389036,0.00071649964,0.037227258,0.04929739],"study_design_scores_gemma":[0.06560551,0.0034777764,0.58635753,0.0006478218,0.000089770736,0.00012492112,0.00284338,0.0005602524,0.15050101,0.005212745,0.18345547,0.0011238221],"about_ca_topic_score_codex":0.0012740027,"about_ca_topic_score_gemma":0.000067879104,"teacher_disagreement_score":0.6884026,"about_ca_system_score_codex":0.0009937729,"about_ca_system_score_gemma":0.00092638034,"threshold_uncertainty_score":0.99991214},"labels":[],"label_agreement":null},{"id":"W4389241582","doi":"10.1158/2326-6074.tumimm23-b048","title":"Abstract B048: Multiplex analysis of pancreatic, oesophageal and rectal adenocarcinoma: A cross-cancer approach on the impact of neoadjuvant therapy on the tumour microenvironment","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Medicine; FOXP3; Stromal cell; Pancreatic cancer; Immune system; Cancer research; CD8; Immunotherapy; Tumor-infiltrating lymphocytes; Colorectal cancer; Pathology; Cancer; Immunology; Internal medicine","score_opus":0.11217253789018335,"score_gpt":0.4123460487443221,"score_spread":0.3001735108541388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724509,0.023790462,8.7291977e-7,0.0019968264,0.00006487387,0.0011005653,0.00021437102,0.000020766453,0.00036036308],"genre_scores_gemma":[0.97613215,0.022588024,0.000005518254,0.00012169872,0.0000741897,0.0005151414,0.000035073877,0.000037035614,0.00049116486],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99732363,0.00041804457,0.0004954962,0.0005050527,0.0006079125,0.0006498838],"domain_scores_gemma":[0.99745065,0.0012513179,0.00022120257,0.000837933,0.00017130187,0.00006761373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001864954,0.00027577905,0.0007031755,0.0006019274,0.00030607087,0.000032220643,0.0004399649,0.0001810372,0.0012383838],"category_scores_gemma":[0.00012484788,0.00013863733,0.00046795816,0.0017371601,0.0020577505,0.000041582123,0.00012304458,0.0008308426,0.000012858175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017769985,0.0005169085,0.26381642,0.00006004516,0.01153653,0.0000237263,0.002693676,0.0004320088,0.68583834,0.000052250572,0.0016768255,0.015583301],"study_design_scores_gemma":[0.002273293,0.0012118208,0.9500772,0.000106529216,0.00015771059,0.0000061439596,0.0007694248,0.0006882302,0.04448483,0.000018447476,0.000096894175,0.00010950927],"about_ca_topic_score_codex":0.0057123536,"about_ca_topic_score_gemma":0.000041664753,"teacher_disagreement_score":0.68626076,"about_ca_system_score_codex":0.00040216398,"about_ca_system_score_gemma":0.00032365776,"threshold_uncertainty_score":0.9996746},"labels":[],"label_agreement":null},{"id":"W4389241592","doi":"10.1158/2326-6074.tumimm23-b038","title":"Abstract B038: Targeting a Treg-specific deubiquitinase module for antitumor immune therapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"FOXP3; Cancer research; Immune system; Cancer immunotherapy; Tumor microenvironment; Immunotherapy; Deubiquitinating enzyme; Effector; Biology; Regulatory T cell; Immunology; Immune checkpoint; T cell; Medicine; Gene; IL-2 receptor; Ubiquitin","score_opus":0.10759420896632486,"score_gpt":0.37443864192431087,"score_spread":0.266844432957986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97047603,0.0269646,0.0001586308,0.00075236487,0.0005861185,0.0005518684,0.000081953294,0.000057141595,0.00037131386],"genre_scores_gemma":[0.97596204,0.020481374,0.00015142563,0.00006596385,0.00055051444,0.0005204007,0.00036400254,0.00006657097,0.0018377235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997982,0.00011772106,0.00030053873,0.0005480398,0.00018403592,0.00086765725],"domain_scores_gemma":[0.9989652,0.000095904245,0.0000597281,0.00045582541,0.0003553448,0.00006798787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009829993,0.00018746265,0.00024030036,0.00017932514,0.00042990883,0.00005361353,0.00049061957,0.00025631252,0.00011799873],"category_scores_gemma":[0.000116379255,0.00017901337,0.00016164157,0.0003681653,0.0003780971,0.000007794716,0.00011951037,0.00035623158,0.0000642623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008783331,0.00008659581,0.00093641464,0.00003346492,0.00011265457,0.0000112408015,0.00009923509,0.00004095331,0.96848345,0.00009460017,0.008878509,0.02034456],"study_design_scores_gemma":[0.001784679,0.00045875512,0.012106454,0.000028186549,0.0000031028983,0.0000043129075,0.00021897942,0.00009363296,0.80075604,0.00014777914,0.18416871,0.00022938137],"about_ca_topic_score_codex":0.00017898064,"about_ca_topic_score_gemma":0.00003416117,"teacher_disagreement_score":0.17529021,"about_ca_system_score_codex":0.000050499286,"about_ca_system_score_gemma":0.0002256115,"threshold_uncertainty_score":0.72999537},"labels":[],"label_agreement":null},{"id":"W4389241602","doi":"10.1158/2326-6074.tumimm23-pr06","title":"Abstract PR06: Hallmarks of CD8 T cell dysfunction are established within hours of tumor antigen encounter prior to cell division","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Immunology; T cell; CD8; Cytotoxic T cell; Epigenetics; Immunotherapy; Cancer; Biology; Cancer research; Cancer immunotherapy; Antigen; Context (archaeology); Medicine; Immune system; Genetics; In vitro","score_opus":0.04536079984949287,"score_gpt":0.35569516336923906,"score_spread":0.3103343635197462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917278,0.0037334585,0.000015783711,0.0008846011,0.00076163874,0.0009867019,0.00007078368,0.000059432674,0.001759769],"genre_scores_gemma":[0.9950685,0.0018039005,0.000071068025,0.00011234671,0.000090554306,0.00014773596,0.000038692007,0.00005178537,0.0026154472],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723494,0.00017560608,0.0006590304,0.00051127194,0.000747057,0.0006720688],"domain_scores_gemma":[0.99781036,0.00025634904,0.00030636965,0.000710889,0.00080065464,0.00011536886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018856492,0.0002132547,0.00057686074,0.00093548064,0.00014106641,0.000022883652,0.00039276763,0.0002326907,0.00084227],"category_scores_gemma":[0.00018646268,0.00018187883,0.00016633079,0.0016315788,0.0004997553,0.0001365824,0.00020819606,0.0006778697,0.00008277427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067831315,0.00029236937,0.05347638,0.0005241912,0.00017531737,0.000047886904,0.0014249732,0.00004036167,0.9186228,0.0000018766217,0.009808988,0.008801741],"study_design_scores_gemma":[0.002477811,0.0009843288,0.4840657,0.0006028419,0.000020390087,0.0000050033077,0.0021834776,0.000022477867,0.506865,0.000012296344,0.0026270999,0.00013352963],"about_ca_topic_score_codex":0.0016942697,"about_ca_topic_score_gemma":0.00020215173,"teacher_disagreement_score":0.43058935,"about_ca_system_score_codex":0.00030983106,"about_ca_system_score_gemma":0.00075332745,"threshold_uncertainty_score":0.92222655},"labels":[],"label_agreement":null},{"id":"W4389241634","doi":"10.1158/2326-6074.tumimm23-b032","title":"Abstract B032: CD161+ TRM cells counteract HPV-associated clinical benefits in oropharyngeal cancer immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Cancer; Medicine; Cancer immunotherapy; CD8; Immunology; Cancer research; Context (archaeology); Immune system; Oncology; Biology; Internal medicine","score_opus":0.14820406812954517,"score_gpt":0.46991587073285385,"score_spread":0.32171180260330867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538357,0.035214707,4.275876e-7,0.0055911853,0.002531069,0.0011762502,0.00019285607,0.00029125178,0.0011665127],"genre_scores_gemma":[0.8524166,0.1411352,0.000008353711,0.0009608799,0.00046391794,0.0007464696,0.000106877465,0.00016308742,0.003998669],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9943506,0.00060937565,0.0012905111,0.0010006344,0.00093484996,0.0018140074],"domain_scores_gemma":[0.9969159,0.0011304333,0.00025678286,0.00089089957,0.0006395095,0.00016648017],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004186705,0.00043001608,0.0011628304,0.0010311684,0.00027948347,0.000077166165,0.000703023,0.00078737224,0.004061939],"category_scores_gemma":[0.00023208615,0.0003906134,0.0004063414,0.002794345,0.0010235889,0.00022404258,0.00019570034,0.002563953,0.00041318985],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023710314,0.0013723497,0.13398859,0.00018466683,0.0026988958,0.0006388166,0.0014726778,0.000060425085,0.41738257,0.000046356356,0.049320593,0.36912376],"study_design_scores_gemma":[0.011512845,0.00087230507,0.9364033,0.0006171616,0.00003457414,0.000014592162,0.0005327279,0.00012253497,0.011344588,0.000055528428,0.038085617,0.0004042494],"about_ca_topic_score_codex":0.009810294,"about_ca_topic_score_gemma":0.002743901,"teacher_disagreement_score":0.8024147,"about_ca_system_score_codex":0.0016497948,"about_ca_system_score_gemma":0.0019845553,"threshold_uncertainty_score":0.99985456},"labels":[],"label_agreement":null},{"id":"W4389241701","doi":"10.1158/2326-6074.tumimm23-a040","title":"Abstract A040: Spatially resolved immune cell networks in renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"","keywords":"Mass cytometry; Immune system; Immunotherapy; Cell; Renal cell carcinoma; Clear cell renal cell carcinoma; Tumor microenvironment; Antibody; Computational biology; Medicine; Cancer research; Biology; Immunology; Oncology; Phenotype; Genetics; Gene","score_opus":0.045366380144374725,"score_gpt":0.3139700469654124,"score_spread":0.2686036668210377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825014,0.012396013,0.000098568315,0.00031302316,0.000563758,0.0003316338,0.000021449643,0.000032765507,0.0037413982],"genre_scores_gemma":[0.99131966,0.004370333,0.000043425458,0.000060653023,0.0003665697,0.00015365228,0.0002328005,0.000060177026,0.0033927506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734664,0.00026678471,0.0004188447,0.0006322569,0.0002529995,0.0010824464],"domain_scores_gemma":[0.99888444,0.00008653222,0.00007092515,0.0006538267,0.00021120675,0.00009308992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010076258,0.00022713571,0.0002857649,0.00029726268,0.00021027267,0.00004250664,0.0006734348,0.0005303825,0.00014817405],"category_scores_gemma":[0.000056704586,0.00023408062,0.00012634112,0.00066769635,0.00038112517,0.0000073024285,0.00030344215,0.00095796643,0.00009345791],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006758434,0.00011943087,0.016775943,0.000041788702,0.000029032059,0.00006743541,0.0001294962,0.0014725705,0.9746894,0.0000076195743,0.0021310209,0.0038604178],"study_design_scores_gemma":[0.0026061784,0.00050228235,0.21958457,0.00004345991,0.000008972427,0.000004282749,0.00018469057,0.0008932612,0.76030666,0.00004973164,0.015424662,0.000391233],"about_ca_topic_score_codex":0.0021064337,"about_ca_topic_score_gemma":0.0008213732,"teacher_disagreement_score":0.21438272,"about_ca_system_score_codex":0.000098122575,"about_ca_system_score_gemma":0.00043996505,"threshold_uncertainty_score":0.95455307},"labels":[],"label_agreement":null},{"id":"W4389241714","doi":"10.1158/2326-6074.tumimm23-a009","title":"Abstract A009: CD103+CD56+ innate lymphoid cells are associated with an immunosuppressive microenvironment in ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"","keywords":"CD8; Biology; Ovarian cancer; Tumor microenvironment; Cancer research; CD16; Immunology; Antigen; Cancer; CD3; Immune system","score_opus":0.04907335634722679,"score_gpt":0.32257049648452607,"score_spread":0.2734971401372993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983194,0.00962323,0.0000024972749,0.0006615131,0.0012500621,0.00085466506,0.0032047885,0.00017349087,0.0010357541],"genre_scores_gemma":[0.9828281,0.009386919,0.000008593118,0.00016485501,0.00008550231,0.0010611811,0.00068606756,0.00010550256,0.0056733103],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9945315,0.0011976243,0.00062831864,0.0011150527,0.00023105314,0.0022964515],"domain_scores_gemma":[0.99787307,0.00041928995,0.00030538556,0.00096093904,0.0003577017,0.00008361293],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013902806,0.000501234,0.0007857225,0.00087422197,0.0007512444,0.000060106802,0.001116563,0.0009485894,0.0019854377],"category_scores_gemma":[0.00018349044,0.00044898046,0.00010419246,0.001544973,0.0016316881,0.00031688443,0.00048851356,0.0020726386,0.0014778718],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001567867,0.00046995498,0.027513444,0.000057151767,0.0008879672,0.00031227333,0.0025287324,0.00021255105,0.9575559,0.0000627758,0.005718694,0.0031126835],"study_design_scores_gemma":[0.006580247,0.0006833685,0.5901178,0.00063187245,0.000046289104,0.000040043804,0.0029100387,0.000013069273,0.36627144,0.00019171751,0.031803004,0.0007110918],"about_ca_topic_score_codex":0.005205466,"about_ca_topic_score_gemma":0.0031020765,"teacher_disagreement_score":0.59128445,"about_ca_system_score_codex":0.0012126421,"about_ca_system_score_gemma":0.0009987536,"threshold_uncertainty_score":0.9997962},"labels":[],"label_agreement":null},{"id":"W4389241744","doi":"10.1158/2326-6074.tumimm23-a043","title":"Abstract A043: Identifying critical vulnerabilities that sensitise <i>Lkb1</i>-mutant lung adenocarcinoma to T cell mediated killing","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KRAS; Cancer research; Immune checkpoint; STK11; Biology; Adenocarcinoma; CD8; CRISPR; Immunotherapy; Cancer; Memory T cell; T cell; Immune system; Immunology; Gene; Genetics; Colorectal cancer","score_opus":0.11875345147917762,"score_gpt":0.4189211730398104,"score_spread":0.30016772156063276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95955646,0.021540817,0.000039811992,0.014916957,0.0014277356,0.0009081798,0.00009012282,0.00032009583,0.0011998443],"genre_scores_gemma":[0.9904317,0.0056195664,0.00006610603,0.0008979169,0.00033795706,0.00039633378,0.000075603304,0.000094521085,0.0020802687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99559134,0.00035266418,0.00056360464,0.0008473556,0.0009808468,0.0016641739],"domain_scores_gemma":[0.9958539,0.0023350285,0.00006242535,0.0007957938,0.0006284451,0.00032442767],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022641332,0.00032302536,0.0006079673,0.0009821188,0.0006251013,0.00012553121,0.00040100105,0.00037889302,0.0015337346],"category_scores_gemma":[0.00086051313,0.00030067103,0.00021779186,0.0017586114,0.000982014,0.00019688616,0.0003278661,0.0014610777,0.0006501245],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004083404,0.00014717873,0.04159532,0.0008227362,0.0004541595,0.0013344856,0.0037354338,0.000015535654,0.92145383,0.000059720118,0.020029776,0.0062684366],"study_design_scores_gemma":[0.005198436,0.0008714032,0.57786465,0.0015716448,0.00013535621,0.00023397406,0.014897617,0.00057751534,0.37348446,0.00027668336,0.024001142,0.00088712334],"about_ca_topic_score_codex":0.0015768647,"about_ca_topic_score_gemma":0.00013493375,"teacher_disagreement_score":0.54796934,"about_ca_system_score_codex":0.0008486795,"about_ca_system_score_gemma":0.0007886723,"threshold_uncertainty_score":0.99994457},"labels":[],"label_agreement":null},{"id":"W4389241748","doi":"10.1158/2326-6074.tumimm23-a044","title":"Abstract A044: Screening and characterization of CD38 chimeric antigen receptors for the development of natural killer cell-based therapies","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD38; Jurkat cells; Epitope; Monoclonal antibody; Antigen; Chimeric antigen receptor; Biology; Molecular biology; T cell; Antibody; Chemistry; Immunology; Immune system; Cell biology; CD34; Stem cell","score_opus":0.058183982660818534,"score_gpt":0.33942677344880046,"score_spread":0.2812427907879819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881275,0.007209955,0.0003696488,0.00067054963,0.0030442975,0.00046499062,0.0000060513075,0.00003366276,0.00007332973],"genre_scores_gemma":[0.99295723,0.0016002292,0.00006765906,0.000026796586,0.000021483787,0.00016823084,0.00023309726,0.000017980008,0.0049072965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988907,0.00016630176,0.00035057953,0.00020352867,0.000062290725,0.00032662033],"domain_scores_gemma":[0.9987822,0.00056141394,0.00017657068,0.0001920457,0.00028018234,0.0000075833345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078411243,0.000113372174,0.00021277646,0.00031539274,0.00041951364,0.000009681565,0.00020345321,0.00016037261,0.0005940915],"category_scores_gemma":[0.000066293105,0.00008271443,0.00006264032,0.00037998502,0.00047755102,0.000079888785,0.0000764278,0.00038109577,0.00003712389],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074406236,0.000035792193,0.0019106149,0.00005120822,0.00028673324,7.8875075e-8,0.0015770686,0.0000068848526,0.9526115,0.000016540605,0.0010344129,0.04172512],"study_design_scores_gemma":[0.00085621985,0.00011160085,0.24057251,0.000057111098,0.000009048551,9.207034e-7,0.0013251946,0.00005283271,0.67618465,0.0000043403593,0.08074371,0.00008182505],"about_ca_topic_score_codex":0.0000744491,"about_ca_topic_score_gemma":0.000010129208,"teacher_disagreement_score":0.2764268,"about_ca_system_score_codex":0.000035231315,"about_ca_system_score_gemma":0.00016841058,"threshold_uncertainty_score":0.6504885},"labels":[],"label_agreement":null},{"id":"W4389241775","doi":"10.1158/2326-6074.tumimm23-a054","title":"Abstract A054: Anti-CTLA-4 generates memory T-cell with greater expansion and functionality than anti-PD-1","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Memory T cell; Immunotherapy; Cancer immunotherapy; CD8; Immunology; Immune system; T cell; CTLA-4; Cancer research; Cancer; Antigen; Medicine; Biology; In vitro; Internal medicine; Biochemistry","score_opus":0.08523785618377776,"score_gpt":0.36477024238039285,"score_spread":0.2795323861966151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852055,0.008880933,0.0000025877473,0.0033550162,0.00036123232,0.0005026986,0.00003464565,0.00012609894,0.0015313053],"genre_scores_gemma":[0.98534477,0.008467152,0.000024115343,0.00022461255,0.00023329495,0.00018014516,0.000083825755,0.00004660008,0.0053954786],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99774975,0.00016438295,0.00027262574,0.00059881713,0.0004837728,0.0007306352],"domain_scores_gemma":[0.9988075,0.0001509756,0.00006379954,0.00051069283,0.0003550596,0.000111986905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010363837,0.00022421755,0.00039008816,0.00042416403,0.00039699368,0.000052951134,0.00016588738,0.00023635142,0.0010207654],"category_scores_gemma":[0.000028701606,0.00016339727,0.00007617538,0.00088145206,0.0009943868,0.00013083649,0.00012762303,0.0006493868,0.00013220677],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038966867,0.0001076356,0.1441273,0.0002033687,0.00044104547,0.00017879443,0.00042852532,0.000009291232,0.83270395,0.0000066792472,0.007643252,0.010253498],"study_design_scores_gemma":[0.0033727929,0.00048611182,0.81052166,0.00015436576,0.000031664033,0.000081869475,0.0006828809,0.000023015851,0.18032815,0.000023129003,0.004109741,0.00018464515],"about_ca_topic_score_codex":0.0013504347,"about_ca_topic_score_gemma":0.00006865144,"teacher_disagreement_score":0.66639435,"about_ca_system_score_codex":0.0001793078,"about_ca_system_score_gemma":0.000534759,"threshold_uncertainty_score":0.9998924},"labels":[],"label_agreement":null},{"id":"W4389241782","doi":"10.1158/2326-6074.tumimm23-b011","title":"Abstract B011: Dynamics of predicted tumor neoepitope burden in a pan-cancer solid tumor pediatric cohort","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Context (archaeology); Cohort; Cancer; Pediatric cancer; Germline; Internal medicine; Disease; Human leukocyte antigen; Immunology; Biology; Genetics; Antigen; Gene","score_opus":0.055717692292938714,"score_gpt":0.38698924339892876,"score_spread":0.33127155110599005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9693571,0.022051135,0.0000010320831,0.0048376573,0.00065400015,0.0011284809,0.0002191968,0.00012563125,0.0016257905],"genre_scores_gemma":[0.97821426,0.017920233,0.000011985422,0.00008524505,0.00074689783,0.0012840164,0.000099422075,0.000066188426,0.0015717226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965068,0.0001635662,0.000691953,0.00068084395,0.00075589516,0.001200922],"domain_scores_gemma":[0.9979407,0.00038234782,0.00016171366,0.0006611941,0.0007225008,0.00013150953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010021911,0.00028110362,0.00088365766,0.0011918313,0.00016575043,0.000020981579,0.0004730273,0.00018693315,0.00063467753],"category_scores_gemma":[0.0004224897,0.0002585497,0.00015712579,0.0027028124,0.00066244684,0.00010660657,0.00045053006,0.0013599247,0.000101760685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011066991,0.00013731548,0.97223127,0.0005597114,0.00053769315,0.0005873615,0.0012053703,0.000041956355,0.0071606347,0.000043001015,0.009389634,0.0069993543],"study_design_scores_gemma":[0.0024434903,0.0003453787,0.99252737,0.00026825373,0.00010725025,0.000029533938,0.0013375514,0.00048735866,0.0010588359,0.0001282409,0.001057945,0.00020880272],"about_ca_topic_score_codex":0.007257239,"about_ca_topic_score_gemma":0.0019637684,"teacher_disagreement_score":0.020296091,"about_ca_system_score_codex":0.000845861,"about_ca_system_score_gemma":0.0014383525,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W4389241815","doi":"10.1158/2326-6074.tumimm23-ia015","title":"Abstract IA015: Obesity and immunometabolism in cancer immunotherapy","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Adipokines, Inflammation, and Metabolic Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Adipokine; Inflammation; Immunotherapy; Leptin; Immunology; Tumor microenvironment; Biology; Macrophage; Cancer immunotherapy; Adipose tissue; Cancer; Cancer research; Immunity; T cell; Internal medicine; Endocrinology; Medicine; Obesity","score_opus":0.07229591227182185,"score_gpt":0.40847689797416753,"score_spread":0.33618098570234567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8884144,0.10726806,9.892735e-7,0.0022381884,0.00043024926,0.00057443324,0.000035417866,0.00016343298,0.0008748225],"genre_scores_gemma":[0.8592121,0.13613005,0.000016257236,0.00016585611,0.0003278564,0.0006745158,0.000038037604,0.00005715772,0.0033781515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977968,0.00016077344,0.0003908674,0.00043843105,0.0003943943,0.00081876596],"domain_scores_gemma":[0.99878216,0.00019801395,0.00006783303,0.00048529598,0.0003385626,0.00012816231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00107558,0.0001968019,0.00049672095,0.0009038934,0.00018833029,0.000036035683,0.00023669592,0.00020392599,0.00079082284],"category_scores_gemma":[0.00020738052,0.00017577944,0.00007885792,0.0014072756,0.000644321,0.00018617277,0.00013368424,0.0006998057,0.000116786294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022667453,0.0004693766,0.43819964,0.0004219402,0.00081804505,0.00028164886,0.003785751,0.00004889636,0.19304414,0.0018651724,0.005525561,0.3532731],"study_design_scores_gemma":[0.0023759007,0.00005418876,0.9089071,0.00014379963,0.000022113169,0.000013216238,0.0004515042,0.000032686763,0.0017756934,0.0003992064,0.085676804,0.000147747],"about_ca_topic_score_codex":0.004413456,"about_ca_topic_score_gemma":0.00032930478,"teacher_disagreement_score":0.4707075,"about_ca_system_score_codex":0.00018271955,"about_ca_system_score_gemma":0.0007887453,"threshold_uncertainty_score":0.86589557},"labels":[],"label_agreement":null},{"id":"W4389241834","doi":"10.1158/2326-6074.tumimm23-b005","title":"Abstract B005: Molecular, metabolic and functional CD4 T cell paralysis in lymph node impedes tumor control","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"CD8; Biology; T cell; Lymph node; Adoptive cell transfer; Cancer research; Tumor-infiltrating lymphocytes; Epitope; Antigen; Immunology; Cell biology; Immune system","score_opus":0.053916213096303046,"score_gpt":0.3794539962917979,"score_spread":0.3255377831954948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389241834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632997,0.029432656,0.000010117274,0.004065764,0.00013683987,0.0006442239,0.000033283577,0.000075596225,0.0023017982],"genre_scores_gemma":[0.98340917,0.007921193,0.000019888415,0.00028349864,0.00014899237,0.0007679284,0.000045610126,0.000059109636,0.007344624],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965533,0.0004122803,0.00037711352,0.000638488,0.0008017296,0.0012170717],"domain_scores_gemma":[0.998087,0.0006749421,0.000051200383,0.0005813276,0.0004087726,0.00019676432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019937197,0.00021712795,0.0006046379,0.0013381785,0.00017862981,0.000057678782,0.00024122541,0.00020600726,0.0048130136],"category_scores_gemma":[0.00031762948,0.00019819262,0.00013906344,0.0017892665,0.0007780047,0.0000982435,0.00020959003,0.0012461906,0.00042535708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00217296,0.00012776455,0.091616705,0.000106841886,0.00042057794,0.0005401736,0.00016028548,0.00007988878,0.8929096,0.000119586985,0.00097566604,0.010769955],"study_design_scores_gemma":[0.008059416,0.00014634721,0.9085829,0.00007119303,0.00005470845,0.000066842156,0.0005608398,0.00049574714,0.07269591,0.0003343475,0.008717025,0.00021470393],"about_ca_topic_score_codex":0.002278326,"about_ca_topic_score_gemma":0.00009928829,"teacher_disagreement_score":0.8202137,"about_ca_system_score_codex":0.0003108916,"about_ca_system_score_gemma":0.0009234753,"threshold_uncertainty_score":0.99609673},"labels":[],"label_agreement":null},{"id":"W4389244652","doi":"10.1158/2326-6074.tumimm23-a012","title":"Abstract A012: STING agonists drive intrinsic type I interferon responses in monocytes for optimal anti-tumor immunity","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Stimulator of interferon genes; Sting; Immunology; Interferon; Antigen; Antigen presentation; Biology; Immune system; Cancer research; Immunotherapy; Chemokine; Agonist; T cell; Innate immune system; Receptor","score_opus":0.1160784814119432,"score_gpt":0.41451720734726144,"score_spread":0.2984387259353182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793936,0.016418198,0.000011222259,0.000834411,0.0017513364,0.0009088335,0.00009221834,0.00021827765,0.00037188266],"genre_scores_gemma":[0.99044997,0.0025375306,0.000036978563,0.00007131726,0.000070698654,0.0005550386,0.00016417405,0.00007229424,0.006042008],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953774,0.0013565256,0.0007143047,0.00070068473,0.0001064409,0.0017446333],"domain_scores_gemma":[0.9953295,0.003093984,0.00015615446,0.0007413793,0.0006382969,0.00004070316],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028338332,0.00036380833,0.000699582,0.0015265181,0.0007059743,0.00007550995,0.0010417987,0.00050091196,0.0007966291],"category_scores_gemma":[0.0026150804,0.00035099633,0.00016036189,0.0013092514,0.0013475312,0.00021549428,0.0007804749,0.0020648274,0.0015953918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015995642,0.00018381939,0.0042060735,0.00009660289,0.00040678686,0.00006917763,0.0019069967,0.000038899474,0.9526983,0.00033182165,0.0050838417,0.018982047],"study_design_scores_gemma":[0.0042004352,0.002268914,0.29247686,0.00050442404,0.000024684037,0.00008101119,0.006830332,0.000053080024,0.65268224,0.00017365048,0.040122747,0.0005816002],"about_ca_topic_score_codex":0.0011815439,"about_ca_topic_score_gemma":0.00019872336,"teacher_disagreement_score":0.30001605,"about_ca_system_score_codex":0.00051416276,"about_ca_system_score_gemma":0.0008268621,"threshold_uncertainty_score":0.9998942},"labels":[],"label_agreement":null},{"id":"W4389244706","doi":"10.1158/2326-6074.tumimm23-b045","title":"Abstract B045: EV-mediated immune modulation of CD8+ T cells in renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Cancer research; Renal cell carcinoma; Flow cytometry; CD8; Immunotherapy; Cytotoxic T cell; Biology; Downregulation and upregulation; Cell culture; Immunology; Medicine; Chemistry; Pathology; In vitro","score_opus":0.03481382890091826,"score_gpt":0.3363016341544896,"score_spread":0.30148780525357133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903133,0.008092834,0.000009827486,0.0001462583,0.00019469355,0.0003168881,0.000077158846,0.000017376611,0.00083167484],"genre_scores_gemma":[0.9967648,0.0013793395,0.00003478579,0.000011714807,0.0000930922,0.00011745822,0.00032512104,0.000037479742,0.0012362463],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798733,0.00026636795,0.00040328634,0.00044706394,0.00028007853,0.0006158834],"domain_scores_gemma":[0.99883705,0.00009337707,0.00010241199,0.0006436526,0.00025323418,0.000070266964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094778644,0.00014725584,0.00020976551,0.00035504706,0.0000778158,0.000011254478,0.00048822144,0.00031867577,0.00015092245],"category_scores_gemma":[0.00016640456,0.0001590898,0.00008898523,0.00071405224,0.00042796935,0.000007895248,0.00025816675,0.0004362308,0.00012846138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003416162,0.00010612036,0.009291645,0.00006760745,0.000031743577,0.00003655323,0.00010825385,0.0005329307,0.9868142,0.00001058475,0.0011668775,0.0014918667],"study_design_scores_gemma":[0.0007950378,0.00012638341,0.24855497,0.000020257932,0.0000035388405,0.0000010204333,0.00013096044,0.00023785533,0.7487934,0.00007078758,0.001151525,0.00011423207],"about_ca_topic_score_codex":0.0003972458,"about_ca_topic_score_gemma":0.00006783405,"teacher_disagreement_score":0.23926334,"about_ca_system_score_codex":0.000081539845,"about_ca_system_score_gemma":0.00040602108,"threshold_uncertainty_score":0.6487494},"labels":[],"label_agreement":null},{"id":"W4389244746","doi":"10.1158/2326-6074.tumimm23-a052","title":"Abstract A052: Comprehensive EBV-specific T cell profiling and multi-omics analysis of nasopharyngeal carcinoma CD8 T cells reveals novel cancer-associated phenotype","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CD38; Antigen; Nasopharyngeal carcinoma; Biology; CD8; Immunology; Immune system; TIGIT; Cytotoxic T cell; Cancer research; Medicine; Internal medicine; Stem cell","score_opus":0.10563327961360386,"score_gpt":0.3765125474396494,"score_spread":0.27087926782604554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96569717,0.031258278,0.0000062538497,0.0005778405,0.00036722116,0.00083965785,0.0007598454,0.00008706582,0.00040663878],"genre_scores_gemma":[0.97774,0.020231143,0.00010557969,0.00012619174,0.00007661739,0.00020407692,0.00035796218,0.00006516306,0.0010932784],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967115,0.00019170924,0.0006438048,0.00075407187,0.0005938809,0.0011050472],"domain_scores_gemma":[0.9972667,0.0004842107,0.00032055352,0.00052122935,0.0012183212,0.00018897981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007785282,0.00030804865,0.0011445694,0.0011978907,0.00032318296,0.000033130524,0.00031134317,0.00045514747,0.00026135234],"category_scores_gemma":[0.00011644184,0.00030582334,0.00025303895,0.0037553855,0.0006866087,0.00009154848,0.00022994017,0.0010985767,0.00002928563],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010193435,0.00034106846,0.100822076,0.00025897712,0.0025932936,0.00005016193,0.0012292796,0.00062492565,0.8884593,0.000031185245,0.0024647983,0.002105588],"study_design_scores_gemma":[0.010231044,0.00050938025,0.885807,0.0001885594,0.00096671504,0.0000014137347,0.0045316303,0.0046154573,0.09192047,0.000039205315,0.0007398759,0.00044924635],"about_ca_topic_score_codex":0.0052094855,"about_ca_topic_score_gemma":0.00047212967,"teacher_disagreement_score":0.79653883,"about_ca_system_score_codex":0.000839954,"about_ca_system_score_gemma":0.0007908328,"threshold_uncertainty_score":0.9999394},"labels":[],"label_agreement":null},{"id":"W4389244749","doi":"10.1158/2326-6074.tumimm23-a027","title":"Abstract A027: Exploring autoantibody response to proteins encoded by prostate cancer driver genes","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"KEGG; Prostate cancer; Gene; Cancer; Biology; Computational biology; Autoantibody; Immunogenicity; Candidate gene; Genetics; Immune system; Transcriptome; Antibody; Gene expression","score_opus":0.15501005347750768,"score_gpt":0.44437593238393897,"score_spread":0.2893658789064313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540369,0.017213026,0.0000027414621,0.024067158,0.00051731995,0.0030302007,0.00025548134,0.00034439567,0.0005327992],"genre_scores_gemma":[0.87664384,0.041956272,0.00006785013,0.00016986468,0.00032492075,0.013499122,0.00014540581,0.00014307692,0.06704966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99502784,0.00043528693,0.00042751027,0.000969811,0.0011078718,0.0020316737],"domain_scores_gemma":[0.99742967,0.00039848397,0.000064334745,0.00081760157,0.0008428658,0.00044702884],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002071857,0.0003401231,0.00054918573,0.0011834833,0.00062072463,0.00009003541,0.000510598,0.00024060822,0.0012623136],"category_scores_gemma":[0.00036597074,0.00028007795,0.00012897258,0.0026429077,0.0006764468,0.00026955715,0.00051838584,0.0012367455,0.0013385791],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012759867,0.00016388259,0.019667946,0.00018719645,0.00048683365,0.00051243877,0.0025303136,0.00003049066,0.88636404,0.000013405503,0.025096074,0.052187525],"study_design_scores_gemma":[0.0047738515,0.0013971821,0.22446294,0.0007255016,0.000039775125,0.000016997728,0.0017113949,0.000057695783,0.5328733,0.00006781135,0.23343469,0.00043886644],"about_ca_topic_score_codex":0.002267885,"about_ca_topic_score_gemma":0.00011971766,"teacher_disagreement_score":0.35349074,"about_ca_system_score_codex":0.0013084452,"about_ca_system_score_gemma":0.0021561407,"threshold_uncertainty_score":0.99996513},"labels":[],"label_agreement":null},{"id":"W4389244753","doi":"10.1158/2326-6074.tumimm23-pr02","title":"Abstract PR02: Lyn kinase regulates myeloid-cell responses to mammary tumors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"LYN; Cancer research; Tumor microenvironment; Mammary tumor; Metastasis; Chemokine; Myeloid; Macrophage polarization; Biology; Src family kinase; Immunology; Medicine; Kinase; Macrophage; Cancer; Breast cancer; Immune system; Proto-oncogene tyrosine-protein kinase Src; Internal medicine; Cell biology","score_opus":0.07701884497399324,"score_gpt":0.39625133368253135,"score_spread":0.3192324887085381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782148,0.0051355045,0.0000039088695,0.013083465,0.00026328172,0.00055038754,0.00001677858,0.00020787449,0.0025240004],"genre_scores_gemma":[0.9592286,0.0018617356,0.00012253376,0.00028414465,0.00033706648,0.0002804815,0.000040619914,0.000057739613,0.037787125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997481,0.00017053277,0.00033174365,0.0005345713,0.00050376117,0.0009784035],"domain_scores_gemma":[0.99804485,0.0006046508,0.000045106874,0.00066526775,0.00040327932,0.00023682075],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0014451894,0.00018868555,0.0003937905,0.0008520256,0.00025664424,0.000044460558,0.00037345864,0.0002131643,0.001038038],"category_scores_gemma":[0.00063615973,0.00016863794,0.000110676825,0.0016148173,0.00027737187,0.00010430069,0.00038375283,0.0008724261,0.000950487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015832526,0.00009402935,0.00650568,0.00017957402,0.00009883589,0.0005574416,0.0004913427,0.000012347726,0.9306317,0.00009138439,0.040193114,0.01956132],"study_design_scores_gemma":[0.0015501406,0.00051834557,0.182927,0.00043510742,0.000016643335,0.00005611151,0.0007625867,0.000053663367,0.73657167,0.00026842058,0.07657835,0.00026196477],"about_ca_topic_score_codex":0.00035284017,"about_ca_topic_score_gemma":0.000011305812,"teacher_disagreement_score":0.19406001,"about_ca_system_score_codex":0.000330299,"about_ca_system_score_gemma":0.00082693825,"threshold_uncertainty_score":0.9998751},"labels":[],"label_agreement":null},{"id":"W4389244767","doi":"10.1158/2326-6074.tumimm23-b017","title":"Abstract B017: Single-cell proteogenomic profiling reveals immune cell networks in renal cell carcinoma","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital; Sinai Health System; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Clear cell renal cell carcinoma; Immune system; Stromal cell; Myeloid; T cell; CD8; Cancer research; Cell; Flow cytometry; Renal cell carcinoma; Biology; Phenotype; Medicine; Immunology; Pathology; Genetics","score_opus":0.05663824027177373,"score_gpt":0.3094583303966602,"score_spread":0.2528200901248865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778806,0.016984114,0.000056736073,0.00016774483,0.00047972807,0.0009405862,0.000032570573,0.000041390584,0.003416539],"genre_scores_gemma":[0.99257374,0.0021537372,0.00014018327,0.0000470114,0.00039759895,0.0004010914,0.00025879397,0.00009440023,0.003933445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965588,0.0003553417,0.0005868641,0.0008521382,0.00026427288,0.0013826197],"domain_scores_gemma":[0.99866736,0.00009115277,0.00013162679,0.0007544159,0.00024053977,0.00011492947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013453212,0.00031325122,0.00038440406,0.00035331474,0.00027200932,0.00006761111,0.00078425964,0.00062508724,0.000081968545],"category_scores_gemma":[0.00005622746,0.00032701442,0.00015751175,0.0007049495,0.00033133794,0.0000124946655,0.0003536816,0.0011498744,0.00010691894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056761823,0.0002298571,0.015261883,0.00014002429,0.000025660986,0.000057046218,0.00013100095,0.0010135389,0.9805222,0.0000046794357,0.0008158553,0.001230592],"study_design_scores_gemma":[0.0018278932,0.0005449368,0.022099469,0.000050912357,0.000009026326,0.0000054086254,0.00021798286,0.00030293822,0.97199607,0.000040051356,0.002545294,0.00036001048],"about_ca_topic_score_codex":0.0006203053,"about_ca_topic_score_gemma":0.00012109355,"teacher_disagreement_score":0.014830377,"about_ca_system_score_codex":0.0001929076,"about_ca_system_score_gemma":0.0004583828,"threshold_uncertainty_score":0.99991816},"labels":[],"label_agreement":null},{"id":"W4389244788","doi":"10.1158/2326-6074.tumimm23-a021","title":"Abstract A021: Nutrient competition in the tumor microenvironment alters NK cell metabolism in Pancreatic Cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glycogen; Tumor microenvironment; Pancreatic cancer; Biology; Cancer research; Cytotoxic T cell; Cell culture; Cancer cell; Organoid; Cell biology; Immune system; Endocrinology; Internal medicine; Cancer; Immunology; Biochemistry; In vitro; Medicine","score_opus":0.029300270878236865,"score_gpt":0.32090771148354424,"score_spread":0.29160744060530736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93162644,0.06502529,0.000004146338,0.0013171191,0.0008476451,0.0006239749,0.00006975043,0.000010505183,0.00047510196],"genre_scores_gemma":[0.9021418,0.094552204,0.000012326837,0.00037815905,0.0006473524,0.0014383795,0.00010964747,0.00003152918,0.0006885722],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974939,0.0004237548,0.00033680847,0.00055132696,0.0003256517,0.0008685087],"domain_scores_gemma":[0.9991683,0.000078340956,0.000074861426,0.0005569315,0.00006325471,0.000058319652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001154597,0.00020004594,0.00029435748,0.0003122893,0.00014082223,0.000033268054,0.000558662,0.00015916406,0.00019199168],"category_scores_gemma":[0.000047171437,0.00016793748,0.00009143254,0.00064310693,0.00041181667,0.000009398938,0.00022116688,0.0006168923,0.00007988323],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003257683,0.00015488606,0.0036164918,0.000071669005,0.00005627342,0.000021230651,0.00068060105,0.00027189232,0.9858448,0.00012094154,0.0062656533,0.0025697756],"study_design_scores_gemma":[0.002534466,0.00011085248,0.37695482,0.00010516734,0.000023682715,0.00001052762,0.0019763208,0.000025709052,0.20523745,0.00020048257,0.412522,0.0002985474],"about_ca_topic_score_codex":0.0026896708,"about_ca_topic_score_gemma":0.0015322851,"teacher_disagreement_score":0.78060734,"about_ca_system_score_codex":0.00016631627,"about_ca_system_score_gemma":0.0003090192,"threshold_uncertainty_score":0.6848292},"labels":[],"label_agreement":null},{"id":"W4389244809","doi":"10.1158/2326-6074.tumimm23-a038","title":"Abstract A038: Targeting TCTP overcomes resistance to T cell-mediated immunotherapy by reversing the multi-malignant phenotypes of immune-refractory tumor cells","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Immune checkpoint; Immune system; Medicine; Cancer research; Cancer; Targeted therapy; Immunology; Cancer immunotherapy; Internal medicine","score_opus":0.03711075864348952,"score_gpt":0.34290584805681174,"score_spread":0.30579508941332223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389244809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8721833,0.12179436,0.000009981343,0.0032110412,0.00069602573,0.0012232987,0.00015240093,0.00013825945,0.00059130014],"genre_scores_gemma":[0.9555688,0.03130466,0.00016438734,0.00034266897,0.0002679518,0.00035215533,0.00009700247,0.0001459957,0.0117564015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956076,0.0006239627,0.0009151549,0.0006766025,0.0008262106,0.0013504605],"domain_scores_gemma":[0.9959465,0.0018110882,0.00032364894,0.0011409543,0.0006298126,0.00014797453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026370105,0.00037695802,0.0008461614,0.0005966775,0.00069001014,0.000052503794,0.0008531502,0.00025164615,0.0006024745],"category_scores_gemma":[0.00064728066,0.0002935895,0.00028306598,0.0016991061,0.0010492564,0.00015271053,0.00023322513,0.0012823041,0.00030522546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052366927,0.00024069355,0.0010119266,0.0002914869,0.00026700273,0.00007281505,0.0024446724,0.000025624297,0.94899344,0.000006856963,0.03795107,0.0034577118],"study_design_scores_gemma":[0.003482967,0.00046185334,0.054715294,0.0008793473,0.000042017855,0.00001052247,0.0049218605,0.00004480132,0.5717052,0.00001107533,0.363325,0.00040005724],"about_ca_topic_score_codex":0.0024775171,"about_ca_topic_score_gemma":0.000098293436,"teacher_disagreement_score":0.37728825,"about_ca_system_score_codex":0.0005674578,"about_ca_system_score_gemma":0.00093001215,"threshold_uncertainty_score":0.9999516},"labels":[],"label_agreement":null},{"id":"W4389261506","doi":"10.1158/2326-6074.tumimm23-a042","title":"Abstract A042: Quantitative multiplex immunoprecipitation reveals distinct protein interaction networks responsible for discrepant <i>in vivo</i> activity exhibited by two second generation CD22-targeted chimeric antigen receptors","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Multiplex; CD19; Antigen; CD22; Immunoprecipitation; In vivo; Cancer research; MUC1; CD28; Immunotherapy; Biology; Computational biology; Immunology; Antibody; CD8; Immune system; Bioinformatics; Genetics","score_opus":0.11106423132623436,"score_gpt":0.43683583407814675,"score_spread":0.3257716027519124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389261506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881656,0.0025229384,0.00032928988,0.0016390098,0.0006658119,0.00530167,0.00020901632,0.00016370375,0.0003519858],"genre_scores_gemma":[0.97797054,0.0016668214,0.00033300216,0.00004118009,0.00030010444,0.00408584,0.0010211311,0.00012821233,0.014453168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99469167,0.001476562,0.0007389008,0.0010326419,0.0006886273,0.0013715758],"domain_scores_gemma":[0.99623215,0.0017344463,0.00027375473,0.0007068482,0.0008928865,0.00015993825],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004265106,0.0003682373,0.00070456055,0.0012371814,0.00051997876,0.00011124898,0.00032496912,0.00037013492,0.0031528969],"category_scores_gemma":[0.0016082346,0.0003577913,0.00019383169,0.002689562,0.000504785,0.0004916971,0.00017297831,0.0016668495,0.0000769973],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014131821,0.00028622992,0.0029564397,0.00011505672,0.0003521903,0.00001854073,0.00082387007,0.00022578269,0.94881105,0.000032541,0.011908245,0.0203382],"study_design_scores_gemma":[0.007304095,0.0019105971,0.12708667,0.0005086805,0.000027692675,0.000010055107,0.001299526,0.02242594,0.81415683,0.00012822266,0.024585297,0.0005563868],"about_ca_topic_score_codex":0.0029082068,"about_ca_topic_score_gemma":0.0027898971,"teacher_disagreement_score":0.13465425,"about_ca_system_score_codex":0.0012664214,"about_ca_system_score_gemma":0.00076870417,"threshold_uncertainty_score":0.9998874},"labels":[],"label_agreement":null},{"id":"W4389261533","doi":"10.1158/2326-6074.tumimm23-b037","title":"Abstract B037: Single-cell analysis reveals immune characteristics linked to poor prognosis in <i>Fusobacterium nucleatum</i>-infected colorectal cancer","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fusobacterium nucleatum; Immune system; Transcriptome; Colorectal cancer; Biology; Cancer research; Cell; Cancer; Immunology; Gene expression; Gene; Genetics","score_opus":0.04287220124879889,"score_gpt":0.356041591496834,"score_spread":0.31316939024803514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389261533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942663,0.0017182474,0.0000025391346,0.0019795299,0.000459183,0.00085921586,0.00033468884,0.00006220029,0.00031814937],"genre_scores_gemma":[0.9925341,0.003987992,0.00004049835,0.00021879676,0.00024516034,0.0007144009,0.0006902625,0.00006947116,0.0014993078],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99651587,0.00035739812,0.000631109,0.0008637186,0.00024358151,0.0013883039],"domain_scores_gemma":[0.99853677,0.00009514253,0.00015615825,0.00045719344,0.0005676622,0.00018709718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010169898,0.0003004181,0.00062063686,0.00093376124,0.00024569497,0.00007604998,0.0005988654,0.00054953655,0.0003559897],"category_scores_gemma":[0.00023404004,0.00031084445,0.00019428102,0.0030266463,0.00026960383,0.000010863641,0.00051164953,0.0007817875,0.00021661779],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005646889,0.00022547552,0.08248444,0.00009099177,0.0003975835,0.000029890338,0.00027149328,0.00001738214,0.9108744,0.000002813909,0.0031148738,0.001925954],"study_design_scores_gemma":[0.0007141249,0.00046996318,0.80335623,0.00006573619,0.000055258428,0.000003336278,0.00012778112,0.000016231208,0.18785746,0.0000041948033,0.007042201,0.00028745492],"about_ca_topic_score_codex":0.001562955,"about_ca_topic_score_gemma":0.0015956761,"teacher_disagreement_score":0.723017,"about_ca_system_score_codex":0.00039747354,"about_ca_system_score_gemma":0.0006423508,"threshold_uncertainty_score":0.9999344},"labels":[],"label_agreement":null},{"id":"W4389892676","doi":"10.1158/2326-6066.cir-23-0498","title":"Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation","year":2023,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Legend Biotech; Juno Therapeutics; Genentech; National Institutes of Health; National Cancer Institute; Natera; Regeneron Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; Amgen; Society of Memorial Sloan Kettering; Seres Therapeutics; Da Volterra; BeiGene; Cycle for Survival; Daiichi Sankyo Europe; Sanofi; Eli Lilly and Company; AstraZeneca; National Institute on Aging; Parker Institute for Cancer Immunotherapy","keywords":"Dysbiosis; Fecal bacteriotherapy; Microbiome; Medicine; Feces; Gut flora; Context (archaeology); Colitis; Transplantation; Immunology; Internal medicine; Inflammatory bowel disease; Gastroenterology; Antibiotics; Clostridium difficile; Disease; Biology; Microbiology; Bioinformatics","score_opus":0.03188858580801742,"score_gpt":0.3309719139326852,"score_spread":0.2990833281246678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389892676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97387826,0.006195221,0.0000012047851,0.017222844,0.00023702248,0.00086826616,0.0011676194,0.00017947718,0.00025007004],"genre_scores_gemma":[0.9785977,0.01214756,0.0000091971615,0.000740262,0.000037427842,0.00020097349,0.001485463,0.00007507454,0.00670634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99704343,0.00041863142,0.0004703349,0.00063585164,0.0003812058,0.0010505558],"domain_scores_gemma":[0.99873316,0.00027833358,0.000107504864,0.00034250706,0.00039291376,0.00014559079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008447147,0.00029188648,0.0005436067,0.00045469607,0.0004821759,0.00006522509,0.00021895253,0.00055291306,0.0006967626],"category_scores_gemma":[0.000065425615,0.00025986534,0.00011761852,0.0018121599,0.0016355449,0.00008208972,0.0000699822,0.00096787594,0.000029462062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064815357,0.00012182679,0.0057923137,0.00010299489,0.0017699191,0.00018655184,0.0020107934,3.1396766e-7,0.9494367,0.000010370038,0.030194113,0.003892551],"study_design_scores_gemma":[0.023382748,0.0022889022,0.34469315,0.0012666732,0.00034959966,0.00065750704,0.0011817536,0.00006991643,0.60958856,0.000031083666,0.01580206,0.0006880681],"about_ca_topic_score_codex":0.004160872,"about_ca_topic_score_gemma":0.0008277658,"teacher_disagreement_score":0.33984816,"about_ca_system_score_codex":0.00060879823,"about_ca_system_score_gemma":0.00063829665,"threshold_uncertainty_score":0.99998534},"labels":[],"label_agreement":null},{"id":"W4390706751","doi":"10.1158/2326-6066.cir-23-0480","title":"Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell–Based Immunotherapies","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"University of Pittsburgh; Leids Universitair Medisch Centrum; National Institutes of Health; Universiteit Leiden; Istituto Pasteur-Fondazione Cenci Bolognetti; Oncolytics Biotech","keywords":"Oncolytic virus; Medicine; Immunotherapy; Antibody; Cancer immunotherapy; Regimen; Cancer; Neutralizing antibody; Cancer research; Immunology; Internal medicine","score_opus":0.031371503910255456,"score_gpt":0.37407636577103637,"score_spread":0.3427048618607809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390706751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9337403,0.06333292,0.00006600392,0.0010351297,0.00015628138,0.0010796994,0.000031067906,0.000035244822,0.0005233264],"genre_scores_gemma":[0.9949661,0.0031756659,0.000023695578,0.000071679984,0.000119727585,0.00052449165,0.00003698921,0.00006851536,0.0010131634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99708027,0.0010189291,0.0002559951,0.0005371808,0.0004481384,0.00065947074],"domain_scores_gemma":[0.99807245,0.00056424155,0.000063335836,0.0007473161,0.00050483254,0.000047808167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014904741,0.00023257188,0.0002706089,0.00030352556,0.0003642942,0.00008748946,0.000664755,0.00020951565,0.0000653146],"category_scores_gemma":[0.00009138232,0.0001586132,0.00013791287,0.0006530733,0.001573919,0.0000128744905,0.00017764793,0.0007360345,0.000026169982],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068454975,0.00017771446,0.0015302756,0.00015945095,0.0005506841,0.000016149843,0.00056198786,0.00028165043,0.971502,0.00007587943,0.0003704164,0.017928308],"study_design_scores_gemma":[0.001985511,0.0074240267,0.008058651,0.00016999483,0.000029221477,0.0000107631795,0.0005063633,0.00024384074,0.9776535,0.000060556777,0.0036592074,0.00019836728],"about_ca_topic_score_codex":0.0004129457,"about_ca_topic_score_gemma":0.00022349959,"teacher_disagreement_score":0.061225746,"about_ca_system_score_codex":0.00016470846,"about_ca_system_score_gemma":0.0009647502,"threshold_uncertainty_score":0.6468058},"labels":[],"label_agreement":null},{"id":"W4400002746","doi":"10.1158/2326-6066.cir-23-1114","title":"Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université Laval; Queen's University","funders":"Canada Foundation for Innovation; Bladder Cancer Canada; Cancer Research Society","keywords":"Bladder cancer; Immune system; Immunotherapy; Cancer; Medicine; Tumor microenvironment; Inflammation; Immunology; Cancer research; Cancer immunotherapy; Internal medicine","score_opus":0.05586856429779632,"score_gpt":0.4219470691131157,"score_spread":0.3660785048153194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400002746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9255578,0.04771117,0.000006820473,0.023105215,0.00077491935,0.0022839392,0.00016986621,0.000079583486,0.00031068482],"genre_scores_gemma":[0.9783573,0.00886961,0.0001258954,0.00073796575,0.00037418172,0.004482488,0.000010644332,0.000095726165,0.0069461614],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99627817,0.0004865482,0.0004025963,0.0010618021,0.0006107763,0.001160129],"domain_scores_gemma":[0.9984182,0.00037687918,0.00003578612,0.0004789294,0.00033416785,0.00035601904],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009158436,0.0003443511,0.0005748648,0.0007691885,0.00020001616,0.00008666855,0.00026543715,0.000374397,0.0015105002],"category_scores_gemma":[0.00018255586,0.00027361626,0.00008997704,0.0013538682,0.0005638746,0.00014817118,0.0003737946,0.0013356891,0.00018132817],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01435418,0.00028377262,0.009183605,0.00043072633,0.0006020513,0.0011306762,0.0039932136,0.000015006179,0.67675567,0.00001851341,0.0100874975,0.2831451],"study_design_scores_gemma":[0.009180065,0.0050010122,0.4357409,0.0054204324,0.0002662281,0.00011070425,0.000922686,0.00036625733,0.3877034,0.00017462959,0.15427105,0.00084265636],"about_ca_topic_score_codex":0.004739685,"about_ca_topic_score_gemma":0.0027465594,"teacher_disagreement_score":0.42655727,"about_ca_system_score_codex":0.0014428485,"about_ca_system_score_gemma":0.002743492,"threshold_uncertainty_score":0.9999716},"labels":[],"label_agreement":null},{"id":"W4401879340","doi":"10.1158/2326-6066.cir-24-0463","title":"Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; Ludwig Center at Harvard; Fondation pour la Recherche Médicale; Glenn Foundation for Medical Research; Canadian Institutes of Health Research; American Cancer Society","keywords":"Immune system; Immunotherapy; CD8; Immunology; Cytotoxic T cell; Antigen; T cell; Cancer; Medicine; Immunity; Cancer research; Biology; Internal medicine","score_opus":0.05197326157117774,"score_gpt":0.34573866911676804,"score_spread":0.29376540754559033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401879340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9065656,0.06943396,0.000056879773,0.00045184727,0.01596582,0.00049778994,0.00004246491,0.00021586966,0.0067697596],"genre_scores_gemma":[0.9669539,0.005552711,0.000004945767,0.000043659176,0.00006627305,0.000120481316,0.00016031775,0.000041655963,0.027056074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99688697,0.0011852584,0.0005768654,0.00046757312,0.000117371455,0.00076594925],"domain_scores_gemma":[0.9979307,0.00086361094,0.00013467055,0.00050756644,0.000537671,0.000025804082],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001392836,0.00023221655,0.0004574133,0.0007126825,0.00043468058,0.000064240754,0.0004154606,0.00039928223,0.009370799],"category_scores_gemma":[0.00020012121,0.00021509263,0.00021212088,0.0008601206,0.0010823242,0.00029471505,0.00016433137,0.0022076096,0.0024763541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006157645,0.00022828345,0.00025419373,0.0000517873,0.0006239141,0.000035338286,0.0004817542,0.0000063833927,0.9313143,0.00086692465,0.060731415,0.0047899536],"study_design_scores_gemma":[0.0009379236,0.00046958058,0.0074466667,0.0002323689,0.00003064771,0.00007847419,0.001083138,0.000020166171,0.62888515,0.000102423786,0.3605185,0.00019494038],"about_ca_topic_score_codex":0.0014741613,"about_ca_topic_score_gemma":0.00007174315,"teacher_disagreement_score":0.3024291,"about_ca_system_score_codex":0.0005021681,"about_ca_system_score_gemma":0.0003267345,"threshold_uncertainty_score":0.9983003},"labels":[],"label_agreement":null},{"id":"W4403222422","doi":"10.1158/2326-6066.cir-23-0639","title":"Level of Expression of MHCI-Presented Neoepitopes Influences Tumor Rejection by Neoantigen-Specific CD8+ T Cells","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research - Antimicrobial Resistance Research Initiative; Terry Fox Research Institute; Canadian Cancer Society","keywords":"Immunogenicity; CD8; Cancer immunotherapy; Immunotherapy; T cell; Cancer; Cytotoxic T cell; Antigen; Cancer research; Biology; Immunology; T-cell receptor; Immune system; In vitro; Genetics","score_opus":0.10180865058364161,"score_gpt":0.3742992026682734,"score_spread":0.2724905520846318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403222422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68961686,0.30709073,0.00012511441,0.00029214408,0.0019468969,0.00036431433,0.00021834919,0.00006518084,0.0002803873],"genre_scores_gemma":[0.9580073,0.031140957,0.000040004168,0.00002179191,0.000049981038,0.00015021577,0.00006162138,0.000048274673,0.010479856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961248,0.001509517,0.000790246,0.00058923487,0.00018830725,0.00079791504],"domain_scores_gemma":[0.99754214,0.001041812,0.00018959417,0.00070623157,0.00049730303,0.00002292974],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012209127,0.00028385298,0.00060786295,0.0007926207,0.0003394626,0.000036282123,0.0008446535,0.00045521586,0.0021518108],"category_scores_gemma":[0.00013332548,0.00023897843,0.00020314661,0.0010249631,0.0022685137,0.0002785608,0.0002972065,0.0011783317,0.0003026843],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022687055,0.00016683927,0.0003508708,0.00013745671,0.00042222894,0.000008697515,0.001100963,0.000007499377,0.94243366,0.00021627868,0.03657444,0.016312372],"study_design_scores_gemma":[0.00070251175,0.00047596483,0.0019818882,0.0004583079,0.000013009923,0.000030444813,0.00083982863,0.0000029402497,0.7610518,0.00009922952,0.23418237,0.00016170088],"about_ca_topic_score_codex":0.0013491216,"about_ca_topic_score_gemma":0.000012229467,"teacher_disagreement_score":0.27594978,"about_ca_system_score_codex":0.00012000712,"about_ca_system_score_gemma":0.00045527596,"threshold_uncertainty_score":0.99876034},"labels":[],"label_agreement":null},{"id":"W4403429512","doi":"10.1158/2326-6066.cir-24-0138","title":"Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Cancer research; Immunotherapy; Antigen; Chimeric antigen receptor; Cytotoxicity; Immunology; Cytotoxic T cell; In vivo; Medicine; In vitro; Chemistry; Immune system; Biology; Biochemistry","score_opus":0.09737323653413922,"score_gpt":0.4412458670481349,"score_spread":0.3438726305139957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403429512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97826976,0.015383852,0.0004510341,0.0009902939,0.00053088827,0.001628835,0.000048060087,0.000103253384,0.0025940405],"genre_scores_gemma":[0.976228,0.0017764741,0.0022968603,0.00007801323,0.00033426718,0.00062540936,0.000046519926,0.000113716276,0.018500755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957147,0.00037811013,0.0008131752,0.00082076143,0.0010033025,0.0012699048],"domain_scores_gemma":[0.9970893,0.0010692844,0.00005400367,0.0005832866,0.00089273346,0.00031135388],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028346914,0.00027026556,0.0007071926,0.00082277565,0.00018057328,0.000055737106,0.0005364447,0.00031135604,0.0061131297],"category_scores_gemma":[0.00034100958,0.00024617038,0.00016603705,0.0011822646,0.0005294217,0.000077876604,0.0005682781,0.0017847499,0.0004126174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015445728,0.00022546393,0.0008906733,0.00040965807,0.0005265738,0.00016958122,0.0047112578,0.000055795,0.96254015,0.00001742195,0.011230249,0.017678618],"study_design_scores_gemma":[0.0010988519,0.0006899903,0.003786754,0.0008420872,0.000019296915,0.000015168372,0.00084758323,0.0006302129,0.94540703,0.000016671704,0.046421837,0.00022453813],"about_ca_topic_score_codex":0.00018147787,"about_ca_topic_score_gemma":0.000012692936,"teacher_disagreement_score":0.035191588,"about_ca_system_score_codex":0.0007041617,"about_ca_system_score_gemma":0.0025910607,"threshold_uncertainty_score":0.99999905},"labels":[],"label_agreement":null},{"id":"W4403519928","doi":"10.1158/2326-6074.tumimm24-a038","title":"Abstract A038: Antigen Presentation By Cancer-Associated Fibroblasts","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Université de Montréal; Institute for Research in Immunology and Cancer","funders":"","keywords":"Medicine; Cancer; Antigen; Cancer immunotherapy; Presentation (obstetrics); Antigen presentation; Immunology; Immunotherapy; Cancer research; Immune system; Internal medicine; T cell; Surgery","score_opus":0.11191344090386023,"score_gpt":0.48049826228805137,"score_spread":0.36858482138419113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403519928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83150303,0.1437456,0.00001425577,0.018885925,0.00094563834,0.000360651,0.00008928813,0.00019618055,0.0042594466],"genre_scores_gemma":[0.96756864,0.018164493,0.000018827184,0.0003706917,0.00030047935,0.00036582898,0.00008593473,0.000035820227,0.013089316],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99797565,0.00020413812,0.00025288755,0.00045342912,0.00042847835,0.00068544794],"domain_scores_gemma":[0.99882317,0.000479119,0.000032488784,0.00024063277,0.00031096907,0.00011364837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008228324,0.00014604104,0.00031407288,0.0002430123,0.00023911215,0.00003666102,0.00016330433,0.00023598729,0.0011194599],"category_scores_gemma":[0.0005310252,0.000119732715,0.00007232685,0.0005867994,0.0009505235,0.000085220156,0.00010938501,0.0012547352,0.00022329345],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026014686,0.00016598347,0.06752307,0.00035036178,0.0012615542,0.0003753625,0.00151908,0.0000024755084,0.23270866,0.000061070554,0.6313504,0.06442183],"study_design_scores_gemma":[0.0027490507,0.000781526,0.58121616,0.0029496567,0.00017430671,0.00009268354,0.0011875929,0.00057507335,0.050866675,0.0005947027,0.3583513,0.0004612808],"about_ca_topic_score_codex":0.0023148898,"about_ca_topic_score_gemma":0.00013955572,"teacher_disagreement_score":0.5136931,"about_ca_system_score_codex":0.00030300333,"about_ca_system_score_gemma":0.0005651007,"threshold_uncertainty_score":0.99979365},"labels":[],"label_agreement":null},{"id":"W4403519959","doi":"10.1158/2326-6074.tumimm24-b028","title":"Abstract B028: Claudin-18 expression (using the 43-14A antibody kit) in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for immunotherapy with zolbetuximab","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Immunotherapy; Pancreatic ductal adenocarcinoma; Biomarker; Medicine; Claudin; Adenocarcinoma; Antibody; Immunology; Cancer research; Cancer; Pancreatic cancer; Immune system; Internal medicine; Biology; Tight junction","score_opus":0.13943216474690143,"score_gpt":0.5130102213733195,"score_spread":0.3735780566264181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403519959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96180385,0.03218602,0.0011274474,0.0019342417,0.00033939056,0.002170236,0.0000329055,0.000036763893,0.00036915863],"genre_scores_gemma":[0.99270064,0.0046920795,0.0012240442,0.00004224725,0.000210961,0.00044192123,0.00005072186,0.00009666536,0.000540731],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9954483,0.00078012724,0.0008824991,0.00082914805,0.0010381638,0.0010217509],"domain_scores_gemma":[0.9968546,0.0013424504,0.00012852812,0.00091413903,0.0006407156,0.00011955618],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003656249,0.0002808,0.0007566059,0.00061702245,0.00024988002,0.00008334499,0.00054928986,0.00036275707,0.0009170184],"category_scores_gemma":[0.00024444202,0.00017750385,0.00027195908,0.0011534657,0.0016181222,0.00012913207,0.00031119294,0.0019503165,0.000012923031],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054638837,0.0004991828,0.11484487,0.00050513085,0.0007162454,0.000455747,0.0001877219,0.0000149009065,0.86871475,0.000050462575,0.0007205965,0.007826492],"study_design_scores_gemma":[0.006928787,0.0018576315,0.95327723,0.001729328,0.00010990185,0.00025700225,0.0009343911,0.007082462,0.025815714,0.00011676338,0.0016420198,0.00024879145],"about_ca_topic_score_codex":0.00065947964,"about_ca_topic_score_gemma":0.00003186877,"teacher_disagreement_score":0.842899,"about_ca_system_score_codex":0.000560199,"about_ca_system_score_gemma":0.0023630066,"threshold_uncertainty_score":0.9999963},"labels":[],"label_agreement":null},{"id":"W4403520007","doi":"10.1158/2326-6074.tumimm24-a049","title":"Abstract A049: NKG2D and NKp30 activating receptors drive allogeneic natural killer cell responsiveness against pancreatic cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"NKG2D; Medicine; Receptor; Pancreatic cancer; Immunotherapy; Immunology; Natural killer cell; Cancer; Immune system; Cancer research; Cytotoxic T cell; Biology; Internal medicine","score_opus":0.033934821150558694,"score_gpt":0.34384930452207874,"score_spread":0.30991448337152006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7997468,0.1799359,0.0000063737093,0.001867709,0.015780043,0.00042882902,0.000010381328,0.00015928737,0.002064654],"genre_scores_gemma":[0.9022731,0.019921843,0.000012263556,0.00019819039,0.00017865215,0.00043249183,0.00011329262,0.00006648536,0.07680368],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99675936,0.0008219473,0.0004711173,0.0008280442,0.00012814868,0.0009914126],"domain_scores_gemma":[0.9978476,0.0011951154,0.00011154431,0.0004254302,0.00037444168,0.000045837205],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000886861,0.00035100142,0.00044872655,0.000559394,0.0007301866,0.00011963876,0.00035941033,0.00057075714,0.0044318894],"category_scores_gemma":[0.00025214715,0.00030602005,0.00013795967,0.00062238093,0.00086056336,0.0003723613,0.000283105,0.0025263778,0.0008179705],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010843881,0.0000591775,0.0012920513,0.00014349697,0.0006615636,0.00002361131,0.001118702,0.000016455368,0.9141076,0.00010473028,0.03107554,0.050312687],"study_design_scores_gemma":[0.0010774743,0.00022257662,0.022311533,0.0006073756,0.000047372923,0.000053961896,0.002282642,0.000040655006,0.4179843,0.000048073394,0.55488855,0.0004354881],"about_ca_topic_score_codex":0.0009967483,"about_ca_topic_score_gemma":0.000092672926,"teacher_disagreement_score":0.523813,"about_ca_system_score_codex":0.00061905646,"about_ca_system_score_gemma":0.00058207347,"threshold_uncertainty_score":0.99996},"labels":[],"label_agreement":null},{"id":"W4403520012","doi":"10.1158/2326-6074.tumimm24-b007","title":"Abstract B007: Upregulation of PD-L1 as a mechanism of resistance to CD47 inhibition in non-small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Downregulation and upregulation; Mechanism (biology); Cancer; PD-L1; CD47; Cancer research; Medicine; Lung cancer; Acquired resistance; Immunotherapy; Immunology; Immune system; Biology; Oncology; Internal medicine; Biochemistry","score_opus":0.031904079087619795,"score_gpt":0.3501959446331875,"score_spread":0.3182918655455677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9331588,0.0625939,0.00017722494,0.0006710707,0.00075993483,0.0008282498,0.0000766093,0.000031537977,0.0017026622],"genre_scores_gemma":[0.9929706,0.002401281,0.000035688987,0.000022951888,0.00004169234,0.000440566,0.0000640424,0.000035417146,0.0039877985],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977001,0.00033281685,0.0006992441,0.0005222973,0.0001363943,0.0006091706],"domain_scores_gemma":[0.9986894,0.00028437347,0.0001535164,0.00044104224,0.0004055155,0.000026159698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011626858,0.0002048428,0.00047375515,0.0008966645,0.00011587332,0.000018659604,0.00026672287,0.00047948735,0.0009106331],"category_scores_gemma":[0.00007903611,0.00020225774,0.00011786332,0.0010447801,0.00032921258,0.00018432955,0.00018698444,0.0007271039,0.000092676586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008714584,0.000118556076,0.0006171336,0.0004968284,0.00016841164,0.000007959186,0.0019358889,0.00016843813,0.987439,0.0030475445,0.0014419742,0.003686844],"study_design_scores_gemma":[0.0010635074,0.00018695423,0.063293986,0.0014645291,0.000028681497,0.0000049921173,0.00038884667,0.000086447486,0.9302771,0.0011258491,0.0018985862,0.00018050782],"about_ca_topic_score_codex":0.0024132272,"about_ca_topic_score_gemma":0.0008466826,"teacher_disagreement_score":0.062676854,"about_ca_system_score_codex":0.00046715853,"about_ca_system_score_gemma":0.0006039555,"threshold_uncertainty_score":0.99707943},"labels":[],"label_agreement":null},{"id":"W4403520103","doi":"10.1158/2326-6074.tumimm24-b032","title":"Abstract B032: Novel immunotherapy approach for metastatic triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Triple-negative breast cancer; Immunotherapy; Medicine; Breast cancer; Cancer immunotherapy; Cancer; Metastatic breast cancer; Oncology; Internal medicine; Cancer research","score_opus":0.08897110372185572,"score_gpt":0.3986291801122491,"score_spread":0.3096580763903934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520103","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1855259,0.78163373,0.0062248637,0.0060017845,0.007821952,0.005293919,0.0043406608,0.0007371427,0.0024200585],"genre_scores_gemma":[0.9150615,0.033440176,0.0008311768,0.00039428336,0.00035658313,0.008933231,0.0003978264,0.00030362443,0.04028165],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99521863,0.0007387039,0.00081418594,0.0011526527,0.00019877357,0.0018770742],"domain_scores_gemma":[0.9959821,0.0022347195,0.000150896,0.00087220425,0.0007128044,0.000047250047],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024293596,0.0005933652,0.0008960451,0.0009984116,0.0010469889,0.0002010318,0.0011857117,0.0006205185,0.005008688],"category_scores_gemma":[0.00019747973,0.00049444684,0.0004807276,0.0012181484,0.0020512058,0.00046111233,0.00018858786,0.0021352763,0.00039411357],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074843597,0.0005126057,0.000073625546,0.00026689036,0.0050878106,0.000008840156,0.0018586541,0.000031076474,0.85755795,0.0022679695,0.011392265,0.11345795],"study_design_scores_gemma":[0.01893806,0.0014272743,0.026922708,0.0010456713,0.00030670228,0.0008821784,0.004646676,0.00037167952,0.4422433,0.0016800086,0.4995341,0.002001609],"about_ca_topic_score_codex":0.0023880491,"about_ca_topic_score_gemma":0.00004307076,"teacher_disagreement_score":0.74819356,"about_ca_system_score_codex":0.0006288452,"about_ca_system_score_gemma":0.001602811,"threshold_uncertainty_score":0.99975073},"labels":[],"label_agreement":null},{"id":"W4403520141","doi":"10.1158/2326-6074.tumimm24-pr-07","title":"Abstract PR-07: Optimally designed mRNA vaccine encoding tumor-specific antigens identified in a colorectal cancer model leads to complete tumor rejection in mice","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Colorectal cancer; Medicine; Antigen; Cancer; Messenger RNA; Cancer immunotherapy; Immunology; Immunotherapy; Cancer research; Gene; Immune system; Biology; Genetics; Internal medicine","score_opus":0.06872976233229297,"score_gpt":0.38325896576257934,"score_spread":0.31452920343028634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769748,0.020241603,0.00007493478,0.0005858567,0.000394799,0.0010205398,0.00013748079,0.000029797684,0.0005402026],"genre_scores_gemma":[0.99237394,0.005203684,0.00014103118,0.000057047913,0.00021888597,0.0014003156,0.00008087374,0.00006045164,0.00046375822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967823,0.00024054032,0.00043291494,0.0010114604,0.00037436665,0.0011583937],"domain_scores_gemma":[0.99908495,0.000083498024,0.000046418612,0.00032884217,0.00030811023,0.00014819579],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092467305,0.00026864093,0.00034713425,0.0007597628,0.00017834127,0.00013945323,0.00048980175,0.00017083371,0.0002003328],"category_scores_gemma":[0.00014505965,0.00027314376,0.00009707188,0.0010006548,0.00017342684,0.000024792747,0.00032729623,0.00079248,0.000109431916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002482622,0.00012316575,0.006249891,0.000081892824,0.00013389441,0.00030525407,0.00025843893,0.0028086524,0.982401,0.000042591222,0.0032080081,0.0019045866],"study_design_scores_gemma":[0.0030375223,0.0009457003,0.06973641,0.0005876575,0.000013320577,0.000054787604,0.00030661834,0.0028946064,0.91658354,0.00013183393,0.0051614633,0.0005465636],"about_ca_topic_score_codex":0.0048015006,"about_ca_topic_score_gemma":0.017138602,"teacher_disagreement_score":0.06581749,"about_ca_system_score_codex":0.0010027555,"about_ca_system_score_gemma":0.0012005458,"threshold_uncertainty_score":0.99997205},"labels":[],"label_agreement":null},{"id":"W4403520195","doi":"10.1158/2326-6074.tumimm24-b022","title":"Abstract B022: Tumoral GLI1 controls the resident innate and adaptive tumor immune microenvironment in triple negative breast cancer","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Triple-negative breast cancer; Immune system; Tumor microenvironment; Cancer; Breast cancer; Innate immune system; Medicine; Immunotherapy; Immunology; Cancer immunotherapy; Acquired immune system; Cancer research; Internal medicine","score_opus":0.04032041317806927,"score_gpt":0.36141426816272637,"score_spread":0.3210938549846571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9259949,0.04248715,0.0000030511355,0.0298462,0.000096466574,0.0007605159,0.000208703,0.000033228443,0.0005697961],"genre_scores_gemma":[0.9909345,0.0052440213,0.000007949513,0.00038943038,0.000154462,0.0007511128,0.000013170722,0.000028902245,0.0024764552],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99772084,0.00033436273,0.00041405228,0.00050454953,0.00039224903,0.00063392136],"domain_scores_gemma":[0.9990328,0.00032739763,0.000063006315,0.00032865076,0.00014931937,0.00009882412],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010056943,0.00020028486,0.00044171597,0.0004442905,0.00021305965,0.00007770585,0.00018144977,0.00009693232,0.0024434729],"category_scores_gemma":[0.00008115704,0.00013741165,0.00011671303,0.00068173086,0.0011629271,0.00012864347,0.00018609397,0.0014221539,0.00009139945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008040439,0.00040940393,0.013053417,0.00032042214,0.0021732827,0.002616241,0.0053017046,0.00007162777,0.9206446,0.00095054024,0.008043869,0.038374484],"study_design_scores_gemma":[0.0048156832,0.00032850812,0.94744515,0.0027375054,0.00010768868,0.00028164437,0.0055374736,0.000967236,0.034384314,0.0005666063,0.0025502078,0.00027800712],"about_ca_topic_score_codex":0.007982244,"about_ca_topic_score_gemma":0.0011187369,"teacher_disagreement_score":0.93439174,"about_ca_system_score_codex":0.00089233444,"about_ca_system_score_gemma":0.00055081845,"threshold_uncertainty_score":0.99862367},"labels":[],"label_agreement":null},{"id":"W4403520285","doi":"10.1158/2326-6074.tumimm24-b012","title":"Abstract B012: Reviving exhausted T cells in pediatric B-cell acute lymphoblastic leukemia","year":2024,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Lymphoblastic Leukemia; Medicine; Cancer research; Immunology; Leukemia","score_opus":0.05261392441516446,"score_gpt":0.3874645670991617,"score_spread":0.3348506426839973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403520285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93263596,0.050762724,0.000008222287,0.000945251,0.0008409575,0.001059453,0.000026027905,0.00016026745,0.013561144],"genre_scores_gemma":[0.90571856,0.049128905,0.00004192682,0.00007242505,0.00073695165,0.0004078076,0.000023486706,0.0001213122,0.043748595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99556595,0.00033820412,0.0005792917,0.00092191575,0.0009581577,0.001636464],"domain_scores_gemma":[0.9972673,0.0012301794,0.00004566561,0.00083838915,0.0003804426,0.00023802341],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0022238542,0.00030388832,0.0005830525,0.0019171622,0.00015747594,0.00013393088,0.0005673095,0.00046604083,0.010058054],"category_scores_gemma":[0.00018841439,0.0002783864,0.00018120377,0.0029466017,0.00048037912,0.00017864528,0.0003735065,0.003002789,0.0017626256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011108326,0.00017108677,0.0057184696,0.0013588801,0.00029325802,0.00253901,0.0005927523,0.000032883057,0.9424049,0.000039769726,0.01190887,0.033829235],"study_design_scores_gemma":[0.016828515,0.0028637024,0.29941687,0.0037088683,0.00056216365,0.0007469696,0.0013272036,0.0035956255,0.48668218,0.0005007991,0.18199196,0.0017751268],"about_ca_topic_score_codex":0.0010634795,"about_ca_topic_score_gemma":0.00010374635,"teacher_disagreement_score":0.45572275,"about_ca_system_score_codex":0.0035066474,"about_ca_system_score_gemma":0.0037874766,"threshold_uncertainty_score":0.99996686},"labels":[],"label_agreement":null},{"id":"W4407578969","doi":"10.1158/2326-6066.cir-24-0151","title":"CD103+CD56+ ILCs Are Associated with an Altered CD8+ T-cell Profile within the Tumor Microenvironment","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"IL-33, ST2, and ILC Pathways","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Artificial Intelligence in Medicine (Canada); Vector Institute; University of Toronto; University Health Network; Structural Genomics Consortium; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Princess Margaret Cancer Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institutes of Health; Canadian Cancer Society; Princess Margaret Cancer Foundation","keywords":"Tumor microenvironment; CD8; Cytotoxic T cell; Immunotherapy; Biology; Cancer research; Immunology; Antigen; Immune system; Genetics","score_opus":0.03959988273125058,"score_gpt":0.3094242174564884,"score_spread":0.2698243347252378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407578969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98089486,0.009787165,0.000027425014,0.0011751427,0.001189635,0.0011849155,0.0011794266,0.00012054094,0.0044409046],"genre_scores_gemma":[0.96569264,0.00046226344,0.000035086818,0.0005952394,0.0000676672,0.0008192204,0.00030167526,0.00004994,0.031976264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953769,0.0018959264,0.00045345596,0.000817156,0.00015128095,0.0013052709],"domain_scores_gemma":[0.997847,0.0003853971,0.00024448926,0.0011119039,0.00036667808,0.00004449542],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0013927639,0.00036525645,0.0005323305,0.00029216942,0.0013343235,0.000057827074,0.0011897705,0.0004559903,0.0006230073],"category_scores_gemma":[0.00026455315,0.00025049626,0.00008669225,0.0007564167,0.0024082656,0.00013840412,0.00045377755,0.0021218173,0.00057951105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022137507,0.0009370224,0.01953152,0.00008634747,0.0012935061,0.000055794702,0.0022245294,0.000028769387,0.94168353,0.0011662781,0.029364113,0.0014148348],"study_design_scores_gemma":[0.008023999,0.002556601,0.09761136,0.0005622094,0.00018779295,0.000085044056,0.008669456,0.000035445846,0.7223126,0.00087654503,0.15825899,0.0008199095],"about_ca_topic_score_codex":0.00056723045,"about_ca_topic_score_gemma":0.00082197064,"teacher_disagreement_score":0.21937089,"about_ca_system_score_codex":0.000511391,"about_ca_system_score_gemma":0.0009960445,"threshold_uncertainty_score":0.99999475},"labels":[],"label_agreement":null},{"id":"W4407863592","doi":"10.1158/2326-6074.io2025-a116","title":"Abstract A116: Single cell analyses of syngeneic ovarian cancer models implicates macrophage skewing as key to evoking anti-tumor immunity via coordinated TGF-β and PD-L1 blockade","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Blockade; Ovarian cancer; Immunotherapy; Immunology; Cancer; Immunity; Medicine; Cancer research; Macrophage; Cancer immunotherapy; Immune system; Biology; Receptor; Internal medicine; In vitro","score_opus":0.0755580791581171,"score_gpt":0.3952990855604798,"score_spread":0.3197410064023627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407863592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8411991,0.15193053,0.00027787534,0.0009021071,0.0010986438,0.00088523194,0.00012520535,0.000101395075,0.0034799508],"genre_scores_gemma":[0.9911456,0.0042239367,0.000101172554,0.00023505838,0.00004639562,0.00051448174,0.000052672294,0.00008148618,0.003599198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950364,0.00092760584,0.0010181963,0.0011124898,0.00017699924,0.0017282674],"domain_scores_gemma":[0.99632066,0.0008813639,0.0003352154,0.0013354341,0.0010427289,0.00008461336],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001375599,0.00055708986,0.0011711473,0.0012701969,0.0009926709,0.00008045743,0.0014646525,0.00072731706,0.0013344026],"category_scores_gemma":[0.00024829165,0.00055438036,0.00019872368,0.001876242,0.0017606023,0.00025077426,0.0014469101,0.0021542776,0.00012093628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097644055,0.0003141356,0.0024791972,0.0002924556,0.0013759453,0.00002685642,0.0008822134,0.00075921905,0.9809042,0.000110449044,0.001055596,0.010823256],"study_design_scores_gemma":[0.0020928085,0.0002951456,0.02251746,0.00047039634,0.00017390228,0.000036611164,0.00074872037,0.000069283786,0.9681923,0.0008193332,0.0041181264,0.00046592037],"about_ca_topic_score_codex":0.025793906,"about_ca_topic_score_gemma":0.00025638813,"teacher_disagreement_score":0.14994653,"about_ca_system_score_codex":0.0007582789,"about_ca_system_score_gemma":0.0010158676,"threshold_uncertainty_score":0.9996908},"labels":[],"label_agreement":null},{"id":"W4407863613","doi":"10.1158/2326-6074.io2025-a015","title":"Abstract A015: GPNMB CAR T cells target both Glioblastoma and its immunosuppressive niche to relieve immune evasion","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; McMaster University","funders":"","keywords":"Evasion (ethics); Glioblastoma; Niche; Immune system; Immunotherapy; Immunology; Cancer immunotherapy; Biology; Cancer research; Medicine; Ecology","score_opus":0.03854279659123545,"score_gpt":0.39178252174718603,"score_spread":0.3532397251559506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407863613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91989595,0.06258427,0.000010071295,0.007686005,0.00075057853,0.0022959732,0.0000636836,0.00010709639,0.006606374],"genre_scores_gemma":[0.9313163,0.012725157,0.000112735375,0.0004110394,0.00022868771,0.0008139112,0.000026881438,0.00010020979,0.054265086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950575,0.00054109574,0.00066658517,0.001087002,0.0009788283,0.0016689472],"domain_scores_gemma":[0.9960871,0.00085387245,0.00009554876,0.0013257508,0.0013033992,0.00033434865],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020202077,0.0004104825,0.0008689252,0.0013337486,0.0005357926,0.00010409084,0.000809947,0.00058769307,0.005206645],"category_scores_gemma":[0.00071201904,0.00037710796,0.0001860335,0.0017334728,0.00071137754,0.00017010028,0.0011547654,0.0027117128,0.00044414724],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074057127,0.00020976781,0.0011697528,0.00025974287,0.00064746407,0.0001973271,0.00078458287,0.000017451192,0.963058,0.00015614112,0.012547648,0.013546388],"study_design_scores_gemma":[0.0037387104,0.001494872,0.0399599,0.0007203622,0.000045818575,0.00005205015,0.00077911094,0.00008480994,0.8583045,0.000215301,0.0943014,0.0003031493],"about_ca_topic_score_codex":0.00096105476,"about_ca_topic_score_gemma":0.000060640115,"teacher_disagreement_score":0.10475351,"about_ca_system_score_codex":0.0009853891,"about_ca_system_score_gemma":0.0016129848,"threshold_uncertainty_score":0.9998681},"labels":[],"label_agreement":null},{"id":"W4407866429","doi":"10.1158/2326-6074.io2025-b034","title":"Abstract B034: The immune checkpoint molecule B7-H3 is a driver of tumor immune exclusion by mediating TGF-β activation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Q & T Research; Université de Sherbrooke","funders":"","keywords":"Immune system; Cancer research; Immune checkpoint; Cancer immunotherapy; Medicine; Immunotherapy; Immunology","score_opus":0.022527636315242603,"score_gpt":0.36444219741222433,"score_spread":0.3419145610969817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624121,0.03191026,0.000065363434,0.0028775502,0.0001490758,0.00063532125,0.00008637392,0.000011448048,0.0018525092],"genre_scores_gemma":[0.99279594,0.004398882,0.00002408004,0.00012329019,0.00007029875,0.00041940346,0.00016495906,0.000025735939,0.0019773785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977592,0.0002504354,0.0004259363,0.00048482994,0.00041973885,0.000659807],"domain_scores_gemma":[0.99840283,0.00012234713,0.00015748602,0.0007713779,0.0004901519,0.000055785167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081061944,0.00019693698,0.00026979935,0.00017502061,0.0004172009,0.000035937363,0.0006775432,0.00019598553,0.00026474803],"category_scores_gemma":[0.00035006087,0.00015302225,0.00015711677,0.0005106224,0.0006730067,0.000013706177,0.0007489841,0.0005274063,0.000016531198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068076636,0.0001508172,0.0013712245,0.00005415127,0.0004415668,0.0000038736835,0.00017764777,0.0000051321686,0.9841667,0.00004057652,0.004308618,0.008598954],"study_design_scores_gemma":[0.0014082601,0.00025972305,0.020514738,0.00009872154,0.000013205946,0.0000025999436,0.00035198004,0.000022648703,0.9664802,0.00014856354,0.010582223,0.00011711961],"about_ca_topic_score_codex":0.004470883,"about_ca_topic_score_gemma":0.00011197578,"teacher_disagreement_score":0.030383876,"about_ca_system_score_codex":0.00021896098,"about_ca_system_score_gemma":0.00063679705,"threshold_uncertainty_score":0.6758667},"labels":[],"label_agreement":null},{"id":"W4407866505","doi":"10.1158/2326-6074.io2025-b016","title":"Abstract B016: Prime-Boost: mRNA Tumor Vaccines in Combination with Oncolytic Virotherapy for Durable Anti-Tumor Immunity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Virotherapy; Medicine; Immunity; Immunotherapy; Immunology; Virology; Cancer research; Immune system","score_opus":0.03169217769698976,"score_gpt":0.38019406700288555,"score_spread":0.34850188930589576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985748,0.009603749,0.00010548795,0.0016427985,0.0001473794,0.0018346529,0.000032887474,0.000022530627,0.00086250936],"genre_scores_gemma":[0.9935413,0.0021046693,0.00007253974,0.0002631751,0.00008265584,0.0016123554,0.00007981121,0.00005602204,0.0021874795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973545,0.00042903083,0.0003681789,0.00062398,0.00028724654,0.00093705434],"domain_scores_gemma":[0.99809813,0.00020922934,0.00009411706,0.00083989924,0.0006923054,0.00006628809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001735763,0.00025063066,0.00037044575,0.0005276307,0.00037423676,0.00006506677,0.00079688936,0.00020516403,0.00013694963],"category_scores_gemma":[0.00022460375,0.00022703713,0.00008392404,0.0007775472,0.00044577091,0.000018322286,0.00018599552,0.0007257256,0.000016306154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012727435,0.00043301136,0.0097372215,0.00009724519,0.00027240175,0.000013133823,0.00006241329,0.00007545309,0.9632836,0.00008898519,0.0008197293,0.012389392],"study_design_scores_gemma":[0.0071233218,0.0041631213,0.05523802,0.00015485461,0.0000093554445,0.000009125362,0.0002494883,0.000104139675,0.9210271,0.000413491,0.011231783,0.0002761624],"about_ca_topic_score_codex":0.0006870218,"about_ca_topic_score_gemma":0.0019541744,"teacher_disagreement_score":0.0455008,"about_ca_system_score_codex":0.00031490935,"about_ca_system_score_gemma":0.0017049611,"threshold_uncertainty_score":0.9258306},"labels":[],"label_agreement":null},{"id":"W4407866525","doi":"10.1158/2326-6074.io2025-a0","title":"Abstract A089: Methotrexate preserves anti-PD1 anti-tumor benefits while reducing arthritic inflammation in a tumor and ICI-arthritis combination mouse model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Inflammation; Methotrexate; Arthritis; Rheumatoid arthritis; Immunology; Cancer research","score_opus":0.056128609333595925,"score_gpt":0.36372974049113727,"score_spread":0.30760113115754134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97452146,0.02123786,0.000048328937,0.0023008352,0.00011794499,0.000748685,0.000021358188,0.000054451826,0.00094907085],"genre_scores_gemma":[0.9915326,0.00717021,0.00019721958,0.00006285935,0.00006875592,0.00025184898,0.000040670726,0.00003044394,0.0006453424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780166,0.0002001925,0.0005380865,0.00051671144,0.00033086538,0.0006125001],"domain_scores_gemma":[0.99868244,0.0002927529,0.00009603613,0.0003578486,0.00049045956,0.000080475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013932026,0.00019494032,0.00054339523,0.00080923917,0.00022971192,0.00007651837,0.00016645955,0.00016032768,0.00012738915],"category_scores_gemma":[0.0005711905,0.00019914917,0.00006154861,0.0007150071,0.00029825888,0.0002876754,0.00018447255,0.00092025177,0.0000069159864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029201005,0.00019642802,0.017670656,0.00048108608,0.00011867106,0.0000451503,0.00062085025,0.0020716656,0.9286659,0.0010107453,0.00030697035,0.048519887],"study_design_scores_gemma":[0.0061995243,0.00023191715,0.11165961,0.0030476216,0.0000343415,0.000040432256,0.00057645433,0.028524699,0.8476325,0.0013251342,0.00041672506,0.00031100583],"about_ca_topic_score_codex":0.00093931117,"about_ca_topic_score_gemma":0.00021538114,"teacher_disagreement_score":0.09398895,"about_ca_system_score_codex":0.00029097512,"about_ca_system_score_gemma":0.0005859789,"threshold_uncertainty_score":0.8121067},"labels":[],"label_agreement":null},{"id":"W4407866526","doi":"10.1158/2326-6074.io2025-a089","title":"Abstract A089: Methotrexate preserves anti-PD1 anti-tumor benefits while reducing arthritic inflammation in a tumor and ICI-arthritis combination mouse model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Arthritis; Methotrexate; Inflammation; Cancer research; Inflammatory arthritis; Immunology","score_opus":0.056128609333595925,"score_gpt":0.36372974049113727,"score_spread":0.30760113115754134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97452146,0.02123786,0.000048328937,0.0023008352,0.00011794499,0.000748685,0.000021358188,0.000054451826,0.00094907085],"genre_scores_gemma":[0.9915326,0.00717021,0.00019721958,0.00006285935,0.00006875592,0.00025184898,0.000040670726,0.00003044394,0.0006453424],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780166,0.0002001925,0.0005380865,0.00051671144,0.00033086538,0.0006125001],"domain_scores_gemma":[0.99868244,0.0002927529,0.00009603613,0.0003578486,0.00049045956,0.000080475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013932026,0.00019494032,0.00054339523,0.00080923917,0.00022971192,0.00007651837,0.00016645955,0.00016032768,0.00012738915],"category_scores_gemma":[0.0005711905,0.00019914917,0.00006154861,0.0007150071,0.00029825888,0.0002876754,0.00018447255,0.00092025177,0.0000069159864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029201005,0.00019642802,0.017670656,0.00048108608,0.00011867106,0.0000451503,0.00062085025,0.0020716656,0.9286659,0.0010107453,0.00030697035,0.048519887],"study_design_scores_gemma":[0.0061995243,0.00023191715,0.11165961,0.0030476216,0.0000343415,0.000040432256,0.00057645433,0.028524699,0.8476325,0.0013251342,0.00041672506,0.00031100583],"about_ca_topic_score_codex":0.00093931117,"about_ca_topic_score_gemma":0.00021538114,"teacher_disagreement_score":0.09398895,"about_ca_system_score_codex":0.00029097512,"about_ca_system_score_gemma":0.0005859789,"threshold_uncertainty_score":0.8121067},"labels":[],"label_agreement":null},{"id":"W4407866599","doi":"10.1158/2326-6074.io2025-b108","title":"Abstract B108: nELISA high-throughput proteomics enables scalable biomarker discovery: identification of IL-1 pathway intermediates as novel CRC biomarkers","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Biomarker discovery; Proteomics; Computational biology; Biomarker; Identification (biology); Throughput; Biology; Computer science; Gene; Genetics","score_opus":0.031611479988859104,"score_gpt":0.37022501254226203,"score_spread":0.33861353255340293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98353225,0.002397633,0.010292867,0.0017140098,0.00024688558,0.0008495967,0.00029972332,0.000038179318,0.0006288491],"genre_scores_gemma":[0.99237925,0.0027463054,0.001945218,0.00007061722,0.00005986711,0.0004412877,0.0002733565,0.00002602921,0.0020580527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983212,0.000075551674,0.0004345606,0.0005694304,0.0001651039,0.00043419303],"domain_scores_gemma":[0.9984792,0.00006857544,0.00017339108,0.0007708923,0.0004706542,0.00003730766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006009179,0.0001739436,0.0002151725,0.00020976894,0.00022057693,0.00005847581,0.000506317,0.0003119637,0.000018300861],"category_scores_gemma":[0.00029081103,0.00016385804,0.00008441696,0.0005029542,0.0010193974,0.000023657012,0.00042740777,0.0002513629,0.000008752852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029144797,0.00014916064,0.00038121612,0.00006089174,0.00020596712,8.2421093e-7,0.000018307277,0.00000913196,0.98688114,0.0022032156,0.0021751989,0.007623494],"study_design_scores_gemma":[0.00043454903,0.00009813956,0.008530967,0.00009535299,0.000011701702,0.0000029876192,0.00015836937,0.00002978983,0.9707099,0.0027542363,0.01702678,0.00014722835],"about_ca_topic_score_codex":0.000674747,"about_ca_topic_score_gemma":0.00006687967,"teacher_disagreement_score":0.016171247,"about_ca_system_score_codex":0.0001115584,"about_ca_system_score_gemma":0.00048268397,"threshold_uncertainty_score":0.6681937},"labels":[],"label_agreement":null},{"id":"W4407866624","doi":"10.1158/2326-6074.io2025-a016","title":"Abstract A016: Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; McMaster University","funders":"","keywords":"Glioblastoma; Cancer research; Medicine; Immunotherapy; Computational biology; Cancer; Biology; Internal medicine","score_opus":0.041151855758443136,"score_gpt":0.38099791652814474,"score_spread":0.3398460607697016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96651816,0.016096069,0.00002960735,0.0028632167,0.0002607896,0.0009591643,0.000013399503,0.000067043424,0.013192524],"genre_scores_gemma":[0.9712558,0.0020411415,0.00019887785,0.00016418636,0.00016139036,0.00051442726,0.0000073664937,0.00004922601,0.025607618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961923,0.00033739905,0.00045103606,0.00071152044,0.00090697984,0.0014007586],"domain_scores_gemma":[0.9976335,0.0006403597,0.000060406237,0.00069475145,0.0008428569,0.00012809942],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020754535,0.0002503145,0.00053655263,0.001086793,0.000252056,0.000057049238,0.00057963317,0.00031500857,0.0041359826],"category_scores_gemma":[0.00031168736,0.00021310692,0.00009087665,0.0018479314,0.0011020391,0.0001288306,0.000325551,0.002444342,0.00013458615],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051570437,0.00017983824,0.038626757,0.00024588467,0.00029977073,0.0005112561,0.0003870439,0.00012155627,0.93423796,0.00016414543,0.005085874,0.014982902],"study_design_scores_gemma":[0.0052371286,0.0010416592,0.12967414,0.0011196602,0.00002285257,0.000059142756,0.0020052996,0.00014361345,0.81211644,0.00020330849,0.048046768,0.00032996447],"about_ca_topic_score_codex":0.0022659453,"about_ca_topic_score_gemma":0.0019234141,"teacher_disagreement_score":0.12212146,"about_ca_system_score_codex":0.0011604725,"about_ca_system_score_gemma":0.0023165508,"threshold_uncertainty_score":0.99985707},"labels":[],"label_agreement":null},{"id":"W4407866625","doi":"10.1158/2326-6074.io2025-a067","title":"Abstract A067: PRMT7 deficiency in T cells enhances immune response and fosters an anti-tumor microenvironment in melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto; McGill University","funders":"","keywords":"Immune system; Tumor microenvironment; Melanoma; Immunology; Cancer research; Immunotherapy; Medicine; Cancer immunotherapy; Tumor immunology; Biology","score_opus":0.017046726403289213,"score_gpt":0.3290419966659493,"score_spread":0.3119952702626601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96261615,0.03590756,0.000011816278,0.0006327283,0.00020181552,0.0004364443,0.000011321149,0.000005585477,0.00017658205],"genre_scores_gemma":[0.99485403,0.0044242153,0.000038447943,0.000036817324,0.000025866837,0.00016492096,0.000022027549,0.00001610739,0.000417547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799335,0.0004305963,0.00033767518,0.0005769752,0.00013487808,0.0005265172],"domain_scores_gemma":[0.9993318,0.00006907203,0.00006172214,0.00044872778,0.000050874685,0.000037854086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011357729,0.00015272397,0.00021001695,0.00040604034,0.000099654026,0.00002684161,0.00029273392,0.00023058325,0.000044506607],"category_scores_gemma":[0.000062100335,0.00016305839,0.000033508528,0.00037558397,0.00049486395,0.000013285345,0.00025369046,0.000381125,0.0000069029047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016530107,0.00010414939,0.0074483063,0.000029291863,0.00002592736,0.000011619104,0.00016233526,0.00026852818,0.98171765,0.000007991463,0.00007036148,0.008500861],"study_design_scores_gemma":[0.00075949385,0.00018608454,0.42696613,0.00006329962,0.0000027142805,0.0000041784015,0.00024396507,0.000025874306,0.57015014,0.000025347847,0.0014746398,0.00009814221],"about_ca_topic_score_codex":0.0004663932,"about_ca_topic_score_gemma":0.0007419259,"teacher_disagreement_score":0.41951784,"about_ca_system_score_codex":0.0002583308,"about_ca_system_score_gemma":0.00037542923,"threshold_uncertainty_score":0.6649328},"labels":[],"label_agreement":null},{"id":"W4407866630","doi":"10.1158/2326-6074.io2025-b054","title":"Abstract B054: Immune checkpoint inhibitor-induced myocarditis and myocarditis-myositis overlap syndrome: identifying distinct molecular pathways for targeted therapeutic interventions","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Christie (Canada); McGill University Health Centre; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"","keywords":"Myocarditis; Myositis; Medicine; Immunotherapy; Immune checkpoint; Immunology; Immune system; Internal medicine","score_opus":0.08281328274867114,"score_gpt":0.39597794455155993,"score_spread":0.3131646618028888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.881064,0.11122635,0.00071580836,0.0023218915,0.00141322,0.0019374345,0.00020582518,0.00012470502,0.0009907467],"genre_scores_gemma":[0.9929703,0.004127016,0.00008372535,0.00022337091,0.00010901055,0.0016465106,0.00016574064,0.00007129919,0.00060306047],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99660784,0.00029095946,0.00085485575,0.0008061336,0.00045522343,0.0009849918],"domain_scores_gemma":[0.9980001,0.00037039688,0.00017353243,0.0007696949,0.0005642969,0.000122010424],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015383553,0.00036423042,0.0008336758,0.0007224782,0.00064822397,0.00015563649,0.0003568882,0.00041112743,0.00031667078],"category_scores_gemma":[0.00024625854,0.00036104655,0.0007453365,0.0008884077,0.00077658315,0.00018573663,0.00028290568,0.0010398906,0.00001647155],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015762406,0.00018536168,0.0017884909,0.0009908827,0.0031786172,0.00022211265,0.00020785461,8.661187e-7,0.8925881,0.0005466023,0.0005430241,0.098171845],"study_design_scores_gemma":[0.007977495,0.0011679747,0.7222688,0.0034173601,0.0003376991,0.00032996715,0.0010875223,0.000035299832,0.25769168,0.001914898,0.003324209,0.00044705844],"about_ca_topic_score_codex":0.00092185347,"about_ca_topic_score_gemma":0.000054077726,"teacher_disagreement_score":0.7204803,"about_ca_system_score_codex":0.0008098987,"about_ca_system_score_gemma":0.0007034612,"threshold_uncertainty_score":0.9998841},"labels":[],"label_agreement":null},{"id":"W4407866729","doi":"10.1158/2326-6074.io2025-b122","title":"Abstract B122: Genetically engineered Vaccinia Virus expressing MHC-I as a precision medicine cancer vaccine","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Vaccinia; Virology; Genetically engineered; Cancer; Virus; Cancer vaccine; Genetically modified organism; Cancer immunotherapy; Medicine; Major histocompatibility complex; Biology; Immunology; Immunotherapy; Immune system; Recombinant DNA; Genetics; Gene","score_opus":0.03941943681818824,"score_gpt":0.4162353845623751,"score_spread":0.3768159477441868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8760126,0.11353816,0.00010866621,0.005840718,0.0005095341,0.00071887235,0.000036936828,0.000043699023,0.0031907617],"genre_scores_gemma":[0.9561639,0.036720168,0.00007281271,0.0005185604,0.00064612576,0.0008146733,0.00007562462,0.000078736564,0.0049093976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995976,0.0005034777,0.00057477644,0.0010450722,0.00063703547,0.0012636887],"domain_scores_gemma":[0.9972162,0.00025714052,0.00008798454,0.0012905777,0.00094803254,0.00020005432],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015919626,0.00037038402,0.0004845698,0.00060027576,0.00040937256,0.000063035,0.001252856,0.00057853817,0.0024314113],"category_scores_gemma":[0.0007708942,0.0003292945,0.0001205549,0.0008948513,0.00060154306,0.000012958801,0.0006922295,0.0011026587,0.000094064555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008094894,0.000105651045,0.0005406712,0.00005593959,0.00043939534,0.00001815084,0.000090469715,0.00014302578,0.8887417,0.000055079698,0.0144908875,0.087224156],"study_design_scores_gemma":[0.003099239,0.0022803491,0.009398664,0.000315999,0.000028634458,0.000008280086,0.00014064799,0.000098178694,0.9184106,0.00041262666,0.065488525,0.00031825586],"about_ca_topic_score_codex":0.0013529289,"about_ca_topic_score_gemma":0.0011206858,"teacher_disagreement_score":0.086905904,"about_ca_system_score_codex":0.00025075415,"about_ca_system_score_gemma":0.0014374752,"threshold_uncertainty_score":0.9999159},"labels":[],"label_agreement":null},{"id":"W4407866806","doi":"10.1158/2326-6074.io2025-a060","title":"Abstract A060: Reactive oligodendrocytes promote glioblastoma progression through CCL5/CCR5-mediated glioma stem cell maintenance","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioblastoma; Glioma; Stem cell; Cancer research; CCL5; Temozolomide; Medicine; Biology; T cell; Immunology; Immune system; Cell biology","score_opus":0.021816199533360496,"score_gpt":0.35325700406390054,"score_spread":0.33144080453054003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97246575,0.021472309,0.000108432614,0.00058419415,0.00032095984,0.0009083164,0.000067098124,0.000054596174,0.004018359],"genre_scores_gemma":[0.9956473,0.001326891,0.00011829337,0.0000599454,0.00013765757,0.0005381554,0.00010976967,0.00004491372,0.002017085],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973039,0.0002961279,0.00037132236,0.0008331723,0.0003242005,0.0008712551],"domain_scores_gemma":[0.9981561,0.00008517937,0.00016092368,0.00079666387,0.00071780157,0.00008333732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049541524,0.00027650784,0.0002806931,0.00023390056,0.00030679032,0.000055601842,0.0006197298,0.0005110393,0.00009270938],"category_scores_gemma":[0.0001326338,0.00025718994,0.00011685531,0.00069789315,0.0006779522,0.0000235179,0.00049671676,0.000569043,0.00008401007],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015423754,0.0002007097,0.00060099695,0.00013911843,0.00020981632,0.000040142466,0.00013070721,0.000014149862,0.98218125,0.00009102402,0.0075385636,0.0073111597],"study_design_scores_gemma":[0.0012477472,0.00033653778,0.010526931,0.0002801844,0.000017494041,0.000015970747,0.00029919963,0.00003594509,0.9566391,0.00018967639,0.030178873,0.0002323583],"about_ca_topic_score_codex":0.000100744466,"about_ca_topic_score_gemma":0.000056698085,"teacher_disagreement_score":0.025542155,"about_ca_system_score_codex":0.00026040818,"about_ca_system_score_gemma":0.0008887595,"threshold_uncertainty_score":0.999988},"labels":[],"label_agreement":null},{"id":"W4407866822","doi":"10.1158/2326-6074.io2025-a058","title":"Abstract A058: nELISA high-throughput protein profiling captures immune secretomes for high-resolution phenotypic screens","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Advanced Biosensing Techniques and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Profiling (computer programming); Computational biology; Phenotype; Immune system; High resolution; Throughput; Biology; Computer science; Genetics; Gene; Geography; Remote sensing","score_opus":0.03600245217277007,"score_gpt":0.38102337572036243,"score_spread":0.34502092354759234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407866822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9429709,0.01576046,0.03265265,0.004668065,0.00026928674,0.0027643573,0.00021351162,0.00012797478,0.00057283853],"genre_scores_gemma":[0.98079383,0.0009787616,0.013218316,0.00012459328,0.00026914058,0.0017576711,0.0004890872,0.00003525534,0.002333318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819183,0.000093056566,0.00031403784,0.00062010007,0.00014381275,0.0006371467],"domain_scores_gemma":[0.9985548,0.000057949266,0.00009628639,0.0007068669,0.00054369494,0.000040359482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047976512,0.0001990796,0.000243744,0.00015213444,0.00051530683,0.00003849228,0.00043122386,0.00039438668,0.000020860769],"category_scores_gemma":[0.00020303082,0.0001908436,0.00008868548,0.00032825276,0.0005409141,0.00000953153,0.00030929162,0.0004324325,0.000006296539],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042139416,0.000059718364,0.000057520927,0.00005969428,0.0001304104,8.552484e-7,0.000012538754,0.000059577782,0.96843773,0.019875241,0.0023633312,0.008521956],"study_design_scores_gemma":[0.0008325403,0.00020098076,0.0033971467,0.00009564189,0.000014950133,0.0000017364341,0.00010849682,0.00004587027,0.95429355,0.010939468,0.029869806,0.00019978671],"about_ca_topic_score_codex":0.000734673,"about_ca_topic_score_gemma":0.00010070526,"teacher_disagreement_score":0.037823003,"about_ca_system_score_codex":0.00013100819,"about_ca_system_score_gemma":0.00037144526,"threshold_uncertainty_score":0.7782376},"labels":[],"label_agreement":null},{"id":"W4408362108","doi":"10.1158/2326-6066.cir-24-0758","title":"IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Amgen (Canada); Lunenfeld-Tanenbaum Research Institute; Ontario Institute for Cancer Research; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute on Aging; Congressionally Directed Medical Research Programs; National Institute of Allergy and Infectious Diseases; Natural Sciences and Engineering Research Council of Canada; American Cancer Society; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Pancreatic Cancer Action Network","keywords":"CD8; CD40; T cell; Cancer research; Cytotoxic T cell; Biology; Immunology; Antigen; Immune system; Genetics; In vitro","score_opus":0.06724943435714295,"score_gpt":0.39998855345792045,"score_spread":0.33273911910077747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408362108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756171,0.009019715,0.00012171144,0.006924258,0.00067649275,0.0021362565,0.00004898403,0.00007013297,0.0053853183],"genre_scores_gemma":[0.9827652,0.0011559369,0.00008144896,0.0005897583,0.00026215773,0.0006465534,0.000053380318,0.000056440545,0.014389136],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9946608,0.0012488716,0.0007459805,0.00089205557,0.0008346949,0.0016176058],"domain_scores_gemma":[0.99587935,0.0022127007,0.000106054635,0.0010171715,0.00061795715,0.00016678941],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025714096,0.00035064016,0.000873105,0.00079945603,0.00076470297,0.00019394273,0.0009058951,0.00026863613,0.0025028063],"category_scores_gemma":[0.000982064,0.00028755423,0.00012358518,0.0026924019,0.0012567829,0.0001246074,0.000534575,0.0023243604,0.00015482894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060986803,0.0001472781,0.07473718,0.00016167597,0.00029400247,0.00009524355,0.0016297743,0.00003654797,0.90447503,0.00011782561,0.009784404,0.00791115],"study_design_scores_gemma":[0.003198323,0.0010389186,0.20961796,0.00082036504,0.00007677412,0.00016581017,0.008211839,0.00097175484,0.7627731,0.00011846717,0.0125598535,0.0004468483],"about_ca_topic_score_codex":0.0040663923,"about_ca_topic_score_gemma":0.00067091506,"teacher_disagreement_score":0.14170197,"about_ca_system_score_codex":0.00085839775,"about_ca_system_score_gemma":0.0014766072,"threshold_uncertainty_score":0.9999773},"labels":[],"label_agreement":null},{"id":"W4408812473","doi":"10.1158/2326-6066.cir-24-0743","title":"Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Parker Institute for Cancer Immunotherapy","keywords":"PDGFRB; Mesenchymal stem cell; Stromal cell; Cancer research; Glioma; Endoglin; Biology; Angiogenesis; Cancer stem cell; Stem cell; Pathology; Medicine; Cell biology; CD34; Gene","score_opus":0.012996252969319317,"score_gpt":0.31219995113242266,"score_spread":0.2992036981631033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408812473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771651,0.019262975,0.0009144963,0.00131277,0.00009996842,0.0011721294,0.00003055448,0.000012913944,0.000029115432],"genre_scores_gemma":[0.995398,0.0026063917,0.000084054016,0.00014171907,0.000024991563,0.00034288946,0.000013014342,0.000030035832,0.0013588913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99764764,0.0004299592,0.00028772888,0.000752974,0.00024647146,0.000635251],"domain_scores_gemma":[0.99900156,0.00006342661,0.00005368932,0.0003866059,0.00037400858,0.00012069083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006992458,0.00022201732,0.00032871906,0.000451625,0.00022765883,0.00009001052,0.00020277474,0.00040665033,0.000009968907],"category_scores_gemma":[0.000095381045,0.00019958489,0.000028890647,0.00053016393,0.00038714986,0.000014168273,0.0006810703,0.00063653005,0.0000031922752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002703344,0.000038335682,0.0057859006,0.00010197097,0.00019959729,0.00003286121,0.000106248575,0.000101640886,0.98533154,0.000048551665,0.00039291038,0.005157119],"study_design_scores_gemma":[0.0036010775,0.0011820977,0.010244823,0.0003974902,0.000021074657,0.000059073434,0.0003956109,0.000371361,0.97890383,0.00002866796,0.004555342,0.00023957583],"about_ca_topic_score_codex":0.00020498617,"about_ca_topic_score_gemma":0.0005967094,"teacher_disagreement_score":0.018232936,"about_ca_system_score_codex":0.0001296136,"about_ca_system_score_gemma":0.00029709446,"threshold_uncertainty_score":0.81388354},"labels":[],"label_agreement":null},{"id":"W4412825944","doi":"10.1158/2326-6066.cir-24-0897","title":"Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; Sarcoma Foundation of America","keywords":"Chimeric antigen receptor; Cancer research; Metastasis; Sarcoma; Cytotoxic T cell; Stromal cell; Tumor microenvironment; Immunotherapy; Cancer; Antigen; Medicine; Immunology; Biology; Immune system; Pathology; In vitro; Internal medicine","score_opus":0.053936030644522716,"score_gpt":0.4012525384342819,"score_spread":0.34731650778975914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412825944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9438518,0.024988696,0.000011314441,0.0037474502,0.00051894836,0.001845649,0.00003083654,0.00018077891,0.024824472],"genre_scores_gemma":[0.9356631,0.0051739383,0.0005676387,0.0004169759,0.000114957154,0.0007184064,0.000040830797,0.00007489848,0.05722923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99583584,0.0007230624,0.00052861305,0.00079777057,0.00066846213,0.001446266],"domain_scores_gemma":[0.99701244,0.00071858405,0.00005502262,0.0009470261,0.0011027111,0.00016423274],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010164889,0.00028003243,0.0007923771,0.001569649,0.00022155227,0.000031121257,0.00058978744,0.0003098043,0.005020108],"category_scores_gemma":[0.00040603452,0.00027566022,0.00014137506,0.002187043,0.0011086268,0.00008589392,0.00044208657,0.0025080417,0.00018122536],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034451773,0.00021228672,0.01791928,0.0001358507,0.0002822406,0.00039391057,0.00032820288,0.000044670174,0.9461976,0.00050800235,0.0023457492,0.028186973],"study_design_scores_gemma":[0.00914861,0.00073056406,0.10437742,0.00063705276,0.00002190802,0.00004374902,0.0010974598,0.0004714586,0.6905146,0.0010302071,0.19158484,0.00034211928],"about_ca_topic_score_codex":0.0015980076,"about_ca_topic_score_gemma":0.00025197738,"teacher_disagreement_score":0.25568303,"about_ca_system_score_codex":0.0011259331,"about_ca_system_score_gemma":0.0015502064,"threshold_uncertainty_score":0.99996954},"labels":[],"label_agreement":null},{"id":"W4414458510","doi":"10.1158/2326-6074.cimm25-pr-01","title":"Abstract PR-01: Targeting the ApoE-LDLR pathway disrupts MDSC-mediated systemic immunosuppression and enhances the efficacy of NK cell immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Immunosuppression; Immunotherapy; Cancer immunotherapy; Tumor microenvironment; T cell; Immune tolerance; Ex vivo; Myeloid-derived Suppressor Cell","score_opus":0.021941002524156625,"score_gpt":0.3261121331413621,"score_spread":0.30417113061720547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414458510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79062897,0.20032333,0.000038704606,0.0014000647,0.0042057713,0.00090623467,0.000015787557,0.0000620248,0.002419126],"genre_scores_gemma":[0.9683101,0.020619385,0.0000040133004,0.0001469344,0.000056893547,0.00031671143,0.00008229498,0.000029058316,0.010434592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963158,0.0014914296,0.00077895354,0.00050915836,0.00013987806,0.0007648108],"domain_scores_gemma":[0.9951853,0.0031999045,0.00034044337,0.0008173556,0.0004401054,0.000016851198],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020107157,0.00030262783,0.00047178584,0.0003102466,0.0013351932,0.000067327,0.0009313235,0.0004742242,0.0012542143],"category_scores_gemma":[0.00050169416,0.00017704099,0.00016003777,0.0006223885,0.0017311374,0.00017721835,0.0003770832,0.0019482007,0.0002125878],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001731885,0.00016494762,0.0007489289,0.000117330004,0.00045697545,0.0000015658578,0.0017247058,0.00000786883,0.9740237,0.00020603828,0.010666891,0.010149187],"study_design_scores_gemma":[0.0026790232,0.000248885,0.018597178,0.00051156554,0.000032940105,0.000026849313,0.006549182,0.000013102276,0.86213964,0.00006233316,0.108931,0.00020827903],"about_ca_topic_score_codex":0.0011944636,"about_ca_topic_score_gemma":0.000027289681,"teacher_disagreement_score":0.17970394,"about_ca_system_score_codex":0.00017064132,"about_ca_system_score_gemma":0.00041098188,"threshold_uncertainty_score":0.99996495},"labels":[],"label_agreement":null},{"id":"W4414465146","doi":"10.1158/2326-6074.cimm25-pr-16","title":"Abstract PR-16: Therapeutic inhibition of TREX1 elicits type I interferon–mediated antitumor immunity with minimal autoimmune toxicity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Knockout mouse; Immunotherapy; Cancer immunotherapy; Immunity; Downregulation and upregulation; Inflammation; Cancer; Interferon; Cytotoxic T cell","score_opus":0.07872362776945517,"score_gpt":0.39940011158254946,"score_spread":0.32067648381309427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863582,0.00513178,0.000049919046,0.0016901259,0.00029536412,0.00051448424,0.000032900316,0.0000638138,0.005863377],"genre_scores_gemma":[0.99745846,0.0007989009,0.000028684952,0.00014942641,0.000050796665,0.00009276803,0.000085030064,0.000023779772,0.0013121595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983136,0.00019256608,0.00043806384,0.0003118809,0.00028136224,0.0004625063],"domain_scores_gemma":[0.9978581,0.00034786435,0.00012209528,0.0005141101,0.0011070659,0.0000507695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00056136,0.00017990814,0.0004599691,0.0005897177,0.00021239837,0.00002185095,0.00019628051,0.00018493929,0.0012458354],"category_scores_gemma":[0.0002648595,0.00014313283,0.000086405074,0.0011035008,0.00069562456,0.00010994413,0.00012735614,0.001268315,0.00004504589],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049422504,0.0005313445,0.0048221187,0.00016098013,0.0005217324,0.000019214624,0.00030331904,0.000004430706,0.9812447,0.00026579766,0.000830095,0.006354006],"study_design_scores_gemma":[0.0022809939,0.0023899514,0.2835579,0.0012585815,0.00007134511,0.000026209222,0.000757061,0.00006246388,0.70507437,0.00008110894,0.004306024,0.00013400162],"about_ca_topic_score_codex":0.0015085442,"about_ca_topic_score_gemma":0.00020095843,"teacher_disagreement_score":0.2787358,"about_ca_system_score_codex":0.00039593258,"about_ca_system_score_gemma":0.0010438344,"threshold_uncertainty_score":0.99966717},"labels":[],"label_agreement":null},{"id":"W4414465149","doi":"10.1158/2326-6074.cimm25-b014","title":"Abstract B014: SYNCRIP drives therapy resistance via ferroptosis suppression and metabolic activation in Glioblastoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Downregulation and upregulation; Glioblastoma; Reprogramming; Cancer; Regulator; Cancer cell; Immunotherapy; Mechanism (biology)","score_opus":0.042119258215151736,"score_gpt":0.3829273282088889,"score_spread":0.3408080699937372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436639,0.045099225,0.000021587728,0.008419461,0.00019365494,0.00069425436,0.000004943472,0.000045326775,0.0018576465],"genre_scores_gemma":[0.97211903,0.025134297,0.00005616103,0.0002935454,0.00006702593,0.00078270753,0.000005665191,0.000025630807,0.0015159313],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99787027,0.0002618431,0.0003482224,0.0005670134,0.00035102083,0.00060164474],"domain_scores_gemma":[0.9988183,0.00024491746,0.00006632159,0.0004648085,0.00033158337,0.000074085874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006363802,0.00020101707,0.00047154116,0.0007895848,0.00024071141,0.00004455111,0.00020505745,0.00027157596,0.0003270985],"category_scores_gemma":[0.00014315707,0.0001694871,0.000067161905,0.0011084076,0.0005488556,0.00018840343,0.00013845554,0.0009075981,0.00001034661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005538242,0.00030146562,0.08055622,0.00020753047,0.00030596773,0.000010118592,0.0006479026,0.0000023919213,0.7729943,0.0006853319,0.0031465455,0.13560401],"study_design_scores_gemma":[0.0020077138,0.00017494455,0.56083274,0.00063213735,0.000014255432,0.0000016511508,0.00033859655,0.000020162537,0.4178982,0.00033779204,0.01762843,0.0001133683],"about_ca_topic_score_codex":0.00045183933,"about_ca_topic_score_gemma":0.00021716749,"teacher_disagreement_score":0.48027653,"about_ca_system_score_codex":0.00025549528,"about_ca_system_score_gemma":0.0003621908,"threshold_uncertainty_score":0.69114834},"labels":[],"label_agreement":null},{"id":"W4414465151","doi":"10.1158/2326-6074.cimm25-pr-11","title":"Abstract PR-11: B cell infiltration and clonal expansion in tertiary lymphoid structures: Insights from intravital microscopy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"High endothelial venules; Immune system; Lymph; Lymphatic system; B cell; Intravital microscopy; Infiltration (HVAC); Tumor microenvironment; Lymphocyte","score_opus":0.016223602725056893,"score_gpt":0.31025442311668533,"score_spread":0.2940308203916284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8772457,0.12129176,0.000033814515,0.00015911342,0.00055779103,0.0003459242,0.00009966562,0.000028955394,0.0002372405],"genre_scores_gemma":[0.995064,0.004062421,0.000019147632,0.00015411306,0.00004412071,0.00016821895,0.00024291089,0.000017802866,0.00022724368],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979048,0.00051425205,0.0003470162,0.0005886436,0.00008819175,0.0005571026],"domain_scores_gemma":[0.9990938,0.00025669447,0.000057477657,0.00043111556,0.0001323207,0.000028634306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002874037,0.000216518,0.00035103605,0.00033695853,0.00033963454,0.00005103068,0.00032381958,0.0005217077,0.00034695977],"category_scores_gemma":[0.000060090868,0.00019397779,0.00010354661,0.0002895391,0.0006985429,0.00016071695,0.00025712675,0.00067001756,0.000044094562],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003281344,0.00014307837,0.08793924,0.000032945267,0.00021985751,0.000007751619,0.00057528244,0.0000044977182,0.90079427,0.0003139636,0.0008378631,0.008803137],"study_design_scores_gemma":[0.0023462146,0.000046767622,0.6957037,0.000110395056,0.000025285326,0.000004120178,0.0009848039,0.0000022332817,0.29537848,0.0011259903,0.0041215494,0.00015049768],"about_ca_topic_score_codex":0.0020013156,"about_ca_topic_score_gemma":0.0005804542,"teacher_disagreement_score":0.6077644,"about_ca_system_score_codex":0.0001906298,"about_ca_system_score_gemma":0.00042228427,"threshold_uncertainty_score":0.7910185},"labels":[],"label_agreement":null},{"id":"W4414465152","doi":"10.1158/2326-6074.cimm25-a002","title":"Abstract A002: Comprehensive blood profiling for immunotherapy outcome prediction and longitudinal immune trajectory characterisation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adjuvant; Immunotherapy; Immune system; Peripheral blood mononuclear cell; Antibody; Clinical trial; Adverse effect; Univariate","score_opus":0.10022597285674148,"score_gpt":0.41030359151371626,"score_spread":0.3100776186569748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97028697,0.025375744,0.00017504868,0.0016513445,0.0005331698,0.0016072437,0.000054479213,0.000068875495,0.00024714146],"genre_scores_gemma":[0.9933737,0.0048104855,0.0002051009,0.00009699591,0.00015528307,0.00066729,0.00009547597,0.000027380518,0.00056830834],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983685,0.0000856621,0.00043998813,0.00043756425,0.00020914037,0.00045915044],"domain_scores_gemma":[0.99876565,0.0002562699,0.00006317569,0.0003252395,0.0005426245,0.000047014124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057547796,0.00017316075,0.00041894108,0.00040184738,0.00039944152,0.000034463836,0.00011488258,0.0002651985,0.00009164504],"category_scores_gemma":[0.000053832115,0.00015630745,0.000106788466,0.0003095794,0.00036323332,0.00012195328,0.00004538956,0.00075021375,0.000004063833],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022671944,0.00023672542,0.21569586,0.0004908265,0.00062253844,0.000008173441,0.00022576009,0.0000011718344,0.75223,0.0003480428,0.0000307683,0.027842946],"study_design_scores_gemma":[0.0057712253,0.00059088133,0.93014985,0.00022185873,0.00012441793,0.000027653914,0.0002854843,0.00005906992,0.060981352,0.00013620881,0.0015507791,0.000101233425],"about_ca_topic_score_codex":0.00025615227,"about_ca_topic_score_gemma":0.000015706299,"teacher_disagreement_score":0.714454,"about_ca_system_score_codex":0.00012026431,"about_ca_system_score_gemma":0.00024731108,"threshold_uncertainty_score":0.6374033},"labels":[],"label_agreement":null},{"id":"W4414465153","doi":"10.1158/2326-6074.cimm25-pr-10","title":"Abstract PR-10: Leveraging peripheral leukocyte recruitment to improve efficacy and mitigate toxicities following checkpoint blockade","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blockade; Cytotoxic T cell; Immune checkpoint; T cell; CD8; Immune system; Cancer immunotherapy; Immunotherapy; Effector","score_opus":0.08873159915895826,"score_gpt":0.40836903552775927,"score_spread":0.31963743636880104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9407779,0.04253582,0.00001043018,0.012180586,0.00065870833,0.0016634954,0.000007672078,0.000086260734,0.0020791108],"genre_scores_gemma":[0.9653607,0.0041714534,0.00011389609,0.0006721106,0.00036667145,0.0012185435,0.0000116128285,0.000051235453,0.028033804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970721,0.00023428824,0.00048733392,0.0007172288,0.00041046253,0.0010786137],"domain_scores_gemma":[0.99842405,0.00040777028,0.00006408927,0.0006602556,0.00025718554,0.00018665157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010285412,0.00031000611,0.00065748865,0.0005734439,0.00049329107,0.00011606319,0.0002987979,0.00023353047,0.0003571308],"category_scores_gemma":[0.0004388015,0.0002901954,0.00018364903,0.00053838827,0.0005446829,0.00011694324,0.0003067137,0.00095551537,0.00003500833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008258656,0.00018967604,0.0019329689,0.0003516077,0.0010108902,0.00021956973,0.0034484803,0.000021342643,0.8171585,0.000039906932,0.0034531895,0.16391519],"study_design_scores_gemma":[0.008939381,0.0014566057,0.21153551,0.0022939516,0.00015991638,0.0000934461,0.004703298,0.00007417113,0.51575947,0.00010377441,0.2543477,0.0005327806],"about_ca_topic_score_codex":0.0011188159,"about_ca_topic_score_gemma":0.000056997127,"teacher_disagreement_score":0.30139908,"about_ca_system_score_codex":0.0011252684,"about_ca_system_score_gemma":0.0011145556,"threshold_uncertainty_score":0.999955},"labels":[],"label_agreement":null},{"id":"W4414465155","doi":"10.1158/2326-6074.cimm25-b010","title":"Abstract B010: α-Synuclein preformed fibrils suppress cell cycle progression and glycolytic flux in glioblastoma cells","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Cell cycle; Cancer cell; Flux (metallurgy); Glycolysis; Neurodegeneration; Tumor progression; Cyclin; Cell","score_opus":0.04064383925663431,"score_gpt":0.3710928370987603,"score_spread":0.330448997842126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329525,0.0012606054,0.0000013019193,0.00054404465,0.0002649432,0.000906351,0.000040913375,0.00006092324,0.0036256611],"genre_scores_gemma":[0.99720836,0.00056386535,0.000011365867,0.00014857712,0.000016710721,0.00047443243,0.0000017110933,0.00001893518,0.0015560419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973905,0.00036389762,0.0002720926,0.00078668084,0.0003250508,0.00086174684],"domain_scores_gemma":[0.99886996,0.0005003947,0.000054220392,0.00039996434,0.000059171136,0.00011632296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002625813,0.00020096802,0.00027137614,0.00037586424,0.00029666699,0.00009195617,0.00044264103,0.00020577932,0.00042544267],"category_scores_gemma":[0.0001816629,0.00015831167,0.00005139886,0.0006865264,0.00052242057,0.00017463711,0.000516806,0.0006305812,0.000110308196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010918764,0.00040241057,0.00089634774,0.000099540666,0.00001119507,0.00029588037,0.000076180826,0.0000158859,0.9846936,0.00034385914,0.00026780722,0.011805415],"study_design_scores_gemma":[0.0017170147,0.00052749657,0.033365596,0.00011243931,0.000007494007,0.000004461633,0.000033300814,0.00020629929,0.9604763,0.0024411306,0.0009802197,0.00012826611],"about_ca_topic_score_codex":0.000093199844,"about_ca_topic_score_gemma":0.000035816673,"teacher_disagreement_score":0.032469247,"about_ca_system_score_codex":0.00015347546,"about_ca_system_score_gemma":0.0001849634,"threshold_uncertainty_score":0.64557624},"labels":[],"label_agreement":null},{"id":"W4414465159","doi":"10.1158/2326-6074.cimm25-b017","title":"Abstract B017: Impact of gut microbiota on response to Bacillus Calmette-Guérin immunotherapy in bladder cancer: Towards a predictive molecular model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Immunotherapy; Gut flora; Bladder cancer; Antibiotics; Bacteria; Probiotic; Cancer","score_opus":0.051216184011676304,"score_gpt":0.4408723039258178,"score_spread":0.38965611991414145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762029,0.012781778,0.00008582285,0.0053185043,0.00020640642,0.0018032816,0.0005445937,0.000038505674,0.0030181813],"genre_scores_gemma":[0.99303526,0.002265839,0.00009522948,0.0006765637,0.000039471215,0.0011353334,0.000016947968,0.00006067671,0.0026746746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967922,0.00041928588,0.00054723356,0.0007526788,0.0004930732,0.0009955297],"domain_scores_gemma":[0.9979492,0.00023564481,0.000082839135,0.00096980593,0.00060902536,0.00015351383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009086211,0.00037425003,0.000808573,0.0014037444,0.00011570647,0.000024301624,0.00048552253,0.00037812334,0.00062179525],"category_scores_gemma":[0.00022118409,0.00031506387,0.00028141204,0.001470018,0.0004809056,0.000075781245,0.00018488351,0.0011376882,0.00003175691],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06190057,0.00065625395,0.0068468587,0.00007135693,0.0021076072,0.000122729,0.0011293888,0.003725541,0.89051837,0.000034216853,0.0029596926,0.029927408],"study_design_scores_gemma":[0.012828276,0.0047815153,0.80865103,0.0011656025,0.000096138894,0.0000133959775,0.00024961669,0.00056474167,0.16958311,0.0002681599,0.0014402753,0.00035814976],"about_ca_topic_score_codex":0.017107485,"about_ca_topic_score_gemma":0.00032630903,"teacher_disagreement_score":0.8018041,"about_ca_system_score_codex":0.0031152808,"about_ca_system_score_gemma":0.005686568,"threshold_uncertainty_score":0.9999503},"labels":[],"label_agreement":null},{"id":"W4414465161","doi":"10.1158/2326-6074.cimm25-b023","title":"Abstract B023: A scalable, proteome-wide protein profiling platform with absolute quantification of 1000 proteins","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ouranos","funders":"","keywords":"Profiling (computer programming); Proteomics; KEGG; Biomarker; Quantitative proteomics; Redundancy (engineering)","score_opus":0.050840511920718076,"score_gpt":0.37482568781807757,"score_spread":0.3239851758973595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96287084,0.001493456,0.01177814,0.0016463577,0.000021297066,0.0039383285,0.00007624541,0.00023328088,0.017942067],"genre_scores_gemma":[0.9567069,0.0003498054,0.01691872,0.000014289514,0.000036724487,0.017949471,0.000051274215,0.0000464354,0.007926383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979045,0.000030922918,0.00050077384,0.0005763975,0.0003599168,0.00062753336],"domain_scores_gemma":[0.9977344,0.00015379692,0.00023578052,0.00097067346,0.0008535689,0.000051749514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006589556,0.00020634,0.00031647185,0.000286827,0.00036863188,0.00004041273,0.0006875156,0.00033241307,0.00026964577],"category_scores_gemma":[0.00016573693,0.00018281247,0.00005846307,0.0008879802,0.00072382635,0.00017801413,0.00020176632,0.0011887116,0.000018543928],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005474827,0.00015076865,0.0012732678,0.000730995,0.00010907988,0.0000023198547,0.000049174403,0.000046372927,0.9792065,0.012207631,0.0000891875,0.00558722],"study_design_scores_gemma":[0.00052631093,0.0000713937,0.0012608351,0.0008632,0.000009576669,0.0000020192017,0.00016730609,0.00008363116,0.98723227,0.0057436647,0.0038656644,0.00017412244],"about_ca_topic_score_codex":0.00058797194,"about_ca_topic_score_gemma":0.000096699085,"teacher_disagreement_score":0.014011143,"about_ca_system_score_codex":0.00034494343,"about_ca_system_score_gemma":0.0011029921,"threshold_uncertainty_score":0.74548763},"labels":[],"label_agreement":null},{"id":"W4414465163","doi":"10.1158/2326-6074.cimm25-a004","title":"Abstract A004: Modulating chromatin remodeling as a strategy to reverse immune evasion in ovarian cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Immune system; Chromatin remodeling; Antigen presentation; Immunotherapy; Chromatin; Immunogenicity; Ovarian cancer; Immune checkpoint; Downregulation and upregulation","score_opus":0.09923062220342622,"score_gpt":0.4569732006418941,"score_spread":0.3577425784384679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9477167,0.020092271,0.000026874528,0.020627236,0.00046991976,0.0015440566,0.000020952983,0.000051541356,0.009450459],"genre_scores_gemma":[0.9912883,0.003971721,0.00037729292,0.0006723236,0.00014487919,0.0013876663,0.000018821804,0.000038935894,0.0021000823],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970659,0.00019296538,0.0006290274,0.00075818534,0.00043149455,0.00092242355],"domain_scores_gemma":[0.99834806,0.00024125737,0.00008296857,0.0007454722,0.00044317622,0.00013904869],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011204653,0.00025593757,0.0006011943,0.0008401695,0.00026313777,0.000054162807,0.00028498023,0.00028949245,0.0013808386],"category_scores_gemma":[0.0003096067,0.0002374823,0.000110764915,0.001477603,0.00015353496,0.00012190349,0.00024014355,0.0010534653,0.00013029607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032186094,0.0009488717,0.048619807,0.00063891214,0.0010629809,0.0005266978,0.0018509503,0.007169139,0.50938034,0.0022848507,0.0045733443,0.41972548],"study_design_scores_gemma":[0.009543951,0.0010014636,0.91347873,0.00761502,0.000121534445,0.000029231483,0.0018002415,0.00195319,0.054002795,0.0017697948,0.008218539,0.00046551984],"about_ca_topic_score_codex":0.040764287,"about_ca_topic_score_gemma":0.002044579,"teacher_disagreement_score":0.8648589,"about_ca_system_score_codex":0.0022171529,"about_ca_system_score_gemma":0.002174556,"threshold_uncertainty_score":0.99953204},"labels":[],"label_agreement":null},{"id":"W4414465167","doi":"10.1158/2326-6074.cimm25-b022","title":"Abstract B022: Investigating Biased GPCRs Activation by Nutraceutical Caffeine and Nicotine in Transactivating Glycosylated Receptors to Induce EMT in Cancer Metastasis","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"G protein-coupled receptor; Receptor; Cancer cell; Signal transduction; Inflammation; Caffeine; Cell signaling","score_opus":0.09163168663077802,"score_gpt":0.4273441446349585,"score_spread":0.3357124580041805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97020346,0.011761623,0.000016028122,0.016462535,0.00018776077,0.0011107181,0.000020529626,0.000045197186,0.00019215667],"genre_scores_gemma":[0.9944837,0.0034571555,0.00010924775,0.0004887433,0.00007730858,0.0007189119,0.000032746608,0.000044433113,0.00058777316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966551,0.0005546623,0.00070808374,0.00072028826,0.00040769464,0.0009541703],"domain_scores_gemma":[0.99793637,0.0011331736,0.00010260707,0.000382593,0.00027572372,0.00016954256],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001585375,0.00029987015,0.0007230395,0.0013561195,0.00019679095,0.000048419093,0.00024065864,0.0003941901,0.00027990292],"category_scores_gemma":[0.0015510014,0.00029767348,0.000063433,0.0028520846,0.00051028596,0.0002100842,0.00008355753,0.0019007945,0.0000050148865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004149499,0.00029242953,0.04716129,0.00030777304,0.00019456875,0.00001576059,0.0017111421,0.00009666006,0.7603873,0.000020179876,0.0010881847,0.1845752],"study_design_scores_gemma":[0.0060135094,0.00047269082,0.35331848,0.0035189309,0.000046860463,0.00001164743,0.0027407948,0.0003366893,0.6226823,0.000048097136,0.010435281,0.00037471313],"about_ca_topic_score_codex":0.017569218,"about_ca_topic_score_gemma":0.0020679194,"teacher_disagreement_score":0.3061572,"about_ca_system_score_codex":0.0013194828,"about_ca_system_score_gemma":0.001339804,"threshold_uncertainty_score":0.99994755},"labels":[],"label_agreement":null},{"id":"W4414465170","doi":"10.1158/2326-6074.cimm25-pr-04","title":"Abstract PR-04: Targeting PRMT5 to modulate endogenous retroviruses expression in melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Protein arginine methyltransferase 5; Melanoma; Histone; Immune checkpoint; Epigenetics; Blockade; Endogeny; Immune system","score_opus":0.04452812077411537,"score_gpt":0.3593245265273861,"score_spread":0.3147964057532707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97121847,0.024848634,0.00011023538,0.0007459261,0.00044348335,0.00057875586,0.000016336104,0.000021301023,0.0020168517],"genre_scores_gemma":[0.99629813,0.001678085,0.00017852546,0.00008889145,0.00018792432,0.00033199452,0.000056307304,0.00002908636,0.001151053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793005,0.00022704339,0.00033832822,0.0006212781,0.0002100232,0.0006732688],"domain_scores_gemma":[0.9990238,0.000054412634,0.000060681734,0.0005378459,0.00026075845,0.00006247667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006783288,0.0001701366,0.00021194118,0.00040477322,0.00019113533,0.000031376952,0.00041211705,0.00039533782,0.00009328642],"category_scores_gemma":[0.00032453306,0.0001758201,0.00006066623,0.0006029475,0.00016524992,0.000009054869,0.0004086918,0.0004815368,0.000033164586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006018091,0.00004753043,0.009614638,0.000032200624,0.000091022,0.000007935748,0.00012080583,0.001768777,0.97098076,0.000022330643,0.003510057,0.013202113],"study_design_scores_gemma":[0.0007375086,0.00018295753,0.0648047,0.00014116752,0.0000059089325,0.000004182543,0.00011152279,0.0000349749,0.8993584,0.0001224765,0.034323875,0.00017232024],"about_ca_topic_score_codex":0.0005416136,"about_ca_topic_score_gemma":0.00034910298,"teacher_disagreement_score":0.07162237,"about_ca_system_score_codex":0.00027655822,"about_ca_system_score_gemma":0.00050188764,"threshold_uncertainty_score":0.71697354},"labels":[],"label_agreement":null},{"id":"W4414465177","doi":"10.1158/2326-6074.cimm25-b008","title":"Abstract B008: Unraveling the sexually dimorphic immune microenvironment in gastric cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Immune system; CD8; Cytotoxic T cell; Antigen; Sexual dimorphism; Immunotherapy; Tumor microenvironment; CDH1","score_opus":0.05364733650164636,"score_gpt":0.3832631809748934,"score_spread":0.32961584447324704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8040209,0.17221624,0.000014603588,0.020410316,0.00066219515,0.00092990964,0.000017525805,0.00003040721,0.0016979004],"genre_scores_gemma":[0.9429727,0.04961391,0.000027063183,0.000901006,0.00013571016,0.0008683063,0.00001424775,0.000033138887,0.0054339226],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972076,0.0002567904,0.0005846457,0.0005422332,0.00042357517,0.0009851982],"domain_scores_gemma":[0.9985539,0.00035005625,0.00009284008,0.0007962347,0.00015232372,0.000054681335],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016615748,0.00024333509,0.0004374988,0.00063577486,0.0003564547,0.000044663902,0.0005680221,0.00024776705,0.0018457386],"category_scores_gemma":[0.00009549037,0.00017799769,0.00013688099,0.0014904091,0.0010441528,0.00006879397,0.00026074832,0.0016500375,0.000052650394],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045012888,0.0002863288,0.05158738,0.00018182116,0.0008566188,0.000075227224,0.00072326825,0.000064620035,0.7610808,0.000082212806,0.0028026663,0.17775777],"study_design_scores_gemma":[0.0040935287,0.000210823,0.9197121,0.000901961,0.000048015223,0.000027393535,0.0013463384,0.000044303488,0.026350833,0.00010362852,0.046972424,0.00018864262],"about_ca_topic_score_codex":0.0060574687,"about_ca_topic_score_gemma":0.0007421452,"teacher_disagreement_score":0.8681247,"about_ca_system_score_codex":0.0014747878,"about_ca_system_score_gemma":0.0013014121,"threshold_uncertainty_score":0.9990667},"labels":[],"label_agreement":null},{"id":"W4414465186","doi":"10.1158/2326-6074.cimm25-a009","title":"Abstract A009: Novel roles of the nuclear autoantigen LEDGF/p75 in modulating prostate cancer related inflammatory pathways and cancer patient response to immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Downregulation and upregulation; Prostate cancer; Cancer; Gene silencing; Gene knockdown; Immunotherapy; Transcription factor; Autoantibody","score_opus":0.029976874850282574,"score_gpt":0.34496921669977226,"score_spread":0.3149923418494897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94417495,0.045130223,6.8381365e-7,0.008053605,0.00047170345,0.0017238052,0.000075036456,0.000054527536,0.00031544184],"genre_scores_gemma":[0.9857461,0.012166066,0.000048874677,0.0005254001,0.000028697494,0.0006537755,0.0000025097956,0.000056402274,0.00077221147],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99702775,0.0003887103,0.00081125734,0.00057054195,0.0004523118,0.0007494268],"domain_scores_gemma":[0.99825233,0.00029566803,0.00021162855,0.00072239805,0.00044212947,0.0000758513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015921877,0.00027628834,0.0005394845,0.0006738769,0.00032987935,0.000036225283,0.00040477444,0.00031739508,0.00028192587],"category_scores_gemma":[0.0001939968,0.0002134819,0.00013408877,0.0014324551,0.00073125423,0.00011106091,0.0003146271,0.0010472803,0.0000039339757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018666865,0.00016687556,0.0480501,0.00016418114,0.0006089802,0.000010789245,0.010817916,0.0001593072,0.8032685,0.000085509746,0.0002779169,0.117723055],"study_design_scores_gemma":[0.0055678706,0.0003574227,0.9103497,0.002496261,0.000027679205,0.000008067305,0.0021377103,0.00023094089,0.052201238,0.00007560927,0.026308166,0.00023927975],"about_ca_topic_score_codex":0.004183611,"about_ca_topic_score_gemma":0.00087531225,"teacher_disagreement_score":0.8622997,"about_ca_system_score_codex":0.0010962569,"about_ca_system_score_gemma":0.0020163178,"threshold_uncertainty_score":0.8705539},"labels":[],"label_agreement":null},{"id":"W4414465197","doi":"10.1158/2326-6074.cimm25-a018","title":"Abstract A018: Targeting PTPN1/PTPN2 with KQ-791 enhances NK cell cytotoxicity during tumor rechallenge","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Cytotoxic T cell; Cytotoxicity; Lymphokine-activated killer cell; Cytolysis; NK-92; Immune system; Cancer immunotherapy; Immunotherapy; Interleukin 12","score_opus":0.032745077183752684,"score_gpt":0.33717363056702915,"score_spread":0.30442855338327646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9102898,0.0707033,0.000025363674,0.0009889471,0.001171881,0.0006207649,0.000041936295,0.00016478734,0.015993197],"genre_scores_gemma":[0.9820569,0.006545042,0.00006399923,0.00015297148,0.00013830612,0.000683177,0.000043984306,0.000044439315,0.010271174],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99546194,0.00075898634,0.0005791446,0.0011178486,0.000121933575,0.0019601367],"domain_scores_gemma":[0.99798125,0.0005030364,0.00020728324,0.00073884276,0.0005145482,0.000055047665],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001318729,0.00042479605,0.00070231734,0.0005764497,0.0012188192,0.00004690622,0.0010117397,0.0006695889,0.0024835777],"category_scores_gemma":[0.00018179617,0.00035294928,0.00013464548,0.00086871383,0.0016659562,0.00015377959,0.00049711845,0.0026411568,0.00044908506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017332751,0.00021911167,0.0068170438,0.00023261704,0.0005169243,0.00004741561,0.00044631667,0.000008066184,0.98391753,0.00028323632,0.0032739341,0.0025045092],"study_design_scores_gemma":[0.002551329,0.0005409803,0.047934283,0.00026043318,0.000032616543,0.00004612864,0.0018881983,0.0000010494562,0.9184276,0.00021448142,0.027701965,0.00040096953],"about_ca_topic_score_codex":0.0010872297,"about_ca_topic_score_gemma":0.00076228724,"teacher_disagreement_score":0.07176708,"about_ca_system_score_codex":0.00052186876,"about_ca_system_score_gemma":0.0009883957,"threshold_uncertainty_score":0.99989223},"labels":[],"label_agreement":null},{"id":"W4414465199","doi":"10.1158/2326-6074.cimm25-a017","title":"Abstract A017: Neutrophil extracellular traps reprogram macrophages to an immunosuppressive phenotype in non-small-cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Immune system; Tumor microenvironment; Innate immune system; Macrophage; Neutrophil extracellular traps; Extracellular matrix; Lung cancer; Phenotype; Immunotherapy; Monocyte","score_opus":0.033842212402346486,"score_gpt":0.3616354447072392,"score_spread":0.3277932323048927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88736844,0.105598554,0.0001035934,0.0017114962,0.001671973,0.0019289454,0.00011049028,0.0001151318,0.0013913648],"genre_scores_gemma":[0.9810731,0.005236918,0.00013938632,0.0003608459,0.00011802424,0.002641811,0.00011994658,0.0000890926,0.010220883],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9942675,0.00104975,0.00083424104,0.0016188187,0.00015899894,0.0020706935],"domain_scores_gemma":[0.9971908,0.00035312906,0.0001710229,0.0015167492,0.0006598747,0.00010843923],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001310463,0.0005915058,0.00090326485,0.0012539156,0.0007278595,0.00011199895,0.0017425626,0.00088042935,0.0022900663],"category_scores_gemma":[0.000101326725,0.00056879956,0.00018156857,0.0017014258,0.0008090639,0.0002780286,0.0007084003,0.0027699291,0.00043332268],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001316109,0.0006480418,0.0031272422,0.00015203039,0.00047845521,0.00020262101,0.0013913513,0.000095648444,0.95084864,0.0008727646,0.0021220748,0.03874503],"study_design_scores_gemma":[0.0039307205,0.0006008372,0.06438024,0.0004841382,0.00007679341,0.000011112575,0.0014997064,0.000016299922,0.90586656,0.0004023185,0.022105828,0.00062544184],"about_ca_topic_score_codex":0.0045912312,"about_ca_topic_score_gemma":0.0007173044,"teacher_disagreement_score":0.10036164,"about_ca_system_score_codex":0.00060099777,"about_ca_system_score_gemma":0.00090043,"threshold_uncertainty_score":0.99967635},"labels":[],"label_agreement":null},{"id":"W4414465201","doi":"10.1158/2326-6074.cimm25-a008","title":"Abstract A008: Relationship between CD4+ T cells and cancer stem cells in squamous cancers of the oro-esophageal tract","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Q & T Research; Université de Sherbrooke","funders":"","keywords":"Cancer stem cell; CDKN2A; Tumor microenvironment; Stem cell; Flow cytometry; Cancer; Context (archaeology); Carcinogenesis; Immunotherapy","score_opus":0.07941855897713583,"score_gpt":0.3902459849650642,"score_spread":0.31082742598792834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9485118,0.045104437,0.0000020283446,0.0032106962,0.0006627944,0.0009826162,0.00013603515,0.000021148926,0.0013684669],"genre_scores_gemma":[0.98930764,0.0048197107,0.000009952184,0.00018573145,0.00009708926,0.00026147865,0.0000043718096,0.000027730559,0.0052862656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746954,0.00036141637,0.00061026256,0.00048068175,0.00041522604,0.00066284585],"domain_scores_gemma":[0.99772507,0.0011944058,0.00015697502,0.0006130734,0.00023953353,0.000070971684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012436465,0.00022071497,0.00053413544,0.0005071115,0.00025352015,0.000024380037,0.00041647037,0.00037485783,0.00025773913],"category_scores_gemma":[0.00006895215,0.00016999799,0.00013375303,0.0014247535,0.0014563488,0.00009774893,0.00015186821,0.0014354116,0.0000059413405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020066774,0.00011437086,0.79453945,0.00047892772,0.00031474486,0.000021187067,0.0010030782,0.000045959692,0.15030566,0.00012384848,0.00234809,0.048698],"study_design_scores_gemma":[0.0029421032,0.00014406603,0.8680474,0.0005481365,0.000060505776,0.0000034160228,0.0005134054,0.000010314321,0.12212933,0.000121914345,0.0053561954,0.00012322707],"about_ca_topic_score_codex":0.013283601,"about_ca_topic_score_gemma":0.0014455616,"teacher_disagreement_score":0.073507935,"about_ca_system_score_codex":0.0013429043,"about_ca_system_score_gemma":0.0023627563,"threshold_uncertainty_score":0.993287},"labels":[],"label_agreement":null},{"id":"W4414465206","doi":"10.1158/2326-6074.cimm25-b007","title":"Abstract B007: Tissue-Specific B Cell Differentiation Limits Anti-Tumor Efficacy of Radiation and Immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunotherapy; Myeloid; Tumor microenvironment; Immune system; B cell; T cell; Context (archaeology); CD40; Blockade","score_opus":0.04515627670786234,"score_gpt":0.37673717325141115,"score_spread":0.33158089654354883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8828518,0.11262201,0.00007105761,0.0013514445,0.0004790741,0.00075126707,0.000014437168,0.000033972472,0.0018249581],"genre_scores_gemma":[0.9514675,0.046738416,0.000032885422,0.00011541041,0.00008857712,0.00009239087,0.00003253412,0.000023973162,0.0014082772],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982567,0.00016185986,0.0004590012,0.00039278023,0.0003003312,0.00042934602],"domain_scores_gemma":[0.99869156,0.00035949654,0.00014043365,0.0004790444,0.0002843084,0.000045178323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006407037,0.00017520663,0.000427756,0.00059651653,0.00019644137,0.00003374232,0.00019804205,0.0001952387,0.0005687307],"category_scores_gemma":[0.000054338754,0.00015820666,0.000090332935,0.0007218222,0.00056186575,0.000089277935,0.00005018653,0.00051606545,0.000013910533],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00356014,0.0002405577,0.00910904,0.00014638758,0.00027740138,0.000005462949,0.00028499277,0.0000013713741,0.7394333,0.00011638703,0.0015684526,0.2452565],"study_design_scores_gemma":[0.005045824,0.000270595,0.59358895,0.00017860849,0.000018434772,0.0000045125926,0.00012939204,0.000009198519,0.37305582,0.000040938732,0.027571112,0.000086606895],"about_ca_topic_score_codex":0.00032710226,"about_ca_topic_score_gemma":0.000011808582,"teacher_disagreement_score":0.5844799,"about_ca_system_score_codex":0.00026197766,"about_ca_system_score_gemma":0.00037786766,"threshold_uncertainty_score":0.64514804},"labels":[],"label_agreement":null},{"id":"W4414465210","doi":"10.1158/2326-6074.cimm25-a007","title":"Abstract A007: Radiomics of anaplastic Wilms tumors: Unraveling oncogenic immune dynamics","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radiomics; Immune system; Wilms' tumor; Immunotherapy; Chromothripsis; Tumor microenvironment; Myeloid","score_opus":0.018075518893864925,"score_gpt":0.33855697529164996,"score_spread":0.320481456397785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511794,0.044024825,0.00027783102,0.00043640911,0.0006219424,0.00024316642,0.000040476243,0.000012235691,0.0031637293],"genre_scores_gemma":[0.983992,0.013203594,0.00005559722,0.000043284763,0.000100996825,0.000063166364,0.00008802713,0.000023594848,0.0024297861],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998295,0.0001215401,0.00042815332,0.0004142372,0.00018549096,0.00055557984],"domain_scores_gemma":[0.9988856,0.00008337829,0.00011067578,0.00050311495,0.00036534073,0.000051930536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005401194,0.00017029697,0.00030813846,0.00027813434,0.0001709325,0.000016882443,0.00056210184,0.00040627053,0.000048079906],"category_scores_gemma":[0.0001777395,0.0001563023,0.00014957633,0.0005526731,0.00075691665,0.0000049915593,0.00026737055,0.0006751331,0.000011357726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010573147,0.00006608324,0.0013170182,0.00012342255,0.00076410506,0.0000114293525,0.000045537614,0.00114756,0.97394806,0.00072486536,0.00080619176,0.019988423],"study_design_scores_gemma":[0.0026061684,0.00077813765,0.015655393,0.0006462023,0.00006672902,0.00003184899,0.0007331465,0.0011044733,0.9663166,0.00073045376,0.010924431,0.00040644952],"about_ca_topic_score_codex":0.0004896866,"about_ca_topic_score_gemma":0.00011945884,"teacher_disagreement_score":0.03281257,"about_ca_system_score_codex":0.00023364884,"about_ca_system_score_gemma":0.0010882723,"threshold_uncertainty_score":0.63738227},"labels":[],"label_agreement":null},{"id":"W4414465211","doi":"10.1158/2326-6074.cimm25-a022","title":"Abstract A022: Therapeutic inhibition of TREX1 elicits type I interferon–mediated antitumor immunity with minimal autoimmune toxicity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Knockout mouse; Immunotherapy; Cancer immunotherapy; Immunity; Downregulation and upregulation; Inflammation; Cancer; Interferon; Cytotoxic T cell","score_opus":0.04960441073779465,"score_gpt":0.3623942273463089,"score_spread":0.31278981660851424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561674,0.03744925,0.000028097977,0.00089628994,0.00085464434,0.00055952393,0.000059816364,0.00010002467,0.0038849625],"genre_scores_gemma":[0.99113035,0.0020971545,0.000011370186,0.00015084728,0.000016534781,0.00012814734,0.00013481553,0.000034574823,0.0062962193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965652,0.0011421255,0.0006943121,0.000503767,0.00012810223,0.00096646964],"domain_scores_gemma":[0.99705833,0.00088660145,0.00020874092,0.0008170017,0.0010044243,0.000024889781],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011166774,0.00034372596,0.0007217166,0.0008990112,0.00045473126,0.000031419957,0.0007112435,0.0005574215,0.0024115595],"category_scores_gemma":[0.00036686825,0.00028133072,0.00012764266,0.0011985763,0.002357167,0.00017324179,0.00039415713,0.0018617347,0.0003687769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013864838,0.0004988927,0.0020925996,0.000100459125,0.0010951146,0.000012625403,0.000559457,0.0000024489766,0.9705047,0.0008648582,0.0014194004,0.008984612],"study_design_scores_gemma":[0.0027429012,0.0020455178,0.17363219,0.0005486875,0.00004691481,0.000026802829,0.0011808074,0.0000043621176,0.80847555,0.00008340926,0.010968454,0.0002444013],"about_ca_topic_score_codex":0.0012488577,"about_ca_topic_score_gemma":0.0001752862,"teacher_disagreement_score":0.17153959,"about_ca_system_score_codex":0.0002988258,"about_ca_system_score_gemma":0.0010535251,"threshold_uncertainty_score":0.9999639},"labels":[],"label_agreement":null},{"id":"W4414465220","doi":"10.1158/2326-6074.cimm25-a001","title":"Abstract A001: nELISA high-throughput protein profiling applied to the RADIOHEAD cohort: insights from the largest plasma proteomics study of patients receiving checkpoint inhibitor therapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Proteomics; Pembrolizumab; Biomarker discovery; Immunotherapy; Antibody; Antibody microarray; Biomarker; Limiting; Chemokine","score_opus":0.030574614917593085,"score_gpt":0.35456210833617924,"score_spread":0.3239874934185861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98029363,0.001621545,0.0000743179,0.008822811,0.00053662405,0.008101659,0.000014068941,0.000043755314,0.00049158535],"genre_scores_gemma":[0.9955753,0.0003792566,0.00043884057,0.00041641222,0.0003674392,0.0025164937,0.00003843986,0.000043738386,0.0002240618],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99691904,0.00049523154,0.0006437281,0.0006245499,0.0007299363,0.0005875458],"domain_scores_gemma":[0.99767375,0.0006287915,0.0001771124,0.00095117965,0.00048140757,0.00008773168],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017315216,0.00024554622,0.000553082,0.00021279194,0.0005955526,0.00006888888,0.0007398448,0.00018333239,0.000055393833],"category_scores_gemma":[0.0011225473,0.0001406218,0.000071949,0.00083549664,0.0004968654,0.00005920793,0.00038482493,0.0023582599,0.000017239787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058198543,0.0025163754,0.31521684,0.00017468623,0.002119192,0.000023955407,0.01141506,0.00035333604,0.55279994,0.0006598052,0.0029159754,0.105984986],"study_design_scores_gemma":[0.0067900894,0.000746234,0.8692913,0.0005624351,0.000053775722,9.1478023e-7,0.002388232,0.00030642777,0.11407826,0.00027809857,0.0053194696,0.00018476957],"about_ca_topic_score_codex":0.004462553,"about_ca_topic_score_gemma":0.00022159703,"teacher_disagreement_score":0.55407447,"about_ca_system_score_codex":0.00034368414,"about_ca_system_score_gemma":0.0006116847,"threshold_uncertainty_score":0.9999433},"labels":[],"label_agreement":null},{"id":"W4414465312","doi":"10.1158/2326-6074.cimm25-b026","title":"Abstract B026: Targeting the ApoE-LDLR pathway disrupts MDSC-mediated systemic immunosuppression and enhances the efficacy of NK cell immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Immunosuppression; Immunotherapy; Cancer immunotherapy; Tumor microenvironment; T cell; Immune tolerance; Ex vivo; Myeloid-derived Suppressor Cell","score_opus":0.02173951862785936,"score_gpt":0.326722989498132,"score_spread":0.30498347087027267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78934574,0.20175256,0.000040458184,0.0013425635,0.004215726,0.00080760854,0.000015224555,0.00005898617,0.0024211593],"genre_scores_gemma":[0.96808326,0.02080814,0.0000037893303,0.00015005705,0.000055058565,0.00028027082,0.00007751929,0.000028004391,0.010513923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99642444,0.0014444493,0.0007585116,0.0004936308,0.00013480613,0.0007441908],"domain_scores_gemma":[0.99513555,0.0032482191,0.00032428862,0.00080311054,0.00047259455,0.000016222293],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019780635,0.0002934749,0.00045961497,0.00030838494,0.0013295433,0.00006532357,0.00092391757,0.00046028162,0.0012264176],"category_scores_gemma":[0.0004905916,0.00017133656,0.00015835054,0.00061345374,0.0017285673,0.00017007845,0.00037260036,0.0019192497,0.00022365924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015462609,0.00015228426,0.0007199608,0.00010606251,0.0004388741,0.0000015023691,0.0016549634,0.000007706019,0.97383523,0.00021763687,0.01030544,0.01101408],"study_design_scores_gemma":[0.0025657339,0.00022840781,0.017456431,0.00047760067,0.00003137001,0.000025763986,0.006713199,0.000012546236,0.8660105,0.00006438354,0.10621354,0.0002005363],"about_ca_topic_score_codex":0.0012238983,"about_ca_topic_score_gemma":0.000024104655,"teacher_disagreement_score":0.18094441,"about_ca_system_score_codex":0.00016391528,"about_ca_system_score_gemma":0.0003863569,"threshold_uncertainty_score":0.9999706},"labels":[],"label_agreement":null},{"id":"W4414465317","doi":"10.1158/2326-6074.cimm25-pr-13","title":"Abstract PR-13: Myeloid checkpoint blockade potentiates radiotherapy by modulating dendritic cells and reducing Treg-driven immunosuppression","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioresistance; Immunotherapy; Blockade; Tumor microenvironment; Immune checkpoint; Immune system; Immunogenic cell death; Myeloid; Radiation therapy; Dendritic cell","score_opus":0.021755572307615836,"score_gpt":0.33174573685429964,"score_spread":0.3099901645466838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73384714,0.26011992,0.000093711176,0.0015895145,0.0023497473,0.0006893148,0.00006080321,0.00012303262,0.0011267802],"genre_scores_gemma":[0.96176416,0.022878055,0.00020452042,0.000118250806,0.000082344966,0.00037953872,0.00009119189,0.000078272365,0.014403665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955733,0.0008068717,0.00081196503,0.001080865,0.00015683929,0.0015702017],"domain_scores_gemma":[0.9976464,0.0007660063,0.00021439987,0.0009652948,0.00036035274,0.000047561934],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011037271,0.00046528902,0.00073712296,0.00061321503,0.0011756425,0.0001094989,0.00093958527,0.0009002955,0.0016426343],"category_scores_gemma":[0.00017680829,0.00045070922,0.00016097739,0.0006172255,0.0019528656,0.00023161682,0.0006272138,0.0024080412,0.00011377171],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004911013,0.00015308158,0.0014994254,0.00015613907,0.00086314767,0.000011231482,0.0008536193,0.00012538338,0.9511738,0.0000435156,0.010008913,0.034620665],"study_design_scores_gemma":[0.0030367218,0.00017693362,0.010203768,0.00075831974,0.00005222657,0.000042236086,0.0008104488,0.00013306347,0.9547252,0.00019612782,0.029449323,0.0004156019],"about_ca_topic_score_codex":0.0020958823,"about_ca_topic_score_gemma":0.000027911681,"teacher_disagreement_score":0.23724188,"about_ca_system_score_codex":0.0006282749,"about_ca_system_score_gemma":0.00047364796,"threshold_uncertainty_score":0.9998934},"labels":[],"label_agreement":null},{"id":"W4414465321","doi":"10.1158/2326-6074.cimm25-ia06","title":"Abstract IA06: Lifestyle induced susceptibility of immune related adverse events","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse effect; Immune system; Cancer; Microbiome; Immunotherapy; Immunity; Downregulation and upregulation; Immune Dysfunction","score_opus":0.03058466263710136,"score_gpt":0.37330585407823286,"score_spread":0.3427211914411315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98441166,0.012472787,0.0000069054745,0.00038097048,0.00039610313,0.00036101567,0.00004986721,0.000012950937,0.0019077706],"genre_scores_gemma":[0.99503356,0.0027020366,0.000028522216,0.00004023786,0.000063567604,0.00009728409,0.000116703675,0.000016085094,0.0019020198],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99817336,0.00027537282,0.00045728544,0.00046129408,0.00018677296,0.00044593133],"domain_scores_gemma":[0.9983875,0.00005020277,0.00009401047,0.0007936334,0.0006010107,0.00007362491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077496277,0.0001419063,0.0002230015,0.0001903342,0.00015571338,0.000004369799,0.000437218,0.0003670108,0.0002396739],"category_scores_gemma":[0.0004633918,0.0001497175,0.00015280888,0.0003586451,0.00047813385,0.000005375615,0.00030167217,0.0003645409,0.000022378716],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007216927,0.0003152628,0.063479744,0.00010191675,0.0002322897,0.0000028550278,0.00004966544,0.000009635097,0.93210614,0.0001026316,0.0009900867,0.0018880909],"study_design_scores_gemma":[0.0018017783,0.00024746152,0.52088183,0.00008116511,0.000019825975,0.0000014050667,0.0003087059,0.0000032208197,0.47240913,0.0010289775,0.0030828489,0.00013366895],"about_ca_topic_score_codex":0.000327105,"about_ca_topic_score_gemma":0.00012136373,"teacher_disagreement_score":0.459697,"about_ca_system_score_codex":0.000075912576,"about_ca_system_score_gemma":0.0007848538,"threshold_uncertainty_score":0.6105302},"labels":[],"label_agreement":null},{"id":"W4414465336","doi":"10.1158/2326-6074.cimm25-ia05","title":"Abstract IA05: Endocrine organs in the crosshairs of the immune system","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Endocrine system; Immune system; Cancer; Adverse effect; Immunity; Immunotherapy","score_opus":0.016546669077372872,"score_gpt":0.34049742273075134,"score_spread":0.32395075365337844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96165293,0.026159167,0.0000019730905,0.0023458798,0.0002621866,0.00030617934,0.000025088657,0.000004991068,0.009241593],"genre_scores_gemma":[0.9974623,0.00087477814,0.0000018055814,0.000078143836,0.000027739241,0.00012390659,0.000011732805,0.000008589081,0.00141103],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987478,0.000258401,0.00022804816,0.0002081495,0.00015352172,0.00040407327],"domain_scores_gemma":[0.99914426,0.000075885626,0.000058492602,0.0005401076,0.00017130077,0.000009986967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000728947,0.00008900563,0.00014718215,0.00007313654,0.00017146855,0.000020703357,0.0008364155,0.0001302531,0.000027111824],"category_scores_gemma":[0.00018913034,0.000055418415,0.00008627592,0.00053937477,0.00047109576,0.0000025408335,0.0002839007,0.00039294545,0.0000049685273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001527351,0.00016234128,0.050189342,0.00013936873,0.0003095671,0.000003941427,0.00026612103,0.000060617524,0.9361227,0.0033625185,0.0035486205,0.0056820977],"study_design_scores_gemma":[0.0015163564,0.0001181303,0.44199234,0.0002173954,0.000016161583,0.0000028949216,0.006194694,0.000010558566,0.5095897,0.00020085412,0.04000864,0.00013228635],"about_ca_topic_score_codex":0.0008322345,"about_ca_topic_score_gemma":0.00035053186,"teacher_disagreement_score":0.42653304,"about_ca_system_score_codex":0.000060767466,"about_ca_system_score_gemma":0.0003271764,"threshold_uncertainty_score":0.22598973},"labels":[],"label_agreement":null},{"id":"W4414465438","doi":"10.1158/2326-6074.cimm25-b001","title":"Abstract B001: Leveraging peripheral leukocyte recruitment to improve efficacy and mitigate toxicities following checkpoint blockade","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blockade; Cytotoxic T cell; Immune checkpoint; T cell; CD8; Immune system; Cancer immunotherapy; Immunotherapy; Effector","score_opus":0.08841217000830207,"score_gpt":0.40870611114633854,"score_spread":0.32029394113803644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9386077,0.04417044,0.000013340369,0.013127728,0.00078067044,0.0015466007,0.000007163011,0.0000840484,0.0016623134],"genre_scores_gemma":[0.9793713,0.0050664516,0.00011670701,0.00081053923,0.0003553088,0.0010443794,0.000009553475,0.0000476675,0.013178072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99712276,0.00022522509,0.0004764161,0.0007025169,0.00039967438,0.001073404],"domain_scores_gemma":[0.99846876,0.00040420445,0.000060054368,0.00064944685,0.00023063122,0.0001868988],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010165091,0.0003026013,0.0006506913,0.0005795438,0.0004960592,0.000112589965,0.0002928746,0.00022868211,0.00018486919],"category_scores_gemma":[0.0003906638,0.00028417836,0.00018215133,0.0005400526,0.00053896214,0.00011333654,0.00029783885,0.001026077,0.000024528503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060696336,0.00016125575,0.0026031544,0.00029075128,0.00089604815,0.00021408517,0.0032634449,0.000020096162,0.820804,0.00004619861,0.0018994375,0.16373192],"study_design_scores_gemma":[0.008920043,0.0012635168,0.26262656,0.0022577788,0.00015671199,0.00010142524,0.005362131,0.00007369948,0.5301997,0.00012987758,0.18838248,0.0005260676],"about_ca_topic_score_codex":0.0013888219,"about_ca_topic_score_gemma":0.000066457884,"teacher_disagreement_score":0.29060426,"about_ca_system_score_codex":0.0011075162,"about_ca_system_score_gemma":0.0010221985,"threshold_uncertainty_score":0.999961},"labels":[],"label_agreement":null},{"id":"W4414465448","doi":"10.1158/2326-6074.cimm25-b020","title":"Abstract B020: NETosis-specific clipped histone H3 is a novel biomarker of response to neoadjuvant chemo-immunotherapy in resectable lung cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Nivolumab; Biomarker; Lung cancer; Immunotherapy; Chemotherapy; Pathological; Neoadjuvant therapy; Cancer","score_opus":0.0484603173720193,"score_gpt":0.4168798171258093,"score_spread":0.36841949975379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85009605,0.1439879,0.00015095479,0.0042096213,0.00029582932,0.00049353327,0.000065677574,0.000010401183,0.0006900497],"genre_scores_gemma":[0.9805989,0.011271168,0.00016257001,0.0006550278,0.00011195057,0.000504823,0.000026830065,0.00004395839,0.0066247173],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974267,0.00026069186,0.00054091215,0.0006939537,0.00027639337,0.00080136675],"domain_scores_gemma":[0.9983416,0.00021743093,0.000101947524,0.00080818875,0.00046038404,0.000070428374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014733385,0.00023829027,0.0004111696,0.0006166206,0.00015558687,0.0000254796,0.00068625755,0.00039424305,0.0006735605],"category_scores_gemma":[0.00017185652,0.00023887557,0.00011406084,0.0011463185,0.00034916963,0.000009953546,0.0003495708,0.00051892485,0.000008833071],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0112717,0.00015891752,0.004907195,0.00005347401,0.00030899938,0.000007262272,0.00035453757,0.00013523486,0.9138331,0.000027692358,0.065217204,0.0037247038],"study_design_scores_gemma":[0.0032522974,0.00025411736,0.07355043,0.00034661934,0.0000116594565,0.0000039650986,0.00028522956,0.00007842259,0.68992203,0.000024486337,0.23197977,0.00029093417],"about_ca_topic_score_codex":0.0027016408,"about_ca_topic_score_gemma":0.0001683099,"teacher_disagreement_score":0.22391102,"about_ca_system_score_codex":0.00034778024,"about_ca_system_score_gemma":0.0009937177,"threshold_uncertainty_score":0.9741063},"labels":[],"label_agreement":null},{"id":"W4414465449","doi":"10.1158/2326-6074.cimm25-b013","title":"Abstract B013: Evaluating Chi3L1 as a potential target for immunotherapy in chordoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chordoma; Immunotherapy; Immune system; Peripheral blood mononuclear cell; Monoclonal antibody; Mesenchymal stem cell; Cancer immunotherapy; Progenitor cell","score_opus":0.08709911150087546,"score_gpt":0.499722002632255,"score_spread":0.41262289113137957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9516302,0.03692725,0.000013916855,0.0057805735,0.00038336657,0.0015978233,0.000018300252,0.000032086486,0.0036165242],"genre_scores_gemma":[0.9898076,0.002373629,0.00037514837,0.0002353954,0.00009525385,0.0025084137,0.000041446423,0.000030854884,0.0045322655],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980534,0.0001454265,0.00035653432,0.00043966898,0.0002932611,0.0007117385],"domain_scores_gemma":[0.99880654,0.00032864165,0.000054708282,0.00041617578,0.0003443373,0.000049598304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010934083,0.0001638631,0.0004179298,0.0005087303,0.00022478563,0.000031530137,0.00020951843,0.00017752107,0.0009128446],"category_scores_gemma":[0.00031798947,0.00014429945,0.00012942076,0.0005383237,0.0002482323,0.00006443093,0.00008269026,0.0006306134,0.00006658739],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011024961,0.0021594393,0.13361497,0.0003171475,0.002004298,0.0002886853,0.0005568211,0.000041993815,0.26012263,0.0018902108,0.004785514,0.58319336],"study_design_scores_gemma":[0.017722588,0.001898936,0.9343789,0.0006525076,0.000053441214,0.000027713839,0.0003894606,0.00030764515,0.026825665,0.0051763332,0.012373359,0.0001934136],"about_ca_topic_score_codex":0.0017521064,"about_ca_topic_score_gemma":0.000081258935,"teacher_disagreement_score":0.80076396,"about_ca_system_score_codex":0.00049449556,"about_ca_system_score_gemma":0.0009916807,"threshold_uncertainty_score":0.9995008},"labels":[],"label_agreement":null},{"id":"W4414465452","doi":"10.1158/2326-6074.cimm25-b012","title":"Abstract B012: Bromodomain and extra-terminal domain (BET) as a therapeutic target in a mouse model of secondary hemophagocytic lymphohistiocytosis (HLH)","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bromodomain; Spleen; Cytotoxic T cell; BET inhibitor; Perforin; Adoptive cell transfer; Anemia; Lymphocyte; Peripheral blood mononuclear cell","score_opus":0.04491956817156655,"score_gpt":0.37390060098249267,"score_spread":0.3289810328109261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528984,0.037407555,0.00008472247,0.0012335841,0.000046152814,0.00082737947,0.000035016586,0.000029872828,0.0074373055],"genre_scores_gemma":[0.98705775,0.0040895576,0.00020818603,0.00022735893,0.000017449325,0.0004063504,0.000016141645,0.00003799626,0.007939232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705523,0.00032955522,0.0006683385,0.00055080774,0.00049419474,0.0009018753],"domain_scores_gemma":[0.99851465,0.0003245861,0.000090390364,0.0006514054,0.00031525904,0.000103724924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015632932,0.000246774,0.00075276126,0.0011481349,0.00020807477,0.000030068539,0.00039922152,0.00036953518,0.00071029266],"category_scores_gemma":[0.00019569305,0.00023435157,0.000112351474,0.00071746425,0.0015324852,0.00016467119,0.00029475914,0.0013247478,0.000030052017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047292677,0.0006239187,0.0162158,0.0013677411,0.000593427,0.00022708384,0.001882931,0.00009383815,0.9153812,0.0037082634,0.0005388906,0.054637633],"study_design_scores_gemma":[0.050277345,0.00312034,0.335318,0.0030813105,0.00018573838,0.00038132916,0.012849113,0.018891687,0.48630977,0.078858264,0.009167611,0.0015595207],"about_ca_topic_score_codex":0.00080139755,"about_ca_topic_score_gemma":0.00006777203,"teacher_disagreement_score":0.42907146,"about_ca_system_score_codex":0.00068030483,"about_ca_system_score_gemma":0.0041778074,"threshold_uncertainty_score":0.95565796},"labels":[],"label_agreement":null},{"id":"W4414465467","doi":"10.1158/2326-6074.cimm25-b011","title":"Abstract B011: Mast cells mediate tumor-suppressive effects in head and neck cancer through immune-microenvironmental regulation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Head and neck squamous-cell carcinoma; Downregulation and upregulation; Tumor microenvironment; Cytokine; Mast cell; Chemokine; Immune system; Interleukin 33; Immunotherapy; Cell cycle","score_opus":0.0179766665746558,"score_gpt":0.3154393146258206,"score_spread":0.2974626480511648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86902547,0.12559162,0.000013286284,0.00086624786,0.0012325415,0.0007065243,0.00007320901,0.000030527197,0.002460562],"genre_scores_gemma":[0.979064,0.010156545,0.00003585216,0.00013987778,0.000040378996,0.00050634594,0.00008824466,0.00003018273,0.009938574],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724454,0.0005174247,0.0004758074,0.0006866716,0.00008926968,0.0009863008],"domain_scores_gemma":[0.9989449,0.00034780876,0.00012947652,0.0004646622,0.00008493924,0.000028255554],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00051098515,0.00029014703,0.00053142215,0.00034872393,0.00039648794,0.000032141605,0.00040164916,0.00041555823,0.0023506405],"category_scores_gemma":[0.00004487861,0.00027909243,0.00007122772,0.00038353194,0.0019134583,0.0001731432,0.00045165996,0.0012952151,0.00020857861],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006620791,0.00018274435,0.013229332,0.00019102928,0.00020709648,0.000039613078,0.00096081354,0.000026877173,0.9673663,0.0006015405,0.0034960906,0.013036511],"study_design_scores_gemma":[0.0047224476,0.0001848615,0.4628349,0.0005302453,0.0000297956,0.00001802466,0.0004553397,0.000009583393,0.47898012,0.0006878887,0.05126274,0.0002840301],"about_ca_topic_score_codex":0.004461801,"about_ca_topic_score_gemma":0.0008144783,"teacher_disagreement_score":0.48838612,"about_ca_system_score_codex":0.00044462804,"about_ca_system_score_gemma":0.00023488367,"threshold_uncertainty_score":0.99996614},"labels":[],"label_agreement":null},{"id":"W4414465471","doi":"10.1158/2326-6074.cimm25-a013","title":"Abstract A013: Fibroblast activation protein (FAP) enhances adoptive NK cell therapy in solid tumors","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cytotoxic T cell; Extracellular matrix; Fibroblast activation protein, alpha; Stromal cell; Immunotherapy; Cell therapy; Tumor microenvironment; Fibroblast; Lymphokine-activated killer cell; Adoptive cell transfer","score_opus":0.0491018179758357,"score_gpt":0.4026614558409911,"score_spread":0.35355963786515543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98253715,0.00085995335,0.000035537083,0.004293172,0.00001599994,0.0006841634,0.0000073080078,0.000038943028,0.011527778],"genre_scores_gemma":[0.9901573,0.0005456826,0.00004054691,0.00024348113,0.000070961745,0.00055896485,0.000028198256,0.000014422329,0.0083404435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832314,0.00016732205,0.00032893248,0.0003876085,0.0002907244,0.0005022925],"domain_scores_gemma":[0.999007,0.00015058542,0.00007573563,0.00030921772,0.00040392968,0.00005352048],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005032226,0.00014710677,0.0003348557,0.00082842977,0.00015772722,0.000029045572,0.00017178613,0.00018396364,0.0012075014],"category_scores_gemma":[0.00014859869,0.00012837342,0.00008934904,0.0012124786,0.0003952338,0.00013232428,0.00006712629,0.00096960436,0.00009594273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092424866,0.00026988753,0.0008973965,0.00011967201,0.00009694774,0.000023682624,0.00032122177,0.000013886467,0.9884262,0.00009490398,0.0008349506,0.007976993],"study_design_scores_gemma":[0.0017308064,0.00028209158,0.044826597,0.0032176233,0.000003058724,0.0000012444791,0.0010531488,0.000042753054,0.94753885,0.00026358038,0.00093899807,0.00010123552],"about_ca_topic_score_codex":0.00077941903,"about_ca_topic_score_gemma":0.00013260444,"teacher_disagreement_score":0.0439292,"about_ca_system_score_codex":0.0004019284,"about_ca_system_score_gemma":0.00077449664,"threshold_uncertainty_score":0.99970555},"labels":[],"label_agreement":null},{"id":"W4414465472","doi":"10.1158/2326-6074.cimm25-a006","title":"Abstract A006: Assessment of EBV DNA methylation to guide antiviral use in EBV-associated lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DNA methylation; Lytic cycle; Methylation; CpG site; Biomarker; Lymphoma; Epstein–Barr virus","score_opus":0.0634626538248882,"score_gpt":0.4454780904948172,"score_spread":0.382015436669929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97968894,0.0020454205,0.000031754294,0.0028997564,0.00030220125,0.0007439972,0.000038607635,0.000038197886,0.014211135],"genre_scores_gemma":[0.99392796,0.0010996311,0.00008876045,0.00035672536,0.000024067265,0.00021184715,0.000048075817,0.000023053863,0.00421987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744153,0.00033782,0.00057695946,0.00043449085,0.0004918654,0.00071731035],"domain_scores_gemma":[0.9983261,0.0003871116,0.00012728346,0.0004237783,0.0006707354,0.00006495551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016033285,0.00017120519,0.0005656181,0.00096689444,0.000121436395,0.000029945804,0.00024790125,0.000343355,0.00017586659],"category_scores_gemma":[0.0011244522,0.00016940168,0.000108843946,0.001862019,0.00024641425,0.00015029182,0.00016433102,0.00053595786,0.000014614709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016327398,0.0008860842,0.6063299,0.00014039803,0.00088897423,0.000054164768,0.0005912674,0.0001197245,0.28802305,0.00095518865,0.017529812,0.08284867],"study_design_scores_gemma":[0.0051005026,0.00034355524,0.97611034,0.00042066493,0.0000364565,4.4883348e-7,0.0007164929,0.0001338087,0.012122539,0.0002603101,0.0046257675,0.00012914326],"about_ca_topic_score_codex":0.010006956,"about_ca_topic_score_gemma":0.0031296336,"teacher_disagreement_score":0.3697804,"about_ca_system_score_codex":0.0025587133,"about_ca_system_score_gemma":0.00231312,"threshold_uncertainty_score":0.9965855},"labels":[],"label_agreement":null},{"id":"W4414465958","doi":"10.1158/2326-6074.cimm25-pr-12","title":"Abstract PR-12: Single-cell profiling of tumor-infiltrating B cells reveals autoantibody repertoires and potential cross-talk with T cells","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antigen; Antibody; Immunogenicity; Somatic cell; Autoantibody; Monoclonal antibody; Antibody Repertoire; Somatic hypermutation; B cell","score_opus":0.04045549451952006,"score_gpt":0.3715541339117001,"score_spread":0.33109863939218004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779567,0.007759556,0.00002013785,0.0009561712,0.00021498452,0.0009056438,0.000060347735,0.00004290791,0.012083559],"genre_scores_gemma":[0.9824802,0.0012286024,0.0009752462,0.00010025992,0.00013932418,0.00008776465,0.00002345133,0.000037377402,0.014927721],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99669236,0.00023013089,0.0006307183,0.0006901051,0.0007400392,0.0010166364],"domain_scores_gemma":[0.9976891,0.0005676833,0.00016395452,0.000533618,0.0008881879,0.00015740216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011590339,0.0002755774,0.0006533165,0.0005101262,0.00045219937,0.00009188631,0.00035635105,0.00022310839,0.00037661463],"category_scores_gemma":[0.00016449114,0.00021067655,0.00011158775,0.0005779285,0.0020030125,0.00013568542,0.00035352167,0.0013484854,0.000013980255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002816111,0.00030161554,0.038762476,0.0015486634,0.00026925892,0.0003612996,0.00015033755,0.000031839598,0.9520019,0.00014848904,0.00052881864,0.0030791543],"study_design_scores_gemma":[0.0017779741,0.0009688892,0.0598715,0.0009127833,0.000040806335,0.00009148128,0.0003788708,0.0001535764,0.9338236,0.00010611859,0.001687266,0.00018717613],"about_ca_topic_score_codex":0.0013583483,"about_ca_topic_score_gemma":0.000043845623,"teacher_disagreement_score":0.021109022,"about_ca_system_score_codex":0.00014839695,"about_ca_system_score_gemma":0.0009921779,"threshold_uncertainty_score":0.85911405},"labels":[],"label_agreement":null},{"id":"W4414465964","doi":"10.1158/2326-6074.cimm25-ia03","title":"Abstract IA03: Therapeutic modulation of nucleic acids-induced immune activation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Innate immune system; Nucleic acid; Crosstalk; Epigenetics; Immunotherapy; DNA damage; Interferon; Immunity","score_opus":0.05852038867188895,"score_gpt":0.38309083767506785,"score_spread":0.3245704490031789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935634,0.0034658627,0.0001859854,0.0005079591,0.00022135928,0.00020642391,0.000004961872,0.000008022869,0.0018359984],"genre_scores_gemma":[0.9975935,0.0010717384,0.000015188311,0.000069140915,0.000060981052,0.00007602588,0.000041490945,0.00001137344,0.0010605179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998962,0.00011663603,0.00023532055,0.00027771795,0.00013036403,0.0002779657],"domain_scores_gemma":[0.99902433,0.000034915483,0.000069414345,0.00043051946,0.0004237643,0.000017055434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035050683,0.00010064706,0.00015008889,0.00019431002,0.00011235012,0.000014509587,0.00031948718,0.0002468719,0.00010578513],"category_scores_gemma":[0.000075499425,0.00009738454,0.00006950955,0.00027026187,0.00017830443,0.000009119284,0.00013616256,0.00026495446,0.0000160594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037033495,0.000051326228,0.0018708735,0.000022661028,0.00019578527,3.3241338e-7,0.00005994245,0.000034350578,0.95600533,0.000184657,0.00021871354,0.040985662],"study_design_scores_gemma":[0.0003603277,0.00018283875,0.2105425,0.000050787206,0.0000052744845,5.434373e-7,0.00017742011,0.000044014836,0.78674287,0.00036392483,0.0014612718,0.000068255584],"about_ca_topic_score_codex":0.00030355412,"about_ca_topic_score_gemma":0.000024339488,"teacher_disagreement_score":0.20867161,"about_ca_system_score_codex":0.000056483572,"about_ca_system_score_gemma":0.00028140476,"threshold_uncertainty_score":0.39712262},"labels":[],"label_agreement":null},{"id":"W4414465967","doi":"10.1158/2326-6074.cimm25-pr-03","title":"Abstract PR-03: Tumor-derived Complement Factor B drives tumor growth and anti-PD-1 resistance in <i>STK11</i>-mutant lung adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Complement system; Immunotherapy; Immune system; CD8; Downregulation and upregulation; Alternative complement pathway; Adenocarcinoma; Transfection; CD59","score_opus":0.025398230157341276,"score_gpt":0.34162553743679414,"score_spread":0.31622730727945286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94284743,0.052091368,0.00022719993,0.001595381,0.00026292665,0.0011771108,0.00013425827,0.000027717984,0.0016366286],"genre_scores_gemma":[0.9931908,0.005162804,0.00015592837,0.0002494343,0.00009141123,0.00055449025,0.00006906869,0.000056091445,0.0004699528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959911,0.00048532634,0.00053957064,0.0011689434,0.00049475516,0.0013202848],"domain_scores_gemma":[0.99838907,0.000120933335,0.00010995114,0.00079953024,0.00042949436,0.00015103065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006792309,0.00035580574,0.0004780231,0.0005877179,0.00035538452,0.00010203094,0.0008133587,0.00028063383,0.00016985276],"category_scores_gemma":[0.0003470506,0.0003699158,0.00010246392,0.0007787589,0.0008566809,0.00001778995,0.00097622,0.0011624496,0.000012323763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080122077,0.00010470399,0.008190091,0.0002528721,0.00026621408,0.00015497193,0.00016150487,0.000008493632,0.9877857,0.0007269927,0.0011993557,0.00034788664],"study_design_scores_gemma":[0.0022563303,0.0001858152,0.14784485,0.0002879451,0.000013961013,0.000015722248,0.00041124926,0.000029694345,0.8431061,0.00032236744,0.005184216,0.0003417469],"about_ca_topic_score_codex":0.00064273004,"about_ca_topic_score_gemma":0.0014056092,"teacher_disagreement_score":0.14467959,"about_ca_system_score_codex":0.0003520759,"about_ca_system_score_gemma":0.0011823289,"threshold_uncertainty_score":0.9998753},"labels":[],"label_agreement":null},{"id":"W4414465977","doi":"10.1158/2326-6074.cimm25-pr-02","title":"Abstract PR-02: Loss of tumor-intrinsic type I IFN facilitates and predicts bone-metastatic progression in advanced prostate cancer and drives radiotherapeutic resistance","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prostate cancer; Bone metastasis; Metastasis; Immunotherapy; Tumor microenvironment; Lymph node; Cancer","score_opus":0.03552965024291679,"score_gpt":0.40923102450864074,"score_spread":0.373701374265724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73486227,0.2605345,6.7920746e-7,0.0026966832,0.00010299896,0.0014820428,0.00005360207,0.0000243295,0.0002428736],"genre_scores_gemma":[0.91376066,0.0803509,0.00018598037,0.000046934514,0.000019589897,0.00075596274,0.000018149722,0.000026313177,0.0048354967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974582,0.00022306383,0.00046683158,0.0006345245,0.0004211814,0.0007961871],"domain_scores_gemma":[0.9984781,0.00037313186,0.00010473635,0.00038373357,0.00053898845,0.00012130097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075076876,0.00024465102,0.0006445133,0.00071203086,0.00017458336,0.000031565003,0.0001611818,0.00011725291,0.00006699143],"category_scores_gemma":[0.00023265582,0.00019037402,0.00003993363,0.0011064798,0.0019228536,0.00017133642,0.0001770149,0.00079764583,0.0000026881396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02299875,0.0004925047,0.6415744,0.0050080917,0.00072719366,0.0004663535,0.0036110845,0.00001266461,0.12628107,0.00037132035,0.0005272815,0.1979293],"study_design_scores_gemma":[0.010226326,0.0010280579,0.9363623,0.0046449425,0.000066682755,0.000021451639,0.0013272262,0.000046129135,0.040189553,0.0010354567,0.004828346,0.00022351612],"about_ca_topic_score_codex":0.0003279088,"about_ca_topic_score_gemma":0.00037666847,"teacher_disagreement_score":0.2947879,"about_ca_system_score_codex":0.00042694755,"about_ca_system_score_gemma":0.0013138425,"threshold_uncertainty_score":0.7763227},"labels":[],"label_agreement":null},{"id":"W4414465979","doi":"10.1158/2326-6074.cimm25-ia04","title":"Abstract IA04: Reprogramming the tumor–immune microenvironment: From stromal circuits to engineered microbial immunotherapies","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reprogramming; Immunotherapy; Stromal cell; Cancer immunotherapy; Tumor microenvironment; Immune system; Immune checkpoint; Chemokine","score_opus":0.022969191705989617,"score_gpt":0.28945892621860436,"score_spread":0.26648973451261476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92758477,0.06729108,0.0006166831,0.0008399688,0.0017777405,0.0008845202,0.00013913676,0.00026765882,0.0005984537],"genre_scores_gemma":[0.9960361,0.002004088,0.00021890434,0.00013873109,0.00020348749,0.00053921324,0.000033844568,0.0000994539,0.0007261358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974263,0.000074411226,0.00052990834,0.00049592706,0.0003100748,0.0011634282],"domain_scores_gemma":[0.99819607,0.00040749996,0.00004454578,0.0011717431,0.000109325185,0.00007081384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059262343,0.00034505548,0.00041428505,0.00037437654,0.00041039466,0.00015798939,0.0012574153,0.00021275278,0.00042689734],"category_scores_gemma":[0.00008299131,0.00030558006,0.000143107,0.0008100147,0.00044807515,0.00014414404,0.0002837908,0.001342029,0.0002263594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012983283,0.000034894012,0.00036291327,0.000045810706,0.00077771064,0.0000171576,0.00095277437,0.001301474,0.94664854,0.00009092734,0.001378843,0.048259124],"study_design_scores_gemma":[0.0018766158,0.00012310402,0.06343025,0.0004295717,0.000051278894,0.000009613821,0.0010069885,0.00012938748,0.7640928,0.0006047705,0.16769461,0.0005509811],"about_ca_topic_score_codex":0.0011810937,"about_ca_topic_score_gemma":0.00013852041,"teacher_disagreement_score":0.1825557,"about_ca_system_score_codex":0.0008742532,"about_ca_system_score_gemma":0.00016895923,"threshold_uncertainty_score":0.9999396},"labels":[],"label_agreement":null},{"id":"W4414465995","doi":"10.1158/2326-6074.cimm25-b003","title":"Abstract B003: Oncolytic VSVd51-LIGHT and folfirinox chemotherapy increases anti-tumor immune response in pancreatic ductal adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Oncolytic virus; Immune system; Pancreatic cancer; Immunotherapy; Tumor microenvironment; FOLFIRINOX; Cytokine; Cancer; Oncolytic adenovirus","score_opus":0.021452818381954876,"score_gpt":0.3614463486068182,"score_spread":0.3399935302248633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92128414,0.07561538,0.0000033233441,0.0016313342,0.000097856544,0.0006734732,0.00003172223,0.000015298354,0.0006474963],"genre_scores_gemma":[0.9879683,0.009796148,0.000022969767,0.00013918169,0.000078143996,0.0005682737,0.000033478962,0.000034976776,0.0013584861],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99719775,0.00050797214,0.00036056523,0.00073406834,0.00027167337,0.0009279493],"domain_scores_gemma":[0.99869967,0.00021131155,0.00006175067,0.00069699425,0.00020773437,0.00012253244],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010157672,0.00026195688,0.00041140255,0.0005067061,0.0002481792,0.00007161399,0.00045556593,0.00022639867,0.00013867926],"category_scores_gemma":[0.00042901756,0.00024798576,0.00008841755,0.0006048866,0.0005444237,0.000015942822,0.0004042199,0.0005391407,0.000023582748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010332575,0.00032422406,0.22958791,0.000078392055,0.0004914926,0.0002509435,0.00008400291,0.0000021956312,0.7547442,0.000052459192,0.0009587497,0.0030929102],"study_design_scores_gemma":[0.0037622203,0.00070824096,0.8228063,0.00015009992,0.000015512911,0.00005504907,0.00021356915,0.0000067309443,0.16668504,0.00013915478,0.0052691777,0.00018889204],"about_ca_topic_score_codex":0.0046449043,"about_ca_topic_score_gemma":0.000679941,"teacher_disagreement_score":0.5932184,"about_ca_system_score_codex":0.0003452165,"about_ca_system_score_gemma":0.0013761723,"threshold_uncertainty_score":0.99999726},"labels":[],"label_agreement":null},{"id":"W4414465996","doi":"10.1158/2326-6074.cimm25-pr-14","title":"Abstract PR-14: Unraveling the sexually dimorphic immune microenvironment in gastric cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Immune system; CD8; Cytotoxic T cell; Antigen; Sexual dimorphism; Immunotherapy; Tumor microenvironment; CDH1","score_opus":0.05215571832167075,"score_gpt":0.38088370511138075,"score_spread":0.32872798678971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414465996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8182487,0.15700097,0.000015583613,0.021052243,0.0007449546,0.0010993691,0.000019900965,0.000033497843,0.001784776],"genre_scores_gemma":[0.94783795,0.043058157,0.000029838717,0.0008839571,0.0001427808,0.0009999545,0.000015960972,0.000036063426,0.006995349],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9970743,0.00027260048,0.0006092454,0.0005674195,0.00045290065,0.0010235141],"domain_scores_gemma":[0.998491,0.0003525699,0.00010089299,0.0008216703,0.0001765603,0.000057330715],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017641899,0.00025532386,0.0004536515,0.0006400325,0.00036242112,0.00004796529,0.0005866564,0.00026458802,0.0018285009],"category_scores_gemma":[0.00011042452,0.0001869399,0.00013899998,0.0014643931,0.0010577994,0.00007352836,0.00027266028,0.001735752,0.000053803793],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051167523,0.00032799604,0.052227225,0.00020231685,0.0009523684,0.00007936685,0.000813273,0.00006954621,0.7600099,0.00008355394,0.0034843928,0.17663334],"study_design_scores_gemma":[0.0045204144,0.00024238268,0.90955704,0.0008862627,0.000053217023,0.000029479137,0.0012041392,0.000042804364,0.02755732,0.0001048217,0.055597402,0.00020468679],"about_ca_topic_score_codex":0.0051391064,"about_ca_topic_score_gemma":0.0007112092,"teacher_disagreement_score":0.85732985,"about_ca_system_score_codex":0.0015333856,"about_ca_system_score_gemma":0.001387966,"threshold_uncertainty_score":0.99908394},"labels":[],"label_agreement":null},{"id":"W4414466001","doi":"10.1158/2326-6074.cimm25-pr-05","title":"Abstract PR-05: Sumoylation blockade exposes the dark epigenome to drive ZBP1 viral mimicry for cancer immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Necroptosis; Innate immune system; Cancer immunotherapy; Epigenome; Effector; Cancer cell; SUMO protein; Chromatin","score_opus":0.03855332204006988,"score_gpt":0.35829045335405285,"score_spread":0.31973713131398296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.923139,0.063201725,0.0023582673,0.0035675867,0.0033345849,0.0027288033,0.00026009273,0.0004003597,0.0010096072],"genre_scores_gemma":[0.9844869,0.009133863,0.0002338902,0.00035123108,0.0003735147,0.0035514645,0.000027304925,0.0001472153,0.0016946518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771136,0.000061209335,0.00045215708,0.00041527607,0.00029258785,0.0010673932],"domain_scores_gemma":[0.9981224,0.00064192666,0.000052514108,0.00071543775,0.0004023431,0.00006538859],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006410277,0.0002997673,0.00036967022,0.00045252906,0.00044636274,0.00010196031,0.0009315892,0.00027517922,0.00014860935],"category_scores_gemma":[0.00008936901,0.00024999457,0.00013457866,0.0008010031,0.00033820164,0.00018433236,0.00012658362,0.0008252921,0.00003305024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065218465,0.000033042048,0.0008065611,0.0001264023,0.0007802053,0.0000031630834,0.0015834236,0.005112944,0.906146,0.0004686373,0.00838491,0.07590252],"study_design_scores_gemma":[0.0026335241,0.00032317336,0.031697378,0.0003566891,0.00005711769,0.0000028795357,0.0008404196,0.0006343745,0.51475614,0.0057682213,0.44228202,0.0006480612],"about_ca_topic_score_codex":0.00070530275,"about_ca_topic_score_gemma":0.0006287543,"teacher_disagreement_score":0.4338971,"about_ca_system_score_codex":0.0012330335,"about_ca_system_score_gemma":0.00051837973,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W4414466003","doi":"10.1158/2326-6074.cimm25-b004","title":"Abstract B004: Route dependent T-cell activation by mRNA cluster therapies","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Peripheral blood mononuclear cell; Immunogenicity; Flow cytometry; Messenger RNA; Cell; T cell; Immunotherapy; CD8; Cancer vaccine","score_opus":0.053018574797816256,"score_gpt":0.40494907590402934,"score_spread":0.3519305011062131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91889566,0.016534615,0.0000801547,0.017370569,0.0003757936,0.0013109833,0.000024521047,0.00009070237,0.045317],"genre_scores_gemma":[0.83821005,0.0057142773,0.000030270849,0.0006570776,0.00014645472,0.0004826727,0.000052112213,0.000043568125,0.15466353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969571,0.00035852825,0.00035308005,0.00058583135,0.0007768401,0.0009685789],"domain_scores_gemma":[0.99775755,0.00058978784,0.00005937921,0.00082316523,0.0006610124,0.00010908423],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014203568,0.00021868094,0.00039020297,0.0006389248,0.00032124828,0.000085330445,0.00049133936,0.00037353608,0.0072064023],"category_scores_gemma":[0.00016203162,0.00019192658,0.00011858978,0.0007953858,0.00059395866,0.00015069327,0.00028032198,0.0018906455,0.00022640369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024649033,0.0002782587,0.008289086,0.00012761872,0.0004661818,0.000014676295,0.00038328586,0.000003926602,0.8761973,0.00008415427,0.035719827,0.07597078],"study_design_scores_gemma":[0.005314747,0.00039243454,0.047958214,0.0002253162,0.000026273765,0.000009814951,0.0009276779,0.000042092975,0.68448514,0.00046866486,0.25993836,0.00021126162],"about_ca_topic_score_codex":0.0019208571,"about_ca_topic_score_gemma":0.000102728874,"teacher_disagreement_score":0.22421852,"about_ca_system_score_codex":0.0011164527,"about_ca_system_score_gemma":0.0010645494,"threshold_uncertainty_score":0.99370116},"labels":[],"label_agreement":null},{"id":"W4414466009","doi":"10.1158/2326-6074.cimm25-a019","title":"Abstract A019: Timed intracranial therapy with NK cells and NK cell-derived extracellular vesicles following temozolomide exhibits curative potential in mesenchymal glioblastoma model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Temozolomide; Glioma; Mesenchymal stem cell; Immunotherapy; NKG2D; In vivo; Immune system; Chemotherapy; CD8; Tumor microenvironment","score_opus":0.01584222301064171,"score_gpt":0.3088102247314494,"score_spread":0.2929680017208077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563122,0.041070353,0.0008282085,0.00037779054,0.00017219286,0.0008013208,0.0000318189,0.000026275566,0.0003798404],"genre_scores_gemma":[0.9937492,0.0039876876,0.0006393904,0.00007879338,0.00009164659,0.00025002254,0.00003085783,0.000058015754,0.0011144127],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99690276,0.00042179137,0.0004406421,0.0009647798,0.00034470618,0.0009253043],"domain_scores_gemma":[0.9987971,0.00010042648,0.00010947332,0.0006202038,0.00023414257,0.00013866345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071289233,0.0003685517,0.0003922143,0.0003196801,0.00030363473,0.00008767419,0.00056635286,0.00046754,0.00004569542],"category_scores_gemma":[0.000077843266,0.0003444714,0.00012416924,0.00042604734,0.00084018987,0.000035648252,0.0003483192,0.00083109277,0.000011018467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003745692,0.00028464783,0.0010205025,0.00005796597,0.0002517232,0.00026527166,0.0002738739,0.0013251178,0.98709595,0.00003295179,0.0003367757,0.005309513],"study_design_scores_gemma":[0.0040842914,0.00050030486,0.0037113212,0.00012596653,0.000024601473,0.000009990575,0.0005668413,0.002794382,0.98721564,0.00029139826,0.0003115553,0.00036372594],"about_ca_topic_score_codex":0.0001403753,"about_ca_topic_score_gemma":0.00017177446,"teacher_disagreement_score":0.037436973,"about_ca_system_score_codex":0.000118300726,"about_ca_system_score_gemma":0.0008656519,"threshold_uncertainty_score":0.99990076},"labels":[],"label_agreement":null},{"id":"W4414466019","doi":"10.1158/2326-6074.cimm25-ia07","title":"Abstract IA07: Tumor editing suppresses innate and adaptive anti-tumor immunity and is reversed by inhibiting DNA methylation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"DNA methylation; Carcinogenesis; Immune system; Innate immune system; Acquired immune system; Gene; Mammary tumor; Tumor microenvironment; Cancer","score_opus":0.034316785893821714,"score_gpt":0.3543683575743931,"score_spread":0.3200515716805714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9600618,0.037689213,0.0001400234,0.0005831315,0.00014304121,0.0002630483,0.000069347494,0.00001087143,0.0010395403],"genre_scores_gemma":[0.9946563,0.0045536645,0.0001231365,0.00011584508,0.00009859475,0.00006441887,0.00006748857,0.000017797338,0.00030273484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984461,0.00028875063,0.00026898785,0.00045091257,0.00014669127,0.0003985526],"domain_scores_gemma":[0.99905896,0.00015921815,0.00010833738,0.00023804931,0.00038432714,0.000051103678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010312796,0.00015653123,0.00020354368,0.00016407526,0.00041449323,0.000064112406,0.00015374528,0.00017440744,0.000031895084],"category_scores_gemma":[0.00048763206,0.00016205649,0.00003205163,0.00024366452,0.00046864603,0.000016710084,0.0003645434,0.0004570623,0.0000018952206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103991326,0.000023227121,0.0046973196,0.000049038827,0.00010796126,0.0000026332943,0.00013381567,0.000003996403,0.98504585,0.00005579864,0.00085548265,0.008920868],"study_design_scores_gemma":[0.00063194835,0.00013719017,0.032975283,0.00008105521,0.000014710014,0.0000020564094,0.000694433,0.00007303468,0.95795995,0.00047684298,0.0068109115,0.00014257643],"about_ca_topic_score_codex":0.00046255122,"about_ca_topic_score_gemma":0.0000476335,"teacher_disagreement_score":0.034594536,"about_ca_system_score_codex":0.00004184646,"about_ca_system_score_gemma":0.00017698867,"threshold_uncertainty_score":0.6608472},"labels":[],"label_agreement":null},{"id":"W4414466025","doi":"10.1158/2326-6074.cimm25-pr-09","title":"Abstract PR-09: Meta-Analysis of Neoantigens: Insights from the Cancer Epitope Database and Analysis Resource (CEDAR)","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epitope; Human leukocyte antigen; Cancer; Gene; Colorectal cancer; Mutation; MHC class I; Major histocompatibility complex","score_opus":0.175173290439086,"score_gpt":0.45151718684010383,"score_spread":0.27634389640101786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69044274,0.28833213,0.000026346604,0.016833458,0.000062353334,0.00047521433,0.0010051577,0.000016611739,0.0028059601],"genre_scores_gemma":[0.9555741,0.03519163,0.00010493807,0.00080922415,0.0001134184,0.00033584365,0.00046272943,0.000020839307,0.0073872725],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9963327,0.000691697,0.0006194685,0.0008085191,0.0009065143,0.00064112537],"domain_scores_gemma":[0.9951931,0.0023590864,0.00013837374,0.0013643125,0.0008039889,0.00014110014],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012647634,0.0002538019,0.0016505759,0.001547788,0.0005054744,0.00005344685,0.00074209925,0.0002048388,0.003785851],"category_scores_gemma":[0.00038725766,0.0001493416,0.00089409284,0.0058251168,0.0018169788,0.000085159976,0.00074265694,0.0012454152,0.000016665792],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022921504,0.00023429783,0.12576294,0.00015258697,0.7748339,0.00009680367,0.00095578335,0.00013184932,0.07084709,0.0017072377,0.007849131,0.015136212],"study_design_scores_gemma":[0.00071674393,0.00010461998,0.74390984,0.000059622176,0.15100126,0.0000015717025,0.0007476548,0.00071067567,0.012944724,0.00025512694,0.089356236,0.0001919183],"about_ca_topic_score_codex":0.048524637,"about_ca_topic_score_gemma":0.007785834,"teacher_disagreement_score":0.62383264,"about_ca_system_score_codex":0.000121007666,"about_ca_system_score_gemma":0.00066108425,"threshold_uncertainty_score":0.99712485},"labels":[],"label_agreement":null},{"id":"W4414466036","doi":"10.1158/2326-6074.cimm25-pr-07","title":"Abstract PR-07: Immunosuppressive γδ T cells limit anti-tumor immunity in ICI-resistant tumors from autoimmune-prone mice","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoimmunity; Immune system; Immunotherapy; Immunity; T cell; Nod; Tumor microenvironment; Genetic predisposition; Phenotype","score_opus":0.042586539552492586,"score_gpt":0.36277736093828655,"score_spread":0.32019082138579397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9035192,0.08448392,0.0000066316093,0.0033246942,0.0011767792,0.0016644833,0.0001873255,0.0001314497,0.0055054943],"genre_scores_gemma":[0.9867733,0.0075940927,0.00009378532,0.000621329,0.00013697993,0.00071247877,0.00012849402,0.00008451698,0.0038550054],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9944178,0.0007784224,0.0012965822,0.0010789793,0.000732822,0.0016954084],"domain_scores_gemma":[0.9960869,0.0010289737,0.000295672,0.0017828523,0.00067539106,0.0001301952],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018992681,0.00056415,0.0012810552,0.0012271504,0.00058470893,0.0001226429,0.0012866253,0.000535992,0.002617502],"category_scores_gemma":[0.00035642946,0.00052926294,0.00033398217,0.0019523957,0.0018203838,0.00025842644,0.0006176082,0.0032621655,0.0002587058],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014061895,0.0007607908,0.006667489,0.00025122028,0.001218241,0.00044861317,0.0009011747,0.00001143214,0.96126264,0.00007957376,0.0038575386,0.010479404],"study_design_scores_gemma":[0.007386403,0.000429722,0.62943554,0.002219351,0.000078820354,0.00001788459,0.0025009234,0.0000534114,0.34018153,0.0002457556,0.017021893,0.0004287879],"about_ca_topic_score_codex":0.031690106,"about_ca_topic_score_gemma":0.00079362205,"teacher_disagreement_score":0.62276804,"about_ca_system_score_codex":0.0017450739,"about_ca_system_score_gemma":0.0028460205,"threshold_uncertainty_score":0.99971586},"labels":[],"label_agreement":null},{"id":"W4414466039","doi":"10.1158/2326-6074.cimm25-a015","title":"Abstract A015: The emerging role of basophils in non-muscle-invasive bladder cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Immune system; Bladder cancer; Granzyme B; Tumor microenvironment; Immunotherapy; Flow cytometry; Basophil; Granzyme; FOXP3","score_opus":0.033875515773117454,"score_gpt":0.39130752771747984,"score_spread":0.35743201194436236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8747672,0.1062342,0.0000016134207,0.012238356,0.00039948462,0.0007939498,0.000018086464,0.000021079892,0.0055260723],"genre_scores_gemma":[0.9620944,0.033494852,0.000007654861,0.00030339838,0.0002688374,0.00072985096,0.0000069323046,0.000031683998,0.003062376],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99745864,0.0002898227,0.0005231342,0.00045430788,0.00043265696,0.000841469],"domain_scores_gemma":[0.99748015,0.0009572825,0.0001172053,0.0008303158,0.00055435975,0.00006066899],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011222276,0.00021972596,0.0005764883,0.00073074485,0.0002274993,0.000022584074,0.0005493807,0.00025887243,0.00097026996],"category_scores_gemma":[0.0004697087,0.00016852912,0.00016415851,0.001317103,0.0010849009,0.000096775955,0.00020610167,0.0012964886,0.000027169042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060438463,0.00048724783,0.07153584,0.0006392663,0.0012705061,0.00012263816,0.0054686293,0.00017522534,0.59116745,0.00048587137,0.010409276,0.31219423],"study_design_scores_gemma":[0.0025456361,0.00021597971,0.8701265,0.0014952901,0.00007026006,0.000014573787,0.006384313,0.0000760282,0.07190944,0.00042524136,0.046552114,0.00018462827],"about_ca_topic_score_codex":0.011300175,"about_ca_topic_score_gemma":0.0019941942,"teacher_disagreement_score":0.79859066,"about_ca_system_score_codex":0.000518108,"about_ca_system_score_gemma":0.0025983364,"threshold_uncertainty_score":0.99994296},"labels":[],"label_agreement":null},{"id":"W4414466041","doi":"10.1158/2326-6074.cimm25-a020","title":"Abstract A020: TLR10 as a key innate immune effector regulating metabolic and redox homeostasis in head and neck squamous cell carcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Innate immune system; Head and neck squamous-cell carcinoma; Immune system; Cancer; Effector; Context (archaeology); Cancer cell","score_opus":0.01828997316745211,"score_gpt":0.3262717455150127,"score_spread":0.3079817723475606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6899848,0.30775496,0.000001752473,0.00038071987,0.0004029254,0.00037803466,0.000026277881,0.000009934128,0.001060587],"genre_scores_gemma":[0.9730632,0.024832487,0.00006342832,0.00011432757,0.0002739049,0.00024826676,0.000037111175,0.0000343145,0.0013329978],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975926,0.00032055163,0.0003794029,0.000734412,0.00018122735,0.0007917635],"domain_scores_gemma":[0.99891204,0.00012061079,0.00008335046,0.00057640974,0.00020890697,0.000098701035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00084874174,0.00026121532,0.00047805344,0.00041473302,0.00024258433,0.00006519166,0.00030546013,0.00039335305,0.000044483768],"category_scores_gemma":[0.00032153213,0.00026305168,0.000076210286,0.00053165987,0.0005849875,0.000014325003,0.00053802313,0.000674172,0.000007655689],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090896693,0.000073804316,0.013656886,0.00017806594,0.00008162938,0.000009185969,0.00033948323,0.000006428129,0.9316098,0.00016597523,0.0005944068,0.052375358],"study_design_scores_gemma":[0.004052611,0.00028420714,0.5429358,0.00007642588,0.000032003485,0.000021999525,0.0003097426,0.000015337679,0.36976558,0.00018878428,0.082033664,0.00028387748],"about_ca_topic_score_codex":0.0041671973,"about_ca_topic_score_gemma":0.00072097435,"teacher_disagreement_score":0.5618442,"about_ca_system_score_codex":0.000061511535,"about_ca_system_score_gemma":0.0005074424,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W4414466042","doi":"10.1158/2326-6074.cimm25-a023","title":"Abstract A023: Myeloid checkpoint blockade potentiates radiotherapy by modulating dendritic cells and reducing Treg-driven immunosuppression","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radioresistance; Immunotherapy; Blockade; Tumor microenvironment; Immune checkpoint; Immune system; Immunogenic cell death; Myeloid; Radiation therapy; Dendritic cell","score_opus":0.02251415690197339,"score_gpt":0.33439144070793575,"score_spread":0.31187728380596236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414466042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7343671,0.25965366,0.00009409539,0.0015842479,0.0023879614,0.0006226919,0.000060585,0.00012120688,0.001108467],"genre_scores_gemma":[0.9618115,0.022953577,0.00021452518,0.000120433695,0.000078936166,0.00034120554,0.00008712938,0.00007549761,0.014317235],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99570405,0.0007718272,0.0007867916,0.0010493771,0.00015097183,0.0015370039],"domain_scores_gemma":[0.99769133,0.0007756336,0.00020099376,0.0009404908,0.00034561037,0.000045935558],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010818262,0.0004499604,0.0007174383,0.000612167,0.001166409,0.000104948755,0.0009178353,0.00087445497,0.0016879586],"category_scores_gemma":[0.00016834337,0.0004371865,0.00015884187,0.00061567605,0.0019233301,0.00022063535,0.0006131385,0.0023458672,0.00012070491],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045081408,0.00013905588,0.0013138502,0.00013973739,0.0008334386,0.00001084154,0.0007160477,0.00009508411,0.94808567,0.00005161545,0.010125757,0.038038086],"study_design_scores_gemma":[0.0028539891,0.00015956769,0.009588196,0.00070174236,0.000049067876,0.000038765942,0.0007703167,0.00011019308,0.95356095,0.00019755642,0.031573508,0.00039615252],"about_ca_topic_score_codex":0.0018489686,"about_ca_topic_score_gemma":0.000020296085,"teacher_disagreement_score":0.23670007,"about_ca_system_score_codex":0.0006197844,"about_ca_system_score_gemma":0.00043842194,"threshold_uncertainty_score":0.9999558},"labels":[],"label_agreement":null},{"id":"W4414490560","doi":"10.1158/2326-6074.cimm25-b018","title":"Abstract B018: Gut microbiome influences the antitumor response to BCG immunotherapy in bladder cancer","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Microbiome; Gut flora; ELISPOT; Immunotherapy; Feces; Bladder cancer; Colorectal cancer; Gut microbiome","score_opus":0.058597466461270495,"score_gpt":0.4462746043513444,"score_spread":0.3876771378900739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91635585,0.04212251,0.0000030882413,0.03718841,0.0005683965,0.001396383,0.00006464374,0.000044348046,0.002256394],"genre_scores_gemma":[0.97745985,0.0065834415,0.000033736604,0.0032311336,0.000120742545,0.001695442,0.0000061267456,0.000036969792,0.010832542],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972035,0.0004451583,0.00043861198,0.00059193413,0.00036602915,0.0009547532],"domain_scores_gemma":[0.99813414,0.00048673377,0.00005433595,0.00083255756,0.00040494223,0.00008732286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013721546,0.0002607701,0.00047061316,0.0008831368,0.0003471488,0.00006823044,0.00063672574,0.00021934845,0.0015601619],"category_scores_gemma":[0.00019385357,0.00018106426,0.00010906031,0.00196091,0.0008038913,0.000103952334,0.0001954939,0.0010080917,0.00019224799],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014803314,0.00026974155,0.054841544,0.00005963601,0.0008435238,0.000108671804,0.0015240181,0.000020479407,0.88556886,0.0000806247,0.009617197,0.032262396],"study_design_scores_gemma":[0.0034492852,0.00038213533,0.8477,0.00046947622,0.000030812273,0.0000148555755,0.0006065071,0.0000023894452,0.039806508,0.0001640006,0.10721124,0.00016278506],"about_ca_topic_score_codex":0.010146419,"about_ca_topic_score_gemma":0.0013202067,"teacher_disagreement_score":0.8457624,"about_ca_system_score_codex":0.00091710646,"about_ca_system_score_gemma":0.0025372468,"threshold_uncertainty_score":0.9993526},"labels":[],"label_agreement":null},{"id":"W4414490756","doi":"10.1158/2326-6074.cimm25-b016","title":"Abstract B016: Evaluation of the anti-breast cancer activity of isolates and semi-synthesized compounds from <i>Alstonia scholaris</i> leaves and <i>Psorospermum guineense</i> twigs","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Biological Research and Disease Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Phytochemical; Apocynaceae; Cancer; Cytotoxicity; Lung cancer; Terpene; Cancer cell","score_opus":0.044747573438255264,"score_gpt":0.3833544308863079,"score_spread":0.33860685744805263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92623967,0.07065583,0.000003160485,0.0016972085,0.000080789614,0.00035992006,0.000498067,0.0000044842295,0.00046089935],"genre_scores_gemma":[0.981461,0.018174967,0.000008980863,0.00006637674,0.00004457439,0.000095322124,0.000011773811,0.0000083935365,0.00012864161],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981646,0.0005530125,0.00022055345,0.00042279199,0.00027691788,0.00036215386],"domain_scores_gemma":[0.9983301,0.0002769012,0.00009605525,0.00039861057,0.0008412399,0.00005707153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011425148,0.00015278117,0.00031822117,0.00006928028,0.00025304907,0.000025201021,0.0003115598,0.00024213253,0.00006661004],"category_scores_gemma":[0.00080950744,0.000103801125,0.000072801115,0.00023528404,0.0018456096,0.0000124119015,0.00066151837,0.0003960372,6.826657e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007780233,0.00007592126,0.12545876,0.000054451604,0.00036118078,1.9049737e-7,0.000034849323,0.000003702388,0.8574129,0.000022437327,0.00093993684,0.014857676],"study_design_scores_gemma":[0.00080331025,0.000055435772,0.605428,0.00009452569,0.00004056419,9.695062e-7,0.00009579469,0.00002919748,0.39246914,0.0003458762,0.0005693078,0.00006787976],"about_ca_topic_score_codex":0.0016758868,"about_ca_topic_score_gemma":0.0003108669,"teacher_disagreement_score":0.47996923,"about_ca_system_score_codex":0.00004826263,"about_ca_system_score_gemma":0.00058883015,"threshold_uncertainty_score":0.68002254},"labels":[],"label_agreement":null},{"id":"W4414490802","doi":"10.1158/2326-6074.cimm25-a014","title":"Abstract A014: Chronic stress impairs anti-tumor immunity in ovarian cancer via MDSCs and notch pathway activation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Tumor microenvironment; Myeloid-derived Suppressor Cell; Immunosuppression; Chronic stress; Ovarian cancer; Infiltration (HVAC); Bone marrow; Cancer","score_opus":0.03504871739862629,"score_gpt":0.37237237456404965,"score_spread":0.33732365716542334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487883,0.04428444,0.000023360573,0.004331319,0.00043828465,0.0010227327,0.00004062662,0.000055464778,0.0010154978],"genre_scores_gemma":[0.9805419,0.016720181,0.000012167306,0.00017732235,0.00030414696,0.0006763786,0.000041000112,0.000044563756,0.0014823605],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99685854,0.0004916652,0.0005504054,0.00063754845,0.00040439062,0.0010574326],"domain_scores_gemma":[0.9979113,0.00055823073,0.00013377373,0.00083215715,0.00045082692,0.00011374686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011720642,0.00032071772,0.0007116427,0.00099256,0.00040848035,0.00006535328,0.00039218404,0.0003621173,0.0006938858],"category_scores_gemma":[0.00030118984,0.00030534124,0.00010771553,0.001219507,0.0009513873,0.0002464679,0.0002498217,0.0019440748,0.000019371224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056356234,0.0005181326,0.10696981,0.0010117823,0.0005040073,0.00015101145,0.0012018152,0.0000659647,0.7270377,0.0001549861,0.0009900157,0.15575911],"study_design_scores_gemma":[0.0039169043,0.00032338724,0.8368413,0.0015315493,0.00003161037,0.000036912927,0.0009577412,0.00015295998,0.14389233,0.00008095552,0.011988634,0.00024572926],"about_ca_topic_score_codex":0.025888862,"about_ca_topic_score_gemma":0.002744576,"teacher_disagreement_score":0.72987145,"about_ca_system_score_codex":0.0018440202,"about_ca_system_score_gemma":0.0037628226,"threshold_uncertainty_score":0.99993986},"labels":[],"label_agreement":null},{"id":"W4414490996","doi":"10.1158/2326-6074.cimm25-ia02","title":"Abstract IA02: Mechanisms of TCF1 regulation of stem-like T cells in cancer and autoimmunity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoimmunity; Cancer immunotherapy; Priming (agriculture); Immunotherapy; T cell; Tumor microenvironment; Cytotoxic T cell; Cancer; Peripheral tolerance","score_opus":0.06277460242488528,"score_gpt":0.39214207110304544,"score_spread":0.32936746867816014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414490996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649868,0.031604227,0.000023925235,0.0012567737,0.00036965136,0.0005872638,0.000036953694,0.000014010643,0.0011203984],"genre_scores_gemma":[0.9869888,0.009847273,0.000059635306,0.00007591018,0.000013009528,0.00012729976,0.0000066724924,0.000013702948,0.0028677296],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984409,0.00016971765,0.00049796066,0.0002686815,0.00027149584,0.0003512163],"domain_scores_gemma":[0.9987895,0.00023131522,0.00013244756,0.00044307747,0.00037399263,0.000029681845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011705982,0.00012802792,0.00045938033,0.0006473402,0.00007804443,0.0000070516376,0.00019455723,0.00024435166,0.00041647072],"category_scores_gemma":[0.000024186636,0.00011753771,0.00006938238,0.00090259645,0.0007903493,0.000070029295,0.0001225167,0.0005521042,0.0000015243307],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003586106,0.00015614094,0.0065950714,0.00048154223,0.00030451064,0.0000033947479,0.00046882467,0.000009525278,0.9111439,0.0007238974,0.0003443984,0.07618271],"study_design_scores_gemma":[0.0028895137,0.00026239458,0.50576615,0.00090359146,0.000027122589,0.0000026000334,0.0007384342,0.000051939962,0.48648277,0.0008669175,0.0019265572,0.000081997205],"about_ca_topic_score_codex":0.009680237,"about_ca_topic_score_gemma":0.00081565307,"teacher_disagreement_score":0.49917108,"about_ca_system_score_codex":0.00037738236,"about_ca_system_score_gemma":0.00096084276,"threshold_uncertainty_score":0.9969144},"labels":[],"label_agreement":null},{"id":"W4414491666","doi":"10.1158/2326-6074.cimm25-a021","title":"Abstract A021: Sumoylation blockade exposes the dark epigenome to drive ZBP1 viral mimicry for cancer immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Necroptosis; Innate immune system; Cancer immunotherapy; Epigenome; Effector; Cancer cell; SUMO protein; Chromatin","score_opus":0.039047621450065524,"score_gpt":0.3601640786472587,"score_spread":0.3211164571971932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9203952,0.067320056,0.0023505916,0.0030591472,0.0028793034,0.002284312,0.00022860363,0.0003607559,0.0011220244],"genre_scores_gemma":[0.9844767,0.009818076,0.00022012003,0.00032146127,0.00035893844,0.0032116428,0.000024688257,0.00013709588,0.0014313054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778265,0.000059141366,0.00043694355,0.00040131185,0.00028115773,0.0010388113],"domain_scores_gemma":[0.99814594,0.00065390964,0.00004852313,0.0007054452,0.00038286272,0.00006333699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062706525,0.00028924792,0.00036099678,0.00044610753,0.00044061372,0.00010002116,0.00091585715,0.00026654734,0.00017042736],"category_scores_gemma":[0.0000833774,0.00024190011,0.00013427592,0.00079288427,0.0003301598,0.00017371251,0.00012231882,0.0008034066,0.000035940157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057202874,0.000027370432,0.0009588495,0.00010757237,0.0007339977,0.0000025107602,0.0013619856,0.0048587956,0.91457754,0.00047166125,0.005871424,0.070456274],"study_design_scores_gemma":[0.0025336957,0.00027118524,0.036813453,0.00033892572,0.000056250337,0.0000022496126,0.0008500858,0.0006175126,0.54778844,0.006073891,0.40401158,0.00064274826],"about_ca_topic_score_codex":0.0007314806,"about_ca_topic_score_gemma":0.00060901616,"teacher_disagreement_score":0.39814016,"about_ca_system_score_codex":0.0011731948,"about_ca_system_score_gemma":0.00048048917,"threshold_uncertainty_score":0.98644},"labels":[],"label_agreement":null},{"id":"W4414491675","doi":"10.1158/2326-6074.cimm25-b009","title":"Abstract B009: Targeting PAR-2 improves tumor antigen presentation and primes the immune system for anti-PD-1 immunotherapy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Espace pour la vie","funders":"","keywords":"Immunotherapy; Immune system; Tumor microenvironment; Flow cytometry; Cancer; Myeloid; Cancer immunotherapy; Cytokine; Downregulation and upregulation","score_opus":0.03480508903454207,"score_gpt":0.38543541415212335,"score_spread":0.3506303251175813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7861344,0.20392147,0.00008337247,0.0055507114,0.0007978189,0.002449498,0.000030503132,0.0000910955,0.0009410936],"genre_scores_gemma":[0.98577785,0.010756272,0.00015797824,0.00021972127,0.00020319797,0.0010701197,0.000037672136,0.000044635883,0.0017325603],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99757904,0.00023474898,0.00059663015,0.0005242663,0.0003010974,0.00076419825],"domain_scores_gemma":[0.9979953,0.000669679,0.00017440933,0.00059907784,0.00051518914,0.000046298457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020049345,0.00024904733,0.000509746,0.0003293421,0.0009271264,0.00012367762,0.00033528593,0.00019308188,0.000074464595],"category_scores_gemma":[0.00017246128,0.00017510053,0.00018095937,0.0006039625,0.0010106286,0.00014511822,0.00013248583,0.00062459346,0.000005295213],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053312154,0.00008077266,0.0070124515,0.0005708154,0.0011974163,0.000010160301,0.00053303305,9.836309e-7,0.929844,0.0004116137,0.00243444,0.0525731],"study_design_scores_gemma":[0.0048815385,0.0003458643,0.50127816,0.000571497,0.000052805306,0.000034898567,0.003305384,0.00012345168,0.44783524,0.00011596335,0.041262392,0.0001928432],"about_ca_topic_score_codex":0.0014316508,"about_ca_topic_score_gemma":0.000019155346,"teacher_disagreement_score":0.49426568,"about_ca_system_score_codex":0.00033529507,"about_ca_system_score_gemma":0.0007847024,"threshold_uncertainty_score":0.71403927},"labels":[],"label_agreement":null},{"id":"W4414491700","doi":"10.1158/2326-6074.cimm25-b024","title":"Abstract B024: Tumor Resection Status Modulates Cardiometabolic Response to Imatinib in GIST","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Imatinib; GiST; Stromal tumor; Body mass index; Imatinib mesylate; Cholesterol; Cancer; Hemoglobin","score_opus":0.05933869661216293,"score_gpt":0.4414475311599105,"score_spread":0.3821088345477476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806069,0.0064296587,0.000009284024,0.0078020752,0.00017075363,0.001246108,0.000035694502,0.000053533557,0.0036459598],"genre_scores_gemma":[0.9946452,0.00045474607,0.00027061417,0.000111315465,0.00006026969,0.0010002692,0.000016838205,0.00002656248,0.0034142125],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965288,0.0005742024,0.00038340775,0.00057504105,0.0005565424,0.0013819764],"domain_scores_gemma":[0.997762,0.0006436028,0.000035233283,0.0006622885,0.0006261598,0.00027070803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002101267,0.0001926239,0.0004883684,0.0022880451,0.00020307297,0.000053823962,0.00023888102,0.00007744336,0.00028965675],"category_scores_gemma":[0.003100498,0.00016932731,0.00009490764,0.002501511,0.00041301784,0.000078363,0.0002680562,0.0011918853,0.00024588857],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09600999,0.00085418794,0.29456758,0.00035797883,0.0006188786,0.0025864851,0.0004700606,0.00014985882,0.5583372,0.00043629832,0.004144645,0.041466814],"study_design_scores_gemma":[0.0035076432,0.001676777,0.9590186,0.00054458925,0.000015497992,0.000096796204,0.00061538036,0.000049885715,0.023985058,0.0002818774,0.01010242,0.00010551344],"about_ca_topic_score_codex":0.0059231706,"about_ca_topic_score_gemma":0.0005596123,"teacher_disagreement_score":0.66445094,"about_ca_system_score_codex":0.0014891376,"about_ca_system_score_gemma":0.0016541911,"threshold_uncertainty_score":0.8954102},"labels":[],"label_agreement":null},{"id":"W4414491793","doi":"10.1158/2326-6074.cimm25-ia08","title":"Abstract IA08: Development and use of Engineered Regulatory T cells to treat Autoimmune Diseases","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Peripheral tolerance; Immune tolerance; Effector; T cell; Population; Immunotherapy; Antigen; Regulatory T cell","score_opus":0.06425826163130895,"score_gpt":0.3799349477968155,"score_spread":0.3156766861655066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803175,0.016157994,0.000010586185,0.0013706614,0.00016059019,0.00088356266,0.000026251018,0.00004713493,0.0010257731],"genre_scores_gemma":[0.9416598,0.0022169591,0.0003247299,0.00010946716,0.00004382759,0.00034027421,0.000020236337,0.000037625512,0.05524706],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99790424,0.00013613074,0.0003798575,0.00043674934,0.0004792623,0.0006637885],"domain_scores_gemma":[0.9979977,0.00055654556,0.000033265645,0.00071909727,0.0005201379,0.00017325627],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004995611,0.00017900478,0.00047891223,0.0009196588,0.000146487,0.000032220792,0.00024294184,0.00018220874,0.0014185273],"category_scores_gemma":[0.00020947916,0.00016264427,0.00006789103,0.0008148562,0.0005692166,0.00007405013,0.00033047266,0.00058698864,0.000033675893],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019885942,0.00018814017,0.0062912735,0.00036426558,0.0004437198,0.00004064031,0.0005110101,0.000017459497,0.88314384,0.00011401494,0.005143004,0.10175404],"study_design_scores_gemma":[0.0013593417,0.00017455379,0.47778124,0.00032108906,0.000029297984,0.0000041268777,0.00018011611,0.000012676095,0.4519066,0.000021423459,0.068103954,0.000105573075],"about_ca_topic_score_codex":0.00047462338,"about_ca_topic_score_gemma":0.00002640692,"teacher_disagreement_score":0.47148997,"about_ca_system_score_codex":0.000537126,"about_ca_system_score_gemma":0.0014194452,"threshold_uncertainty_score":0.9994943},"labels":[],"label_agreement":null},{"id":"W4414491827","doi":"10.1158/2326-6074.cimm25-pr-15","title":"Abstract PR-15: Neuroimmune dysregulation in ovarian cancer: the role of chronic stress on microglial activation and systemic inflammation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroinflammation; Inflammation; Microglia; Systemic inflammation; Immune system; Downregulation and upregulation; Ovarian cancer; Hormone; Chronic stress","score_opus":0.02160939953698773,"score_gpt":0.33929256730202645,"score_spread":0.31768316776503874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598357,0.03475009,0.000004934446,0.0036175342,0.00024041033,0.0010787189,0.000014792298,0.000018145325,0.0004396942],"genre_scores_gemma":[0.9901127,0.008545201,0.0000021035864,0.000027185382,0.00025337422,0.00040703002,0.000022858903,0.000019000547,0.000610525],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981524,0.00037764327,0.0004570169,0.00032719795,0.00029513496,0.00039061956],"domain_scores_gemma":[0.9985752,0.0004447318,0.00016598709,0.0004856179,0.00030202244,0.000026419033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007116481,0.0001602591,0.0003597495,0.0005874651,0.00019250378,0.000030391482,0.00021357754,0.00022004177,0.000070813374],"category_scores_gemma":[0.0001887676,0.00013031546,0.000053916872,0.00063081126,0.00047277482,0.00012505974,0.00007943916,0.0007373103,0.000003907059],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00433461,0.00008602209,0.01864043,0.00039479547,0.00013021304,0.0000047086496,0.000720262,0.00028420918,0.7909984,0.00047264624,0.0000597376,0.18387398],"study_design_scores_gemma":[0.002071005,0.00025559484,0.637076,0.0019787916,0.000026902351,0.000015179593,0.000830573,0.00046781448,0.35420847,0.00010566477,0.0028778918,0.0000860893],"about_ca_topic_score_codex":0.0050165267,"about_ca_topic_score_gemma":0.0006241889,"teacher_disagreement_score":0.6184356,"about_ca_system_score_codex":0.0008374392,"about_ca_system_score_gemma":0.0012107715,"threshold_uncertainty_score":0.7583521},"labels":[],"label_agreement":null},{"id":"W4414491842","doi":"10.1158/2326-6074.cimm25-b005","title":"Abstract B005: Tumor-derived extracellular vesicles induce intrinsic apoptosis of activated T cells by early transcriptional activation of cellular stress response genes","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Jurkat cells; Downregulation and upregulation; MAPK/ERK pathway; Cytotoxic T cell; ZAP70; Signal transduction; Transcriptome; Effector; p38 mitogen-activated protein kinases; T cell","score_opus":0.0251646552919913,"score_gpt":0.31365918411537197,"score_spread":0.28849452882338067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97576445,0.022536397,0.00036686403,0.00027066856,0.00019100538,0.0005224062,0.00025688828,0.00001764382,0.000073699004],"genre_scores_gemma":[0.9977023,0.001088607,0.000120312274,0.000023383556,0.00006249787,0.00014783323,0.0001742217,0.00004370843,0.000637163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99691737,0.0008024176,0.0006344787,0.00064498425,0.00043371803,0.00056703895],"domain_scores_gemma":[0.9979077,0.00022730659,0.00025954493,0.00078896736,0.0007229116,0.00009356945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097180635,0.00027211694,0.00038068884,0.00039566564,0.00016913791,0.000025007836,0.00075412524,0.00041939263,0.00013620603],"category_scores_gemma":[0.00025847423,0.0002982445,0.00017164052,0.00062356767,0.0010649957,0.000027865854,0.00022203512,0.00054670736,0.0000054496904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058456836,0.00050359406,0.001700142,0.00020903401,0.00044218113,0.000004235319,0.0001363596,0.00006207078,0.9861477,0.00008876698,0.0006084161,0.0042517968],"study_design_scores_gemma":[0.0012050702,0.000284209,0.023209205,0.00017532661,0.000033142238,6.018491e-7,0.00037860937,0.0000054005973,0.97238797,0.000090243244,0.00201638,0.00021386745],"about_ca_topic_score_codex":0.00026082096,"about_ca_topic_score_gemma":0.0000070209953,"teacher_disagreement_score":0.021937845,"about_ca_system_score_codex":0.00012017535,"about_ca_system_score_gemma":0.0007989145,"threshold_uncertainty_score":0.99994695},"labels":[],"label_agreement":null},{"id":"W4414491856","doi":"10.1158/2326-6074.cimm25-pr-08","title":"Abstract PR-08: Impact of gut microbiota on response to Bacillus Calmette-Guérin immunotherapy in bladder cancer: Towards a predictive molecular model","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Immunotherapy; Gut flora; Bladder cancer; Antibiotics; Bacteria; Probiotic; Cancer","score_opus":0.049512098751903516,"score_gpt":0.4361155299961281,"score_spread":0.3866034312442246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97609705,0.013054625,0.00008907865,0.0051088063,0.00020559673,0.0020222815,0.00055973494,0.000040824416,0.002822021],"genre_scores_gemma":[0.99275875,0.002210687,0.000103279184,0.00065238815,0.000040782717,0.0012814224,0.000018286788,0.0000634764,0.0028709297],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966699,0.0004417161,0.000567675,0.0007785432,0.00051165797,0.0010305179],"domain_scores_gemma":[0.99790466,0.00023593532,0.000087517474,0.000980933,0.0006331351,0.00015784522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009339917,0.00038740053,0.00082591746,0.0014051094,0.000117366646,0.000023388966,0.00049263425,0.00038998597,0.00066419673],"category_scores_gemma":[0.00022897946,0.0003254735,0.0002824645,0.0015202393,0.0004896708,0.0000742355,0.00019112055,0.0011681159,0.000036717494],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06343648,0.0007023228,0.0068411045,0.000080981605,0.0021966442,0.0001226011,0.0012409101,0.0036780678,0.88832676,0.00003337909,0.002797703,0.03054304],"study_design_scores_gemma":[0.013688539,0.0051443544,0.7996435,0.0012524761,0.000103600694,0.0000146234115,0.00026838304,0.00057127967,0.17719479,0.00026623558,0.0014726721,0.00037953924],"about_ca_topic_score_codex":0.014111121,"about_ca_topic_score_gemma":0.00030743866,"teacher_disagreement_score":0.7928024,"about_ca_system_score_codex":0.003206398,"about_ca_system_score_gemma":0.005969831,"threshold_uncertainty_score":0.9999197},"labels":[],"label_agreement":null},{"id":"W4414491882","doi":"10.1158/2326-6074.cimm25-b019","title":"Abstract B019: CCR5 inhibition with leronlimab is associated with enhanced PD-L1 expression, ICI response, and long-term survival in metastatic TNBC.","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Attodyne (Canada)","funders":"","keywords":"Immunotherapy; Metastatic breast cancer; Clinical trial; Metastasis; Breast cancer; Adverse effect; Cancer; Antibody; Breast cancer metastasis","score_opus":0.05078881003570925,"score_gpt":0.3867239364335297,"score_spread":0.33593512639782047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98498654,0.009571912,0.000053109514,0.0035626465,0.00011454446,0.00093865866,0.000039158465,0.00004726743,0.0006861822],"genre_scores_gemma":[0.9938537,0.0023263136,0.000041433177,0.00032341166,0.000022495375,0.00040386236,0.000052537376,0.00003752417,0.0029387507],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99710065,0.00060462503,0.0004175662,0.0006209939,0.00051240326,0.00074375956],"domain_scores_gemma":[0.99808246,0.0007617699,0.00012749482,0.00048151283,0.0004674778,0.0000792974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016930315,0.00026747858,0.0005925574,0.00072405755,0.00023611645,0.000053139425,0.00016422986,0.00022370464,0.00048007202],"category_scores_gemma":[0.00024728742,0.00019860947,0.00005292719,0.0013160718,0.0010647522,0.00017302015,0.000099359124,0.0009799341,0.000006887439],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12089628,0.00049394416,0.064834,0.00022722663,0.0011096457,0.0003864534,0.0012812015,0.0000024537344,0.7980391,0.000014835738,0.00059238647,0.012122487],"study_design_scores_gemma":[0.011645471,0.0011438158,0.82196987,0.0026962569,0.000054937416,0.000022927843,0.000763266,0.0000033613344,0.16123517,0.00003258346,0.00024307393,0.0001892903],"about_ca_topic_score_codex":0.0005234728,"about_ca_topic_score_gemma":0.001535733,"teacher_disagreement_score":0.75713587,"about_ca_system_score_codex":0.00075353927,"about_ca_system_score_gemma":0.0014145616,"threshold_uncertainty_score":0.80990595},"labels":[],"label_agreement":null},{"id":"W4414491888","doi":"10.1158/2326-6074.cimm25-b015","title":"Abstract B015: 3D Organoid-Based Therapeutics with Translational Potential in Cancer Immunity and Autoimmune Risk Prediction","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Cancer immunotherapy; Organoid; Immunotherapy; Immune checkpoint; Immune system; Immunity; Precision medicine; Ipilimumab","score_opus":0.026583111330941735,"score_gpt":0.31514172776611266,"score_spread":0.28855861643517094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625848,0.032769334,0.0023770034,0.0004109737,0.00057255,0.00050161686,0.00019735449,0.0001581479,0.0004282023],"genre_scores_gemma":[0.99014485,0.009103682,0.00020155073,0.00003451952,0.000047612415,0.0002762998,0.00003276252,0.000046326066,0.00011236959],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99845576,0.000094804636,0.000331386,0.00026798368,0.00028711325,0.0005629388],"domain_scores_gemma":[0.9991621,0.00021004133,0.00003992535,0.00033924307,0.00021287981,0.000035848567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004983517,0.00021253736,0.0002668515,0.0005137722,0.000260208,0.00004783523,0.0002761915,0.00027765473,0.000228663],"category_scores_gemma":[0.000016046464,0.00019740155,0.000034056644,0.00087285845,0.0004671148,0.0001787071,0.00003823305,0.0014439251,0.000004746178],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002243312,0.00019920673,0.121312186,0.00042352817,0.0014467597,0.000025507907,0.0012722433,0.14327164,0.5724311,0.00014769532,0.00015766242,0.15706916],"study_design_scores_gemma":[0.0050221044,0.00017442882,0.9064887,0.00039525755,0.00009141836,0.0000036206923,0.0002373918,0.043903,0.03810992,0.00074372714,0.004494828,0.00033556912],"about_ca_topic_score_codex":0.00199176,"about_ca_topic_score_gemma":0.0014268693,"teacher_disagreement_score":0.7851765,"about_ca_system_score_codex":0.00051273144,"about_ca_system_score_gemma":0.0006331976,"threshold_uncertainty_score":0.80498016},"labels":[],"label_agreement":null},{"id":"W4414491893","doi":"10.1158/2326-6074.cimm25-pr-06","title":"Abstract PR-06: Disrupting TACI signaling to restore immune balance: harnessing translational opportunities at the intersection of cancer and autoimmunity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoimmunity; Immune system; Chronic lymphocytic leukemia; Autoantibody; Bruton's tyrosine kinase; Systemic lupus erythematosus; Cancer; Immune dysregulation; Gene knockdown","score_opus":0.13757882584727818,"score_gpt":0.44775759904405665,"score_spread":0.31017877319677845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92909837,0.048207004,0.000023521914,0.01939282,0.00022426611,0.00048864854,0.000061120336,0.000021449425,0.0024828047],"genre_scores_gemma":[0.97671556,0.0039896886,0.000054243148,0.00015153352,0.00011258369,0.00022935311,0.000044109962,0.00001740412,0.018685533],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99798423,0.0002451976,0.00043658543,0.000312433,0.000486201,0.00053538004],"domain_scores_gemma":[0.99819237,0.0007123475,0.000084558684,0.00031590226,0.0006124974,0.00008231036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014010891,0.00016299437,0.00037227923,0.0003303642,0.00084553944,0.000040247603,0.00026070967,0.0001484419,0.00062350766],"category_scores_gemma":[0.00020391894,0.00011843197,0.00009143494,0.0005412608,0.0012831527,0.00010181255,0.0003469593,0.0010767295,0.0000075046655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003623668,0.00010759337,0.12297388,0.0008116006,0.0006738449,0.000031568496,0.003058069,0.0001070934,0.70073205,0.0017423808,0.0011757447,0.16496249],"study_design_scores_gemma":[0.0011692592,0.0002079162,0.90928847,0.0019620406,0.000055136028,0.000030957985,0.0034683787,0.0005508705,0.051773697,0.00035267413,0.030968439,0.00017216465],"about_ca_topic_score_codex":0.0063690525,"about_ca_topic_score_gemma":0.0005144472,"teacher_disagreement_score":0.7863146,"about_ca_system_score_codex":0.00035627763,"about_ca_system_score_gemma":0.00093091227,"threshold_uncertainty_score":0.96281445},"labels":[],"label_agreement":null},{"id":"W4414491894","doi":"10.1158/2326-6074.cimm25-b002","title":"Abstract B002: Meta-Analysis of Neoantigens: Insights from the Cancer Epitope Database and Analysis Resource (CEDAR)","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Epitope; Human leukocyte antigen; Cancer; Gene; Colorectal cancer; Mutation; MHC class I; Major histocompatibility complex","score_opus":0.17940600139161,"score_gpt":0.45245536011773907,"score_spread":0.27304935872612907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68606895,0.2935744,0.000025228714,0.016218513,0.000059139333,0.00040573135,0.00097566604,0.000015359443,0.0026570212],"genre_scores_gemma":[0.9573339,0.03467419,0.00009178806,0.00088797015,0.00010170774,0.00027426114,0.00041086727,0.000018400378,0.0062069236],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9964772,0.0006566977,0.0005973095,0.0007803702,0.0008703495,0.00061810494],"domain_scores_gemma":[0.9952253,0.0024084277,0.00012946906,0.0013340871,0.0007675197,0.00013520286],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001208075,0.00024428545,0.0016211763,0.0015501153,0.0004957653,0.00005090304,0.0007218881,0.00019777927,0.0042576035],"category_scores_gemma":[0.00036367556,0.00014361805,0.0008995277,0.0058556153,0.0017944571,0.00008017313,0.0007226476,0.0012062566,0.000015695685],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020845076,0.00021199175,0.115970515,0.0001311009,0.7864047,0.00009186677,0.0009013792,0.0001241014,0.07113138,0.0016926177,0.008443313,0.012812516],"study_design_scores_gemma":[0.0006604498,0.00009111596,0.75050646,0.000052307856,0.15499915,0.0000013764603,0.0007136695,0.00067548774,0.012302907,0.0002499678,0.07956909,0.0001780322],"about_ca_topic_score_codex":0.0501216,"about_ca_topic_score_gemma":0.0075923265,"teacher_disagreement_score":0.6345359,"about_ca_system_score_codex":0.000112868234,"about_ca_system_score_gemma":0.00058891636,"threshold_uncertainty_score":0.99665266},"labels":[],"label_agreement":null},{"id":"W4414491903","doi":"10.1158/2326-6074.cimm25-ia01","title":"Abstract IA01: B cell checkpoints as regulators of tumor immunity and self-tolerance","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; TIGIT; Cancer immunotherapy; Immunity; Melanoma; B cell; Cancer; Immune checkpoint; Immunotherapy","score_opus":0.029520254604255947,"score_gpt":0.36995281460628293,"score_spread":0.340432560002027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94082844,0.043917704,0.0000017389323,0.0018395813,0.00030234575,0.00054997957,0.0000119257165,0.00004944737,0.012498862],"genre_scores_gemma":[0.98835754,0.0073710857,0.00008985328,0.00027023396,0.00004511124,0.00011627269,0.0000060566504,0.000022122758,0.0037217273],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816287,0.00017185218,0.00043101632,0.00038246563,0.0003126401,0.0005391784],"domain_scores_gemma":[0.9985122,0.00020393658,0.000110257075,0.0006817498,0.0004186566,0.000073179675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011093151,0.00018262037,0.0004685306,0.00043509147,0.00022691018,0.000019296536,0.0002996078,0.00020743016,0.0004728322],"category_scores_gemma":[0.000106784355,0.00016552312,0.00011342705,0.00082719006,0.00091261877,0.000082351544,0.00018584424,0.0008533694,0.00002087756],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007985974,0.00068883924,0.03286778,0.0010839495,0.00088247634,0.0000476662,0.0011353825,0.0000011162252,0.92423135,0.00032004953,0.0037678122,0.026987603],"study_design_scores_gemma":[0.0046671866,0.0004817077,0.5087386,0.0005854432,0.000050391434,0.000035683235,0.0010661336,0.000016344584,0.4638003,0.00041373522,0.019985396,0.00015912474],"about_ca_topic_score_codex":0.0024854522,"about_ca_topic_score_gemma":0.000055004977,"teacher_disagreement_score":0.47587076,"about_ca_system_score_codex":0.0003046147,"about_ca_system_score_gemma":0.0011712727,"threshold_uncertainty_score":0.6749837},"labels":[],"label_agreement":null},{"id":"W4414491946","doi":"10.1158/2326-6074.cimm25-b027","title":"Abstract B027: iSIGN panel identifies germ cell tumors via whole-proteome phage immunoprecipitation sequencing","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biomarker; Seminoma; Autoantibody; Antibody; Phage display; Antigen; Differential diagnosis; Cancer; Immunoprecipitation","score_opus":0.04663039989724286,"score_gpt":0.34755375773832153,"score_spread":0.30092335784107865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414491946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670284,0.026302483,0.00070681743,0.0005995131,0.0008367983,0.0005647384,0.00008031098,0.000024253042,0.0038567286],"genre_scores_gemma":[0.98879766,0.0037832935,0.00010845174,0.00020786034,0.00024729627,0.00042151395,0.00017382631,0.00003839418,0.0062217126],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977743,0.00018841369,0.00042362107,0.0006441753,0.0002398874,0.0007296135],"domain_scores_gemma":[0.9983623,0.00017656044,0.00012725119,0.00074173283,0.0005248287,0.00006734029],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093456835,0.00023235187,0.00026760125,0.0002962322,0.0004004863,0.00012526783,0.00063487916,0.00032810625,0.00013569914],"category_scores_gemma":[0.00031712666,0.0002497197,0.00012070563,0.00039239417,0.0004738623,0.000015288939,0.00043534613,0.00059245084,0.00010469818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022974714,0.000051296272,0.0007983853,0.0000888193,0.0001341516,0.000017239841,0.00019903804,0.00020009982,0.9865457,0.00007861907,0.004726729,0.00693017],"study_design_scores_gemma":[0.000973065,0.00020545088,0.019854153,0.00009652555,0.000020550882,0.0000068848613,0.0007471045,0.00005349043,0.95720714,0.0012947784,0.019256735,0.0002840901],"about_ca_topic_score_codex":0.001150311,"about_ca_topic_score_gemma":0.00020081991,"teacher_disagreement_score":0.029338533,"about_ca_system_score_codex":0.0003534707,"about_ca_system_score_gemma":0.0011646042,"threshold_uncertainty_score":0.9999955},"labels":[],"label_agreement":null},{"id":"W4414492330","doi":"10.1158/2326-6074.cimm25-a011","title":"Abstract A011: Tumor-derived Complement Factor B drives tumor growth and anti-PD-1 resistance in <i>STK11</i>-mutant lung adenocarcinoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Complement system; Immunotherapy; Immune system; CD8; Downregulation and upregulation; Alternative complement pathway; Adenocarcinoma; Transfection; CD59","score_opus":0.02575699047768508,"score_gpt":0.341683828428069,"score_spread":0.3159268379503839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94155264,0.053674135,0.0002814354,0.0015397095,0.00026312732,0.0010540402,0.00012892192,0.000026508573,0.0014794633],"genre_scores_gemma":[0.9931143,0.005341467,0.00014770954,0.00025894976,0.00008845016,0.00049710297,0.00006442093,0.000054087915,0.0004334926],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99609554,0.00046839344,0.00052574225,0.001140213,0.00047807512,0.0012920508],"domain_scores_gemma":[0.9984326,0.00011911822,0.00010423739,0.00078454777,0.0004120014,0.00014750927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066303357,0.00034638305,0.0004674241,0.0005902102,0.00034878292,0.00009736391,0.000799267,0.00027268037,0.00017456607],"category_scores_gemma":[0.00032785637,0.00036199647,0.00010172525,0.00076212967,0.0008452768,0.000016805954,0.000960883,0.0011377098,0.000010061965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076592516,0.00009741248,0.007985027,0.00022836453,0.00025728927,0.0001532268,0.00015140542,0.00000815304,0.9880324,0.0007715734,0.0011732231,0.0003759873],"study_design_scores_gemma":[0.00220788,0.00017099951,0.14866704,0.00026754744,0.000013332494,0.000014791078,0.0004121218,0.000027891867,0.8426453,0.00033901044,0.004900699,0.00033340443],"about_ca_topic_score_codex":0.0006852657,"about_ca_topic_score_gemma":0.0014124586,"teacher_disagreement_score":0.14538713,"about_ca_system_score_codex":0.00033739404,"about_ca_system_score_gemma":0.0011071949,"threshold_uncertainty_score":0.9998832},"labels":[],"label_agreement":null},{"id":"W4414492800","doi":"10.1158/2326-6074.cimm25-b025","title":"Abstract B025: An agentic platform for designing cancer immunotherapies: From automated variant interpretation to in silico therapeutic validation","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"In silico; CRISPR; Workflow; Precision medicine; Adept; Bottleneck; Mechanism (biology); Cancer","score_opus":0.11748728624943236,"score_gpt":0.4718240936813109,"score_spread":0.35433680743187856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824197,0.009400778,0.0011307048,0.004308326,0.00038550643,0.0017591525,0.0000788007,0.00011008654,0.0004069181],"genre_scores_gemma":[0.9937793,0.0015642554,0.00039012145,0.0005960234,0.00010860413,0.0017619891,0.00016624274,0.000034508605,0.0015989545],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976892,0.00021144995,0.0004603083,0.00052765856,0.00036716508,0.00074420846],"domain_scores_gemma":[0.99811256,0.0008264381,0.000058268448,0.00038857912,0.00051619037,0.00009796196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010929919,0.00019771056,0.00040816155,0.00083853176,0.00026220828,0.0000841176,0.00036949295,0.00022981832,0.0007078547],"category_scores_gemma":[0.00019338504,0.00017221998,0.00008649189,0.0008447404,0.0002165248,0.00020096303,0.000106777734,0.0006641378,0.00004167517],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010197045,0.00029521695,0.012725486,0.0002383516,0.0008707242,0.00003088266,0.004095427,0.00028094128,0.8116049,0.00052889186,0.0005633069,0.15856881],"study_design_scores_gemma":[0.0059213075,0.0014020388,0.65702647,0.002240208,0.000102824924,0.000008673978,0.0026404432,0.031344004,0.2849512,0.0046798023,0.0092055835,0.0004774176],"about_ca_topic_score_codex":0.012401441,"about_ca_topic_score_gemma":0.0011473225,"teacher_disagreement_score":0.644301,"about_ca_system_score_codex":0.0007069054,"about_ca_system_score_gemma":0.00085522706,"threshold_uncertainty_score":0.9941751},"labels":[],"label_agreement":null},{"id":"W4414492857","doi":"10.1158/2326-6074.cimm25-a003","title":"Abstract A003: Identification of immunomodulatory compounds by high-throughput proteomics: Insights from quantification of 1000 proteins in a 20,000 sample screen","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Immune system; Proteomics; Identification (biology); Drug discovery; Immunotherapy; Quantitative proteomics; Label-free quantification; Leverage (statistics); In vitro","score_opus":0.0721455010753637,"score_gpt":0.41212643617966,"score_spread":0.3399809351042963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851389,0.009189581,0.0010575113,0.0007373763,0.00016396426,0.0026901239,0.0003749018,0.000034557623,0.0006130905],"genre_scores_gemma":[0.99675256,0.00077795936,0.00026503863,0.000022851991,0.00004280435,0.0011239545,0.00034575243,0.00003204797,0.000637017],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99630076,0.0006450111,0.0012629875,0.0006460456,0.0006554796,0.00048972457],"domain_scores_gemma":[0.9963801,0.0005304327,0.00031796528,0.00130868,0.001402676,0.000060150338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001465855,0.00020007101,0.00064176496,0.0014565894,0.00018717481,0.00003780395,0.0005638038,0.00039686493,0.00026702313],"category_scores_gemma":[0.0006732416,0.00019779097,0.00009355121,0.0019352247,0.0013632065,0.000278385,0.00021225723,0.0011965754,0.000036074256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013367849,0.0006469459,0.033406783,0.00024211676,0.00031289426,0.0000028009047,0.00023003799,0.000044303015,0.95646065,0.0013331461,0.0009208735,0.0050626877],"study_design_scores_gemma":[0.001484607,0.00024747307,0.39187884,0.00031964417,0.000015383408,5.54927e-7,0.00017748501,0.000115024995,0.6025786,0.0012002337,0.00189057,0.000091571485],"about_ca_topic_score_codex":0.04582043,"about_ca_topic_score_gemma":0.000991782,"teacher_disagreement_score":0.35847208,"about_ca_system_score_codex":0.00087258377,"about_ca_system_score_gemma":0.0014051826,"threshold_uncertainty_score":0.96053356},"labels":[],"label_agreement":null},{"id":"W4414492865","doi":"10.1158/2326-6074.cimm25-b006","title":"Abstract B006: Immunosuppressive γδ T cells limit anti-tumor immunity in ICI-resistant tumors from autoimmune-prone mice","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autoimmunity; Immune system; Immunotherapy; Immunity; T cell; Nod; Tumor microenvironment; Genetic predisposition; Phenotype","score_opus":0.04207406639913272,"score_gpt":0.3629962655184762,"score_spread":0.3209221991193435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.904387,0.08391209,0.0000067811116,0.0032037252,0.0011502096,0.0014886898,0.00018440999,0.00012650914,0.0055405935],"genre_scores_gemma":[0.9872568,0.007488435,0.00008971008,0.0006379886,0.00013128814,0.0006323082,0.00012714663,0.00008073347,0.0035555493],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.994584,0.00074305024,0.0012640475,0.0010478414,0.0007073089,0.0016537108],"domain_scores_gemma":[0.9961811,0.0010241977,0.00027846041,0.0017431526,0.00064739777,0.0001256921],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018433762,0.00054694136,0.001254423,0.0012861677,0.000572366,0.00011815,0.001252565,0.0005209458,0.0021572174],"category_scores_gemma":[0.00033111288,0.00051469577,0.00032933845,0.0021156478,0.0017884609,0.00024935845,0.0005985112,0.0031883977,0.00017606169],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013285885,0.00071328686,0.0067122863,0.00022215862,0.0011482838,0.00044019762,0.0008146505,0.000011223805,0.9614994,0.00008006791,0.0036582958,0.01141427],"study_design_scores_gemma":[0.007068012,0.00038132808,0.6168175,0.0020210939,0.000072376984,0.000015952275,0.0024162128,0.000051010713,0.35559255,0.00024469412,0.014917818,0.00040148795],"about_ca_topic_score_codex":0.03569729,"about_ca_topic_score_gemma":0.0009260206,"teacher_disagreement_score":0.61010516,"about_ca_system_score_codex":0.0016934886,"about_ca_system_score_gemma":0.0026232079,"threshold_uncertainty_score":0.99973047},"labels":[],"label_agreement":null},{"id":"W4414492908","doi":"10.1158/2326-6074.cimm25-b021","title":"Abstract B021: Multi-functional telodendrimer nanodrug: Nanocarrier for ovarian cancer treatment and immunomodulator to control inflammation and sensitize the tumor","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Dendrimers and Hyperbranched Polymers","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Proinflammatory cytokine; Inflammation; TLR2; Ovarian cancer; Immune system; Autocrine signalling; Nanocarriers; TLR4; Ovarian tumor","score_opus":0.04545716927208186,"score_gpt":0.35485480440199646,"score_spread":0.3093976351299146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414492908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97429067,0.015599896,0.00020193229,0.0072882054,0.0010447314,0.0011762241,0.00018740221,0.000029189892,0.00018175268],"genre_scores_gemma":[0.99401253,0.0003861274,0.00015558161,0.00031203046,0.0001741871,0.0015159381,0.000007715889,0.00002101068,0.0034148942],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983424,0.00017426813,0.0002681236,0.00048391192,0.00016871138,0.00056259],"domain_scores_gemma":[0.9987988,0.00041963378,0.00006276958,0.00032543257,0.00031039788,0.00008295303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007195818,0.00019341825,0.0003011666,0.00018748887,0.0007614064,0.00014983813,0.00017516127,0.000113043185,0.00032250673],"category_scores_gemma":[0.00010269414,0.00013736253,0.00005214557,0.00021226196,0.0005743276,0.00013107558,0.00010349067,0.00018996892,0.000024282728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009183777,0.000025982145,0.0012742579,0.000027109121,0.00022459016,0.0000032491698,0.00071496,0.000053980126,0.9790682,0.0007266933,0.00077953585,0.01618304],"study_design_scores_gemma":[0.0061354376,0.00022525346,0.16370176,0.000111079746,0.000111440284,0.000019691332,0.00074099115,0.00038041172,0.76802784,0.0001765281,0.06006667,0.00030292178],"about_ca_topic_score_codex":0.0034488395,"about_ca_topic_score_gemma":0.0008116843,"teacher_disagreement_score":0.2110404,"about_ca_system_score_codex":0.00027022613,"about_ca_system_score_gemma":0.00057962077,"threshold_uncertainty_score":0.5856199},"labels":[],"label_agreement":null},{"id":"W4414493011","doi":"10.1158/2326-6074.cimm25-a016","title":"Abstract A016: KRASG12D inhibition enhances tumor cell sensitivity to natural killer cell-mediated cytotoxicity","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tumor microenvironment; Immunotherapy; Immune system; Natural killer cell; Cancer immunotherapy; Lymphokine-activated killer cell; Cancer; Immunosuppression; Flow cytometry; Cytotoxicity","score_opus":0.01809014768180236,"score_gpt":0.34952513686847375,"score_spread":0.3314349891866714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414493011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891184,0.0027077121,0.00015546699,0.0015652406,0.001098075,0.0006602504,0.000060059305,0.000035179473,0.004599611],"genre_scores_gemma":[0.9902495,0.0004304129,0.00010610695,0.00051852973,0.00020368634,0.00045975603,0.00012857624,0.00002448615,0.00787896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99774057,0.00038493663,0.00028101666,0.0006641681,0.0002339933,0.0006952914],"domain_scores_gemma":[0.99858415,0.00018862884,0.00007538164,0.00053839077,0.00052410096,0.00008937601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006737164,0.000211894,0.00022616227,0.000291927,0.00033974572,0.000053738633,0.00025416605,0.0002651725,0.00023380792],"category_scores_gemma":[0.00044742643,0.00021236579,0.000101457605,0.00050512474,0.0003515309,0.000015514559,0.00043452007,0.000926817,0.00027679026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004097861,0.00013892978,0.00048380267,0.00004751441,0.00007003064,0.000023368186,0.000057680056,0.000021143036,0.9803981,0.000013114075,0.01782147,0.00051503925],"study_design_scores_gemma":[0.0005119946,0.00016519889,0.014273659,0.00006862926,0.0000066835387,0.00000725013,0.00018242834,0.0000135359705,0.9603989,0.000039405786,0.024140637,0.00019164964],"about_ca_topic_score_codex":0.0006076171,"about_ca_topic_score_gemma":0.000677057,"teacher_disagreement_score":0.019999195,"about_ca_system_score_codex":0.0002254869,"about_ca_system_score_gemma":0.00052766444,"threshold_uncertainty_score":0.86600256},"labels":[],"label_agreement":null},{"id":"W4414493055","doi":"10.1158/2326-6074.cimm25-a012","title":"Abstract A012: Cancer acquires therapy resistance by converting immune infiltration to exclusion through NK cell-macrophage interactions","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immune system; Immunotherapy; Tumor microenvironment; Melanoma; Innate immune system; Crosstalk; Immunoediting; Cancer; Cancer immunotherapy","score_opus":0.04525560702644258,"score_gpt":0.39722058720615167,"score_spread":0.35196498017970906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414493055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55723345,0.40875044,0.00031973948,0.007502992,0.006774769,0.001439638,0.00016148,0.0002025583,0.0176149],"genre_scores_gemma":[0.87776506,0.03951617,0.00006828007,0.001131409,0.00011142454,0.0016746209,0.00013542785,0.000070718146,0.07952689],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995527,0.0008188056,0.000942086,0.0010257824,0.00019638528,0.0014899248],"domain_scores_gemma":[0.99682015,0.00091671536,0.000264112,0.0011388861,0.0008172036,0.000042947177],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010909631,0.00046423683,0.00065387296,0.0004966612,0.0015936017,0.00009575353,0.0012872451,0.00064769905,0.006542036],"category_scores_gemma":[0.00025289753,0.0004542722,0.00018136033,0.0013610573,0.0011630642,0.0004607034,0.0006443035,0.0022032931,0.00074637204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021219542,0.00020559329,0.00042791854,0.0000899069,0.00042459034,0.000006118642,0.0018229845,0.000030944386,0.8550678,0.00023429202,0.11797537,0.021592507],"study_design_scores_gemma":[0.0014478909,0.00008208856,0.0034288776,0.0003453516,0.000014735502,0.000002476036,0.0006491926,0.0000015601611,0.5934055,0.00017076133,0.400201,0.00025058287],"about_ca_topic_score_codex":0.0057491204,"about_ca_topic_score_gemma":0.0008712169,"teacher_disagreement_score":0.3692343,"about_ca_system_score_codex":0.0012878783,"about_ca_system_score_gemma":0.0009227074,"threshold_uncertainty_score":0.9997909},"labels":[],"label_agreement":null},{"id":"W4416548268","doi":"10.1158/2326-6066.cir-25-0445","title":"Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Canada's Michael Smith Genome Sciences Centre; Spinal Cord Injury BC; University of British Columbia; Terry Fox Research Institute; BC Cancer Agency","funders":"BC Cancer Foundation; Canada Research Chairs; Canadian Cancer Society; Michael Smith Health Research BC; Terry Fox Research Institute; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Flow cytometry; Lymph node; Phenotype; Lymphoma; Cytotoxic T cell; Population; Immunophenotyping; Diffuse large B-cell lymphoma; T cell; Transcriptome","score_opus":0.02971413439104169,"score_gpt":0.38436654717757895,"score_spread":0.35465241278653725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416548268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011844,0.0065560495,0.00003166673,0.00048103655,0.00014696314,0.00145102,0.000044259403,0.000024418305,0.0011461505],"genre_scores_gemma":[0.9706055,0.005098554,0.000011670334,0.000041115083,0.00005709829,0.00027808113,0.000047139645,0.00003340253,0.02382742],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974026,0.0004997236,0.0004012155,0.0004548687,0.0004179448,0.0008236348],"domain_scores_gemma":[0.9984474,0.00038645967,0.00006915244,0.0005606918,0.00043073163,0.00010555314],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010535344,0.0001849098,0.00050864316,0.001073857,0.00010363147,0.000029533656,0.00026558666,0.0002479786,0.0013355372],"category_scores_gemma":[0.00022881932,0.00016399051,0.00007446022,0.0011594567,0.00051331084,0.00009023839,0.00032205632,0.00057784264,0.00003094403],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019078226,0.0014737098,0.06697901,0.0003395458,0.00016779611,0.000052601696,0.0008026561,0.0000010172265,0.88812965,0.00004125688,0.00022619416,0.039878722],"study_design_scores_gemma":[0.013461799,0.0007345654,0.6317052,0.00030882403,0.000027266091,0.0000090911,0.00023679472,0.00015743481,0.35148665,0.000060139595,0.0016981811,0.0001140084],"about_ca_topic_score_codex":0.0017669401,"about_ca_topic_score_gemma":0.0001253289,"teacher_disagreement_score":0.56472623,"about_ca_system_score_codex":0.00075152674,"about_ca_system_score_gemma":0.0013074725,"threshold_uncertainty_score":0.9995774},"labels":[],"label_agreement":null},{"id":"W4417129324","doi":"10.1158/2326-6066.cir-25-0070","title":"A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; McMaster University Medical Centre","funders":"Institute of Cancer Research; Terry Fox Foundation; Canada Research Chairs","keywords":"Boosting (machine learning); Antigen; Chimeric antigen receptor; Adoptive cell transfer; Cytotoxic T cell; Epitope; Immunotherapy; Cancer immunotherapy","score_opus":0.1669757946377332,"score_gpt":0.44288927577131776,"score_spread":0.27591348113358455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417129324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96825784,0.020806085,0.00048991665,0.0018737466,0.00036515595,0.0027894212,0.000037737736,0.00010247502,0.0052776355],"genre_scores_gemma":[0.93677354,0.012277675,0.0013189516,0.00030262885,0.0004525652,0.0006023048,0.000083836814,0.00013027414,0.048058253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966863,0.00054730923,0.00036316048,0.00070667564,0.0004263774,0.0012701993],"domain_scores_gemma":[0.99717945,0.00071314396,0.00008351064,0.00064287527,0.0012467963,0.00013423276],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013301707,0.00026496808,0.0005782261,0.0008939781,0.00054321904,0.000059666185,0.0004705526,0.00032491592,0.002776491],"category_scores_gemma":[0.00019749331,0.00024830727,0.0001960917,0.0017381279,0.00045508295,0.000116997115,0.00022020465,0.0011759585,0.000028572804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008959454,0.00024202901,0.008065829,0.000102303435,0.0007487063,0.000025312691,0.0005308835,0.000038075494,0.89037526,0.00015581335,0.0043301904,0.08642616],"study_design_scores_gemma":[0.03142487,0.0063185575,0.022767255,0.0008064578,0.00012657871,0.000048695016,0.010912823,0.0059625343,0.6463122,0.00058730075,0.27389824,0.00083446415],"about_ca_topic_score_codex":0.0016015321,"about_ca_topic_score_gemma":0.00004504729,"teacher_disagreement_score":0.26956806,"about_ca_system_score_codex":0.0010429347,"about_ca_system_score_gemma":0.003168024,"threshold_uncertainty_score":0.9999969},"labels":[],"label_agreement":null},{"id":"W7083170942","doi":"10.1158/2326-6074.cimm25-a010","title":"Abstract A010: B cell infiltration and clonal expansion in tertiary lymphoid structures: Insights from intravital microscopy","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Agriculture, Water, and Health","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"High endothelial venules; Immune system; Lymph; Lymphatic system; B cell; Intravital microscopy; Infiltration (HVAC); Tumor microenvironment; Lymphocyte","score_opus":0.014596035716897493,"score_gpt":0.32404795399174047,"score_spread":0.309451918274843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7083170942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933553,0.004290394,0.0000144031455,0.00040585865,0.00023197677,0.00028711505,0.00002325954,0.000014130899,0.0013775715],"genre_scores_gemma":[0.9973342,0.0019352823,0.00009125124,0.0002428886,0.000053231946,0.0000582763,0.00005752698,0.0000067485907,0.00022062904],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985322,0.0001520247,0.00023902598,0.00042484683,0.00020819934,0.00044371004],"domain_scores_gemma":[0.99957156,0.00011427432,0.000038006037,0.00019577458,0.000020618942,0.00005975128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019375578,0.00012996267,0.00015658242,0.00011705744,0.00027200388,0.000041616542,0.0002438397,0.00024181105,0.0004643759],"category_scores_gemma":[0.00001539041,0.00009975686,0.00001956044,0.0002746795,0.00041742163,0.00020450461,0.00024699347,0.00056338625,0.000054546133],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001570494,0.00007514922,0.29177684,0.000023338423,0.000010897295,0.000010700847,0.0019012121,0.000018573593,0.69921136,0.00012750611,0.0014683681,0.00521903],"study_design_scores_gemma":[0.0007202199,0.000045537374,0.9058583,0.00003799974,0.0000025234795,0.0000021000524,0.0006695981,0.000023593127,0.085913025,0.0052963514,0.001334149,0.00009660193],"about_ca_topic_score_codex":0.010750453,"about_ca_topic_score_gemma":0.00436185,"teacher_disagreement_score":0.61408144,"about_ca_system_score_codex":0.00047073877,"about_ca_system_score_gemma":0.00012566545,"threshold_uncertainty_score":0.99583703},"labels":[],"label_agreement":null},{"id":"W7083171088","doi":"10.1158/2326-6074.cimm25-a005","title":"Abstract A005: TAZ-TEAD signaling alters the immune microenvironment of cutaneous melanoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Hippo pathway signaling and YAP/TAZ","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Melanoma; Immune checkpoint; Immune system; Tumor microenvironment; Downregulation and upregulation; Immunotherapy; Galectin-1; Galectin; Transcription factor","score_opus":0.0263870912666626,"score_gpt":0.32734256560252073,"score_spread":0.3009554743358581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7083171088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561403,0.04085379,0.00007413083,0.0009863741,0.00027493443,0.00028781494,0.000033860037,0.000009570322,0.0013392671],"genre_scores_gemma":[0.99375355,0.003050043,0.00004982552,0.00010782273,0.000102082304,0.00011381942,0.000039812043,0.00002222981,0.0027608252],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981518,0.0002772427,0.00036430373,0.00042123816,0.0002141978,0.00057122554],"domain_scores_gemma":[0.99887353,0.00013554934,0.00009524721,0.0007105565,0.00014477524,0.000040342322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078403833,0.00017205717,0.000242217,0.00012822848,0.000295137,0.000022115431,0.0007109899,0.00024456385,0.00017251215],"category_scores_gemma":[0.00010949557,0.00013637962,0.00013526427,0.000214366,0.0008646839,0.0000029546202,0.0003258902,0.0005326467,0.00003253929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032091737,0.000069196,0.0007410438,0.000040175237,0.00034368085,0.000013823948,0.00014274174,0.0002819488,0.98883265,0.0000874834,0.00028388784,0.008842427],"study_design_scores_gemma":[0.00043770624,0.00030808937,0.001876918,0.00009169047,0.000019685836,0.000018233783,0.00045124354,0.000013983683,0.9688734,0.00010801619,0.027678248,0.00012279979],"about_ca_topic_score_codex":0.00036778214,"about_ca_topic_score_gemma":0.000032337553,"teacher_disagreement_score":0.037803747,"about_ca_system_score_codex":0.00008236539,"about_ca_system_score_gemma":0.00034181974,"threshold_uncertainty_score":0.55613995},"labels":[],"label_agreement":null},{"id":"W7117449343","doi":"10.1158/2326-6066.cir-25-0583","title":"The CCL17–CCR4 Axis Is Critical for Mutant STAT6-Mediated Microenvironmental Remodeling and Therapeutic Resistance in Relapsed/Refractory Diffuse Large B-Cell Lymphoma","year":2025,"lang":"en","type":"article","venue":"Cancer Immunology Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University; Jewish General Hospital","funders":"Cole Foundation; Canadian Cancer Society; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Lymphoma; Infiltration (HVAC); Chemokine; STAT protein; Ex vivo; In vivo; Chemokine receptor; Mutant; Doxorubicin; STAT3","score_opus":0.033104659551749814,"score_gpt":0.3643765976180743,"score_spread":0.3312719380663245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117449343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84953827,0.13718304,0.000014940997,0.011593949,0.00014885433,0.00088774617,0.00012709382,0.000019089737,0.0004870473],"genre_scores_gemma":[0.9709211,0.024963828,0.000084327454,0.00078566215,0.000032464854,0.0008961572,0.00002046145,0.00002955076,0.0022664769],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99763626,0.00026039864,0.00037603494,0.00055450056,0.0002681977,0.00090461876],"domain_scores_gemma":[0.99708337,0.0021268222,0.000041016865,0.0005219756,0.00013626527,0.0000905599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007416373,0.00020214437,0.00035541426,0.00020594486,0.00054775865,0.00004478127,0.00020288126,0.00021473468,0.000038631275],"category_scores_gemma":[0.00027240574,0.00014510532,0.00008185477,0.00029393518,0.00082394126,0.000038808677,0.000174001,0.00035153443,0.000016830998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04383132,0.040268965,0.25828862,0.0018861761,0.0029928624,0.0009725266,0.010414519,0.0000024989822,0.39351735,0.017808614,0.018509792,0.21150677],"study_design_scores_gemma":[0.116868965,0.001997611,0.35564452,0.0012743734,0.00033227404,0.00004144604,0.0076942327,0.0016382746,0.0617357,0.0051924386,0.44691405,0.0006660977],"about_ca_topic_score_codex":0.00019808745,"about_ca_topic_score_gemma":0.00029708052,"teacher_disagreement_score":0.42840424,"about_ca_system_score_codex":0.0012418109,"about_ca_system_score_gemma":0.0005093826,"threshold_uncertainty_score":0.5917223},"labels":[],"label_agreement":null}]}